File No. 811-04347
As filed with the Securities and Exchange Commission on June 26, 2015
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM N-1A
REGISTRATION STATEMENT
UNDER
THE INVESTMENT COMPANY ACT OF 1940
Amendment No. 228 | x |
(Check appropriate box or boxes)
GMO Trust
(Exact name of registrant as specified in charter)
40 Rowes Wharf, Boston, Massachusetts 02110
(Address of principal executive offices)
(617) 330-7500
(Registrants Telephone Number, including Area Code)
J.B. Kittredge, Esq.
GMO Trust
40 Rowes Wharf
Boston, Massachusetts 02110
(Name and address of agent for service)
with a copy to:
Thomas R. Hiller, Esq.
Ropes & Gray LLP
Prudential Tower
800 Boylston Street
Boston, Massachusetts 02199
It is intended that this filing become effective immediately upon filing in accordance with Section 8 of the Investment Company Act of 1940.
THIS FILING RELATES SOLELY TO GMO GAAR IMPLEMENTATION FUND, GMO HIGH QUALITY SHORT-DURATION BOND FUND, GMO SYSTEMATIC GLOBAL MACRO OPPORTUNITY FUND, AND GMO WORLD OPPORTUNITY OVERLAY FUND. NO INFORMATION CONTAINED HEREIN IS INTENDED TO AMEND OR SUPERSEDE ANY PRIOR FILING RELATING TO ANY OTHER SERIES OF THE REGISTRANT.
GMO TRUST
PRIVATE PLACEMENT MEMORANDUM
June 26, 2015
GMO GAAR Implementation Fund |
GMO Systematic Global Macro Opportunity Fund Class III |
|
GMO High Quality Short-Duration Bond Fund Class III, Class VI |
GMO World Opportunity Overlay Fund |
Each of the funds listed above (each, a Fund, and collectively, the Funds) is a separate investment portfolio of GMO Trust (the Trust). The Trust is an open-end management investment company and operates as a series investment company that consists of separate series of investment portfolios, including the Funds. Other portfolios are described in separate prospectuses or private placement memoranda. At this time, the Funds do not intend to offer their shares publicly and do not intend to make their shares available other than to other funds of the Trust (GMO Funds) and certain other accredited investors.
Investment Manager
Grantham, Mayo, Van Otterloo & Co. LLC
40 Rowes Wharf Boston, Massachusetts 02110
This Private Placement Memorandum concisely describes the information which you ought to know about the Funds before investing. Please read this memorandum carefully and keep it for further reference. A Statement of Additional Information dated June 26, 2015, as revised from time to time (SAI), is available free of charge by writing to GMO Shareholder Services, 40 Rowes Wharf, Boston, Massachusetts 02110 or by calling 1-617-346-7646. The SAI, which contains more detailed information about the Funds, has been filed with the Securities and Exchange Commission (SEC) and is incorporated by reference into this Private Placement Memorandum.
THE SECURITIES AND EXCHANGE COMMISSION AND THE COMMODITY FUTURES TRADING COMMISSION HAVE NOT APPROVED OR DISAPPROVED THESE SECURITIES OR PASSED UPON THE ADEQUACY OF THIS PRIVATE PLACEMENT MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE TRANSFERRED OR RESOLD UNLESS SO REGISTERED OR IN TRANSACTIONS EXEMPT THEREFROM. HOWEVER, THE SECURITIES ARE REDEEMABLE AS DESCRIBED IN THIS PRIVATE PLACEMENT MEMORANDUM. IN CERTAIN CASES INVESTORS MAY BE REDEEMED IN-KIND AND RECEIVE PORTFOLIO SECURITIES HELD BY THE FUNDS IN LIEU OF CASH UPON REDEMPTION.
THIS PRIVATE PLACEMENT MEMORANDUM AND THE INFORMATION CONTAINED HEREIN ARE FOR THE EXCLUSIVE USE OF THE RECIPIENT FOR THE SOLE PURPOSE OF EVALUATING THE PRIVATE PLACEMENT OF SHARES OF THE FUNDS DESCRIBED HEREIN. IT MAY NOT BE REPRODUCED, PROVIDED, OR DISCLOSED TO OTHERS, OR USED FOR ANY OTHER PURPOSE, WITHOUT WRITTEN AUTHORIZATION, AND DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY SHARES OF THE FUNDS TO
ANY ENTITY OR INDIVIDUAL NOT POSSESSING THE QUALIFICATIONS DESCRIBED IN THIS MEMORANDUM.
NO PERSON HAS BEEN AUTHORIZED TO MAKE ANY REPRESENTATIONS OR PROVIDE ANY INFORMATION WITH RESPECT TO THE SHARES EXCEPT SUCH INFORMATION AS IS CONTAINED IN THIS MEMORANDUM AND IN THE SAI OR IN OTHER MATERIALS APPROVED BY THE TRUST. NO SALES MADE IN RELIANCE ON THIS DOCUMENT SHALL UNDER ANY CIRCUMSTANCES CREATE AN IMPLICATION THAT THERE HAS BEEN NO CHANGE IN MATTERS DISCUSSED HEREIN SINCE THE DATE HEREOF.
GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC (GMO) IS NOT OFFERING OR PLACING INTERESTS IN THE SERIES OF GMO TRUST SET FORTH ABOVE (EACH A FUND, AND COLLECTIVELY, THE FUNDS) TO OR WITH OR OTHERWISE PROMOTING THE FUNDS TO ANY NATURAL OR LEGAL PERSONS DOMICILED OR WITH A REGISTERED OFFICE IN ANY EUROPEAN ECONOMIC AREA (EEA) MEMBER STATE WHERE THE ALTERNATIVE INVESTMENT FUND MANAGERS DIRECTIVE (DIRECTIVE 2011/61/EU) IS IN FORCE AND EFFECT. GMO, IN ITS DISCRETION, MAY ACCEPT ANY SUCH INVESTOR INTO A FUND, BUT ONLY IF IT IS SATISFIED THAT, BY ACCEPTING SUCH INVESTOR, IT WOULD NOT BE IN BREACH OF ANY LAW, RULE, REGULATION OR OTHER LEGISLATIVE OR ADMINISTRATIVE MEASURE IN OR OTHERWISE APPLICABLE TO THE RELEVANT EEA MEMBER STATE AND SUCH INVESTOR IS OTHERWISE ELIGIBLE UNDER THE LAWS OF SUCH EEA MEMBER STATE TO INVEST IN THE FUND. NONE OF THE FUNDS, GMO, THEIR RESPECTIVE AFFILIATES OR ANY NATURAL OR LEGAL PERSON ACTING ON THEIR BEHALF HAVE BEEN REGISTERED WITH, HAVE BEEN APPROVED BY OR HAVE MADE A NOTIFICATION TO ANY EEA MEMBER STATE, EUROPEAN UNION OR OTHER REGULATORY, GOVERNMENTAL OR SIMILAR BODY WITH RESPECT TO THE FUNDS, AND NO SUCH BODY HAS APPROVED, ENDORSED, REVIEWED, ACQUIESCED OR TAKEN ANY SIMILAR ACTION WITH RESPECT TO ANY OFFERING, MARKETING OR OTHER PROMOTIONAL MATERIALS RELATING TO THE FUNDS.
Page | ||||
FUND SUMMARIES |
||||
1 | ||||
7 | ||||
12 | ||||
17 | ||||
ADDITIONAL INFORMATION ABOUT THE FUNDS INVESTMENT STRATEGIES, RISKS, AND EXPENSES |
21 | |||
24 | ||||
40 | ||||
44 | ||||
46 | ||||
46 | ||||
47 | ||||
50 | ||||
53 | ||||
56 | ||||
56 | ||||
65 | ||||
66 | ||||
69 | ||||
72 | ||||
72 | ||||
72 |
i
Investment Objective
Positive total return, not relative return.
Fees and Expenses
The table below describes the fees and expenses that you may bear if you buy and hold shares of the Fund.
Annual Fund Operating Expenses
(expenses that you bear each year as a percentage of the value of your investment)
Management fee |
0.00 | % | ||
Other expenses |
0.11 | % 1,2 | ||
Total annual operating expenses |
0.11 | % 1 | ||
Expense reimbursement |
(0.03 | %) 1,3 | ||
Total annual operating expenses after expense reimbursement |
0.08 | % 1 |
1 | The amounts represent an annualized estimate of the Funds operating expenses for its initial fiscal year. |
2 | The amount includes an annualized estimate of dividend expenses incurred by the Fund as a result of short sales for its initial fiscal year. Other expenses (before addition of dividend expenses on short sales) and dividend expenses on short sales are estimated to be approximately 0.04% and 0.07%, respectively. |
3 | Grantham, Mayo, Van Otterloo & Co. LLC (GMO) has contractually agreed to reimburse the Fund for the following expenses: audit expenses, fund accounting expenses, pricing service expenses, expenses of non-investment related tax services, transfer agency expenses, expenses of non-investment related legal services provided to the Fund by or at the direction of GMO, federal securities law filing expenses, printing expenses, state and federal registration fees, and non-emerging market custody expenses. This reimbursement will continue through at least June 30, 2016, and may not be terminated prior to this date without the action or consent of the Funds Board of Trustees. |
Portfolio Turnover
The Fund pays transaction costs, such as commissions, when it buys and sells securities. Because for U.S. federal income tax purposes the Fund will be an entity disregarded as separate from its sole shareholder, GMO Benchmark-Free Fund (BFF), a higher portfolio turnover rate may result in higher transaction costs and higher taxes for BFF shareholders that hold BFF shares in a taxable account. These costs, which are not reflected in Annual Fund Operating Expenses, affect the Funds performance. Because the Fund had not commenced operations as of the fiscal year ended February 28, 2015, the Funds portfolio turnover rate is not available.
Principal Investment Strategies
GMO will pursue investment strategies for the Fund that are intended to complement the strategies it is pursuing in GMO Benchmark-Free Fund (BFF), another GMO Fund described in a separate prospectus. Accordingly, the Fund is not a standalone investment. GMO will use its multi-year forecasts of returns among asset classes, together with its assessment of the relative risks of such asset classes, to determine the Funds strategic direction. An important component of those forecasts is the expectation that valuations ultimately revert to their historical mean (average). The factors considered and investment methods used by GMO can change over time.
GMO will not manage the Fund to, or control the Funds risk relative to, any securities index or securities benchmark. Depending on GMOs outlook, the Fund may have exposure to any asset class (e.g., non-U.S. equity, U.S. equity, emerging country equity, emerging country debt, non-U.S. fixed income, U.S. fixed income, real estate, and commodities) and at times may be substantially invested in a single asset class. The Fund may invest in companies of any market capitalization. In addition, the Fund is not limited in how much it may invest in any market, and it may invest all of its assets in the securities of a limited number of companies in a single country and/or capitalization range. The Fund may invest a significant portion of its assets in the securities of issuers in industries that are subject to the same or
1
GMO GAAR IMPLEMENTATION FUND
similar risk factors. To the extent the Fund invests in fixed income securities, it may have significant exposure to fixed income instruments of any credit quality, including those that are below investment grade (commonly referred to as junk bonds) and having any maturity or duration. The Fund also may have exposure to short sales. GMOs ability to shift investments among asset classes is not subject to any limits.
The Fund may engage in transactions in which it purchases securities at prices below the value of the consideration GMO expects to be paid for them upon consummation of a proposed merger, exchange offer, tender offer, or other similar transaction (merger arbitrage transactions). The purchase price may substantially exceed the market price of the securities before the announcement of the transaction.
In conjunction with merger arbitrage transactions, the Fund may invest in derivatives or sell securities short in an effort to protect against market fluctuations or other risks or to adjust long or short investment exposure to one or more asset classes or issuers.
As an alternative for investing directly in securities, the Fund may invest in exchange-traded and over-the-counter (OTC) derivatives (e.g., selling put options on securities) and exchange-traded funds (ETFs). The Fund also may invest in derivatives and ETFs: (i) in an attempt to reduce investment exposures (which may result in a reduction below zero); (ii) in an attempt to adjust elements of the Funds investment exposure; and (iii) as a substitute for securities lending. Derivatives used may include options, futures, warrants, swap contracts and reverse repurchase agreements. The Funds foreign currency exposure may differ from the currency exposure of its securities. In addition, the Fund may lend its portfolio securities.
The Fund will not be limited in its use of derivatives or in the total notional value of its derivative positions. As a result of its derivative positions, the Fund may have gross investment exposures in excess of its net assets (i.e., the Fund may be leveraged) and therefore will be subject to heightened risk of loss. The Funds performance can depend substantially, if not primarily, on the performance of assets or indices underlying its derivatives even though it does not own those assets or indices.
The Fund may gain exposure to commodities and some other assets by investing through a wholly-owned subsidiary. GMO will serve as the investment manager to this subsidiary but will not receive any additional management or other fees for its services. GMO expects that the subsidiary will invest primarily in commodity-related derivatives and fixed income securities, but also may invest in any other investments in which the Fund may invest directly. References in this Private Placement Memorandum to the Fund may refer to actions undertaken by the Fund or the subsidiary company. The Fund does not invest directly in commodities and commodity-related derivatives.
The Fund also may invest in GMO U.S. Treasury Fund (U.S. Treasury Fund), another GMO Fund described in a separate prospectus (see Investment in Other GMO Funds below for a more detailed description of U.S. Treasury Funds investment objectives and strategies) and in money market funds unaffiliated with GMO.
Principal Risks of Investing in the Fund
The value of the Funds shares changes with the value of the Funds investments. Many factors can affect this value, and you may lose money by investing in the Fund. References to investments include those held directly by the Fund and indirectly through the Funds investments in its wholly-owned subsidiary and in any underlying funds in which it invests. The Fund is a non-diversified investment company under the Investment Company Act of 1940, as amended, and therefore a decline in the market price of a particular security held by the Fund may affect the Funds performance more than if the Fund were a diversified investment company. The principal risks of investing in the Fund are summarized below. For a more complete discussion of these risks, including those risks to which the Fund is exposed as a result of its investments in its wholly-owned subsidiary and in any underlying funds, see Description of Principal Risks.
2
GMO GAAR IMPLEMENTATION FUND
| Market Risk Equities The market prices of equities may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equities for less than their value as determined by GMO, the Fund runs the risk that the market prices of these equities will not appreciate or will decline for a variety of reasons, one of which may be GMOs incorrect assessment of their intrinsic value. The Fund also may purchase equities that typically trade at higher multiples of current earnings than other securities, and the market prices of these equities often are more sensitive to changes in future earnings expectations than the market prices of equities trading at lower multiples. Declines in stock market prices generally are likely to reduce the net asset value of the Funds shares. |
| Market Risk Fixed Income Investments The market price of a fixed income investment can decline due to market-related factors, including rising interest rates and widening credit spreads, or decreased liquidity stemming from the markets uncertainty about the value of a fixed income investment (or class of fixed income investments). |
| Non-U.S. Investment Risk The market prices of many non-U.S. securities fluctuate more than those of U.S. securities. Many non-U.S. securities markets are less stable, smaller, less liquid and less regulated than U.S. securities markets, and the cost of trading in those markets often is higher than in U.S. securities markets. Non-U.S. portfolio transactions generally involve higher commission rates, transfer taxes, and custodial costs than similar transactions in the United States. In addition, the Fund may be subject to non-U.S. taxes, including potentially on a retroactive basis, on (i) capital gains it realizes or dividends, interest, or other amounts it realizes or accrues in respect of non-U.S. investments, (ii) transactions in those investments, and (iii) repatriation of proceeds generated from the sale or other disposition of those investments. Also, the Fund needs a license to invest directly in many non-U.S. securities markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some non-U.S. securities markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Funds investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of non-U.S. issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which may be predominantly based on only a few industries or dependent on revenues from particular commodities and which often are more volatile than the economies of developed countries. |
| Management and Operational Risk The Fund runs the risk that GMOs investment techniques will fail to produce desired results. GMO often uses quantitative analyses and models as part of its investment process. All models support portfolio decisions but are not necessarily predictive of future market events. These analyses and models also make simplifying assumptions that may limit their effectiveness. In addition, there are limitations (e.g., inaccuracies, staleness) on the data available for analysis or manipulation by the models. Any of those assumptions and/or limitations could adversely affect the Funds performance. The Fund also runs the risk that GMOs assessment of an investment may be wrong or that deficiencies in GMOs or another service providers internal systems or controls will cause losses for the Fund or impair Fund operations. |
| Derivatives and Short Sales Risk The use of derivatives involves the risk that their value may not change as expected relative to changes in the value of the underlying assets, rates, or indices. Derivatives also present other risks, including market risk, illiquidity risk, currency risk, credit risk, and counterparty risk. The market price of an option is affected by many factors, including changes in the market prices or dividend rates of underlying securities (or in the case of indices, the securities in such indices); the time remaining before expiration; changes in interest rates or exchange rates; and changes in the actual or perceived volatility of the relevant stock market and underlying securities. In addition, the risks of loss associated with derivatives that provide short investment exposure and short sales of securities are theoretically unlimited. |
3
GMO GAAR IMPLEMENTATION FUND
| Smaller Company Risk Smaller companies may have limited product lines, markets, or financial resources, may lack the competitive strength of larger companies, may have inexperienced managers or may depend on a few key employees. The securities of companies with smaller market capitalizations often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations. |
| Illiquidity Risk Low trading volume, lack of a market maker, large position size or legal restrictions may limit or prevent the Fund from selling particular securities or closing derivative positions at desirable prices. |
| Currency Risk Fluctuations in exchange rates can adversely affect the market value of the Funds foreign currency holdings and investments denominated in foreign currencies. |
| Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income investment or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligation to pay principal and interest or otherwise to honor its obligations in a timely manner. The market price of a fixed income investment will normally decline as a result of the issuers, guarantors, or obligors failure to meet its payment obligations. Below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the ability of issuers of those securities to make principal and interest payments than is the case with issuers of investment grade securities. |
| Market Risk Asset-Backed Securities The market price of fixed income investments with complex structures, such as asset-backed securities, can decline due to a variety of factors, including market uncertainty about their credit quality and the reliability of their payment streams. Payment streams associated with asset-backed securities held by the Fund depend on many factors (e.g., the cash flow generated by the assets backing the securities, the deal structure, the credit worthiness of any credit-support provider, and the reliability of various other service providers with access to the payment stream), and a problem in any one of these factors can lead to a reduction in the payment stream GMO expected the Fund to receive at the time the Fund purchased the asset-backed security. |
| Counterparty Risk The Fund runs the risk that the counterparty to a derivatives contract, a clearing member used by the Fund to hold a cleared derivatives contract, or a borrower of the Funds securities will be unable or unwilling to make timely settlement payments, return the Funds margin, or otherwise honor its obligations. |
| Leveraging Risk The use of reverse repurchase agreements and other derivatives and securities lending creates leverage. Leverage increases the Funds losses when the value of its investments (including derivatives) declines. |
| Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events, as well as other changes in non-U.S. and U.S. economic and political conditions, could adversely affect the value of the Funds investments. |
|
Merger Arbitrage Risk If the Fund purchases securities in anticipation of a proposed merger, exchange offer, tender offer, or other similar transaction, and that transaction later appears unlikely to be consummated or, in fact, is not consummated or is delayed, the market prices of the securities purchased by the Fund may decline sharply, resulting in losses to the Fund. The risk/reward payout of merger arbitrage strategies typically is asymmetric - the losses in failed transactions often far exceeding the gains in successful transactions. A merger arbitrage transaction can fail for many reasons, including regulatory and antitrust restrictions, political motivations, industry weakness, stock specific events, failed financings, and general market declines. When merger activity is low, GMO |
4
GMO GAAR IMPLEMENTATION FUND
may be unable to identify enough opportunities to provide sufficient diversification. Merger arbitrage strategies are subject to the risk of overall market movements, and the Fund may experience losses even if a transaction is consummated. The Funds investments in derivatives or short sales of securities to hedge or otherwise adjust investment exposure in connection with a merger arbitrage transaction may not perform as expected or may otherwise reduce the Funds gains or increase its losses. |
| Commodities Risk Commodities prices can be extremely volatile, and exposure to commodities can cause the net asset value of the Funds shares to decline or fluctuate in a rapid and unpredictable manner. |
| Focused Investment Risk Investments focused in a limited number of countries, regions, sectors, industries, or issuers that are subject to the same or similar risk factors and investments whose prices are strongly correlated are subject to greater overall risk than investments that are more diversified. |
| Large Shareholder Risk After commencing operations on or after the date of this Private Placement Memorandum, it is expected that all of the Funds shares will be held by a single shareholder. As a result, the Fund is subject to the risk that a redemption by that shareholder of all or a large portion of its Fund shares will cause the Fund to sell securities at disadvantageous prices or otherwise will disrupt the Funds operations. |
| Fund of Funds Risk The Fund will be indirectly exposed to all of the risks of its investment in its wholly-owned subsidiary and in any underlying funds in which it invests (including ETFs), including the risk that its wholly-owned subsidiary and those underlying funds will not perform as expected. |
Management of the Fund
Investment Adviser: Grantham, Mayo, Van Otterloo & Co. LLC
Investment Team and Senior Members of GMO primarily responsible for portfolio management of the Fund:
Investment Team |
Senior Member (Length of Service with Fund) |
Title |
||
Asset Allocation | Ben Inker (since the Funds inception) | Co-Head, Asset Allocation Team and Co-Head, Developed Fixed Income Team, GMO. | ||
Asset Allocation | Sam Wilderman (since the Funds inception) | Co-Head, Asset Allocation Team and Co-Head, Developed Fixed Income Team, GMO. |
Purchase and Sale of Fund Shares
Currently, shares of the Fund are principally available for purchase by other GMO Funds and certain other accredited investors. All investors must be accredited investors as defined in Regulation D under the Securities Act of 1933.
Under ordinary circumstances, you may purchase the Funds shares directly from the Trust on days when the New York Stock Exchange (NYSE) is open for business.
No minimum initial investment is required to purchase shares of the Fund. For investors owning shares of the Fund, no minimum additional investment is required to purchase additional shares of the Fund.
Fund shares are redeemable and, under ordinary circumstances, you may redeem the Funds shares on days when the NYSE is open for business. Redemption orders should be submitted directly to the Trust. For instructions on redeeming shares, call the Trust at 1-617-346-7646 or send an e-mail to SHS@GMO.com.
5
GMO GAAR IMPLEMENTATION FUND
Purchase order forms and redemption orders can be submitted by mail, facsimile or e-mail (or by other form of communication pre-approved by GMO Shareholder Services) to the Trust at:
GMO Trust
c/o Grantham, Mayo, Van Otterloo & Co. LLC
40 Rowes Wharf
Boston, Massachusetts 02110
Facsimile: 1-617-439-4192
Attention: Shareholder Services
E-mail: clientorder@gmo.com
Tax Information
The Fund may make distributions to its sole shareholder, BFF, in the sole discretion of the Trustees (or their delegates). Because the Fund will be an entity disregarded from its sole shareholder, BFF, for U.S. federal income tax purposes and as a result BFF will be treated as owning the Funds assets directly for U.S. federal tax purposes, any such distributions will have no effect on BFFs U.S. federal income tax liability. Thus, any income, gain, loss, deduction or other tax items arising in respect of the Funds assets will be treated as if they are realized or incurred, as applicable, directly by BFF.
6
Investment Objective
Total return in excess of that of its benchmark, the J.P. Morgan U.S. 3 Month Cash Index.
Fees and Expenses
The table below describes the fees and expenses that you may bear for each class of shares if you buy and hold shares of the Fund.
Annual Fund Operating Expenses
(expenses that you bear each year as a percentage of the value of your investment)
Class III | Class VI | |||||||||
Management fee |
0.05 | % 1 | 0.05 | % 1 | ||||||
Shareholder service fee |
0.15 | % 1 | 0.055 | % 1 | ||||||
Other expenses |
0.39 | % 2 | 0.39 | % 2 | ||||||
Total annual operating expenses |
0.59 | % 2 | 0.50 | % 2 | ||||||
Expense reimbursement/waiver |
(0.39 | %) 1,2 | (0.39 | %) 1,2 | ||||||
Total annual operating expenses after expense reimbursement/waiver |
0.20 | % 2 | 0.11 | % 2 |
1 | Grantham, Mayo, Van Otterloo & Co. LLC (GMO) has contractually agreed to reimburse the Fund for the following expenses: audit expenses, fund accounting expenses, pricing service expenses, expenses of non-investment related tax services, transfer agency expenses, expenses of non-investment related legal services provided to the Fund by or at the direction of GMO, federal securities law filing expenses, printing expenses, state and federal registration fees, and custody expenses. GMO also has contractually agreed to waive or reduce the Funds management fees and shareholder service fees to the extent necessary to offset the management fees and shareholder service fees paid to GMO that are directly or indirectly borne by the Fund or a class of shares of the Fund as a result of the Funds direct or indirect investments in other GMO Funds. Management fees and shareholder service fees will not be waived below zero. This reimbursement and waiver will continue through at least June 30, 2016, and may not be terminated prior to this date without the action or consent of the Funds Board of Trustees. |
2 | The amounts represent an annualized estimate of the Funds operating expenses for its initial fiscal year. |
Portfolio Turnover
The Fund pays transaction costs, such as commissions, when it buys and sells securities. A higher portfolio turnover rate may result in higher transaction costs and, when Fund shares are held in a taxable account, higher taxes. These costs, which are not reflected in Annual Fund Operating Expenses, affect the Funds performance. Because the Fund had not yet commenced operations as of the fiscal year ended February 28, 2015, the Funds portfolio turnover rate is not available.
Principal Investment Strategies
The Fund seeks to add value relative to its benchmark to the extent consistent with the preservation of capital and liquidity.
The Fund will invest primarily in high quality U.S. and non-U.S. fixed income securities. The Fund may invest in fixed income securities of any type, including asset-backed securities, corporate debt securities, money market instruments, and commercial paper, and enter into credit default swaps, reverse repurchase agreements, and repurchase agreements. The Fund also may invest in other exchange-traded and over-the-counter (OTC) derivatives. The Fund is not limited in its use of derivatives or in the total notional value of its derivative positions. As a result of its derivative positions, the Fund typically will have gross investment exposures in excess of its net assets (i.e., the Fund typically will be leveraged) and therefore is subject to heightened risk of loss. The Funds performance can depend substantially, if not primarily, on the performance of assets or indices underlying its derivatives even though it does not own those assets or indices.
7
GMO HIGH QUALITY SHORT-DURATION BOND FUND
The Funds fixed income securities may include all types of interest rate, payment, and reset terms, including fixed rate, adjustable rate, zero coupon, contingent, deferred, payment-in-kind, and auction rate features. While the Fund primarily invests in high quality bonds, it may invest in securities that are not high quality and may hold bonds and other fixed income securities whose ratings after they were acquired were reduced below high quality.
The Fund also may invest in GMO U.S. Treasury Fund (U.S. Treasury Fund), another GMO Fund described in a separate prospectus (see Investment in Other GMO Funds below for a more detailed description of U.S. Treasury Funds investment objectives and strategies) and in money market funds unaffiliated with GMO.
In selecting fixed income securities for the Funds portfolio, GMO focuses primarily on the securities credit quality. GMO uses fundamental investment techniques to identify the credit risk associated with investments in fixed income securities and bases its investment decisions on that assessment. The factors considered and investment methods used by GMO can change over time.
GMO will normally seek to maintain an estimated interest rate duration of 365 days or less for the Funds portfolio (which may be substantially shorter than the Funds dollar-weighted average portfolio maturity). GMO estimates the Funds dollar-weighted average interest rate duration by aggregating the durations of the Funds direct and indirect individual holdings and weighting each holding based on its market value.
Under normal circumstances, the Fund invests directly and indirectly (e.g., through other GMO Funds or derivatives) at least 80% of its assets in high quality bonds (the Name Policy) (see Name Policies below for more information).
Principal Risks of Investing in the Fund
The value of the Funds shares changes with the value of the Funds investments. Many factors can affect this value, and you may lose money by investing in the Fund. An investment in the Fund is subject to different risks, and greater overall risk, than an investment in the underlying components of the Funds benchmark. The Fund is a non-diversified investment company under the Investment Company Act of 1940, as amended, and therefore a decline in the market price of a particular security held by the Fund may affect the Funds performance more than if the Fund were a diversified investment company. The principal risks of investing in the Fund are summarized below. For a more complete discussion of these risks, see Description of Principal Risks.
| Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income investment or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligation to pay principal and interest or otherwise to honor its obligations in a timely manner. The market price of a fixed income investment will normally decline as a result of the issuers, guarantors, or obligors failure to meet its payment obligations. Below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the ability of issuers of those securities to make principal and interest payments than is the case with issuers of investment grade securities. |
| Market Risk Asset-Backed Securities The market price of fixed income investments with complex structures, such as asset-backed securities, can decline due to a variety of factors, including market uncertainty about their credit quality and the reliability of their payment streams. Payment streams associated with asset-backed securities held by the Fund depend on many factors (e.g., the cash flow generated by the assets backing the securities, the deal structure, the credit worthiness of any credit-support provider, and the reliability of various other service providers with access to the payment stream), and a problem in any one of these factors can lead to a reduction in the payment stream GMO expected the Fund to receive at the time the Fund purchased the asset-backed security. |
8
GMO HIGH QUALITY SHORT-DURATION BOND FUND
| Illiquidity Risk Low trading volume, lack of a market maker, large position size or legal restrictions may limit or prevent the Fund from selling particular securities or closing derivative positions at desirable prices. |
| Market Risk Fixed Income Investments The market price of a fixed income investment can decline due to market-related factors, including rising interest rates and widening credit spreads, or decreased liquidity stemming from the markets uncertainty about the value of a fixed income investment (or class of fixed income investments). |
| Focused Investment Risk Investments focused in a limited number of countries, regions, sectors, industries, or issuers that are subject to the same or similar risk factors and investments whose prices are strongly correlated are subject to greater overall risk than investments that are more diversified. |
| Management and Operational Risk The Fund runs the risk that GMOs investment techniques will fail to produce desired results. GMO often uses quantitative analyses and models as part of its investment process. All models support portfolio decisions but are not necessarily predictive of future market events. These analyses and models also make simplifying assumptions that may limit their effectiveness. In addition, there are limitations (e.g., inaccuracies, staleness) on the data available for analysis or manipulation by the models. Any of those assumptions and/or limitations could adversely affect the Funds performance. The Fund also runs the risk that GMOs assessment of an investment may be wrong or that deficiencies in GMOs or another service providers internal systems or controls will cause losses for the Fund or impair Fund operations. |
| Derivatives and Short Sales Risk The use of derivatives involves the risk that their value may not change as expected relative to changes in the value of the underlying assets, rates, or indices. Derivatives also present other risks, including market risk, illiquidity risk, credit risk, and counterparty risk. In addition, the risks of loss associated with derivatives that provide short investment exposure and short sales of securities are theoretically unlimited. |
| Leveraging Risk The use of reverse repurchase agreements and other derivatives creates leverage. Leverage increases the Funds losses when the value of its investments (including derivatives) declines. |
| Counterparty Risk The Fund runs the risk that the counterparty to a derivatives contract, a clearing member used by the Fund to hold a cleared derivatives contract, or a borrower of the Funds securities will be unable or unwilling to make timely settlement payments, return the Funds margin, or otherwise honor its obligations. |
| Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an investment in any underlying funds in which it invests, including the risk that those underlying funds will not perform as expected. |
| Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events, as well as other changes in non-U.S. and U.S. economic and political conditions, could adversely affect the value of the Funds investments. |
| Large Shareholder Risk To the extent that a large number of shares of the Fund is held by a single shareholder (e.g., an institutional investor or another GMO Fund) or a group of shareholders with a common investment strategy (e.g., GMO asset allocation accounts), the Fund is subject to the risk that a redemption by those shareholders of all or a large portion of their Fund shares will cause the Fund to sell securities at disadvantageous prices or otherwise will disrupt the Funds operations. |
|
Non-U.S. Investment Risk The market prices of many non-U.S. securities fluctuate more than those of U.S. securities. Many non-U.S. securities markets are less stable, smaller, less liquid and less |
9
GMO HIGH QUALITY SHORT-DURATION BOND FUND
regulated than U.S. securities markets, and the cost of trading in those markets often is higher than in U.S. securities markets. Non-U.S. portfolio transactions generally involve higher commission rates, transfer taxes, and custodial costs than similar transactions in the United States. In addition, the Fund may be subject to non-U.S. taxes, including potentially on a retroactive basis, on (i) capital gains it realizes or dividends, interest, or other amounts it realizes or accrues in respect of non-U.S. investments, (ii) transactions in those investments, and (iii) repatriation of proceeds generated from the sale or other disposition of those investments. Also, the Fund needs a license to invest directly in many non-U.S. securities markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some non-U.S. securities markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Funds investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of non-U.S. issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which may be predominantly based on only a few industries or dependent on revenues from particular commodities and which often are more volatile than the economies of developed countries. |
Management of the Fund
Investment Adviser: Grantham, Mayo, Van Otterloo & Co. LLC
Investment Team and Senior Members of GMO primarily responsible for portfolio management of the Fund:
Investment Team |
Senior Member (Length of Service with Fund) |
Title |
||
Developed Fixed Income | Ben Inker (since 2014) | Co-Head, Asset Allocation Team and Co-Head, Developed Fixed Income Team, GMO. | ||
Developed Fixed Income | Sam Wilderman (since 2014) | Co-Head, Asset Allocation Team and Co-Head, Developed Fixed Income Team, GMO. | ||
Developed Fixed Income | Joe Auth (since February 2015) | Portfolio Manager, Developed Fixed Income Team, GMO. |
Purchase and Sale of Fund Shares
Currently, shares of the Fund are principally available for purchase by other GMO Funds and certain other accredited investors. All investors must be accredited investors as defined in Regulation D under the Securities Act of 1933.
Under ordinary circumstances, you may purchase the Funds shares directly from the Trust on days when both the New York Stock Exchange (NYSE) and the U.S. bond markets are open for business.
An investors eligibility to purchase Fund shares or different classes of Fund shares depends on its meeting either (i) the Minimum Total Fund Investment, which involves only an investors total investment in a particular Fund, or (ii) the Minimum Total GMO Investment, both of which are set forth in the table below. For investors owning shares of the Fund, no minimum additional investment is required to purchase additional shares of the Fund.
Minimum Investment Criteria for Class Eligibility
Minimum Total Fund Investment |
Minimum Total GMO Investment |
|||
Class III Shares | N/A | $10 million | ||
Class VI Shares | $300 million | $750 million |
10
GMO HIGH QUALITY SHORT-DURATION BOND FUND
Fund shares are redeemable and, under ordinary circumstances, you may redeem the Funds shares on days when both the NYSE and the U.S. bond markets are open for business. Redemption orders should be submitted directly to the Trust. For instructions on redeeming shares, call the Trust at 1-617-346-7646 or send an e-mail to SHS@GMO.com.
Purchase order forms and redemption orders can be submitted by mail, facsimile, or e-mail (or by other form of communication pre-approved by GMO Shareholder Services) to the Trust at:
GMO Trust
c/o Grantham, Mayo, Van Otterloo & Co. LLC
40 Rowes Wharf
Boston, Massachusetts 02110
Facsimile: 1-617-439-4192
Attention: Shareholder Services
E-mail: clientorder@gmo.com
Tax Information
The Fund intends to elect and be treated and intends to qualify and be treated each year as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended, for U.S. federal income tax purposes and to distribute net investment income and net realized capital gains, if any, to shareholders. These distributions generally are taxable to U.S. shareholders as ordinary income or capital gains, unless they are exempt from income tax or are investing through a tax-advantaged account. U.S. shareholders who are investing through a tax-advantaged account may be taxed upon withdrawals from that account.
11
Investment Objective
Long-term total return.
Fees and Expenses
The table below describes the fees and expenses that you may bear if you buy and hold shares of the Fund.
Annual Fund Operating Expenses
(expenses that you bear each year as a percentage of the value of your investment)
Class III | |||||
Management fee |
0.70 | % 1 | |||
Shareholder service fee |
0.15 | % 1 | |||
Other expenses |
0.02 | % | |||
Acquired fund fees and expenses (underlying fund expenses) |
0.01 | % | |||
Total annual operating expenses |
0.88 | % | |||
Expense reimbursement/waiver |
(0.02 | %) 1 | |||
Total annual operating expenses after expense reimbursement/waiver (Fund and underlying fund expenses) |
0.86 | % |
1 | Grantham, Mayo, Van Otterloo & Co. LLC (GMO) has contractually agreed to reimburse the Fund for the following expenses: audit expenses, fund accounting expenses, pricing service expenses, expenses of non-investment related tax services, transfer agency expenses, expenses of non-investment related legal services provided to the Fund by or at the direction of GMO, federal securities law filing expenses, printing expenses, state and federal registration fees and custody expenses. GMO also has contractually agreed to waive or reduce the Funds management fees and shareholder service fees to the extent necessary to offset the management fees and shareholder service fees paid to GMO that are directly or indirectly borne by the Fund as a result of the Funds direct or indirect investments in other GMO Funds. Management fees and shareholder service fees will not be waived below zero as a result of this waiver. This reimbursement and waiver will continue through at least June 30, 2016, and may not be terminated prior to this date without the action or consent of the Funds Board of Trustees. |
Portfolio Turnover
The Fund pays transaction costs, such as commissions, when it buys and sells securities. A higher portfolio turnover rate may result in higher transaction costs and, when Fund shares are held in a taxable account, higher taxes. These costs, which are not reflected in Annual Fund Operating Expenses, affect the Funds performance. During its fiscal year ended February 28, 2015, the Funds portfolio turnover rate (including the accounts of the Funds wholly-owned subsidiary GMO Alternative Asset SPC Ltd. and excluding short-term investments) was 45% of the average value of its portfolio.
Principal Investment Strategies
The Fund invests in a range of global equity, bond, currency, and commodity markets using exchange-traded futures and forward non-U.S. exchange contracts, as well as making other investments. The Fund seeks to take advantage of GMOs proprietary investment models for global tactical asset allocation and equity, bond, currency, and commodity market selection.
The Fund normally invests assets not held as margin for futures or forward transactions or paid as option premiums in cash directly (i.e., Treasury Bills) or money market funds. The Fund also may invest in U.S. and non-U.S. fixed income securities and in shares of other GMO Funds (such other GMO Funds, the underlying Funds), including GMO Debt Opportunities Fund (Debt Opportunities Fund) and GMO U.S. Treasury Fund (U.S. Treasury Fund), each of which is described in a separate prospectus. See Investment in Other GMO Funds below for a more detailed description of Debt Opportunities Funds and U.S. Treasury Funds investment objectives and strategies.
12
GMO SYSTEMATIC GLOBAL MACRO OPPORTUNITY FUND
GMOs models for this systematic process are based on the following strategies:
| Value-Based Strategies . Value factors compare the price of an asset class or market to an economic fundamental value. Generally, value strategies include yield analysis and mean reversion analysis. |
| Sentiment-Based Strategies . Generally, sentiment-based strategies assess factors such as risk aversion, analyst behavior, and momentum. |
GMO may eliminate strategies or add new strategies in response to additional research, changing market conditions, or other factors. The factors considered and investment methods used by GMO can change over time.
The Fund may gain exposure to commodities and some other assets by investing through a wholly-owned subsidiary. GMO serves as the investment manager to this subsidiary but does not receive any additional management or other fees for its services. The subsidiary invests primarily in commodity-related derivatives and fixed income securities, but also may invest in any other investments in which the Fund may invest directly. References in this Private Placement Memorandum to the Fund may refer to actions undertaken by the Fund or the subsidiary company. The Fund does not invest directly in commodities and commodity-related derivatives.
The Funds benchmark is the Citigroup 3-Month Treasury Bill Index. The Fund does not maintain a specified interest rate duration for its portfolio.
The Fund is not limited in its use of derivatives or in the total notional value of its derivative positions. As a result of its derivative positions, the Fund typically has gross investment exposures in excess of its net assets (i.e., the Fund typically is leveraged) and therefore is subject to heightened risk of loss. The Funds performance can depend substantially, if not primarily, on the performance of assets or indices underlying its derivatives even though it does not own those assets or indices.
Principal Risks of Investing in the Fund
The value of the Funds shares changes with the value of the Funds investments. Many factors can affect this value, and you may lose money by investing in the Fund. An investment in the Fund is subject to different risks, and greater overall risk, than an investment in the underlying components of the Funds benchmark. References to investments include those held directly by the Fund and indirectly through the Funds investments in its wholly-owned subsidiary and in underlying Funds. The Fund and some of the underlying Funds are non-diversified investment companies under the Investment Company Act of 1940, as amended, and therefore a decline in the market price of a particular security held by the Fund or those underlying Funds may affect the Funds or an underlying Funds performance more than if the Fund or the underlying Fund were a diversified investment company. The principal risks of investing in the Fund are summarized below. For a more complete discussion of these risks, including those risks to which the Fund is exposed as a result of its investments in its wholly-owned subsidiary and in underlying Funds, see Description of Principal Risks.
| Management and Operational Risk The Fund runs the risk that GMOs investment techniques will fail to produce desired results. GMO often uses quantitative analyses and models as part of its investment process, and those models are one of the key drivers of investment decisions for the Fund. All models support portfolio decisions but are not necessarily predictive of future market events. These analyses and models also make simplifying assumptions that may limit their effectiveness. In addition, there are limitations (e.g., inaccuracies, staleness) on the data available for analysis or manipulation by the models. Any of those assumptions and/or limitations could adversely affect the Funds performance. The Fund also runs the risk that GMOs assessment of an investment may be wrong or that deficiencies in GMOs or another service providers internal systems or controls will cause losses for the Fund or impair Fund operations. |
13
GMO SYSTEMATIC GLOBAL MACRO OPPORTUNITY FUND
| Market Risk Equities The market prices of equities may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equities for less than their value as determined by GMO, the Fund runs the risk that the market prices of these equities will not appreciate or will decline for a variety of reasons, one of which may be GMOs incorrect assessment of their intrinsic value. The Fund also may purchase equities that typically trade at higher multiples of current earnings than other securities, and the market prices of these equities often are more sensitive to changes in future earnings expectations than the market prices of equities trading at lower multiples. Declines in stock market prices generally are likely to reduce the net asset value of the Funds shares. |
| Currency Risk Fluctuations in exchange rates can adversely affect the market value of the Funds foreign currency holdings and investments denominated in foreign currencies. |
| Commodities Risk Commodities prices can be extremely volatile, and exposure to commodities can cause the net asset value of the Funds shares to decline or fluctuate in a rapid and unpredictable manner. |
| Market Risk Fixed Income Investments The market price of a fixed income investment can decline due to market-related factors, including rising interest rates and widening credit spreads, or decreased liquidity stemming from the markets uncertainty about the value of a fixed income investment (or class of fixed income investments). |
| Non-U.S. Investment Risk The market prices of many non-U.S. securities fluctuate more than those of U.S. securities. Many non-U.S. securities markets are less stable, smaller, less liquid and less regulated than U.S. securities markets, and the cost of trading in those markets often is higher than in U.S. securities markets. Non-U.S. portfolio transactions generally involve higher commission rates, transfer taxes, and custodial costs than similar transactions in the United States. In addition, the Fund may be subject to non-U.S. taxes, including potentially on a retroactive basis, on (i) capital gains it realizes or dividends, interest, or other amounts it realizes or accrues in respect of non-U.S. investments, (ii) transactions in those investments, and (iii) repatriation of proceeds generated from the sale or other disposition of those investments. For information on possible special Australian and Singapore tax consequences of an investment in the Fund, see Taxes For Systematic Global Macro Opportunity Fund. Also, the Fund needs a license to invest directly in many non-U.S. securities markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some non-U.S. securities markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Funds investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of non-U.S. issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which may be predominantly based on only a few industries or dependent on revenues from particular commodities and which often are more volatile than the economies of developed countries. |
| Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events, as well as other changes in non-U.S. and U.S. economic and political conditions, could adversely affect the value of the Funds investments. |
| Derivatives and Short Sales Risk The use of derivatives involves the risk that their value may not change as expected relative to changes in the value of the underlying assets, rates, or indices. Derivatives also present other risks, including market risk, illiquidity risk, currency risk, credit risk, and counterparty risk. In addition, the risks of loss associated with derivatives that provide short investment exposure and short sales of securities are theoretically unlimited. |
14
GMO SYSTEMATIC GLOBAL MACRO OPPORTUNITY FUND
| Leveraging Risk The use of reverse repurchase agreements and other derivatives creates leverage. Leverage increases the Funds losses when the value of its investments (including derivatives) declines. |
| Focused Investment Risk Investments focused in countries, regions, sectors, industries, or issuers that are subject to the same or similar risk factors and investments whose prices are strongly correlated are subject to greater overall risk than investments that are more diversified. |
| Counterparty Risk The Fund runs the risk that the counterparty to a derivatives contract, a clearing member used by the Fund to hold a cleared derivatives contract, or a borrower of the Funds securities will be unable or unwilling to make timely settlement payments, return the Funds margin, or otherwise honor its obligations. |
| Market Risk Asset-Backed Securities The market price of fixed income investments with complex structures, such as asset-backed securities, can decline due to a variety of factors, including market uncertainty about their credit quality and the reliability of their payment streams. Payment streams associated with asset-backed securities held by the Fund depend on many factors (e.g., the cash flow generated by the assets backing the securities, the deal structure, the credit worthiness of any credit-support provider, and the reliability of various other service providers with access to the payment stream), and a problem in any one of these factors can lead to a reduction in the payment stream GMO expected the Fund to receive at the time the Fund purchased the asset-backed security. |
| Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income investment or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligation to pay principal and interest or otherwise to honor its obligations in a timely manner. The market price of a fixed income investment will normally decline as a result of the issuers, guarantors, or obligors failure to meet its payment obligations. Below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the ability of issuers of those securities to make principal and interest payments than is the case with issuers of investment grade securities. |
| Illiquidity Risk Low trading volume, lack of a market maker, large position size or legal restrictions may limit or prevent the Fund from selling particular securities or closing derivative positions at desirable prices. |
| Fund of Funds Risk The Fund is indirectly exposed to all of the risks of its investment in it wholly-owned subsidiary and the underlying Funds in which it invests, including the risk that its wholly-owned subsidiary and those underlying Funds will not perform as expected. |
| Large Shareholder Risk To the extent that a large number of shares of the Fund is held by a single shareholder (e.g., an institutional investor or another GMO Fund) or a group of shareholders with a common investment strategy (e.g., GMO asset allocation accounts), the Fund is subject to the risk that a redemption by those shareholders of all or a large portion of their Fund shares will cause the Fund to sell securities at disadvantageous prices or otherwise will disrupt the Funds operations. |
Management of the Fund
Investment Adviser: Grantham, Mayo, Van Otterloo & Co. LLC
Sub-Adviser: GMO Singapore Pte. Limited
Investment Team and Senior Member of GMO primarily responsible for portfolio management of the Fund:
Investment Team |
Senior Member (Length of Service with Fund) |
Title |
||
Systematic Global Macro | Jason Halliwell (since 2011) | Head, Systematic Global Macro Team, GMO. |
15
GMO SYSTEMATIC GLOBAL MACRO OPPORTUNITY FUND
Purchase and Sale of Fund Shares
Currently, shares of the Fund are principally available for purchase by other GMO Funds and certain other accredited investors. All investors must be accredited investors as defined in Regulation D under the Securities Act of 1933.
Under ordinary circumstances, you may purchase the Funds shares directly from the Trust on days when both the New York Stock Exchange (NYSE) and the U.S. bond markets are open for business.
No minimum initial investment is required to purchase Class III shares of the Fund. For investors owning shares of the Fund, no minimum additional investment is required to purchase additional shares of the Fund.
Fund shares are redeemable and, under ordinary circumstances, you may redeem the Funds shares on days when both the NYSE and the U.S. bond markets are open for business. Redemption orders should be submitted directly to the Trust. For instructions on redeeming shares, call the Trust at 1-617-346-7646 or send an e-mail to SHS@GMO.com.
Purchase order forms and redemption orders can be submitted by mail, facsimile, or e-mail (or by other form of communication pre-approved by GMO Shareholder Services) to the Trust at:
GMO Trust
c/o Grantham, Mayo, Van Otterloo & Co. LLC
40 Rowes Wharf
Boston, Massachusetts 02110
Facsimile: 1-617-439-4192
Attention: Shareholder Services
E-mail: clientorder@gmo.com
Tax Information
The Fund expects to be treated as a partnership for U.S. federal income tax purposes. In general, a partnership is not itself subject to U.S. federal income tax. Instead, each shareholder is required to take into account its distributive share of the Funds income, gain, loss, deduction, credit, and other tax items for each taxable year substantially as though such items had been realized directly by the shareholder and without regard to whether the Fund has made or will make any cash distributions to its shareholders. Accordingly, it is possible that a shareholder will incur income tax liabilities in a taxable year in respect of its investment in the Fund that exceed cash distributions (if any) made by the Fund for that year.
The Fund may declare and pay non-redeeming distributions to its shareholders in the sole discretion of the Trustees (or their delegates).
16
Investment Objective
Total return greater than that of its benchmark, the J.P. Morgan U.S. 3 Month Cash Index.
Fees and Expenses
The table below describes the fees and expenses that you may bear if you buy and hold shares of the Fund.
Annual Fund Operating Expenses
(expenses that you bear each year as a percentage of the value of your investment)
Management fee |
0.00 | % | ||
Other expenses |
0.14 | % 1 | ||
Total annual operating expenses |
0.14 | % | ||
Expense reimbursement |
(0.08 | %) 2 | ||
Total annual operating expenses after expense reimbursement |
0.06 | % |
1 | The amount reflects inclusion of interest expenses incurred by the Fund as a result of entering into reverse repurchase agreements and/or margin on cleared swap contracts, if any. Other expenses (before addition of interest expense) and interest expense were 0.09% and approximately 0.05%, respectively. |
2 | Grantham, Mayo, Van Otterloo & Co. LLC (GMO) has contractually agreed to reimburse the Fund for the following expenses: audit expenses, fund accounting expenses, pricing service expenses, expenses of non-investment related tax services, transfer agency expenses, expenses of non-investment related legal services provided to the Fund by or at the direction of GMO, federal securities law filing expenses, printing expenses, state and federal registration fees, and custody expenses. This reimbursement will continue through at least June 30, 2016, and may not be terminated prior to this date without the action or consent of the Funds Board of Trustees. |
Portfolio Turnover
The Fund pays transaction costs, such as commissions, when it buys and sells securities. A higher portfolio turnover rate may result in higher transaction costs and, when Fund shares are held in a taxable account, higher taxes. These costs, which are not reflected in Annual Fund Operating Expenses, affect the Funds performance. During its fiscal year ended February 28, 2015, the Funds portfolio turnover rate (excluding short-term investments) was 26% of the average value of its portfolio.
Principal Investment Strategies
GMO seeks to achieve the Funds investment objective by attempting to identify and estimate relative misvaluation of global interest rate, credit, and currency markets. Based on those estimates, GMO establishes the Funds positions across those markets. Those positions may include direct investments and derivatives. The Funds direct investments in fixed income securities include U.S. and non-U.S. asset-backed securities and other fixed income securities (including Treasury Separately Traded Registered Interest and Principal Securities (STRIPS), Inflation-Protected Securities issued by the U.S. Treasury (TIPS), Treasury Securities and global bonds). The factors considered and investment methods used by GMO can change over time.
Derivatives used by the Fund are primarily interest rate swaps and futures contracts, currency forwards and options, and credit default swaps on single-issuers or indices. As a result of its derivative positions, the Fund typically will have higher volatility than its benchmark. The Fund is not limited in its use of derivatives or in the total notional value of its derivative positions. As a result of its derivative positions, the Fund typically has gross investment exposures in excess of its net assets (i.e. the Fund typically is leveraged) and therefore is subject to heightened risk of loss. The Funds performance can depend substantially, if not primarily, on the performance of assets or indices underlying its derivatives even though it does not own those assets or indices.
17
GMO WORLD OPPORTUNITY OVERLAY FUND
The Fund typically holds asset-backed securities. The Fund also may invest in government securities, corporate debt securities, money market instruments and commercial paper, and enter into credit default swaps, reverse repurchase agreements, and repurchase agreements. The Funds fixed income securities may include all types of interest rate, payment and reset terms, including fixed rate, zero coupon, contingent, deferred, payment-in-kind and auction rate features.
Because of the deterioration in credit markets that became acute in 2008, the Fund has and is expected to continue to have material exposure to below investment grade securities (commonly referred to as junk bonds).
Principal Risks of Investing in the Fund
The value of the Funds shares changes with the value of the Funds investments. Many factors can affect this value, and you may lose money by investing in the Fund. An investment in the Fund is subject to different risks, and greater overall risk, than an investment in the underlying components of the Funds benchmark. The Fund is a non-diversified investment company under the Investment Company Act of 1940, as amended, and therefore a decline in the market price of a particular security held by the Fund may affect the Funds performance more than if the Fund were a diversified investment company. The principal risks of investing in the Fund are summarized below. For a more complete discussion of these risks, see Description of Principal Risks.
| Market Risk Fixed Income Investments The market price of a fixed income investment can decline due to market-related factors, including rising interest rates and widening credit spreads, or decreased liquidity stemming from the markets uncertainty about the value of a fixed income investment (or class of fixed income investments). |
| Currency Risk Fluctuations in exchange rates can adversely affect the market value of the Funds foreign currency holdings and investments denominated in foreign currencies. |
| Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income investment or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligation to pay principal and interest or otherwise to honor its obligations in a timely manner. The market price of a fixed income investment will normally decline as a result of the issuers, guarantors, or obligors failure to meet its payment obligations. Below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the ability of issuers of those securities to make principal and interest payments than is the case with issuers of investment grade securities. |
| Market Risk Asset-Backed Securities The market price of fixed income investments with complex structures, such as asset-backed securities, can decline due to a variety of factors, including market uncertainty about their credit quality and the reliability of their payment streams. Payment streams associated with asset-backed securities held by the Fund depend on many factors (e.g., the cash flow generated by the assets backing the securities, the deal structure, the credit worthiness of any credit-support provider, and the reliability of various other service providers with access to the payment stream), and a problem in any one of these factors can lead to a reduction in the payment stream GMO expected the Fund to receive at the time the Fund purchased the asset-backed security. |
| Illiquidity Risk Low trading volume, lack of a market maker, large position size or legal restrictions may limit or prevent the Fund from selling particular securities or closing derivative positions at desirable prices. |
|
Derivatives and Short Sales Risk The use of derivatives involves the risk that their value may not change as expected relative to changes in the value of the underlying assets, rates, or indices. Derivatives also present other risks, including market risk, illiquidity risk, currency risk, credit risk, and counterparty risk. The market price of an option is affected by many factors, including changes in |
18
GMO WORLD OPPORTUNITY OVERLAY FUND
the market prices or dividend rates of underlying securities (or in the case of indices, the securities in such indices); the time remaining before expiration; changes in interest rates or exchange rates; and changes in the actual or perceived volatility of the relevant stock market and underlying securities. In addition, the risks of loss associated with derivatives that provide short investment exposure and short sales of securities are theoretically unlimited. |
| Leveraging Risk The use of reverse repurchase agreements and other derivatives creates leverage. Leverage increases the Funds losses when the value of its investments (including derivatives) declines. |
| Counterparty Risk The Fund runs the risk that the counterparty to a derivatives contract, a clearing member used by the Fund to hold a cleared derivatives contract, or a borrower of the Funds securities will be unable or unwilling to make timely settlement payments, return the Funds margin, or otherwise honor its obligations. |
| Focused Investment Risk Investments focused in countries, regions, sectors, industries, or issuers that are subject to the same or similar risk factors and investments whose prices are strongly correlated are subject to greater overall risk than investments that are more diversified. |
| Non-U.S. Investment Risk The market prices of many non-U.S. securities fluctuate more than those of U.S. securities. Many non-U.S. securities markets are less stable, smaller, less liquid and less regulated than U.S. securities markets, and the cost of trading in those markets often is higher than in U.S. securities markets. Non-U.S. portfolio transactions generally involve higher commission rates, transfer taxes, and custodial costs than similar transactions in the United States. In addition, the Fund may be subject to non-U.S. taxes, including potentially on a retroactive basis, on (i) capital gains it realizes or dividends, interest, or other amounts it realizes or accrues in respect of non-U.S. investments, (ii) transactions in those investments, and (iii) repatriation of proceeds generated from the sale or other disposition of those investments. Also, the Fund needs a license to invest directly in many non-U.S. securities markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some non-U.S. securities markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Funds investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of non-U.S. issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which may be predominantly based on only a few industries or dependent on revenues from particular commodities and which often are more volatile than the economies of developed countries. |
| Management and Operational Risk The Fund runs the risk that GMOs investment techniques will fail to produce desired results. GMO often uses quantitative analyses and models as part of its investment process. All models support portfolio decisions but are not necessarily predictive of future market events. These analyses and models also make simplifying assumptions that may limit their effectiveness. In addition, there are limitations (e.g., inaccuracies, staleness) on the data available for analysis or manipulation by the models. Any of those assumptions and/or limitations could adversely affect the Funds performance. The Fund also runs the risk that GMOs assessment of an investment may be wrong or that deficiencies in GMOs or another service providers internal systems or controls will cause losses for the Fund or impair Fund operations. |
| Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events, as well as other changes in non-U.S. and U.S. economic and political conditions, could adversely affect the value of the Funds investments. |
19
GMO WORLD OPPORTUNITY OVERLAY FUND
| Large Shareholder Risk To the extent that a large number of shares of the Fund is held by a single shareholder (e.g., an institutional investor or another GMO Fund) or a group of shareholders with a common investment strategy (e.g., GMO asset allocation accounts), the Fund is subject to the risk that a redemption by those shareholders of all or a large portion of their Fund shares will cause the Fund to sell securities at disadvantageous prices or otherwise will disrupt the Funds operations. |
Management of the Fund
Investment Adviser: Grantham, Mayo, Van Otterloo & Co. LLC
Investment Team and Senior Members of GMO primarily responsible for portfolio management of the Fund:
Investment Team |
Senior Member (Length of Service with Fund) |
Title |
||
Developed Fixed Income | Ben Inker (since 2014) | Co-Head, Asset Allocation Team and Co-Head, Developed Fixed Income Team, GMO. | ||
Developed Fixed Income | Sam Wilderman (since 2014) | Co-Head, Asset Allocation Team and Co-Head, Developed Fixed Income Team, GMO. | ||
Developed Fixed Income | Michael Emanuel (since February 2015) | Portfolio Manager, Developed Fixed Income Team, GMO. | ||
Developed Fixed Income | Greg Jones (since February 2015) | Portfolio Manager, Developed Fixed Income Team, GMO. |
Purchase and Sale of Fund Shares
Currently, shares of the Fund are principally available for purchase by other GMO Funds and certain other accredited investors. All investors must be accredited investors as defined in Regulation D under the Securities Act of 1933.
Under ordinary circumstances, you may purchase the Funds shares directly from the Trust on days when both the New York Stock Exchange (NYSE) and the U.S. bond markets are open for business.
No minimum initial investment is required to purchase shares of the Fund. For investors owning shares of the Fund, no minimum additional investment is required to purchase additional shares of the Fund.
Fund shares are redeemable and, under ordinary circumstances, you may redeem the Funds shares on days when both the NYSE and the U.S. bond markets are open for business. Redemption orders should be submitted directly to the Trust. For instructions on redeeming shares, call the Trust at 1-617-346-7646 or send an e-mail to SHS@GMO.com.
Purchase order forms and redemption orders can be submitted by mail, facsimile, or e-mail (or by other form of communication pre-approved by GMO Shareholder Services) to the Trust at:
GMO Trust
c/o Grantham, Mayo, Van Otterloo & Co. LLC
40 Rowes Wharf
Boston, Massachusetts 02110
Facsimile: 1-617-439-4192
Attention: Shareholder Services
E-mail: clientorder@gmo.com
Tax Information
The Fund expects to be treated as a partnership for U.S. federal income tax purposes. In general, a partnership is not itself subject to U.S. federal income tax. Instead, each shareholder is required to take into account its distributive share of the Funds income, gain, loss, deduction, credit, and other tax items for each taxable year substantially as though such items had been realized directly by the shareholder and without regard to whether the Fund has made or will make any cash distributions to its shareholders. Accordingly, it is possible that a shareholder will incur income tax liabilities in a taxable year in respect of its investment in the Fund that exceed cash distributions (if any) made by the Fund for that year.
The Fund may declare and pay non-redeeming distributions to its shareholders in the sole discretion of the Trustees (or their delegates).
20
ADDITIONAL INFORMATION ABOUT THE FUNDS INVESTMENT STRATEGIES, RISKS, AND EXPENSES
Fund Summaries. The preceding sections contain a summary of the investment objective, fees and expenses, principal investment strategies, principal risks, management, and other important information for each series of the Trust listed on the cover page of this Private Placement Memorandum. The summaries are not all-inclusive, and a Fund may make investments, employ strategies, and be exposed to risks that are not described in its summary. More information about the Funds investments and strategies is contained in the SAI. See page 72 of this Private Placement Memorandum for information about how to receive the SAI. Additional information about the Funds benchmarks may be found under Fund Benchmarks.
Fundamental Investment Objectives/Policies. The Board of Trustees (Trustees) of the Trust may change a Funds investment objective or policies without shareholder approval or prior notice unless an objective or policy is identified in this Private Placement Memorandum or in the SAI as fundamental. Neither the Funds nor GMO guarantee that the Funds will be able to achieve their investment objectives. A Fund, by itself, is not intended to provide a complete investment program, and investment in a Fund should only be considered as part of a diversified portfolio that includes other investments.
Tax Consequences. Unless otherwise specified in this Private Placement Memorandum or in the SAI, GMO is not obligated to, and generally will not consider tax consequences when seeking to achieve a Funds investment objective (e.g., a Fund may engage in transactions or make investments in a manner that is not tax efficient for U.S. federal income or other federal, state, local, or non-U.S. tax purposes).
In particular, a Funds investment either directly or indirectly through a wholly-owned subsidiary could affect the amount, timing and character of its allocations or distributions, as applicable, and, in the case of GAAR Implementation Fund, the amount, timing, and character of BFFs distributions to its shareholders. In addition, such an investment could cause a Fund, its shareholders or sole shareholder, as applicable, to recognize taxable income in excess of the cash generated by such investment, requiring the Fund, its shareholders or sole shareholder, as applicable, in turn to liquidate investments at disadvantageous times to generate cash needed to make required distributions. See Taxes in the SAI for more information about the tax consequences of a Funds investments through a wholly-owned subsidiary.
Because portfolio turnover is not a principal consideration when GMO makes investment decisions for the Funds, GMO may cause a Fund to trade more frequently at times based on its assessment of market conditions and purchase or redemption requests. The Funds are not subject to any limit on the frequency with which portfolio securities may be purchased or sold. High turnover rates may create additional taxable income and gains for shareholders. Because for U.S. federal income tax purposes GMO GAAR Implementation Fund will be an entity disregarded as separate from its sole shareholder, BFF, a higher portfolio turnover rate for GMO GAAR Implementation Fund may create additional taxable income and gains for BFF shareholders. If portfolio turnover results in the recognition of short-term capital gains, those gains, when distributed or allocated, as applicable, typically are taxed to shareholders at ordinary income tax rates. See Distributions and Taxes below for more information.
Special Considerations for Systematic Global Macro Opportunity Fund and World Opportunity Overlay Fund. Each of these Funds expects to be treated as a partnership for U.S. federal income tax purposes. Income and/or gains from certain of such Funds investment practices may be treated as unrelated business taxable income (UBTI) and subject to tax when allocated to U.S. tax-exempt shareholders.
See Distributions and Taxes below for more information about the tax consequences to shareholders of investing in the Funds.
21
Certain Definitions. When used in this Private Placement Memorandum, the term invest includes both direct and indirect investing and the term investments includes both direct and indirect investments. For example, a Fund may invest indirectly in a given asset or asset class by investing in another GMO Fund or a wholly-owned subsidiary or by investing in derivatives and synthetic instruments.
When used in this Private Placement Memorandum, (i) the terms bonds, fixed income investments, and fixed income securities include (a) obligations of an issuer to make payments on future dates of principal, interest (whether fixed or variable) or both and (b) synthetic debt instruments created by GMO by using derivatives (e.g., a futures contract, swap contract, currency forward or option); (ii) the term emerging countries means the worlds less developed countries; (iii) the term equities refers to investments (as defined above) in common and preferred stocks and other stock-related securities, such as convertible securities, depositary receipts, and exchange-traded equity real estate investment trusts (REITs) and income trusts; (iv) the term sovereign debt refers to a fixed income security issued or guaranteed by a government or a governmental agency or political subdivision, or synthetic sovereign debt; and (v) the term total return includes capital appreciation and income.
Credit Quality. For purposes of this Private Placement Memorandum, the term investment grade refers to a rating of Baa3/P-2 or better by Moodys Investors Service, Inc. (Moodys) or BBB-/A-2 or better by Standard & Poors Ratings Services (S&P) and the term below investment grade refers to any rating by Moodys or by S&P below those ratings. Fixed income securities rated below investment grade are commonly referred to as high yield or junk bonds. In addition, in this Private Placement Memorandum, securities and commercial paper that are rated Aa/P-1 or better by Moodys or AA/A-1 or better by S&P are sometimes referred to as high quality. Securities referred to in this Private Placement Memorandum as investment grade, below investment grade, or high quality include securities rated by Moodys, S&P or both, and unrated securities that GMO determines have comparable credit qualities.
Duration. For purposes of this Private Placement Memorandum, the term duration refers to the weighted measure of interest rate sensitivity of a fixed income security. GMO employs a variety of techniques to adjust the sensitivity of a Funds net asset value to changes in interest rates. This sensitivity is often measured by, and correlates with, the estimated interest rate duration of a Funds portfolio. For example, the value of an investment held by a Fund with a duration of five years decreases by approximately 5% for every 1% increase in interest rates, while the value of an investment with a duration of six years increases by approximately 6% with every 1% decrease in interest rates. In the case of High Quality Short-Duration Bond Fund, the Principal Investment Strategies section of the Fund Summary provides the Funds dollar-weighted average interest rate duration. GMO estimates that duration by aggregating the durations of the Funds direct and indirect individual holdings and weighting each holding based on its market value. Duration needs to be estimated when the obligor is required to prepay principal or interest on a fixed income security and the payments are not denominated in U.S. dollars. GMO may significantly alter the duration of a Fund by using derivatives.
Investments in Other GMO Funds. Some Funds may invest in other GMO Funds. See Investment in Other GMO Funds beginning on page 69 of this Private Placement Memorandum for a more detailed description of the investment objectives and strategies of these GMO Funds.
Investments in U.S. Treasury Fund and Unaffiliated Money Market Funds. Each of the Funds, other than World Opportunity Overlay Fund, may invest in GMO U.S. Treasury Fund, and each of the Funds may invest in money market funds unaffiliated with GMO.
Benchmarks. Fund benchmarks (if any) listed in the Fund summaries are described under Fund Benchmarks. In some cases, a Funds summary states that a Fund seeks total return greater than that of its benchmark. Neither the Funds nor GMO can provide any assurance that this goal will be
22
achieved. A Funds benchmark is stated as of the date of this Private Placement Memorandum and may be changed without notice to shareholders.
Fee and Expense Information. The following paragraphs contain additional information about the fee and expense information included in the Fund summaries.
Annual Fund Operating Expenses Other Expenses and Acquired Fund Fees and Expenses. The amounts listed under Other Expenses in the Annual Fund Operating Expenses table included in each Funds summary generally reflect direct expenses associated with an investment in a Fund for the fiscal year ended February 28, 2015, or, in the case of a Fund that had not commenced operations as of February 28, 2015, estimated direct expenses associated with an investment in the Fund for its initial fiscal year. A Fund may invest in other GMO Funds as well as exchange-traded funds (ETFs) and other pooled investment vehicles (collectively, the acquired funds), and by the indirect net expenses associated with a Funds investment (if any) in acquired funds are reflected in Other Expenses if those expenses are less than 0.01% of the average net assets of the Fund. If the indirect net expenses associated with a Funds investment in acquired funds (acquired fund fees and expenses) are 0.01% or more of the Funds average net assets, these expenses are reflected in the Annual Fund Operating Expenses table under Acquired Fund Fees and Expenses. Acquired fund fees and expenses do not include expenses associated with investments in the securities of unaffiliated companies unless those companies hold themselves out to be investment companies. Acquired fund fees and expenses generally are based on expenses incurred by the Fund for the fiscal year ended February 28, 2015, and actual indirect expenses will vary depending on the particular acquired funds in which the Fund invests.
Temporary Defensive Positions. Temporary defensive positions are positions that are inconsistent with a Funds principal investment strategies and are taken in response to adverse market, economic, political, or other conditions.
Each Fund may take temporary defensive positions if deemed prudent by GMO. World Opportunity Overlay Fund has previously taken temporary defensive positions and has exercised the right to honor redemption requests in-kind.
To the extent a Fund takes a temporary defensive position, or otherwise holds cash, cash equivalents, or high quality debt investments on a temporary basis, the Fund may not achieve its investment objective.
23
DESCRIPTION OF PRINCIPAL RISKS
The following chart identifies the Principal Risks associated with each Fund. Risks not marked for a particular Fund may, however, still apply to some extent to that Fund at various times.
GAAR
Implementation Fund |
High Quality Short-
Duration Bond Fund |
Systematic Global
Macro Opportunity Fund |
World Opportunity
Overlay Fund |
|||||
Market Risk Equities |
| | ||||||
Market Risk Fixed Income Investments |
| | | | ||||
Market Risk Asset-Backed Securities |
| | | | ||||
Credit Risk |
| | | | ||||
Illiquidity Risk |
| | | | ||||
Smaller Company Risk |
| |||||||
Derivatives and Short Sales Risk |
| | | | ||||
Non-U.S. Investment Risk |
| | | | ||||
Currency Risk |
| | | |||||
Focused Investment Risk |
| | | | ||||
Leveraging Risk |
| | | | ||||
Counterparty Risk |
| | | | ||||
Commodities Risk |
| | ||||||
Merger Arbitrage Risk |
| |||||||
Market Disruption and Geopolitical Risk |
| | | | ||||
Large Shareholder Risk |
| | | | ||||
Management and Operational Risk |
| | | | ||||
Fund of Funds Risk |
| | | |||||
Non-Diversified Funds |
| | | |
Investing in mutual funds involves many risks. Factors that may affect a particular Funds portfolio as a whole, called principal risks, are discussed briefly in each Funds summary and in additional detail in this section. The risks of investing in a particular Fund depend on the types of investments in its portfolio and the investment strategies GMO employs on its behalf. This section describes the principal risks and some related risks but does not describe every potential risk of investing in the Funds. Funds could be subject to additional risks because of the types of investments they make and market conditions, which may change over time. The SAI includes more information about the Funds and their investments.
Each Fund that invests in other GMO Funds or other investment companies (collectively, Underlying Funds) or in a wholly-owned subsidiary (as indicated under Principal Investment Strategies in those Funds summaries and further described in Additional Information About the Funds Investment Strategies, Risks, and Expenses) is exposed to the risks to which the Underlying Funds or wholly-owned subsidiary are exposed, as well as the risk that the Underlying Funds or wholly-owned subsidiary will not perform as expected. Therefore, unless otherwise noted, the principal risks summarized below include both direct and indirect risks, and, as indicated in the Additional Information About the Funds Investment Strategies, Risks, and Expenses section of this Private Placement Memorandum, references in this section to investments made by a Fund include those made both directly by the Fund and indirectly by the Fund through Underlying Funds or a wholly-owned subsidiary.
An investment in a Fund, by itself, generally does not provide a complete investment program but rather is intended to serve as part of an investors overall investment program. An investment in a Fund is not a bank deposit and, therefore, is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency.
24
MARKET RISK. All of the Funds are subject to market risk, which is the risk that the market value of their holdings will decline. Market risks include:
Equities. Funds that invest in equities run the risk that the market prices of equities will decline. That decline may be attributable to factors affecting the issuing company, such as poor performance by the companys management or reduced demand for its goods or services, or to factors affecting a particular industry, such as a decline in demand, labor or raw material shortages, or increased production costs. A decline also may result from general market conditions not specifically related to a company or industry, such as real or perceived adverse economic conditions, changes in the general outlook for corporate earnings, changes in interest or currency rates, or adverse investor sentiment generally. Equities generally have significant price volatility, and their market prices can decline in a rapid or unpredictable manner. If a Fund purchases equities for less than their value as determined by GMO, the Fund runs the risk that their market price will not appreciate or will decline for a variety of reasons, one of which may be GMOs incorrect assessment of their intrinsic value. The market prices of equities trading at high multiples of current earnings often are more sensitive to changes in future earnings expectations than the market prices of equities trading at lower multiples.
Fixed Income Investments. Funds that invest in fixed income securities (including bonds, notes, bills, synthetic debt instruments, and asset-backed securities) are subject to various market risks. The market price of a fixed income investment can decline due to market-related factors, including rising interest rates and widening credit spreads, or decreased liquidity stemming from the markets uncertainty about the value of a fixed income investment (or class of fixed income investments). In addition, the market price of fixed income investments with complex structures, such as asset-backed securities, and sovereign and quasi-sovereign debt instruments can decline due to market uncertainty about their credit quality and the reliability of their payment streams. Some fixed income securities also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as was provided by the fixed income security. When interest rates rise, these securities also may be repaid more slowly than anticipated, and the market price of the Funds investment may decrease. During periods of economic uncertainty and change, the market price of a Funds investments in below investment grade securities (commonly referred to as junk bonds) may be particularly volatile. Often below investment grade securities are subject to greater sensitivity to interest rate and economic changes than higher rated bonds and can be more difficult to value (see Determination of Net Asset Value), exposing a Fund to the risk that the price at which it sells them will be less than the price at which they were valued when held by the Fund. See Credit Risk and Illiquidity Risk below for more information about these risks.
A principal risk run by each Fund with a significant investment in fixed income securities is that an increase in prevailing interest rates will cause the market price of those securities to decline. The risk associated with increases in interest rates (also called interest rate risk) is generally greater for Funds investing in fixed income securities with longer durations. In addition, in managing some Funds, GMO may seek to evaluate potential investments in part by considering the volatility of interest rates. The value of a Funds investments may be significantly reduced if GMOs assessment proves incorrect.
The extent to which a fixed income securitys price changes with changes in interest rates is referred to as interest rate duration, which can be measured mathematically or empirically. A longer-maturity investment generally has longer interest rate duration because the investments fixed rate is locked in for a longer period of time. Floating-rate or adjustable-rate securities, however, generally have shorter interest rate durations because their interest rates are not fixed but rather float up and down as interest rates change. Conversely, inverse floating-rate securities have durations that move in the opposite direction from short-term interest rates and thus tend to underperform fixed rate securities when interest rates rise but outperform them when interest rates decline. Fixed income securities paying no interest, such as zero coupon and principal-only securities, are subject to additional interest rate risk.
25
The market price of inflation-indexed bonds (including Inflation-Protected Securities issued by the U.S. Treasury (TIPS)) typically declines during periods of rising real interest rates (i.e., nominal interest rate minus inflation) and increases during periods of declining real interest rates. In some interest rate environments, such as when real interest rates are rising faster than nominal interest rates, the market price of inflation-indexed bonds may decline more than the price of non-inflation indexed (or nominal) fixed income bonds with similar maturities.
Fixed income securities denominated in foreign currencies also are subject to currency risk. See Currency Risk below.
In response to government intervention, economic or market developments, or other factors, fixed income markets may experience periods of high volatility, reduced liquidity or both. During those periods, a Fund could have unusually high shareholder redemptions, requiring it to generate cash by selling securities when it would otherwise not do so, including at unfavorable prices. Fixed income investments may be difficult to value during such periods. In recent periods, central banks and governmental financial regulators, including the U.S. Federal Reserve, have maintained historically low interest rates by purchasing bonds. Steps to curtail or taper such activities and other actions by central banks or regulators (such as intervention in foreign currency markets or currency controls) could have a material adverse effect on the Funds.
Asset-Backed Securities. Investments in asset-backed securities not only are subject to all of the market risks described above for fixed income securities but to other market risks as well.
A Funds investments in asset-backed securities are exposed to greater risk of severe credit downgrades, illiquidity, and defaults than many other types of fixed income investments. These risks are particularly acute during periods of adverse market conditions, such as those that occurred in 2008. Asset-backed securities may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, and credit-card receivables. They also may be backed by pools of corporate or sovereign bonds, bank loans to corporations, or a combination of bonds and loans (commonly referred to as collateralized debt obligations or collateralized loan obligations) and by the fees payable to service providers.
As described under Market Risk Fixed Income Investments above, the market price of fixed income investments with complex structures, such as asset-backed securities, can decline due to a variety of factors, including market uncertainty about their credit quality and the reliability of their payment streams. Payment of interest on asset-backed securities and repayment of principal largely depend on the cash flow generated by the assets backing the securities, as well as the deal structure (e.g., the amount of underlying assets or other support available to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets, the level of credit support and the credit quality of the credit-support provider, if any, and the reliability of various other service providers with access to the payment stream. A problem in any one of these factors can lead to a reduction in the payment stream GMO expected a Fund to receive at the time the Fund purchased the asset-backed security. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. Asset-backed securities backed by sub-prime mortgage loans, in particular, may expose a Fund to significantly greater declines in value due to defaults because sub-prime mortgage loans are typically made to less creditworthy borrowers and thus have a higher risk of default than conventional mortgage loans. The obligations of issuers (and obligors of asset-backed securities) also are subject to bankruptcy, insolvency and other laws affecting the rights and remedies of creditors. As of the date of this Private Placement Memorandum, many asset-backed securities owned by World Opportunity Overlay Fund that were once rated investment grade are now rated below investment grade. See Credit Risk below for more information about credit risk.
26
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the market prices of asset-backed and other fixed income securities. These conditions may occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market price of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of documentation for underlying assets also may affect the rights of holders of those underlying assets. The insolvency of an entity that generated the assets underlying an asset-backed security is likely to result in a decline in the market price of that security, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as was provided by the asset-backed security. When interest rates rise, these obligations also may be repaid more slowly than anticipated, and the market price of the Funds investment may decrease. In addition, the existence of insurance on an asset-backed security does not guarantee that the principal and interest will be paid because the insurer could default on its obligations.
The risk of investing in asset-backed securities has increased since the deterioration in worldwide economic and liquidity conditions referred to above because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated. See Focused Investment Risk below for more information about risks of investing in correlated sectors. A single financial institution may serve as trustee for many asset-backed securities. As a result, a disruption in that institutions business may have a material impact on many investments. The risks associated with asset-backed securities are particularly pronounced for World Opportunity Overlay Fund because it invests a significant portion of its assets in asset-backed securities.
CREDIT RISK. This is the risk that the issuer or guarantor of a fixed income investment or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligation to pay principal and interest or otherwise to honor its obligations in a timely manner. The market price of a fixed income investment will normally decline as a result of the issuers, guarantors, or obligors failure to meet its payment obligations or the downgrading of its credit rating. This risk is particularly acute in environments (like those of 2008) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions.
All fixed income securities are subject to credit risk. Financial strength and solvency of an issuer are the primary factors influencing credit risk. The risk varies depending upon whether the issuer is a corporation, a government or government entity, whether the particular security has a priority over other obligations of the issuer in payment of principal and interest and whether it has any collateral backing or credit enhancement. Credit risk may change over the term of a fixed income security. U.S. government securities are subject to varying degrees of credit risk depending upon whether the securities are supported by the full faith and credit of the United States, supported by the ability to borrow from the U.S. Treasury, supported only by the credit of the issuing U.S. government agency, instrumentality, or
27
corporation, or otherwise supported by the United States. For example, issuers of many types of U.S. government securities (e.g., the Federal Home Loan Mortgage Corporation (Freddie Mac), Federal National Mortgage Association (Fannie Mae), and Federal Home Loan Banks), although chartered or sponsored by Congress, are not funded by Congressional appropriations and their fixed income securities, including mortgage-backed and other asset-backed securities, are neither guaranteed nor insured by the U.S. government. These securities are subject to more credit risk than U.S. government securities that are supported by the full faith and credit of the United States (e.g., U.S. Treasury bonds). Investments in sovereign debt involve the risk that the governmental entities responsible for repayment may be unable or unwilling to pay interest and repay principal when due. A governmental entitys ability and willingness to pay interest and repay principal in a timely manner may be affected by a variety of factors, including its cash flow, the size of its reserves, its access to foreign exchange, the relative size of its debt service burden to its economy as a whole, and political constraints. Investments in quasi-sovereign issuers are subject to the additional risk that the issuer may default independently of its sovereign. Sovereign debt risk is greater for fixed income securities issued or guaranteed by emerging countries.
In many cases, the credit risk of a fixed income security is reflected in its credit ratings, and a Fund holding a rated security is subject to the risk that the investments rating will be downgraded.
Securities issued by the U.S. government historically have presented minimal credit risk. However, recent events have led to a downgrade in the long-term credit rating of U.S. bonds by several major rating agencies and have introduced greater uncertainty about the repayment by the United States of its obligations. A further credit rating downgrade could decrease, and a default in the payment of principal or interest on U.S. government securities would decrease, the value of a Funds investments and could increase the volatility of a Funds portfolio.
As described under Market Risk Asset-Backed Securities above, asset-backed securities may be backed by many types of assets and their payment of interest and repayment of principal largely depend on the cash flows generated by the assets backing them. The credit risk of a particular asset-backed security depends on many factors, as described under Market Risk Asset-Backed Securities above.
The obligations of issuers also may be subject to bankruptcy, insolvency and other laws affecting the rights and remedies of creditors. A Fund also is exposed to credit risk on a reference security to the extent it writes protection under credit default swaps. See Derivatives and Short Sales Risk below for more information regarding risks associated with the use of credit default swaps.
The extent to which the market price of a fixed income security changes in response to a credit event depends on many factors and can be difficult to predict. For example, even though the effective duration of a long-term floating rate security is very short, an adverse credit event or change in the perceived creditworthiness of its issuer could cause its market price to decline much more than its effective duration would suggest.
Credit risk is particularly pronounced for below investment grade securities (commonly referred to as junk bonds), which are defined in this Private Placement Memorandum under Additional Information About the Funds Investment Strategies, Risks, and Expenses Certain Definitions Credit Quality. The sovereign debt of many non-U.S. governments, including their sub-divisions and instrumentalities, is below investment grade. Many asset-backed securities also are below investment grade. Below investment grade securities have speculative characteristics, often are less liquid than higher quality securities, present a greater risk of default and are more susceptible to real or perceived adverse industry conditions. Investments in distressed or defaulted debt securities generally are considered speculative and may involve substantial risks not normally associated with investments in higher quality securities, including adverse business, financial or economic conditions that can lead to payment defaults and insolvency proceedings on the part of their issuers. In particular, distressed or defaulted obligations might be repaid, if at all, only after lengthy workout or bankruptcy proceedings, during which the issuer
28
might not make any interest or other payments, and a Fund may incur additional expenses to seek recovery. If GMOs assessment of the eventual recovery value of a distressed or defaulted debt security proves incorrect, a Fund may lose a substantial portion or all of its investment or may be required to accept cash or instruments worth less than its original investment. In the event of default of sovereign debt, the Funds may be unable to pursue legal action against the issuer.
ILLIQUIDITY RISK. Illiquidity risk is the risk that low trading volume, lack of a market maker, large position size, or legal restrictions (including daily price fluctuation limits or circuit breakers) limits or prevents a Fund from selling particular securities or closing derivative positions at desirable prices. In addition to these risks, a Fund is exposed to illiquidity risk when it has an obligation to purchase particular securities (e.g., as a result of entering into reverse repurchase agreements, writing a put, or closing a short position). To the extent a Funds investments include asset-backed securities, distressed or defaulted debt securities, emerging country debt securities, securities of companies with smaller market capitalizations or smaller total float-adjusted market capitalizations, or emerging market securities, it is subject to increased illiquidity risk. These types of investments can be difficult to value (see Determination of Net Asset Value), exposing a Fund to the risk that the price at which it sells them will be less than the price at which they were valued when held by the Fund. Illiquidity risk also may be greater in times of financial stress. For example, TIPS have experienced periods of greatly reduced liquidity during disruptions in fixed income markets, such as the events surrounding the bankruptcy of Lehman Brothers in 2008. Less liquid securities are more susceptible than other securities to price declines when market prices decline generally.
All of the Funds with benchmarks may buy securities that are less liquid than those in their benchmarks.
SMALLER COMPANY RISK. Companies with smaller market capitalizations, including small- and mid-cap companies, may have limited product lines, markets, or financial resources, may lack the competitive strength of larger companies, may have inexperienced managers or may depend on a few key employees. In addition, their securities often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations. Market risk and illiquidity risk are particularly pronounced for securities of these companies.
DERIVATIVES AND SHORT SALES RISK. All of the Funds may invest in derivatives, which are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices. Derivatives involve the risk that their value may not change as expected relative to changes in the value of the assets, rates, or indices they are designed to track. Derivatives include futures contracts, forward contracts, foreign currency contracts, swap contracts, contracts for differences, options on securities and indices, options on futures contracts, options on swap contracts, interest rate caps, floors and collars, reverse repurchase agreements, and other over-the-counter (OTC) contracts. Derivatives may relate to securities, commodities, currencies, currency exchange rates, interest rates, inflation rates, and indices. The SAI describes the various types of derivatives in which the Funds invest and how they are used in the Funds investment strategies.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks of investing directly in securities and other more traditional assets. In particular, a Funds use of OTC derivatives exposes it to the risk that the counterparties will be unable or unwilling to make timely settlement payments or otherwise honor their obligations. An OTC derivatives contract typically can be closed only with the consent of the other party to the contract. If the counterparty defaults, the Fund will still have contractual remedies but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund, and if it does, the Fund may decide not to pursue its claims against the counterparty to avoid the cost and unpredictability of legal proceedings. The Fund, therefore, may be
29
unable to obtain payments GMO believes are owed to it under OTC derivatives contracts, or those payments may be delayed or made only after the Fund has incurred the cost of litigation.
A Fund may invest in derivatives that (i) do not require the counterparty to post collateral (e.g., foreign currency forwards), (ii) require collateral but that do not provide for the Funds security interest in it to be perfected, (iii) require a significant upfront deposit by the Fund unrelated to the derivatives intrinsic value, or (iv) do not require that collateral be regularly marked-to-market. When a counterpartys obligations are not fully secured by collateral, a Fund runs a greater risk of being unable to recover what it is owed if the counterparty defaults. Even when derivatives are required by contract to be collateralized, a Fund typically will not receive the collateral for one or more days after the collateral is required to be posted.
The Funds may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Funds. Derivatives risk is particularly acute in environments (like those of 2008) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. In addition, during those periods, a Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives in which it has invested.
Derivatives also present other risks described in this section, including market risk, illiquidity risk, currency risk, credit risk, and counterparty risk. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used may not produce valuations that are consistent with the values a Fund realizes when it closes or sells an OTC derivative. Valuation risk is more pronounced when a Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of a Funds net asset value.
A Funds use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of a Fund, the Funds will not be permitted to trade with that counterparty. In addition, GMO may decide not to use derivatives to hedge or otherwise reduce a Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives risk is particularly pronounced for Funds (such as Systematic Global Macro Opportunity Fund and World Opportunity Overlay Fund) for which a basic component of the Funds principal investment strategies involves using derivatives, in particular, exchange-traded futures and forward foreign exchange contracts, in which Systematic Global Macro Opportunity Fund invests to gain indirect exposure to global equities, bonds, currencies and commodities.
Swap contracts and other OTC derivatives are highly susceptible to illiquidity risk (see Illiquidity Risk above) and counterparty risk (see Counterparty Risk below). These derivatives are also subject to documentation risk, which is the risk that ambiguities, inconsistencies or errors in the documentation relating to a derivative transaction may lead to a dispute with the counterparty or unintended investment results. In addition, see Commodities Risk below for a discussion of risks specific to commodity-related derivatives. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. See Leveraging Risk below.
30
A Funds use of derivatives may be subject to special tax rules and could generate additional taxable income for shareholders. In addition, the tax treatment of a Funds use of derivatives may be unclear because there is little case or other law interpreting the terms of most derivatives or determining their tax treatment. See Taxes below.
Derivatives Regulation . The U.S. government has enacted legislation that provides for new regulation of the derivatives market, including clearing, margin, reporting, and registration requirements. The European Union (and some other countries) are implementing similar requirements, which will affect a Fund when it enters into a derivatives transaction with a counterparty organized in that country or otherwise subject to that countrys derivatives regulations. Because these requirements are new and evolving (and some of the rules are not yet final), their ultimate impact remains unclear.
Transactions in some types of swaps (including interest rate swaps and credit default swaps on North American and European indices) are required to be centrally cleared. In a transaction involving those swaps (cleared derivatives), a Funds counterparty is a clearing house rather than a bank or broker. Since the Funds are not members of clearing houses and only members of a clearing house (clearing members) can participate directly in the clearing house, the Funds hold cleared derivatives through accounts at clearing members. In cleared derivatives positions, the Funds make payments (including margin payments) to and receive payments from a clearing house through their accounts at clearing members. Clearing members guarantee performance of their clients obligations to the clearing house.
In some ways, cleared derivative arrangements are less favorable to mutual funds than bilateral arrangements, for example, by requiring that funds provide more margin for their cleared derivatives positions. Also, as a general matter, in contrast to a bilateral derivatives position, following a period of notice to a Fund, a clearing member at any time can require termination of an existing cleared derivatives position or an increase in margin requirements above those required at the outset of a transaction. Clearing houses also have broad rights to increase margin requirements for existing positions or to terminate those positions at any time. Any increase in margin requirements or termination of existing cleared derivatives positions by the clearing member or the clearing house could interfere with the ability of a Fund to pursue its investment strategy. Further, any increase in margin requirements by a clearing member could expose a Fund to greater credit risk to its clearing member because margin for cleared derivatives positions in excess of a clearing houses margin requirements typically is held by the clearing member (see Counterparty Risk below). Also, a Fund is subject to risk if it enters into a derivatives transaction that is required to be cleared (or that GMO expects to be cleared), and no clearing member is willing or able to clear the transaction on the Funds behalf. While the documentation in place between the Funds and their clearing members generally provides that the clearing members will accept for clearing all cleared derivatives transactions that are within credit limits (specified in advance) for each Fund, the Funds are still subject to the risk that no clearing member will be willing or able to clear a transaction. In those cases, the position might have to be terminated, and the Fund could lose some or all of the benefit of the position, including loss of an increase in the value of the position and loss of hedging protection. In addition, the documentation governing the relationship between the Funds and clearing members is drafted by the clearing members and generally is less favorable to the Funds than typical bilateral derivatives documentation. For example, documentation relating to cleared derivatives generally includes a one-way indemnity by the Funds in favor of the clearing member for losses the clearing member incurs as the Funds clearing member and typically does not provide the Funds any remedies if the clearing member defaults or becomes insolvent. While futures contracts entail similar risks, the risks likely are more pronounced for cleared derivatives due to their more limited liquidity and market history.
Some types of cleared derivatives are required to be executed on an exchange or on a swap execution facility. A swap execution facility is a trading platform where multiple market participants can execute derivatives by accepting bids and offers made by multiple other participants in the platform. While this execution requirement is designed to increase transparency and liquidity in the cleared
31
derivatives market, trading on a swap execution facility can create additional costs and risks for the Funds. For example, swap execution facilities typically charge fees, and if a Fund executes derivatives on a swap execution facility through a broker intermediary, the intermediary may impose fees as well. Also, a Fund may indemnify a swap execution facility, or a broker intermediary who executes cleared derivatives on a swap execution facility on the Funds behalf, against any losses or costs that may be incurred as a result of the Funds transactions on the swap execution facility. If a Fund wishes to execute a package of transactions that include a swap that is required to be executed on a swap execution facility as well as other transactions (for example, a transaction that includes both a security and an interest rate swap that hedges interest rate exposure with respect to such security), the Fund may be unable to execute all components of the package on the swap execution facility. In that case, the Fund would need to trade some components of the package on the swap execution facility and other components in another manner, which could subject the Fund to the risk that some components would be executed successfully and others would not, or that the components would be executed at different times, leaving the Fund with an unhedged position for a period of time.
The U.S. government and the European Union have proposed mandatory minimum margin requirements for bilateral derivatives. Such requirements could increase the amount of margin required to be provided by a Fund in connection with its derivatives transactions and, therefore, make derivatives transactions more expensive.
These and other new rules and regulations could, among other things, further restrict a Funds ability to engage in, or increase the cost to the Fund of, derivatives transactions, for example, by making some types of derivatives no longer available to the Fund or otherwise limiting liquidity. The implementation of the clearing requirement has increased the costs of derivatives transactions for the Funds, since the Funds have to pay fees to their clearing members and are typically required to post more margin for cleared derivatives than they have historically posted for bilateral derivatives. The costs of derivatives transactions are expected to increase further as clearing members raise their fees as to cover the costs of additional capital requirements and other regulatory changes applicable to the clearing members, and when rules imposing mandatory minimum margin requirements on bilateral swaps become effective. These rules and regulations are new and evolving, so their potential impact on the Funds and the financial system are not yet known. While the new rules and regulations and central clearing of some derivatives transactions are designed to reduce systemic risk (i.e., the risk that the interdependence of large derivatives dealers could cause them to suffer liquidity, solvency or other challenges simultaneously), there is no assurance that they will achieve that result, and in the meantime, as noted above, central clearing and related requirements expose the Funds to new kinds of costs and risks.
Options . Some Funds are permitted to write options. The market price of an option is affected by many factors, including changes in the market prices or dividend rates of underlying securities (or in the case of indices, the securities in such indices); the time remaining before expiration; changes in interest rates or exchange rates; and changes in the actual or perceived volatility of the relevant stock market and underlying securities. The market price of an option also may be adversely affected if the market for the option becomes less liquid. In addition, since an American-style option allows the holder to exercise its rights any time before the options expiration, the writer of an American-style option has no control over when it will be required to fulfill its obligations as a writer of the option. (The writer of a European-style option is not subject to this risk because the holder may only exercise the option on its expiration date.) If a Fund writes a call option and does not hold the underlying security or instrument, the Funds potential loss is theoretically unlimited.
National securities exchanges generally have established limits on the maximum number of options an investor or group of investors acting in concert may write. A Fund, GMO, and other funds advised by GMO will likely constitute such a group. If applicable, these limits restrict a Funds ability to purchase or write options on a particular security.
32
Unlike exchange-traded options, which are standardized with respect to the underlying instrument, expiration date, contract size, and strike price, the terms of OTC options (i.e., options not traded on exchanges) generally are established through negotiation with the other party to the option contract. While a Fund has greater flexibility to tailor an OTC option, OTC options generally expose a Fund to greater credit risk than exchange-traded options, which are guaranteed by the clearing organization of the exchanges where they are traded. Purchasing and writing put and call options are highly specialized activities and entail greater than ordinary market risks.
Special tax rules apply to a Funds transactions in options, which could increase the taxes payable by shareholders. In particular, a Funds options transactions potentially could cause a substantial portion of the Funds income to consist of net short-term capital gain, which, when distributed, is taxable to shareholders subject to U.S. income tax at ordinary income tax rates.
Short Investment Exposure. Some Funds may sell securities or currencies short as part of their investment programs in an attempt to increase their returns or for hedging purposes. Short sales expose a Fund to the risk that it will be required to acquire, convert, or exchange a security or currency to replace the borrowed security or currency when the security or currency sold short has appreciated in value, thus resulting in a loss to the Fund. Purchasing a security or currency to close out a short position can itself cause the price of the security or currency to rise further, thereby exacerbating any losses. A Fund that sells short a security or currency it does not own also may have to pay borrowing fees to a broker and may be required to pay the broker any dividends or interest it receives on a borrowed security.
A Fund also may create short investment exposure by taking a derivative position in which the value of the derivative moves in the opposite direction from the price of an underlying investment, pool of investments, index or currency. See Derivatives and Short Sales Risk above for a discussion of the specific risks of a Funds investments in derivatives.
Short sales of securities or currencies a Fund does not own and short derivative positions involve forms of investment leverage, and the amount of the Funds potential loss is theoretically unlimited. A Fund is subject to increased leveraging risk and other investment risks described in this Description of Principal Risks section to the extent it sells short securities or currencies it does not own or takes short derivative positions.
NON-U.S. INVESTMENT RISK. Funds that invest in non-U.S. securities are subject to additional and more varied risks than Funds that only invest in U.S. securities. Non-U.S. securities markets often include securities of only a small number of companies in a small number of industries. As a result, the market prices of many of the securities traded on those markets fluctuate more than those of U.S. securities. In addition, issuers of non-U.S. securities often are not subject to as much regulation as U.S. issuers, and the reporting, accounting, custody, and auditing standards to which those issuers are subject differ, in some cases significantly, from U.S. standards. Transactions in non-U.S. securities generally involve higher commission rates, transfer taxes, and custodial costs. In addition, some jurisdictions may limit a Funds ability to profit from short-term trading (as defined in the relevant jurisdiction).
A Fund may be subject to non-U.S. taxation, including potentially on a retroactive basis, on (i) capital gains it realizes or dividends, interest, or other amounts it realizes or accrues in respect of non-U.S. investments, (ii) transactions in those investments, and (iii) repatriation of proceeds generated from the sale or other disposition of those investments. A Fund may seek a refund of taxes paid, but its efforts may not be successful, in which case the Fund will have incurred additional expenses for no economic benefit. A Funds decision to seek a refund is in its sole discretion, and, particularly in light of the cost involved, it may decide not to seek a refund, even if eligible. The outcome of a Funds efforts to obtain a refund is not predictable, and some refunds may not be reflected in a Funds net asset value.
33
A Funds investment either directly or indirectly through a wholly-owned subsidiary could affect the amount, timing and character of its distributions and, in the case of GAAR Implementation Fund, the amount, timing, and character of BFFs distributions to its shareholders. In addition, such an investment could cause the Fund, its shareholders or sole shareholder, as applicable, to recognize taxable income in excess of the cash generated by such investment, requiring the Fund, its shareholders or sole shareholder, as applicable, in turn to liquidate investments at disadvantageous times to generate cash needed by the Fund, its shareholders or sole shareholder, as applicable, to make required distributions. See Taxes in the SAI for more information about the tax consequences of a Funds investments in a wholly-owned subsidiary.
Also, investing in non-U.S. securities exposes a Fund to the risk of nationalization, expropriation, or confiscatory taxation of assets of their issuers, other government involvement in the economy or in the affairs of specific companies or industries (including in the case of wholly or partially state-owned enterprises), adverse changes in investment regulations, capital requirements or exchange controls (which may include suspension of the ability to transfer currency from a country), and adverse political and diplomatic developments, including the imposition of economic sanctions.
In some non-U.S. securities markets, custody arrangements for securities provide significantly less protection than custody arrangements in U.S. securities markets, and prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose a Fund to credit and other risks it does not have in the United States with respect to brokers, custodians, clearing banks or other clearing agents, escrow agents, and issuers. Fluctuations in foreign currency exchange rates also affect the market value of a Funds non-U.S. investments (see Currency Risk below).
The Funds need a license to invest directly in many non-U.S. securities markets. These licenses are often subject to limitations, including maximum investment amounts. Once a license is obtained, a Funds ability to continue to invest directly is subject to the risk that the license will be terminated or suspended. If a license to invest in a particular market is terminated or suspended, to obtain exposure to that market the Fund will be required to purchase American Depositary Receipts, Global Depositary Receipts, shares of other funds that are licensed to invest directly, or derivative instruments. The receipt of a non-U.S. license by one of GMOs clients may preclude other clients, including a Fund, from obtaining a similar license, and this could limit the Funds investment opportunities. In addition, the activities of a GMO client could cause the suspension or revocation of a license and thereby limit the Funds investment opportunities.
Funds that invest a significant portion of their assets in securities of issuers tied economically to emerging countries (or investments related to emerging markets) are subject to greater non-U.S. investment risk than Funds investing primarily in more developed non-U.S. countries (or markets). The risks of investing in those securities include: greater fluctuations in currency exchange rates; increased risk of default (by both government and private issuers); greater social, economic, and political uncertainty and instability (including the risk of war or natural disaster); increased risk of nationalization, expropriation, or other confiscation of assets of issuers of securities in a Funds portfolio; greater governmental involvement in the economy or in the affairs of specific companies or industries (including in the case of wholly or partially state-owned enterprises); less governmental supervision and regulation of the securities markets and participants in those markets; controls on non-U.S. investment, capital controls and limitations on repatriation of invested capital, dividends, interest and other income and on a Funds ability to exchange local currencies for U.S. dollars; inability to purchase and sell investments or otherwise settle security or derivative transactions (i.e., a market freeze); unavailability of currency hedging techniques; differences in, or lack of, auditing and financial reporting standards and resulting unavailability of material information about issuers; slower clearance and settlement; difficulties in obtaining and enforcing legal judgments; and significantly smaller market capitalizations of issuers. In addition, the economies of emerging countries may be predominantly based on only a few industries or dependent on revenues from particular commodities.
34
CURRENCY RISK. Currency risk is the risk that fluctuations in exchange rates will adversely affect the market value of a Funds investments. Currency risk includes the risk that the foreign currencies in which a Funds investments are traded, in which a Fund receives income, or in which a Fund has taken a position, will decline in value relative to the U.S. dollar. Currency risk also includes the risk that the currency to which the Fund has obtained exposure through hedging declines in value relative to the currency being hedged, in which event the Fund may realize a loss on both the hedging instrument and the currency being hedged. Currency exchange rates can fluctuate significantly for many reasons. See Market Disruption and Geopolitical Risk below.
Many of the Funds use derivatives to take currency positions that are under- or over-weighted (in some cases significantly) relative to the currency exposure of their portfolios and, if applicable, their benchmarks. If the exchange rates of the currencies involved do not move as expected, a Fund could lose money on both its holdings of a particular currency and the derivative. See also Non-U.S. Investment Risk above.
Some currencies are illiquid (e.g., some emerging country currencies), and a Fund may not be able to convert them into U.S. dollars, in which case GMO may decide to purchase U.S. dollars in a parallel market with an unfavorable exchange rate. Exchange rates for many currencies (e.g., some emerging country currencies) are particularly affected by exchange control regulations.
Derivative transactions in foreign currencies (such as futures, forwards, options and swaps) may involve leveraging risk in addition to currency risk, as described below under Leveraging Risk. In addition, the obligations of counterparties in currency derivative transactions are often not secured by collateral, which increases counterparty risk (see Counterparty Risk below).
FOCUSED INVESTMENT RISK. Funds with investments that are focused in particular countries, regions, sectors, industries or issuers that are subject to the same or similar risk factors and funds with investments whose prices are strongly correlated are subject to greater overall risk than funds with investments that are more diversified.
A Fund that invests in the securities of a small number of issuers has greater exposure to adverse developments affecting those issuers and to a decline in the market price of particular securities than Funds investing in the securities of a larger number of issuers. Securities, sectors, or companies that share common characteristics are often subject to similar business risks and regulatory burdens, and often react similarly to specific economic, market, political or other developments.
Similarly, Funds having a significant portion of their assets in investments tied economically (or related) to a particular geographic region, country or market (e.g., emerging markets) have more exposure to regional and country economic risks than funds making investments throughout the world. The political and economic prospects of one country or group of countries within the same geographic region may affect other countries in that region, and a recession, debt crisis or decline in the value of the currency of one country can spread to other countries. Furthermore, companies in a particular geographic region or country are vulnerable to events affecting other companies in that region or country because they often share common characteristics, are exposed to similar business risks and regulatory burdens, and react similarly to specific economic, market, political or other developments. See also Non-U.S. Investment Risk above.
LEVERAGING RISK. The use of reverse repurchase agreements and other derivatives and securities lending creates leverage (i.e., a Funds investment exposures exceed its net asset value). Leverage increases a Funds losses when the value of its investments (including derivatives) declines. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate, or index may result in a loss substantially greater than the amount invested in the derivative itself. In the case of swaps, the risk of loss generally is related to a notional principal amount, even if the
35
parties have not made any initial investment. Some derivatives have the potential for unlimited loss, regardless of the size of the initial investment. A Funds portfolio also will be leveraged if it borrows money to meet redemption requests or settle investment transactions or if it exercises its right to delay payment on a redemption.
A Fund may manage some of its derivative positions by offsetting derivative positions against one another or against other assets. To the extent offsetting positions do not behave in relation to one another as expected, a Fund may perform as if it were leveraged.
COUNTERPARTY RISK. Funds that enter into contracts with counterparties, such as repurchase or reverse repurchase agreements or OTC derivatives contracts, or that lend their securities run the risk that the counterparty will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. If a counterparty fails to meet its contractual obligations, goes bankrupt, or otherwise experiences a business interruption, the Fund could miss investment opportunities or otherwise hold investments it would prefer to sell, resulting in losses for the Fund. In addition, a Fund may suffer losses if a counterparty fails to comply with applicable laws or other requirements. The Funds are not subject to any limits on their exposure to any one counterparty nor to a requirement that counterparties with whom they enter into contracts maintain a specific rating by a nationally recognized rating organization. Counterparty risk is pronounced during unusually adverse market conditions and is particularly acute in environments (like those of 2008) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions.
Participants in OTC derivatives markets typically are not subject to the same level of credit evaluation and regulatory oversight as are members of exchange-based markets, and, therefore, OTC derivatives generally expose a Fund to greater counterparty risk than exchange-traded derivatives. A Fund is subject to the risk that a counterparty will not settle a derivative in accordance with its terms because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem. If a counterpartys obligation to a Fund is not collateralized, then the Fund is essentially an unsecured creditor of the counterparty. If a counterparty defaults, the Fund will have contractual remedies (whether or not the obligation is collateralized), but the Fund may be unable to enforce them, thus causing the Fund to suffer a loss. Counterparty risk is greater for derivatives with longer maturities because of the longer time during which events may occur that prevent settlement. Counterparty risk also is greater when a Fund has entered into derivatives contracts with a single or small group of counterparties as it sometimes does as a result of its use of swaps and other OTC derivatives. Funds that use swap contracts are subject, in particular, to the creditworthiness of the counterparties because some types of swap contracts have durations longer than six months (and, in some cases, decades). The creditworthiness of a counterparty may be adversely affected by greater than average volatility in the markets, even if the counterpartys net market exposure is small relative to its capital. Counterparty risk still exists even if a counterpartys obligations are secured by collateral because the Funds interest in the collateral may not be perfected or additional collateral may not be promptly posted as required. To the extent that GMOs view with respect to a particular counterparty changes adversely (whether due to external events or otherwise), a Funds existing transactions with that counterparty will not necessarily be terminated or modified. In addition, a Fund may enter into new transactions with a counterparty that GMO no longer considers a desirable counterparty if the transaction is primarily designed to reduce the Funds overall risk of potential exposure to that counterparty (for example, re-establishing the transaction with a lower notional amount).
The Funds also are subject to counterparty risk because they execute their securities transactions through brokers and dealers. If a broker or dealer fails to meet its contractual obligations, goes bankrupt, or otherwise experiences a business interruption, the Funds could miss investment opportunities or be unable to dispose of investments they would prefer to sell, resulting in losses for the Funds.
36
Counterparty risk with respect to derivatives has been and will continue to be affected by new rules and regulations relating to the derivatives market. As described under Derivatives and Short Sales Risk above, some derivatives transactions are required to be centrally cleared, and a party to a cleared derivatives transaction is subject to the credit risk of the clearing house and the clearing member through which it holds its cleared position. Credit risk of market participants with respect to derivatives that are centrally cleared is concentrated in a few clearing houses, and it is not clear how an insolvency proceeding of a clearing house would be conducted and what impact an insolvency of a clearing house would have on the financial system.
COMMODITIES RISK. Commodity prices can be extremely volatile and are affected by many factors. Exposure to commodities can cause the net asset value of a Funds shares to decline or fluctuate in a rapid and unpredictable manner. The value of commodity-related derivatives or indirect investments in commodities may fluctuate more than the commodity, commodities or commodity index to which they relate. See Derivatives and Short Sales Risk above for a discussion of specific risks of a Funds derivatives investments, including commodity-related derivatives.
MERGER ARBITRAGE RISK. Some Funds may engage in transactions in which a Fund purchases securities at prices below the value of the consideration GMO expects to be paid for them upon consummation of a proposed merger, exchange offer, tender offer, or other similar transaction (merger arbitrage transactions). The purchase price may substantially exceed the market price of the securities before the announcement of the transaction.
If a Fund engages in a merger arbitrage transaction and that transaction later appears unlikely to be consummated or, in fact, is not consummated or is delayed, the market prices of the securities purchased by the Fund may decline sharply, resulting in losses to the Fund. The risk/reward payout of merger arbitrage strategies typically is asymmetric the losses in failed transactions often far exceeding the gains in successful transactions. A merger arbitrage transaction can fail for many reasons, including regulatory and antitrust restrictions, political motivations, industry weakness, stock specific events, failed financings, and general market declines.
Merger arbitrage strategies depend for success on the overall volume of merger activity, which has historically been cyclical. When merger activity is low, GMO may be unable to identify enough opportunities to provide sufficient diversification.
Merger arbitrage strategies are subject to the risk of overall market movements, and a Fund may experience losses even if a transaction is consummated. A Funds investments in derivatives or short sales of securities to hedge or otherwise adjust long or short investment exposure in connection with a merger arbitrage transaction may not perform as expected or may otherwise reduce the Funds gains or increase its losses. Also, a Fund may be unable to hedge against market fluctuations or other risks. In addition, a Fund that sells securities short that GMO expects it to receive upon consummation of a transaction but it does not actually receive (and thus has an unintended naked short position) may be required to cover its short position at a time when the securities sold short have appreciated in value, thus resulting in a loss.
MARKET DISRUPTION AND GEOPOLITICAL RISK. The Funds are subject to the risk that geopolitical and other events will disrupt securities markets and adversely affect global economies and markets, thereby decreasing the value of the Funds investments. Sudden or significant changes in the supply or prices of commodities or other economic inputs (e.g., the marked decline in oil prices in late 2014) may have material and unexpected effects on both global securities markets and individual countries, regions, sectors, companies, or industries, which could significantly reduce the value of a Funds investments. Terrorism in the United States and around the world has increased geopolitical risk. The terrorist attacks on September 11, 2001 resulted in the closure of some U.S. securities markets for four days, and similar attacks are possible in the future. Securities markets may be susceptible to market manipulation (e.g., the manipulation of the London Interbank Offered Rate (LIBOR)) or other fraudulent
37
trade practices, which could disrupt the orderly functioning of these markets or reduce the value of investments traded in them, including investments of the Funds. While the U.S. government has always honored its credit obligations, a default by the U.S. government (as has been threatened in recent years) would be highly disruptive to the U.S. and global securities markets and could significantly reduce the value of the Funds investments. Similarly, political events within the United States at times have resulted, and may in the future result, in a shutdown of government services, which could adversely affect the U.S. economy, decrease the value of many Fund investments, and increase uncertainty in or impair the operation of the U.S. or other securities markets. Uncertainty surrounding the sovereign debt of several European Union countries, as well as the continued existence of the European Union itself, has disrupted and may continue to disrupt markets in the United States and around the world. If one or more country changes its currency or leaves the European Union or if the European Union dissolves, the worlds securities markets likely will be significantly disrupted. Substantial government interventions (e.g., currency controls) also could adversely affect the Funds. War, terrorism, economic uncertainty, and related geopolitical events have led, and in the future may lead, to increased short-term market volatility and may have adverse long-term effects on U.S. and world economies and markets generally. Likewise, natural and environmental disasters, such as the earthquake and tsunami in Japan in early 2011, and systemic market dislocations of the kind surrounding the insolvency of Lehman Brothers in 2008, if repeated, would be highly disruptive to economies and markets, adversely affecting individual companies and industries, securities markets, interest rates, credit ratings, inflation, investor sentiment, and other factors affecting the value of the Funds investments. During such market disruptions, the Funds exposure to the risks described elsewhere in this Description of Principal Risks section will likely increase. Market disruptions, including sudden government interventions, can also prevent the Funds from implementing their investment programs and achieving their investment objectives. For example, a market disruption may adversely affect the orderly functioning of the securities markets and may cause the Funds derivatives counterparties to discontinue offering derivatives on some underlying commodities, securities, reference rates, or indices, or to offer them on a more limited basis. To the extent a Fund has focused its investments in the stock index of a particular region, adverse geopolitical and other events in that region could have a disproportionate impact on the Fund.
LARGE SHAREHOLDER RISK. To the extent a large number of shares of a Fund is held by a single shareholder (e.g., an institutional investor or another GMO Fund) or a group of shareholders with a common investment strategy (e.g., GMO asset allocation accounts), the Fund is subject to the risk that a redemption by those shareholders of all or a large portion of their Fund shares will adversely affect the Funds performance by forcing the Fund to sell portfolio securities to raise the cash needed to satisfy the redemption request. It is currently anticipated that GMO Benchmark-Free Fund (BFF), another GMO Fund described in a separate prospectus, will be the sole shareholder of GAAR Implementation Fund. In addition, the Funds and other accounts over which GMO has investment discretion that invest in the Funds are not limited in how often they may purchase or sell Fund shares. GMO asset allocation funds and separate accounts managed by GMO for its clients hold substantial percentages of the shares of many Funds, and asset allocation decisions by GMO may result in substantial redemptions from (or investments in) those Funds. These transactions may adversely affect the Funds performance to the extent that the Fund is required to sell investments (or invest cash) when it would not otherwise do so. Redemptions of a large number of shares also may increase transaction costs or, by necessitating a sale of portfolio securities, have adverse tax consequences for Fund shareholders. Additionally, in the case of High Quality Short-Duration Bond Fund, redemptions by a large shareholder also potentially limit the use of any capital loss carryforwards and certain other losses to offset future realized capital gains (if any) and may limit or prevent High-Quality Short-Duration Bond Funds use of tax equalization. In addition, to the extent a Fund invests in other GMO Funds subject to large shareholder risk, the Fund is indirectly subject to this risk.
38
MANAGEMENT AND OPERATIONAL RISK. Each Fund is subject to management risk because it relies on GMO to achieve its investment objective. Each Fund runs the risk that GMOs investment techniques will fail to produce desired results and cause the Fund to incur significant losses. GMO also may fail to use derivatives effectively, choosing to hedge or not to hedge positions at disadvantageous times.
As described in the Fund summaries, for some Funds, GMO uses quantitative analyses and models as part of its investment process and, in the case of Systematic Global Macro Opportunity Fund, those models are one of the key drivers of investment decisions. All models support portfolio decisions but are not necessarily predictive of future market events. These analyses and models also make simplifying assumptions that may limit their effectiveness. In addition, there are limitations (e.g., inaccuracies, staleness) on the data available for analysis or manipulation by the models. Any of those assumptions and/or limitations could adversely affect a Funds performance. The Funds also run the risk that GMOs assessment of an investment may be wrong.
There can be no assurance that key GMO personnel will continue to be employed by GMO. The loss of their services could have an adverse impact on GMOs ability to achieve the Funds investment objectives.
The Funds also are subject to the risk of loss as a result of other services provided by GMO and other service providers, including pricing, administrative, accounting, tax, legal, custody, transfer agency, and other services. Operational risk includes the possibility of loss caused by inadequate procedures and controls, human error, and system failures by a service provider. For example, trading delays or errors could prevent a Fund from benefiting from potential investment gains or avoiding losses. GMO is not contractually liable to the Funds for losses associated with operational risk absent its willful misfeasance, bad faith, gross negligence, or reckless disregard of its contractual obligations to provide services to the Funds. Other Fund service providers also have contractual limitations on their liability to the Funds for losses resulting from their errors.
The Funds and their service providers (including GMO) are susceptible to cyber-attacks and technological malfunctions that may have effects that are similar to those of a cyber-attack. Cyber-attacks include, among others, stealing or corrupting data maintained online or digitally, preventing legitimate users from accessing information or services on a website, releasing confidential information without authorization, and causing operational disruption. Successful cyber-attacks against, or security breakdowns of, a Fund, GMO, a sub-adviser, or a custodian, transfer agent, or other service provider may adversely affect the Fund or its shareholders. For instance, cyber-attacks may interfere with the processing of shareholder transactions, affect a Funds ability to calculate its net asset value, cause the release of private shareholder information or confidential Fund information, impede trading, cause reputational damage, and subject the Fund to regulatory fines, penalties or financial losses, reimbursement or other compensation costs, and additional compliance costs. While GMO has established business continuity plans and systems designed to prevent cyber-attacks, such plans and systems are subject to inherent limitations. Similar types of cyber security risks also are present for issuers of securities in which the Funds invest, which could result in material adverse consequences for such issuers, and may cause a Funds investment in such securities to lose value.
FUND OF FUNDS RISK AND RELATED CONSIDERATIONS. Funds that invest in Underlying Funds, including other GMO Funds, closed-end funds, money market funds, ETFs and other investment companies, or in a wholly-owned subsidiary are exposed to the risk that the Underlying Funds or wholly-owned subsidiary will not perform as expected. The Funds also are indirectly exposed to all of the risks of an investment in the Underlying Funds or a wholly-owned subsidiary.
Because a Fund bears the fees and expenses of any Underlying Fund or wholly-owned subsidiary in which it invests (absent reimbursement of those fees and expenses), the Fund will incur additional expenses when investing in an Underlying Fund or wholly-owned subsidiary. In addition, total Fund
39
expenses will increase if a Fund makes a new or further investment in Underlying Funds with higher fees or expenses than the average fees and expenses of the Underlying Funds then in the Funds portfolio, or invests through a new wholly-owned subsidiary.
Because some Underlying Funds invest a substantial portion of their assets in other GMO Funds (pursuant to an exemptive order obtained from the SEC), a Fund investing in such Underlying Funds has more tiers of investments than funds in many other groups of investment companies and therefore may be subject to greater fund of funds risk. In addition, to the extent a Fund invests in shares of other GMO Funds, it is indirectly subject to Large Shareholder Risk because those other GMO Funds are more likely to have large shareholders (e.g., other GMO Funds). See Large Shareholder Risk above.
Investments in ETFs involve the risk that the ETFs performance may not track the performance of the index the ETF is designed to track. In addition, ETFs often use derivatives to track the performance of the relevant index, and, therefore, investments in those ETFs are subject to the same derivatives risks discussed above.
A Funds investments through one or more Underlying Funds or a wholly-owned subsidiary could affect the amount, timing and character of its distributions and, and in the case of GAAR Implementation Fund, the amount, timing, and character of BFFs distributions to its shareholders. In the case of GAAR Implementation Fund, Systematic Global Macro Opportunity Fund and World Opportunity Overlay Fund, such an investment could also cause the Funds shareholders or sole shareholder, as applicable, to recognize taxable income in excess of the cash generated by such investment, requiring the Fund, its shareholders or sole shareholder, as applicable, in turn to liquidate investments at disadvantageous times to generate cash needed for the Fund, its shareholders or sole shareholder, as applicable, to make required distributions. See Distributions and Taxes below for more information about the tax consequences of a Funds investments in a wholly-owned subsidiary and Taxes in the SAI for more information about the tax consequences of a Funds investments in wholly-owned subsidiaries or Underlying Funds.
NON-DIVERSIFIED FUNDS. The Funds are not diversified investment companies within the meaning of the Investment Company Act of 1940, as amended. This means they are allowed to invest in the securities of relatively few issuers. As a result, they may be subject to greater credit, market and other risks, and poor performance by a single issuer may have a greater impact on their performance, than if they were diversified.
GMO, 40 Rowes Wharf, Boston, Massachusetts 02110, provides investment management and shareholder servicing to the Funds (and to their respective wholly-owned subsidiary or subsidiaries, if any) and other GMO Funds. GMO is a private company, founded in 1977. As of May 31, 2015, GMO managed on a worldwide basis more than $120 billion.
Subject to the approval of the Trustees, GMO establishes and modifies when it deems appropriate the investment strategies of the Funds. In addition to its management of the Funds investment portfolios and the shareholder services it provides to the Funds, GMO administers the Funds business affairs.
With respect to Systematic Global Macro Opportunity Fund, GMO has entered into a personnel sharing arrangement with GMOs wholly-owned subsidiary, GMO Australia Limited and the GMO Australia Partnership (together, GMO Australia). Pursuant to this arrangement, certain employees of GMO Australia may serve as dual officers and/or associated persons of GMO, and in this capacity may provide investment management and other services to Systematic Global Macro Opportunity Fund. These individuals are identified in GMOs Form ADV, a copy of which is on file with the SEC. See Taxes For Systematic Global Macro Opportunity Fund below for information regarding certain tax matters relating to the personnel sharing arrangement.
40
GMO is registered as an investment adviser with the SEC. GMO Australia is not registered as an investment adviser with the SEC, as its personnels services to Systematic Global Macro Opportunity Fund and other U.S. clients conform to the conditions set forth in a series of SEC staff no-action letters often referred to as the Unibanco Letters.
Each class of shares of High Quality Short-Duration Bond Fund and Systematic Global Macro Opportunity Fund pays GMO directly or indirectly a shareholder service fee for providing client services and reporting, such as performance information, client account information, personal and electronic access to Fund information, access to analysis and explanations of Fund reports, and assistance in maintaining and correcting client-related information. GMO does not charge GAAR Implementation Fund or World Opportunity Overlay Fund a shareholder service fee.
For the fiscal year ended February 28, 2015, GMO received a management fee (after any applicable waivers or reimbursements) equal to 0.63% of Systematic Global Macro Opportunity Funds average daily net assets. As of the date of this Private Placement Memorandum, High Quality Short-Duration Bond Fund had not operated for a full fiscal year. High Quality Short-Duration Bond Fund was paying (or will pay) GMO, as compensation for investment management services, an annual fee equal to 0.05% of the Funds average daily net assets. GMO does not charge either of GAAR Implementation Fund or World Opportunity Overlay Fund a management fee for the management and administrative services provided to the Funds.
A discussion of the basis for the Trustees approval of each Funds investment management contract is included in the Funds shareholder report for the period during which the Trustees approved that contract, except that, in the case of a new Fund, a discussion of the basis for the Trustees approval of the Funds initial investment management contract is included in the Funds initial shareholder report.
GMO has retained its affiliate GMO Singapore Pte. Limited, 1 Raffles Place, #53-00, Singapore, 048616 (GMO Singapore) to assist GMO in furnishing an investment program for Systematic Global Macro Opportunity Fund. GMO Singapore commenced operations in February 2003 and furnishes discretionary investment advisory services, predominantly to institutional clients. Pursuant to a sub-advisory agreement with GMO and Systematic Global Macro Opportunity Fund, GMO Singapore furnishes discretionary investment advisory services and makes investment decisions for and places orders for the purchase and sale of securities for, all or part of Systematic Global Macro Opportunity Funds portfolio, as determined by GMO. GMO (and not Systematic Global Macro Opportunity Fund) will pay a sub-advisory fee to GMO Singapore for its services at a rate equal to 5% of the management fees received by GMO under Systematic Global Macro Opportunity Funds investment management contract, net of any fee waiver or expense reimbursement obligations of GMO as may be in effect. See Taxes For Systematic Global Macro Opportunity Fund below for information regarding certain tax matters relating to GMO Singapores discretionary investment advisory services GMO Singapore provides to Systematic Global Macro Opportunity Fund. A discussion of the basis for the Trustees approval of Systematic Global Macro Opportunity Funds sub-advisory agreement with GMO Singapore is included in Systematic Global Macro Opportunity Funds annual report to shareholders for the period during which the Trustees approved that agreement.
Different GMO Investment Teams have primary responsibility for managing the investments of different Funds. Investment Teams may include personnel of both GMO and its affiliates, including GMO Singapore. Each Investment Teams investment professionals work collaboratively and often share investment insights with, and benefit from the insights of, other Investment Teams. For example, the Global Equity Team, which manages the investments of several other GMO Funds offered through separate prospectuses, and the Asset Allocation Team collaborate on performance forecasts for groups of equities. The table below identifies the Investment Teams and the Funds for which they are primarily responsible.
41
Investment Team | Primary Responsibilities | |
Asset Allocation |
GAAR Implementation Fund | |
Developed Fixed Income |
High Quality Short-Duration Bond Fund, World Opportunity Overlay Fund | |
Systematic Global Macro |
Systematic Global Macro Opportunity Fund |
The following table identifies the senior member(s) of the Investment Team(s) with primary responsibility for managing the investments of different Funds and their title and business experience during the past five years. The senior members directly manage, or allocate to members of their Team responsibility for portions of the portfolios of, Funds for which they have responsibility, oversee the implementation of trades, review the overall composition of the Funds portfolios, including compliance with stated investment objectives and strategies, and monitor cash.
Funds | Senior Member | Title; Business Experience During Past 5 Years | ||
GAAR Implementation Fund* |
Ben Inker | Co-Head, Asset Allocation Team and Co-Head, Developed Fixed Income Team, GMO. Mr. Inker has been responsible for overseeing the portfolio management of GMOs asset allocation portfolios since 1996 and of GMOs developed fixed income portfolios since November 2014. | ||
Sam Wilderman | Co-Head, Asset Allocation Team and Co-Head, Developed Fixed Income Team, GMO. Mr. Wilderman has been responsible for overseeing the portfolio management of GMOs asset allocation portfolios since September 2012 and of GMOs developed fixed income portfolios since November 2014. Previously, Mr. Wilderman had been Co-Head of GMOs Global Equity Team since 2009. | |||
High Quality Short-Duration Bond Fund |
Ben Inker | See above. | ||
Sam Wilderman | See above. | |||
Joe Auth | Portfolio Manager, Developed Fixed Income Team, GMO. Mr. Auth has been responsible for providing portfolio management services to GMOs structured credit portfolios since 2014. Previously, Mr. Auth was a portfolio manager at Harvard Management Company. | |||
World Opportunity Overlay Fund |
Ben Inker | See above. | ||
Sam Wilderman | See above. | |||
Michael Emanuel | Portfolio Manager, Developed Fixed Income Team, GMO. Mr. Emanuel has been responsible for providing portfolio management services to GMOs developed fixed income portfolios since 2014. Previously, Mr. Emanuel was a portfolio manager at Convexity Capital Management. | |||
Greg Jones | Portfolio Manager, Developed Fixed Income Team, GMO. Mr. Jones has been responsible for providing portfolio management and research services to GMOs developed fixed income portfolios since 2008. | |||
Systematic Global Macro Opportunity Fund |
Jason Halliwell | Head, Systematic Global Macro Team, GMO. Mr. Halliwell has been responsible for overseeing the portfolio management of GMOs systematic global macro portfolios since 1999. |
* | In the case of GAAR Implementation Fund, allocations among asset classes are made by the Asset Allocation Team and specific security selections are made primarily by other Investment Teams in collaboration with the Asset Allocation Team. For example, the Global Equity Team selects equity securities within GAAR Implementation Fund. |
42
The SAI contains information about how GMO determines the compensation of the senior members, other accounts they manage and related conflicts, and their ownership of Funds for which they have responsibility.
Custodian, Fund Accounting Agent, and Transfer Agent
State Street Bank and Trust Company (State Street Bank), One Lincoln Street, Boston, Massachusetts 02111, serves as each Funds custodian, fund accounting agent, and transfer agent. State Street Bank provides similar services with respect to each of GAAR Implementation Funds and Systematic Global Macro Opportunity Funds wholly-owned subsidiary.
Expense Reimbursement
GMO has contractually agreed to reimburse each Fund for its Specified Operating Expenses. As used in this Private Placement Memorandum, subject to the exclusion set forth below, Specified Operating Expenses means: audit expenses, fund accounting expenses, pricing service expenses, expenses of non-investment related tax services, transfer agency expenses, expenses of non-investment related legal services provided to the Funds by or at the direction of GMO, federal securities law filing expenses, printing expenses, state and federal registration fees, and custody expenses. In the case of GAAR Implementation Fund, Specified Operating Expenses does not include custody expenses from emerging markets.
For each Fund that pays GMO a management fee, GMO has contractually agreed to waive or reduce that fee, but not below zero, to the extent necessary to offset the management fees paid to GMO that are directly or indirectly borne by the Fund as a result of the Funds direct or indirect investments in other GMO Funds.
For each Fund that charges a shareholder service fee, GMO has contractually agreed to waive or reduce the shareholder service fee charged to holders of each class of shares of the Fund, but not below zero, to the extent necessary to offset the shareholder service fees directly or indirectly borne by the class of shares of the Fund as a result of the Funds direct or indirect investments in other GMO Funds.
These contractual waivers and reimbursements will continue through at least June 30, 2016 for each Fund unless the Funds Board of Trustees authorizes their modification or termination or reduces the fee rates paid to GMO under the Funds management contract or servicing and supplement support agreement.
Additional Information
The Trust enters into contractual arrangements with various parties, including, among others, the Funds investment manager, shareholder service provider, sub-adviser, custodians and fund accounting agents, transfer agent, distributor and placement agent, who provide services to the Funds. Shareholders are not parties to, or intended (or third-party) beneficiaries of, any of those contractual arrangements, and those contractual arrangements are not intended to create in any individual shareholder or group of shareholders any right to enforce them against the service providers or to seek any remedy under them against the service providers, either directly or on behalf of the Trust.
This Private Placement Memorandum provides information concerning the Trust and the Funds that you should consider in determining whether to purchase shares of a Fund. None of this Private Placement Memorandum, the SAI or any contract that is an exhibit to the Trusts registration statement, is intended to, nor does it, give rise to an agreement or contract between the Trust or the Funds and any investor, or give rise to any contract or other rights in any individual shareholder, group of shareholders or other person other than any rights conferred explicitly by federal or state securities laws that may not be waived.
43
DETERMINATION OF NET ASSET VALUE
The net asset value or NAV of a Fund or each class of shares of a Fund, as applicable, is determined as of the close of regular trading on the NYSE, generally at 4:00 p.m. Eastern time. Current net asset values per share for each series of GMO Trust are available at www.gmo.com.
The NAV per share of a class of shares of a Fund is determined by dividing the total value of the Funds portfolio investments and other assets, less any liabilities, allocated to that share class by the total number of outstanding shares of that class. NAV is not determined on any days when the NYSE is closed for business. In addition, in the case of High Quality Short-Duration Bond Fund, Systematic Global Macro Opportunity Fund, and World Opportunity Overlay Fund, NAV is not determined (and accordingly, transactions in shares of the Funds are not processed) on days when the U.S. bond markets are closed for business. In addition, because some Funds hold portfolio securities listed on non-U.S. exchanges that trade on days on which the NYSE or the U.S. bond markets are closed, the net value of those Funds assets may change significantly on days when shares cannot be redeemed.
A Fund may elect not to determine NAV on days when none of its shares are tendered for redemption and it accepts no orders to purchase its shares.
The value of the Funds investments is generally determined as follows:
Exchange-traded securities (other than exchange-traded options) for which market quotations are readily available:
| Last sale price or |
| Official closing price or |
| Most recent quoted price published by the exchange (if no reported last sale or official closing price) or |
| Quoted price provided by a pricing source (in the event GMO deems the private market to be a more reliable indicator of market value than the exchange) |
(Also, see discussion in Fair Value pricing below.)
Exchange-traded options:
| Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. |
Cleared derivatives:
| Price quoted (which may be based on a model) by the relevant clearing house (if an updated quote for a cleared derivative is not available by the time that a Fund calculates its NAV on any business day, then that derivative will generally be valued using an industry standard model, which may differ from the model used by the relevant clearing house) |
OTC derivatives:
| Price generally determined by an industry standard model |
Unlisted non-fixed income securities for which market quotations are readily available:
| Most recent quoted price |
44
Fixed income securities (includes bonds, asset-backed securities, loans, structured notes):
| Most recent quoted price supplied by a single pricing source chosen by GMO (if an updated quoted price for a fixed income security is not available by the time that a Fund calculates its NAV on any business day, the Fund will generally use the most recent quoted price to value that security) |
Note: Reliable quoted prices may not always be available. When they are not available, the Funds may use alternative valuation methodologies (e.g., valuing the relevant assets at fair value as described below).
Shares of other GMO Funds and other open-end registered investment companies:
| Most recent NAV |
Quoted price typically means the bid price for securities held long and the ask price for securities sold short. If a market quotation for a security does not involve a bid or an ask, the quoted price may be the price provided by a market participant or other third party pricing source in accordance with the market practice for that security.
The prices of non-U.S. securities quoted in foreign currencies, foreign currency balances, and the value of non-U.S. forward currency contracts are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 p.m. Eastern time, at then current exchange rates or at such other rates as the Trustees or persons acting at their direction may determine in computing NAV.
Although GMO normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. GMO monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Alternative pricing sources are often but not always available for securities held by a Fund, although the prices supplied by those alternative sources do not necessarily align with the prices supplied by primary pricing sources.
Fair Value pricing:
For all other assets and securities, including derivatives, and in cases where quotations are not readily available or circumstances make an existing valuation methodology or procedure unreliable, the Funds investments are valued at fair value, as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees.
With respect to the Funds use of fair value pricing, you should note the following:
Ø | In some cases, a significant percentage of a Funds assets may be fair valued. Factors that may be considered in determining fair value include, among others, the value of other financial instruments traded on other markets, trading volumes, changes in interest rates, observations from financial institutions, significant events (which may be considered to include changes in the value of U.S. securities or securities indices) that occur after the close of the relevant market and before a Funds NAV is calculated, other news events, and significant unobservable inputs (including the Funds own assumptions in determining the fair value of investments). Because of the uncertainty inherent in fair value pricing, the price determined for a particular security may be materially different from the value realized upon its sale. |
Ø |
The valuation methodologies described above are modified for equities that trade in non-U.S. securities markets that close prior to the close of the NYSE due to time zone differences, including the value of equities that underlie futures, options and other |
45
derivatives (to the extent the market for those derivatives closes prior to the close of the NYSE). In those cases, the price will generally be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees that are intended to reflect valuation changes through the NYSE close. |
Ø | A Funds use of fair value pricing may cause the Funds returns to differ from those of its benchmark or other comparative indices more than would otherwise be the case. For example, a Fund may fair value its international equity holdings as a result of significant events that occur after the close of the relevant market and before the time the Funds NAV is calculated. In these cases, the benchmark or index may use the local market closing price, while the Fund uses an adjusted fair value price. |
To comply with SEC rules regarding the use of descriptive words in a funds name, High Quality Short-Duration Bond Fund has adopted a policy of investing directly or indirectly (e.g., through other GMO Funds or derivatives) at least 80% of its assets in high quality bonds (the Name Policy). The Name Policy is described in the Principal Investment Strategies section of the Funds summary.
High Quality Short-Duration Bond Fund will not change its Name Policy without providing its shareholders at least 60 days prior written notice. When used in connection with the Funds Name Policy, assets include the Funds net assets plus any borrowings made for investment purposes. Funds with the term global, or world included in their names have not adopted formal Name Policies with respect to those terms but typically invest in investments that are tied economically to, or seek exposure to, a number of countries throughout the world.
DISCLOSURE OF PORTFOLIO HOLDINGS
The Funds have established a policy with respect to disclosure of their portfolio holdings. That policy is described in the SAI. The Funds portfolio holdings are available quarterly on the SECs website when the Funds file a Form N-CSR (annual/semiannual report) or Form N-Q (quarterly schedule of portfolio holdings).
Up to the largest fifteen portfolio holdings of some Funds are posted monthly on GMOs website (www.gmo.com). In addition, attribution information regarding the positions of some Funds may be posted monthly on GMOs website (e.g., best/worst performing positions in the Fund over a specified time period). Such information is available without a confidentiality agreement to registered users on GMOs website.
Additional information regarding the portfolio holdings of some Funds as of each months end is made available to shareholders of the Trust (including shareholders of record who have indirect investments in a Fund through another GMO Fund) (permitted shareholders), qualified potential shareholders as determined by GMO (including qualified potential shareholders of record who are considering an indirect investment in a Fund through another fund managed by GMO) (potential shareholders), and their consultants and agents approximately five days after month end.
Permitted shareholders and potential shareholders of Funds that invest in other GMO Funds, as well as their consultants and agents, are able to access the portfolio holdings of the GMO Funds in which those Funds invest when that information is posted each month on GMOs website. Periodically, in response to heightened market interest in specific issuers, a Funds holdings in one or more issuers may be made available on a more frequent basis to permitted shareholders, potential shareholders, and their consultants and agents (collectively, permitted recipients) through a secured link on GMOs website. This information may be posted as soon as the business day following the date to which the information relates.
46
To access this information on GMOs website (www.gmo.com/america/strategies), permitted recipients must contact GMO to obtain a user name and password (to the extent they do not already have them) and generally must enter into a confidentiality and non-use agreement with GMO. Any exception must be approved in advance as described in the SAI. GMO also may make portfolio holdings information (including information regarding underlying GMO Fund holdings) available in alternate formats and under additional circumstances under the conditions described in the SAI.
The Funds or GMO may suspend the posting of portfolio holdings of one or more Funds, and the Funds may modify the disclosure policy, without notice to shareholders. Once posted, a Funds portfolio holdings typically will remain available on the website at least until the Fund files a Form N-CSR (annual/semiannual report) or Form N-Q (quarterly schedule of portfolio holdings) for the period that includes the date of those holdings.
Shares of the Funds are currently principally available for purchase by other GMO Funds and certain other accredited investors. All investors must be accredited investors as defined in Regulation D under the Securities Act of 1933. It is currently anticipated that BFF will be the sole shareholder of GAAR Implementation Fund.
Under ordinary circumstances, you may purchase a Funds shares directly from the Trust on days when the NYSE is open for business and, in the case of High Quality Short-Duration Bond Fund, Systematic Global Macro Opportunity Fund, and World Opportunity Overlay Fund, on days when the U.S. bond markets also are open for business. For instructions on purchasing shares, call the Trust at 1-617-346-7646 or send an e-mail to SHS@GMO.com. The Trust will not accept a purchase order until it has received a GMO Trust Application deemed to be in good order by the Trust or its agent. In addition, the Trust may not accept a purchase order unless an Internal Revenue Service (IRS) Form W-9 (for U.S. shareholders) or the appropriate IRS Form W-8 (for non-U.S. shareholders) with a correct taxpayer identification number (if required) is on file with, and that W-9 or W-8 is deemed to be in good order by, the Trusts withholding agent, State Street Bank and Trust Company. The Trust, its agent or a financial intermediary may require additional tax-related certifications, information or other documentation from you in order to comply with applicable U.S. federal reporting and withholding tax provisions, including the Foreign Account Tax Compliance Act. If you do not provide such IRS forms and other certifications, information or documentation, you may be subject to withholding taxes on distributions or proceeds received upon the sale, exchange or redemption of your Fund shares. For more information on these rules, see Taxes in the SAI. Please consult your tax adviser to ensure all tax forms provided to the Trust or its agent are completed properly and maintained, as required, in good order. GMO and/or its agents have the right to decide when a completed form is in good order.
Purchase Policies. You must submit a purchase order in good order to avoid its being rejected. In general, a purchase order is in good order if it includes:
| The name of the Fund being purchased; |
| The U.S. dollar amount of the shares to be purchased; |
| The date on which the purchase is to be made (subject to receipt prior to the close of regular trading on the NYSE (generally 4:00 p.m. Eastern time) (the Cut-off Time) on that date); |
| The name and/or the account number (if any) set forth with sufficient clarity to avoid ambiguity; and |
| The signature of an authorized signatory as identified in the GMO Trust Application or subsequent authorized signers list. |
47
For retirement accounts, additional information regarding contributions typically is required.
If payment in full (in U.S. funds paid by check or wire or, when approved, by securities) is not received prior to the Cut-off Time on the intended purchase date, the order may be rejected or deferred until payment in full is received unless prior arrangements for later payment have been approved by GMO.
If a purchase order is received in good order by the Trust or its agent, together with payment in full, prior to the Cut-off Time, the purchase price for the Fund shares to be purchased is the net asset value per share of the class of Fund shares being purchased determined on that day (plus any applicable purchase premium). If that order is received after the Cut-off Time, the purchase price for the Fund shares to be purchased is the net asset value per share of the class of Fund shares to be purchased determined on the next business day that the NYSE is open (plus any applicable purchase premium). In the case of High Quality Short-Duration Bond Fund, Systematic Global Macro Opportunity Fund, and World Opportunity Overlay Fund, purchase orders that are received on days when either the NYSE or the U.S. bond markets are closed will not be accepted until the next day on which both the NYSE and the U.S. bond markets are open, and the purchase price will be the net asset value per share of the class of Fund shares to be purchased determined on that day (plus any applicable purchase premium).
To help the U.S. government fight the funding of terrorism and money laundering activities, federal law requires the Trust to verify identifying information provided by each investor in its GMO Trust Application and the Trust may require further identifying documentation. If the Trust is unable to verify the information shortly after your account is opened, the account may be closed and your shares redeemed at their net asset value at the time of the redemption.
The Trust and/or its agents reserve the right to reject any purchase order. In addition, without notice, a Fund in its sole discretion may temporarily or permanently suspend sales of its shares to new investors and/or existing shareholders.
Minimum initial investment amounts (by class, if applicable) are set forth in the table on page 53 of this Private Placement Memorandum. No minimum initial investment is required to purchase Class III shares of Systematic Global Macro Opportunity Fund or shares of GAAR Implementation Fund or World Opportunity Overlay Fund. The Trust may increase minimum initial investment amounts at any time and may waive initial minimums for some investors.
Funds advised or sub-advised by GMO (Top Funds) may purchase shares of other GMO Funds after the Cut-off Time and receive the current days price if the following conditions are met: (i) the Top Fund received a purchase order in good order prior to the Cut-off Time on that day; and (ii) the purchase(s) by the Top Fund of shares of the other GMO Funds are executed pursuant to an allocation predetermined by GMO prior to that days Cut-off Time.
Submitting Your Purchase Order Form . Completed purchase order forms can be submitted by mail, facsimile, or e-mail (provided that a PDF copy of the completed purchase order form is attached to the e-mail) or other form of communication pre-approved by Shareholder Services to the Trust at:
GMO Trust
c/o Grantham, Mayo, Van Otterloo & Co. LLC
40 Rowes Wharf
Boston, Massachusetts 02110
Facsimile: 1-617-439-4192
Attention: Shareholder Services
E-mail: clientorder@gmo.com
48
Call the Trust at 1-617-346-7646 or send an e-mail to SHS@GMO.com to confirm that GMO received, made a good order determination regarding, and accepted your purchase order form. Do not send cash, checks, or securities directly to the Trust. A purchase order submitted by mail, facsimile or e-mail is received by the Trust when it is actually received by the Trust or its agent. The Trust is not responsible for purchase orders submitted but not actually received by the Trust or its agent for any reason, including purchase orders not received on account of a computer virus or other third-party interference.
Funding Your Investment . You may purchase shares:
| with cash (by means of wire transfer or check or other form of payment preapproved by GMO Shareholder Services) |
u | By wire. Instruct your bank to wire your investment to: |
State Street Bank and Trust Company, Boston, Massachusetts
ABA#: 011000028
Attn: Transfer Agent
Credit: GMO Trust Deposit Account 00330902
Further credit: GMO Fund/Account name and number
u | By check. All checks must be made payable to the appropriate Fund or to GMO Trust. The Trust will not accept checks payable to a third party that have been endorsed by the payee to the Trust. Mail checks to: |
By U.S. Postal Service: State Street Bank and Trust Company Attn: GMO Transfer Agent Box 5493 Mail Code CPH0255 Boston, Massachusetts 02206 |
By Overnight Courier: State Street Bank and Trust Company Attn: GMO Transfer Agent 100 Huntington Avenue Mail Code CPH0255 Copley Place Tower 2, Floor 3 Boston, Massachusetts 02116 |
| in exchange for securities acceptable to GMO |
u | securities must be approved by GMO prior to transfer to the Fund |
u | securities will be valued as set forth under Determination of Net Asset Value |
u | you may bear any stamp or other transaction-based taxes or certain other costs arising in connection with the transfer of securities to the Fund |
| by a combination of cash and securities |
The Trust is not responsible for cash (including wire transfers and checks) or securities delivered in connection with a purchase of Fund shares until they are actually received by the Fund. A purchaser will not earn interest on any funds prior to their investment in a Fund.
Frequent Trading Activity. As a matter of policy, the Trust will not honor requests for purchases or exchanges by shareholders identified as engaging in frequent trading strategies, including market timing, that GMO determines could be harmful to a Fund and its shareholders. Frequent trading strategies generally are strategies that involve repeated exchanges and/or purchases and redemptions (or redemptions and purchases) within a short period of time. Frequent trading strategies can be disruptive to the efficient management of a Fund, materially increase portfolio transaction costs and taxes, dilute the value of shares held by long-term investors, or otherwise be harmful to a Fund and its shareholders. Notwithstanding the foregoing, these policies and procedures do not limit frequent trading of GAAR
49
Implementation Fund, High Quality Short-Duration Bond Fund, World Opportunity Overlay Fund, or some other GMO Funds in which a Fund may invest.
For Systematic Global Macro Opportunity Fund, the Trustees have adopted procedures designed to detect and prevent frequent trading activity that could be harmful to a Fund and its shareholders (the Procedures). The Procedures include the fair valuation of non-U.S. securities, periodic surveillance of trading in shareholder accounts and inquiry as to the nature of trading activity. If GMO determines that an account is engaging in frequent trading that has the potential to be harmful to a Fund or its shareholders, the Procedures permit GMO to adopt various preventative measures, including suspension of the accounts exchange and purchase privileges. There is no assurance that the Procedures will be effective in all instances. The Funds reserve the right to reject any order or terminate the sale of Fund shares at any time.
Other funds and accounts over which GMO has investment discretion invest in other GMO Funds and are not subject to restrictions on how often they may purchase those Funds shares. Although GMO may not take affirmative steps to detect frequent trading for certain Funds, GMO will not honor requests for purchases or exchanges by shareholders identified as engaging in frequent trading strategies that GMO determines could be harmful to the Funds involved and their shareholders.
Under ordinary circumstances, you may redeem the Funds shares on days when the NYSE is open for business and, in the case of High Quality Short-Duration Bond Fund, Systematic Global Macro Opportunity Fund, and World Opportunity Overlay Fund, when the U.S. bond markets also are open for business. Redemption orders should be submitted directly to the Trust. For instructions on redeeming shares, call the Trust at 1-617-346-7646 or send an e-mail to SHS@GMO.com. A Fund may remit the redemption proceeds for redemption orders received on the same day at different times for different shareholders and may take up to seven days to remit proceeds.
Redemption Policies. You must submit a redemption order in good order to avoid having it rejected by the Trust or its agent. In general, a redemption order is in good order if it includes:
| The name of the Fund being redeemed; |
| The number of shares or the dollar amount of the shares to be redeemed or, in the case of a Fund with a redemption fee, the dollar amount that the investor wants to receive; |
| The date on which the redemption is to be made (subject to receipt prior to the Cut-off Time on that date); |
| The name or the account number set forth with sufficient clarity to avoid ambiguity; |
| The signature of an authorized signatory as identified in the GMO Trust Application or subsequent authorized signers list; and |
| Wire instructions or registration address that match the wire instructions or registration address (as applicable) on file at GMO or confirmation from an authorized signatory that the wire instructions are valid. |
For retirement accounts, additional information regarding distributions typically is required.
If a redemption order is received in good order by the Trust or its agent prior to the Cut-off Time, the redemption price for the Fund shares being redeemed is the net asset value per share of the class of Fund shares being redeemed determined on that day (less any applicable redemption fee). In the case of High Quality Short-Duration Bond Fund, Systematic Global Macro Opportunity Fund, and World Opportunity Overlay Fund, redemption orders in good order that are received on days when either the
50
NYSE or the U.S. bond markets are closed will not be accepted until the next day on which both the NYSE and the U.S. bond markets are open, and the redemption price will be the net asset value per share of the class of Fund shares being redeemed determined that day (less any applicable redemption fee). If a redemption order is received after the Cut-off Time, the redemption price for the Fund shares to be redeemed will be the net asset value per share determined on the next business day that the NYSE is open (less any applicable redemption fee) or, in the case of High Quality Short-Duration Bond Fund, Systematic Global Macro Opportunity Fund, and World Opportunity Overlay Fund, the next business day that the U.S. bond markets are open (less any applicable redemption fee), unless you or another authorized person on your account have instructed GMO Shareholder Services in writing to defer the redemption to another day. You or another authorized person on your account may revoke your redemption order in writing at any time prior to the Cut-off Time on the redemption date. Redemption fees, if any, apply to all shares of a Fund regardless of how the shares were acquired (e.g., by direct purchase or by reinvestment of dividends or other distributions). In the event of a disaster affecting Boston, Massachusetts, you should contact GMO to confirm that your redemption order was received and is in good order.
Failure to provide the Trust or its agent with a properly authorized redemption order or otherwise satisfy the Trust as to the validity of any change to the wire instructions or registration address may result in a delay in processing a redemption order, delay in remittance of redemption proceeds, or a rejection of the redemption order.
In GMOs sole discretion, a Fund may pay redemption proceeds wholly or partly in securities (selected by GMO) instead of cash. In particular, if market conditions deteriorate and GMO believes a Funds redemption fee (if any) will not fairly compensate a Fund for transaction costs, the Fund may limit cash redemptions and use portfolio securities to pay the redemption price to protect the interests of all Fund shareholders. Redemptions paid with portfolio securities may require shareholders to enter into new custodial arrangements if they do not have accounts available for holding securities directly.
If a redemption is paid in cash:
| payment will generally be made by means of a federal funds transfer to the bank account designated in the relevant GMO Trust Application |
u | designation of one or more additional bank accounts or any change in the bank accounts originally designated in the GMO Trust Application must be made in a recordable format by an authorized signatory according to the procedures in the GMO Trust Redemption Order Form |
u | if an ambiguity in wire instructions cannot be resolved in a timely manner, GMO may elect to remit redemption proceeds by check |
| upon request, payment will be made by check mailed to the registered address (unless another address is specified according to the procedures in the GMO Trust Redemption Order Form). |
The Trust will not process what it reasonably believes are duplicate redemption requests.
The Trust will not pay redemption proceeds to third-parties and does not offer check-writing privileges.
The Trust typically will not pay redemption proceeds to multiple bank accounts.
Redemption requests may be revoked prior to the Cut-off Time on the redemption date.
51
If a redemption is paid with securities, you should note that:
| the securities will be valued as set forth under Determination of Net Asset Value; |
| the securities will be selected by GMO in light of the Funds objective and other practical considerations and may not represent a pro rata distribution of each security held in the Funds portfolio; |
| you will likely incur brokerage charges on the sale of the securities; |
| depending on the Funds tax treatment, redemptions paid in securities can have the same or different tax consequences as redemptions paid in cash (see Taxes below); |
| you may bear any stamp or other transaction-based taxes or certain other costs arising in connection with the Funds transfer of securities to you; and |
| the securities will be transferred and delivered by the Trust as directed in writing by an authorized person on your account. |
Each Fund may suspend the right of redemption and may postpone payment for more than seven days:
| during periods when the NYSE is closed other than customary weekend or holiday closings; |
| during periods when trading on the NYSE is restricted; |
| during an emergency that makes it impracticable for a Fund to dispose of its securities or to fairly determine its net asset value; or |
| during any other period permitted by the SEC. |
Pursuant to the Trusts Amended and Restated Agreement and Declaration of Trust, the Trust has the unilateral right to redeem Fund shares held by a shareholder at any time (i) if at that time the shareholder owns shares of a Fund or a class of shares of a Fund having an aggregate net asset value of less than an amount determined from time to time by the Trustees; (ii) to the extent the shareholder owns shares of a Fund or a class of shares of a Fund equal to or in excess of a percentage of the outstanding shares of the Fund or the class of shares of the Fund determined from time to time by the Trustees; or (iii) as a means of satisfying legal obligations of the Trust in respect of a withholding tax and related interest, penalty and similar charges, including but not limited to obligations occasioned by the failure of a shareholder to provide any documentation requested by the Trust or its agent. The Trustees have authorized GMO in its sole discretion to redeem shares to prevent a shareholder from becoming an affiliated person of a Fund.
Top Funds may redeem shares of other GMO Funds after the Cut-off Time and receive the current days price if the following conditions are met: (i) the Top Fund received a redemption order prior to the Cut-off Time on that day; and (ii) the redemption of the shares of the other GMO Funds is executed pursuant to an allocation predetermined by GMO prior to that days Cut-off Time.
Cost Basis Reporting. If your account is subject to U.S. federal tax reporting or you otherwise have informed a Fund that you would like to receive informational only U.S. federal tax reporting, upon your redemption or exchange of shares in a Fund that is treated as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended, for U.S. federal tax purposes that you hold in that account, the Fund will provide you with cost basis and certain other related tax information about those shares. Please consult the Trust for more information regarding available methods for cost basis reporting, including the Funds default method, and how to select or change a particular method.
52
You should consult your tax adviser to determine which available cost basis method is most appropriate for you.
For all other Funds, shareholders are responsible for keeping their own records for determining their tax basis in all of their shares.
Submitting Your Redemption Order . Redemption orders can be submitted by mail, facsimile, or e-mail or other form of communication pre-approved by Shareholder Services to the Trust at the address/facsimile number/e-mail address set forth under How to Purchase Shares Submitting Your Purchase Order Form. Redemption orders are received by the Trust when they are actually received by the Trust or its agent. Call the Trust at 1-617-346-7646 or send an e-mail to SHS@GMO.com to confirm that GMO received, made a good order determination regarding, and accepted your redemption order.
MULTIPLE CLASSES AND ELIGIBILITY
High Quality Short-Duration Bond Fund offers multiple classes of shares. The sole economic difference among the various classes of shares is in their shareholder service fee. Differences in the shareholder service fee reflect the fact that, as the size of an investor relationship increases, the cost to service that investor decreases as a percentage of the investors assets managed by GMO and its affiliates. Thus, the shareholder service fee generally is lower for classes requiring greater minimum investments.
Minimum Investment Criteria for Class Eligibility
For High Quality Short-Duration Bond Fund, an investors eligibility to purchase Fund shares or different classes of Fund shares depends on its meeting either (i) the Minimum Total Fund Investment, which involves only an investors total investment in a particular Fund, or (ii) the Minimum Total GMO Investment, both of which are set forth in the table below. No minimum initial investment is required to purchase Class III shares of Systematic Global Macro Opportunity Fund or shares of GAAR Implementation Fund or World Opportunity Overlay Fund. For investors owning shares of a Fund, no minimum additional investment is required to purchase additional shares of that Fund.
Minimum Total
Fund Investment |
Minimum
Total GMO Investment (1) |
Shareholder
Service Fee (as a % of average daily net assets) |
||||||||||
Class III Shares |
High Quality Short-Duration Bond Fund | N/A | $ | 10 million | 0.15% | |||||||
Class VI Shares |
High Quality Short-Duration Bond Fund | $ | 300 million | $ | 750 million | 0.055% |
(1) | The eligibility requirements in the table above are subject to exceptions and special rules. See discussion immediately following this table for more information about these exceptions and special rules. |
An investors Minimum Total GMO Investment equals GMOs estimate of the market value of all the investors assets managed by GMO and its affiliates (i) at the time of the investors initial investment, (ii) at the close of business on the last business day of each calendar quarter, or (iii) at other times as determined by GMO (including those described below under Conversions between Classes) (each, a Determination Date). When purchasing shares of a Fund, investors should consult with GMO to determine the applicable Determination Date and the share class for which they are eligible.
Upon request GMO may permit an investor to undertake in writing to meet the applicable Minimum Total Fund Investment or Minimum Total GMO Investment over a specified period (a Commitment Letter).
53
You should note:
| No minimum additional investment is required to purchase additional shares of a Fund or any class of shares of a Fund that you currently hold. |
| GMO makes all determinations as to which investor accounts should be aggregated for purposes of determining eligibility for a Fund or the various classes of shares offered by a Fund, as the case may be. When making decisions regarding whether accounts should be aggregated because they are part of a larger client relationship, GMO considers several factors including, but not limited to, whether: the multiple accounts are for one or more subsidiaries of the same parent company; the multiple accounts have the same beneficial owner regardless of the legal form of ownership; the registered owner has full discretion over all underlying assets; the investment mandate is the same or substantially similar across the relationship; the asset allocation strategies are substantially similar across the relationship; GMO reports to the same investment board; the multiple accounts share the same consultant; GMO services the relationship through a single GMO relationship manager; the relationships have substantially similar reporting requirements; and/or the relationship can be serviced from a single geographic location. |
| Eligibility requirements for a Fund or each class of shares of a Fund, as the case may be, are subject to change. |
| GMO may waive eligibility requirements for some persons, accounts, or special situations. These waivers include the waiver of eligibility requirements for (i) GMO Funds and other accounts over which GMO has investment discretion that invest in other GMO Funds, (ii) GMO directors, partners, employees, agents, and their family members, (iii) the Trustees of the Trust, (iv) Trustees of other mutual funds sponsored by GMO, and (v) clients of an investment consultant or similar investment professional with a substantial ongoing business relationship with GMO. GMO may discontinue such waivers at any time without notice. |
Conversions between Classes
As described in the applicable Fund summaries, in determining whether an investor is eligible to purchase Fund shares, GMO considers each investors Minimum Total Fund Investment and Minimum Total GMO Investment on each Determination Date. Based on this determination, and subject to the following, each investors shares of a Fund eligible for conversion will be converted to the class of shares of that Fund with the lowest shareholder service fee for which the investor satisfies all minimum investment requirements (or, to the extent the investor already holds shares of that class, the investor will remain in that class). Except as noted below, with respect to any Fund:
| If an investor satisfies all minimum investment requirements for a class of shares then being offered that bears a lower shareholder service fee than the class held by the investor on the Determination Date (generally at the close of business on the last business day of each calendar quarter), the investors shares eligible for conversion generally will be automatically converted to that class within 45 calendar days following the Determination Date on a date selected by GMO. |
|
If an investor no longer satisfies all minimum investment requirements for the class of shares of a Fund held by the investor on the last Determination Date of a calendar year (generally at the close of business on the last business day of the calendar year), the Fund generally will convert the investors shares to the class it is then offering bearing the lowest shareholder service fee for which the investor satisfies all minimum investment requirements (which class typically will bear a higher shareholder service fee than the class then held by the investor). If an investor no longer satisfies all minimum investment requirements for any class of a Fund as of the last Determination Date of a calendar year, the Fund will convert the investors |
54
shares to the class of that Fund then being offered bearing the highest shareholder service fee. Notwithstanding the foregoing, an investors shares will not be converted to a class of shares bearing a higher shareholder service fee without at least 15 calendar days prior notice, and if the investor makes an additional investment or the value of the investors shares otherwise increases prior to the end of the notice period so as to satisfy all minimum investment requirements for the investors current class of shares, the investor will remain in the class of shares then held by the investor. Solely for the purpose of determining whether an investor has satisfied the minimum investment requirements for an investors current class of shares, the value of the investors shares is considered to be the greater of (i) the value of the investors shares on the relevant Determination Date, (ii) the value of the investors shares on the date that GMO reassesses the value of the investors account for the purpose of sending notice of a proposed conversion, or (iii) the value of the investors shares immediately prior to the date when the conversion would take place. If the investor is not able to make an additional investment in a Fund solely because the Fund is closed to new investment or is capacity constrained, the class of shares then held by the investor will not be converted unless GMO approves reopening the Fund to permit the investor to make an additional investment. The conversion of an investors shares to a class of shares bearing a higher shareholder service fee generally will occur within 60 calendar days following the last Determination Date of a calendar year or, in the case of conversion due to an abusive pattern of investments or redemptions (see next paragraph), on any other date GMO determines. |
A Fund may at any time without notice convert an investors shares to the class it is then offering bearing the lowest shareholder service fee for which the investor satisfied all minimum investment requirements (or, if the Fund has no such class, the class of that Fund bearing the highest shareholder service fee) if the investor no longer satisfies all minimum investment requirements for the class of shares held by the investor and: (i) GMO believes the investor has engaged in an abusive pattern of investments or redemptions (e.g., a large investment just before a Determination Date and a redemption immediately after the Determination Date), (ii) the investor fails to meet the applicable Minimum Total Fund Investment or Minimum Total GMO Investment by the time specified in the investors Commitment Letter, or (iii) the total expense ratio borne by the investor immediately following the conversion is equal to or less than the total expense ratio borne by the investor immediately before the conversion (after giving effect to any applicable fee and expense waivers or reimbursements).
For U.S. federal income tax purposes, the conversion of an investors investment from one class of shares of a Fund to another class of shares of the same Fund generally should not result in the recognition of gain or loss in the shares that are converted. Thus, in general, the investors tax basis in the new class of shares immediately after the conversion should equal the investors basis in the converted shares immediately before the conversion, and the holding period of the new class of shares should include the holding period of the converted shares.
55
For High Quality Short-Duration Bond Fund:
The policy of the Fund is to declare and pay dividends of its net investment income, if any, at least annually, although the Fund is permitted to declare and pay dividends of net investment income, if any, more frequently. The Fund also intends to distribute net realized capital gains, whether from the sale of investments held by the Fund for not more than one year (net short-term capital gains) or from the sale of investments held by the Fund for more than one year (net long-term capital gains), if any, at least annually. In addition, the Fund may, from time to time and at its discretion, make unscheduled distributions in advance of large redemptions by shareholders or as otherwise deemed appropriate by the Fund. Net investment income of the Fund includes (i) distributions received from an underlying fund taxed as a RIC attributable to the underlying funds own net investment income and net short-term capital gains and (ii) the Funds allocable share of net investment income of an underlying fund taxed as a partnership. Net realized capital gains includes (x) distributions received from an underlying fund taxed as a RIC attributable to the underlying funds net long-term capital gains and (y) the Funds allocable share of net short-term or net long-term capital gains of an underlying fund taxed as a partnership. See Taxes below. From time to time, distributions by the Fund could constitute a return of capital to shareholders for U.S. federal income tax purposes.
Typically, all dividends or other distributions are reinvested in additional shares of the Fund, at net asset value, unless GMO or its agents receive and process a shareholder election to receive cash. Shareholders may elect to receive cash by marking the appropriate boxes on the GMO Trust Application, by writing to the Trust, or by notifying their broker or agent.
See Taxes below for more information about the tax consequences to shareholders of receiving Fund distributions, as well as of investing in a Fund more generally.
For All Other Funds:
GAAR Implementation Fund may make distributions to its sole shareholder, BFF, in the sole discretion of the Trustees (or their delegates).
Systematic Global Macro Opportunity Fund and World Opportunity Overlay Fund may declare and pay non-redeeming distributions to their shareholders in the sole discretion of the Trustees (or their delegates).
See Taxes below for more information about any tax consequences to shareholders of receiving Fund distributions, as well as of investing in a Fund more generally.
Except as specifically noted below, this section provides a general summary of the principal U.S. federal income tax consequences of investing in a Fund for shareholders who are U.S. citizens, residents, or corporations. You should consult your own tax advisers about the precise tax consequences of an investment in a Fund in light of your particular tax situation, including possible non-U.S., state, local, or other applicable taxes (including the federal alternative minimum tax). Please see the Taxes section of the SAI for a more detailed description of the tax consequences of investment in the Funds. The Funds shareholders may include certain other GMO Funds, including GMO Funds not offered in this Private Placement Memorandum, some of which are regulated investment companies (RICs) as defined by the Internal Revenue Code of 1986, as amended (the Code). The summary below does not address tax consequences to shareholders of those other GMO Funds. Shareholders of those other GMO Funds should refer to the prospectuses or private placement memoranda (as applicable) and statements of additional information for those GMO Funds for a summary of the tax consequences applicable to them.
56
It is important for you to note:
For GAAR Implementation Fund:
For U.S. federal income tax purposes, GAAR Implementation Fund will be disregarded as an entity separate from its sole shareholder, BFF. BFF intends each year to qualify and to be eligible to be treated as a RIC under Subchapter M of the Code. For federal income tax purposes, including for purposes of meeting the ongoing distribution, asset diversification, qualifying income, and other requirements applicable to RICs under Subchapter M of the Code, (i) BFF will be treated as owning GAAR Implementation Funds assets, including the wholly-owned subsidiary in which GAAR Implementation Fund invests, directly, (ii) any income, gain, loss, deduction or other tax items arising in respect of GAAR Implementation Funds assets will be treated as if they are realized or incurred, as applicable, directly by BFF, and (iii) any distributions BFF receives from GAAR Implementation Fund will have no effect on BFF for U.S. federal income tax purposes, including in respect of any liability or the requirements applicable to it for RIC treatment under the Code.
For High Quality Short-Duration Bond Fund:
| The Fund is treated as a separate taxable entity for U.S. federal income tax purposes and intends to elect and be treated and intends to qualify and be treated each year as a RIC under Subchapter M of the Code. A RIC generally is not subject to tax at the fund level on income and gains from investments that are timely distributed to shareholders. However, the Funds failure to qualify as a RIC would result in, among other things, Fund-level taxation, and consequently, a reduction in the value of the Fund. See Taxes in the SAI for more information about the tax consequences of not qualifying as a RIC. |
| For U.S. federal income tax purposes, distributions of net investment income generally are taxable to shareholders as ordinary income. |
| For U.S. federal income tax purposes, taxes on distributions of net realized capital gains generally are determined by how long the Fund owned the investments generating the gains, rather than by how long a shareholder has owned shares in the Fund. Distributions of net realized capital gains from the sale of investments that the Fund owned for more than one year and that are reported by the Fund as capital gain dividends generally are taxable to shareholders as long-term capital gains. Distributions of net realized capital gains from the sale of investments that the Fund owned for one year or less generally are taxable to shareholders as ordinary income. Tax rules can alter the Funds holding period in investments and thereby affect the tax treatment of gain or loss on such investments. |
| The Fund may make total distributions during a taxable year in an amount that exceeds the Funds net investment income and net realized capital gains for that year, in which case the excess generally would be treated as a return of capital, which would reduce a shareholders tax basis in its shares, with any amounts exceeding that basis treated as capital gain. A return of capital is not taxable to shareholders to the extent such amount does not exceed a shareholders tax basis, but it reduces a shareholders tax basis in its shares, thus reducing any loss or increasing any gain on a subsequent taxable disposition by the shareholder of its shares. |
|
The Fund will carry any net realized capital losses (i.e., realized capital losses in excess of realized capital gains) from any taxable year forward to one or more subsequent taxable years to offset capital gains, if any, realized during such subsequent years. The Fund will carry net capital losses forward to one or more subsequent years without expiration. The Fund must apply such carryforwards first against gains of the same character. The Funds available capital loss carryforwards, if any, will be set forth in its annual shareholder report for each fiscal year. The Funds ability to utilize these and certain other losses to reduce distributable |
57
net realized capital gains in succeeding taxable years may be limited by reason of direct or indirect changes in the actual or constructive ownership of the Fund. See Taxes in the SAI for more information. |
| Distributions of net investment income properly reported by the Fund as derived from qualified dividend income will be taxable to shareholders taxed as individuals at the rates applicable to net capital gain, provided holding period and other requirements are met at both the shareholder and Fund levels. |
| Distributions of net investment income derived from dividends eligible for the dividends-received deduction may allow a corporate shareholder (other than an S corporation) to deduct a percentage of such distribution, as a dividends-received deduction, in computing its taxable income, provided holding period and other requirements are met at both the shareholder and Fund levels. |
| The Code generally imposes a 3.8% Medicare contribution tax on the net investment income of individuals, and of certain trusts and estates to the extent their income exceeds certain threshold amounts. Net investment income generally includes for this purpose dividends, including any capital gain dividends, paid by the Fund, and net gains recognized on the sale, redemption or exchange of shares in the Fund, and may be reduced by certain allowable deductions. Shareholders are advised to consult their tax advisers regarding the possible implications of this additional tax on their investment in the Fund in light of their particular circumstances. |
| Distributions by the Fund generally are taxable to a shareholder even if they are paid from income or gains earned by the Fund before that shareholder invested in the Fund (and accordingly the income or gains were included in the price the shareholder paid for the Funds shares). Distributions are taxable whether shareholders receive them in cash or reinvest them in additional shares. |
| Distributions by the Fund to retirement plans that qualify for tax-exempt treatment under U.S. federal income tax laws generally will not be taxable. Special tax rules apply to investments through such plans. You should consult your tax adviser to determine the suitability of the Fund as an investment through such a plan and the tax treatment of distributions from such a plan. |
| Any gain resulting from a shareholders sale, exchange, or redemption of Fund shares generally will be taxable to the shareholder as short- or long-term capital gain, depending on how long the Fund shares were held by the shareholder. Redemptions paid in securities generally are treated by shareholders for U.S. federal income tax purposes the same as redemptions paid in cash. |
| To the extent the Fund invests, directly or indirectly, in other GMO Funds, or other investment companies treated as RICs, partnerships, trusts or other pass-through structures for U.S. federal income tax purposes, including certain ETFs, the Funds distributions could vary in terms of their timing, character, and/or amount, in some cases significantly, from what the Funds distributions would have been had the Fund invested directly in the portfolio investments held by the underlying investment companies. See Taxes in the SAI for more information. |
|
The Funds income from or the proceeds of dispositions of its non-U.S. investments may be subject to non-U.S. withholding or other taxes. The Fund may otherwise be subject to non-U.S. taxation on repatriation proceeds generated from those investments or to other transaction-based non-U.S. taxes on those investments. Those withholding and other taxes |
58
will reduce the Funds return on and taxable distributions in respect of its non-U.S. investments. In some cases, the Fund may seek a refund in respect of taxes paid to a non-U.S. country (see Description of Principal Risks Non-U.S. Investment Risk for more information). The non-U.S. withholding and other tax rates applicable to the Funds investments in certain non-U.S. jurisdictions may be higher, in certain circumstances, for instance, if the Fund has a significant number of non-U.S. shareholders or if the Fund or an underlying Fund invests through a subsidiary. In addition, the Funds investments in certain non-U.S. investments, foreign currencies or foreign currency derivatives may accelerate Fund distributions to shareholders and increase the distributions taxed to shareholders as ordinary income. See Taxes in the SAI for more information. |
| Any U.S. withholding or other taxes applicable to the Funds investments, including in respect of investments in its wholly-owned subsidiary, if any, will reduce the Funds return on its investments. |
| Under the Funds securities lending arrangements, if the Fund lends a portfolio security and a dividend is paid in respect of the security out on loan, the borrower will be required to pay to that Fund a substitute payment at least equal, on an after-tax basis, to the dividend that the Fund would have received if it had received the dividend directly. Because some borrowers of non-U.S. securities may be subject to levels of taxation that are lower than the rates applicable to that Fund, some borrowers are likely to be motivated by the ability to earn a profit on those differential tax rates and to pay that Fund for the opportunity to earn that profit. In the United States, Congress has enacted legislation limiting the ability of certain swaps and similar derivative instruments and securities lending transactions to reduce otherwise applicable U.S. withholding taxes on U.S. stock dividends paid to a non-U.S. person. There can be no assurance that similar legislation will not be adopted in other jurisdictions with respect to non-U.S. investments or that non-U.S. taxing authorities will not otherwise challenge beneficial tax results arising from swaps or other derivative instruments or securities lending arrangements. |
| Some of the Funds investment practices, including derivative transactions, short sales, hedging activities generally, and securities lending activities, as well as some of the Funds investments, including debt obligations issued or purchased at a discount, asset-backed securities, assets marked to the market for U.S. federal income tax purposes, REITs, equity in certain non-U.S. corporations, master limited partnerships and, potentially, so-called indexed securities (such as TIPS or other inflation-indexed bonds), are subject to special and complex U.S. federal income tax provisions. These special rules may affect the timing, character, and amount of the Funds distributions and, in some cases, may cause the Fund to liquidate investments at disadvantageous times. |
| The Funds investment either directly or indirectly through a wholly-owned subsidiary could affect the amount, timing and character of its distributions and could cause the Fund to recognize taxable income in excess of the cash generated by such investment, requiring the Fund in turn to liquidate investments at disadvantageous times to generate cash needed to make required distributions. See Taxes in the SAI for more information about the tax consequences of specific Fund investment practices and investments, including a Funds investments in a wholly-owned subsidiary. |
| The Fund does not expect to pass through to shareholders the tax-exempt character of interest from investments in tax-exempt municipal bonds, if any. Therefore, any interest on municipal bonds will be taxable to shareholders of the Fund when received as a distribution from the Fund. |
59
| The Funds ability to pursue its investment strategy, including a strategy involving the ability to engage in certain derivative transactions, may be limited by such Funds intention to qualify as a RIC and such Funds strategy may bear adversely on such Funds ability to so qualify. |
| Dividends (other than capital gain dividends) paid to non-U.S. shareholders are generally subject to withholding of U.S. federal income tax at a rate of 30% (or lower applicable treaty rate). For more information on the tax consequences of investing in a Fund for non-U.S. shareholders, see Taxes in the SAI. Non-U.S. shareholders described in section 892 of the Code should consult their tax advisers with respect to their investment in the Fund. |
| Sections 1471-1474 of the Code, and the U.S. Treasury Regulations and IRS guidance issued thereunder (collectively, FATCA), generally require a Fund to obtain information sufficient to identify the status of each of its shareholders under FATCA or under an applicable intergovernmental agreement (an IGA). If a shareholder fails to provide this information or otherwise fails to comply with FATCA or an IGA, the Fund or its agent may be required to withhold under FATCA 30% of the distributions, other than distributions properly reported as capital gain dividends, the Fund pays to that shareholder, and, after December 31, 2016, 30% of the gross proceeds of the sale, redemption or exchange of Fund shares and certain capital gain dividends the Fund pays to that shareholder. If a payment by the Fund is subject to FATCA withholding, the Fund or its agent is required to withhold even if the payment would otherwise be exempt from withholding under rules applicable to non-U.S. shareholders (e.g., capital gain dividends). Each prospective shareholder is urged to consult its tax adviser regarding the applicability of FATCA and any other reporting requirements. In addition, foreign countries are considering, and may implement, laws similar in purpose and scope to FATCA, as more fully described above. See Taxes in the SAI for more information. |
| Most states permit mutual funds, such as the Fund, to pass through to their shareholders the state tax exemption on income earned from investments in some direct U.S. Treasury obligations, as well as some limited types of U.S. government agency securities, so long as a fund meets all applicable state requirements. Therefore, you may be allowed to exclude from your state taxable income distributions made to you by the Fund that are attributable to interest the Fund directly or indirectly earned on such investments. The availability of these exemptions varies by state. You should consult your tax adviser regarding the applicability of any such exemption to your situation. |
For Systematic Global Macro Opportunity Fund and World Opportunity Overlay Fund:
| Each Fund expects to be treated as a partnership that is not a publicly traded partnership for U.S. federal income tax purposes. As a partnership that is not a publicly traded partnership, each Fund generally is not itself subject to U.S. federal income tax. Instead, each shareholder is required to take into account its distributive share of a Funds income, gain, loss, deduction, credit, and items of tax preference for each taxable year substantially as though such items had been realized directly by the shareholder and without regard to whether a Fund has distributed or will distribute any amount of cash to its shareholders. Allocations of these tax items, for U.S. federal income tax purposes, will be made in accordance with the economics of a Fund as determined at GMOs discretion. Differences in timing, character and/or amount of a shareholders allocable share of the Funds income, gain, loss, or deduction may arise, and, in some cases, may be significant, where a Fund modifies its allocations to comply with applicable tax regulations or makes special allocations of specific tax items to a shareholder. The remainder of this discussion assumes that each Fund will be treated as a partnership for U.S. federal income tax purposes that is not a publicly traded partnership for U.S. federal income tax purposes. |
60
| Each Fund will be required to file an information return on IRS Form 1065 and will provide tax information on Schedule K-1 to each shareholder following the close of the Funds taxable year. Each shareholder will be responsible for keeping its own records for determining its tax basis in its shares and for the preparation and filing of its own tax returns. Shareholders generally should expect to file for extensions for the completion of their U.S. federal, state, local, and other tax returns. |
| It is possible that a shareholder will incur income tax liabilities in a taxable year in respect of its investment in a Fund that exceed cash distributions (if any) made by the Fund for that year. As a result, it is possible that a RIC shareholder will be required to liquidate a portion of its Fund shares or other investments in order to obtain sufficient cash to satisfy its annual RIC distribution requirements and to otherwise avoid incurring RIC-level taxes. |
| The Code generally imposes a 3.8% Medicare contribution tax on the net investment income of individuals and of certain trusts and estates to the extent their income exceeds certain threshold amounts. Very generally, for this purpose and subject to certain exceptions, net investment income will include (i) a shareholders distributive share of a Funds gross investment income (e.g., dividends or interest income received by a Fund or any gains realized on the disposition of Fund property), and (ii) any net gain recognized by the shareholder on the redemption of shares of a Fund, and will be reduced by a shareholders distributive share of Fund deductions that are properly allocable to the type of gross income or gain described in (i) or (ii). Shareholders are advised to consult their tax advisers regarding the possible implications of this additional tax on their investment in a Fund in light of their particular circumstances. |
| In general, distributions of cash by a Fund (including in satisfaction of redemption requests) to a shareholder will represent a nontaxable return of capital to that shareholder up to the amount of the shareholders adjusted tax basis in its Fund shares, with any amounts exceeding that basis treated as capital gain. Any loss on Fund shares may be recognized by a shareholder only if it redeems all of its Fund shares for cash. A shareholder generally will not recognize gain or loss on an in-kind distribution of property from a Fund, including on an in-kind redemption of Fund shares. In some cases, exceptions to these general rules may apply, which, for instance, can result in the recognition of ordinary income instead of capital gain on certain distributions of cash. See Taxes in the SAI for more information on the tax treatment of a Funds distributions. |
| Some of a Funds investment practices, including derivative transactions, short sales and hedging activities generally, and securities lending activities (if any), as well as certain of a Funds investments, including its interests in a subsidiary, debt obligations issued or purchased at a discount, asset-backed securities, assets marked to the market for U.S. federal income tax purposes, and, potentially, so-called indexed securities (such as TIPS and other inflation-indexed bonds), will be subject to special and complex U.S. federal income tax provisions. These special rules may increase or accelerate Fund shareholders recognition of income or gain taxable at ordinary income rates and can otherwise affect the timing, character, and/or amount of income recognized by shareholders. It is possible that these special rules will also cause the Fund to recognize taxable income in excess of the cash generated by such investments. See Taxes in the SAI for more information about the tax consequences of a Funds specific investment practices and investments. |
|
A Funds income from or the proceeds of dispositions of its non-U.S. investments may subject the Fund and/or its shareholders directly or indirectly to taxation, including withholding or other taxes on dividends, interest, or capital gains, and/or tax filing obligations in non-U.S. jurisdictions. A Fund and/or its shareholders may otherwise be subject to non- |
61
U.S. taxation on repatriation proceeds generated from those investments or to other transaction-based non-U.S. taxes on those investments. Subject to certain limitations, shareholders may be entitled to claim a credit or deduction (but not both) in respect of certain non-U.S. taxes paid by them or their Fund. See Taxes in the SAI for more information. In addition, a Funds investments in certain non-U.S. investments, foreign currencies, or foreign currency derivatives may increase or accelerate Fund shareholders recognition of ordinary income. See Taxes in the SAI for more information. For information on possible Australian and Singapore tax consequences of an investment in Systematic Global Macro Opportunity Fund, see Taxes For Systematic Global Macro Opportunity Fund below. |
| Under the GMO Funds securities lending arrangements, when a dividend is paid in respect of a Fund security out on loan, the borrower is required to pay to that Fund a substitute payment at least equal, on an after-tax basis, to the dividend that the Fund would have received if it had received the dividend directly. Because some borrowers of non-U.S. securities may be subject to levels of taxation that are lower than the rates applicable to that Fund, some borrowers are likely to be motivated by the ability to earn a profit on those differential tax rates and to pay that Fund for the opportunity to earn that profit. In the United States, Congress has enacted legislation limiting the ability of certain swaps and similar derivative instruments and securities lending transactions to reduce otherwise applicable U.S. withholding taxes on U.S. stock dividends paid to a non-U.S. person. There can be no assurance that similar legislation will not be adopted in other jurisdictions with respect to non-U.S. investments or that non-U.S. taxing authorities will not otherwise challenge beneficial tax results arising from swaps or other derivative instruments or securities lending arrangements. |
| A tax-exempt shareholders distributive share of income will likely be UBTI to the extent that a Fund borrows money (including, potentially, through the use of reverse repurchase agreements) to acquire investments, or invests in assets or engages in other investment practices that produce UBTI. See Taxes in the SAI for more information. |
| To the extent a Fund invests in other GMO Funds or other investment companies treated as RICs, partnerships, trusts or other pass-through structures for U.S. federal income tax purposes, the recognition of income by Fund shareholders could vary in terms of its timing, character, and/or amount from that which would have been recognized had the Fund invested directly in the portfolio investments held by the underlying investment companies. See Taxes in the SAI for more information. |
| In general, in order to qualify as a RIC, a shareholder must, among other things, derive at least 90% of its gross income from certain specified sources (qualifying income). Because shareholders will be required to take into account their distributive share of items of Fund income for each taxable year as though such items had been realized directly by the shareholder, special tax considerations apply to shareholders that are RICs. For Systematic Global Macro Opportunity Fund, the Funds investment in its wholly-owned subsidiary company is expected to generate qualifying income for shareholders that are RICs. However, there is a risk that the IRS could seek to recharacterize this investment in such a manner that all or a portion of the income derived from the Funds investment in its subsidiary is deemed to be bad income (i.e., non-qualifying income) in the hands of a RIC shareholder, which might adversely affect the RIC shareholders ability to qualify as a RIC in a particular year. |
|
Systematic Global Macro Opportunity Funds subsidiary may be subject to U.S. withholding tax on certain categories of its U.S.-source income. All of the subsidiarys net income and gain from its investments is expected to be includible in the Funds income at the end of its taxable year as so-called subpart F income, whether or not distributed by the subsidiary to |
62
the Fund, and all such subpart F income, regardless of the character of the subsidiarys underlying income and gain, is expected to be treated as ordinary income in the Funds hands. Distributions by the subsidiary to the Fund, including in redemption of the Funds interests in the subsidiary, generally will be tax-free to the Fund to the extent of the subsidiarys previously taxed but undistributed subpart F income, and will correspondingly reduce the Funds tax basis in the subsidiary (but not below zero), with any amount in excess of that basis generally treated as capital gain that is taxable as such when allocated to Fund shareholders. From time to time, the subsidiary may be required to liquidate investments, including at a time when it is not advantageous to do so, in order to make such distributions to the Fund. In liquidating such investments, the subsidiary may incur transaction costs, and recognize net income and gains, which, in turn, must be included in the Funds income as subpart F income as described above. Net losses incurred by the subsidiary during a taxable year will not flow through to the Fund and thus will not be available to Fund shareholders to offset income or capital gain generated from the Funds other investments. In addition, net losses incurred by the subsidiary during a taxable year generally cannot be carried forward by the subsidiary to offset gains it realizes in subsequent taxable years. |
| Sections 1471-1474 of the Code and the U.S. Treasury Regulations and other guidance issued thereunder (collectively, FATCA), generally require a Fund to obtain information sufficient to identify the status of each of its shareholders under FATCA or under an applicable intergovernmental agreement (an IGA). If a shareholder fails to provide this information or otherwise fails to comply with FATCA or an IGA, a Fund or its agent may be required to withhold under FATCA at a rate of 30% with respect to that shareholder on certain U.S-source income (including, among other types of income, dividends, interest and certain payments with respect to derivative instruments that are determined to be dividend equivalent payments) paid or allocated to that shareholder and, after December 31, 2016, 30% of gross proceeds from the sale or other disposition of property that can produce U.S.-source dividends or interest allocated to that shareholder (collectively, Withholdable Payments). Each prospective shareholder is urged to consult its tax adviser regarding the applicability of FATCA and any other reporting requirements. In addition, foreign countries are considering, and may implement, laws similar in purpose and scope to FATCA. See Taxes in the SAI for more information. |
For Systematic Global Macro Opportunity Fund:
As described above under Management of the Trust, GMO Singapore furnishes discretionary investment advisory services and makes investment decisions for and places orders for the purchase and sale of securities for, all or a part of Systematic Global Macro Opportunity Funds (for purposes of the following discussion, the Fund) portfolio, as determined by GMO.
GMO believes that an exemption from Singapore taxation should apply to income and gains derived from the provision of such discretionary investment advisory services and from such investment decisions made by GMO Singapore for a qualifying fund, so long as, among other requirements, such income and gains constitute specified income from designated investments as those terms are defined under current Singapore tax law. In this regard, the sources of specified income from designated investments earned solely by the Fund (and not by any other GMO Fund) are considered. GMO expects that substantially all such income and gains earned by the Fund will constitute specified income from designated investments. This tax position takes into account advice received from Singapore legal counsel and relevant Singapore tax law. All income and gains that are considered to be Singapore-sourced (including amounts attributable to Fund-level permanent establishment in Singapore) and that do not otherwise qualify for the exemption would generally be subject to Singapore taxation at the current corporate rate of 17%. Shareholders bear the risk of all Fund income tax consequences in the event that income or gains are subject to Singapore taxation.
63
In addition to the foregoing, a non-qualifying shareholder (described below) may be required to pay a financial amount to the Inland Revenue Authority of Singapore and fulfill certain Singapore tax reporting requirements. Very generally, non-qualifying shareholders may include, but are not limited to, Singapore-domiciled shareholders that maintain a permanent establishment in Singapore and who, either alone or with their associates, beneficially own applicable qualifying fund shares representing in excess of 50% of a qualifying funds net assets as of the final day of that qualifying funds financial year-end (or in excess of 30% of the qualifying funds net assets, to the extent the qualifying fund has less than 10 shareholders). The financial amount is generally computed by applying the prevailing corporate rate of tax to a non-qualifying shareholders share of qualifying fund profits.
Shareholders are responsible for evaluating their percentage interest of net assets in a qualifying fund for the purpose of their own particular situations. Relevant information may be derived from account statements and other information provided to shareholders in respect of the qualifying fund. Upon the reasonable request of a shareholder, GMO will provide information necessary to allow the shareholder to assess its percentage ownership in the qualifying fund.
GMO Singapore also furnishes discretionary investment advisory services and makes investment decisions for and places orders for the purchase and sale of securities for, all or a part of GMO Emerging Domestic Opportunities Funds (EDOF) portfolio, as determined by GMO. EDOF is another series of GMO Trust not offered by this Private Placement Memorandum. To the extent a Fund invests in EDOF, it is indirectly exposed to the Singapore taxation issues described above.
As described above under Management of the Trust, GMO has entered into a personnel sharing agreement with GMO Australia. GMO currently believes that the Funds income or gains should not become Australian sourced and thus should not be subject to Australian income tax merely by virtue of such personnel sharing arrangement. The Australian Government has recently enacted certain legislation and has released further draft legislation relating to the taxation of foreign managed funds in Australia that may mitigate the Australian tax risks for the Fund. The income or gains of Systematic Global Macro Opportunity Fund, as a non-resident of Australia and to the extent the Fund (including its subsidiary) or its shareholders are not qualified to claim tax treaty benefits with Australia, will be subject to Australian income tax where that income or those gains constitute ordinary income which is Australian sourced. Given the way in which Systematic Global Macro Opportunity Fund undertakes its trading activities, there is a low risk of any Australian sourced income or gains being derived by the Fund.
GMO currently believes that the Funds income or gains should not become Australian sourced merely by virtue of GMO Australia sharing personnel with GMO and the provision of certain investment management and other services in Australia, as described above in Management of the Trust. Its position takes into account advice received from Australian counsel and the published views of the Australian Commissioner of Taxation (Commissioner) in respect of similar arrangements. Any income or gains of Systematic Global Macro Opportunity Fund (including its subsidiary) which the Commissioner considers to be Australian sourced and which do not otherwise qualify for tax treaty benefits with Australia (or with the announced or future concessions/exemptions described below) would generally be subject to Australian tax at the corporate rate of 30%. Shareholders of Systematic Global Macro Opportunity Fund bear the risk of any such Australian income tax consequences in the event the Funds income or gains were to be subject to Australian tax.
The Australian Government is undertaking a review of the laws relating to the taxation of foreign managed funds in Australia. In particular, it has enacted or is implementing certain tax exemptions/concessions as part of the Investment Manager Regime (IMR) that may mitigate the Australian tax risks for Systematic Global Macro Opportunity Fund (including its subsidiary) and its shareholders. Certain provisions have already been enacted, which apply from the 2010-11 and later tax years, and legislation in relation to the third and final (full) element of the IMR was introduced into Parliament on May 27, 2015, which is expected to apply from the 2015-16 and later tax years (however
64
taxpayers may choose to apply the new provisions from the 2011-12 tax year). The effect of the full IMR may be to exempt Systematic Global Macro Opportunity Fund (including its subsidiary) and its shareholders from Australian taxes even if the income or gains of the Fund were held to have an Australian source. As the full IMR has not yet been legislated, future developments will need to be monitored, as the application of the full IMR to Systematic Global Macro Opportunity Fund and its subsidiary and shareholders will not be certain until it is finalized.
Shareholders should consult their own tax advisers regarding the tax consequences of an investment in the Fund, including the implications described herein.
See Taxes in the SAI for more information, including a summary of some of the tax consequences of investing in a Fund for non-U.S. shareholders.
The following section provides additional information about the Funds benchmarks (if any) listed under Investment Objective and Principal Investment Strategies in the Fund summaries:
Benchmark |
Description |
|
Citigroup 3-Month Treasury Bill Index | The Citigroup 3-Month Treasury Bill Index is an independently maintained and widely published index comprised of short-term U.S. Treasury bills. | |
J.P. Morgan U.S. 3 Month Cash Index | The J.P. Morgan U.S. 3 Month Cash Index is an independently maintained and widely published index comprised of three month U.S. dollar Euro-deposits. |
65
(For a share outstanding throughout each period)
The financial highlights tables are intended to help you understand each Funds financial performance for the past five years (or, if shorter, the period of the Funds operations). Some information reflects financial results for a single Fund share. The total returns in the tables represent the rate that an investor would have earned (or lost) on an investment in the Fund (assuming reinvestment of all dividends and distributions). This information has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, whose report, along with each Funds financial statements, is incorporated by reference in the SAI and included in the Trusts annual reports, which are available upon request. Information is presented for each Fund, and class of Fund shares, that had investment operations during the reporting periods and is currently being offered by this Private Placement Memorandum.
Information presented in the table for Systematic Global Macro Opportunity Fund includes the accounts of Systematic Global Macro Opportunity Fund and its wholly-owned subsidiary GMO Alternative Asset SPC Ltd. The consolidated financial highlights include 100% of the assets and liabilities of GMO Alternative Asset SPC Ltd. All significant interfund accounts and transactions have been eliminated in consolidation.
66
GMO Systematic Global Macro Opportunity Fund Consolidated Financial Highlights
Class III Shares | ||||||||||||||||||||
Year Ended February 28/29, | ||||||||||||||||||||
2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||||||
Net asset value, beginning of period |
$ | 32.18 | $ | 30.47 | $ | 30.05 | $ | 32.55 | $ | 27.24 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) from investment operations: |
||||||||||||||||||||
Net investment income (loss) (a) |
(0.25 | ) | (0.22 | ) | (0.18 | ) | 0.00 | (b) | 0.11 | |||||||||||
Net realized and unrealized gain (loss) |
1.87 | (c) | 1.93 | 0.60 | (2.50 | ) | 5.20 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total from investment operations |
1.62 | 1.71 | 0.42 | (2.50 | ) | 5.31 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net asset value, end of period |
$ | 33.80 | $ | 32.18 | $ | 30.47 | $ | 30.05 | $ | 32.55 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Return (d) |
5.03 | % | 5.61 | % | 1.40 | % | (7.68 | )% | 19.49 | % | ||||||||||
Ratios/Supplemental Data: |
||||||||||||||||||||
Net assets, end of period (000s) |
$ | 1,499,443 | $ | 1,662,189 | $ | 959,752 | $ | 44,320 | $ | 25,546 | ||||||||||
Net expenses to average daily net assets (e) |
0.80 | % | 0.75 | % | 0.75 | % (f) | 0.69 | % (f) | 0.60 | % | ||||||||||
Net investment income to average daily net assets (a) |
(0.76 | )% | (0.70 | )% | (0.61 | )% | (0.01 | )% | 0.38 | % | ||||||||||
Portfolio turnover rate |
45 | % | 97 | % | 17 | % | 48 | % | 60 | % | ||||||||||
Fees and expenses reimbursed and/or waived by GMO to average daily net assets: |
0.08 | % | 0.13 | % | 0.17 | % | 1.64 | % | 1.15 | % |
(a) | Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests. |
(b) | Net investment income (loss) was less than $0.01 per share. |
(c) | The amount shown for a share outstanding does not correspond with the aggregate net realized and unrealized gain (loss) on investments due to the timing of purchases and redemptions of Fund shares in relation to fluctuating market values of the investments of the Fund. |
(d) | Total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any. |
(e) | Net expenses exclude expenses incurred indirectly through investment in the underlying funds. |
(f) | The net expense ratio does not include the effect of expense reductions. |
| Calculated using average shares outstanding throughout the period. |
67
GMO World Opportunity Overlay Fund
Year Ended February 28/29, | ||||||||||||||||||||
2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||||||
Net asset value, beginning of period |
$ | 26.84 | $ | 25.68 | $ | 24.00 | $ | 22.68 | $ | 21.30 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) from investment operations: |
||||||||||||||||||||
Net investment income (loss) |
0.18 | 0.13 | 0.32 | 0.37 | 0.37 | |||||||||||||||
Net realized and unrealized gain (loss) |
(1.52 | ) | 1.03 | 1.36 | 0.95 | 1.01 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total from investment operations |
(1.34 | ) | 1.16 | 1.68 | 1.32 | 1.38 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Less distributions to shareholders: |
||||||||||||||||||||
From cash distributions |
| | | | | |||||||||||||||
Total distributions |
| | | | | |||||||||||||||
Net asset value, end of period |
$ | 25.50 | $ | 26.84 | $ | 25.68 | $ | 24.00 | $ | 22.68 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Return (a) |
(4.99 | )% | 4.52 | % | 7.00 | % | 5.82 | % | 6.48 | % | ||||||||||
Ratios/Supplemental Data: |
||||||||||||||||||||
Net assets, end of period (000s) |
$ | 179,957 | $ | 562,337 | $ | 691,486 | $ | 855,176 | $ | 850,192 | ||||||||||
Net operating expenses to average daily net assets (b) |
0.00 | % | 0.00 | % (c) | 0.00 | % (c) | 0.00 | % (c) | 0.00 | % (c) | ||||||||||
Interest expense to average daily net assets |
0.05 | % (e) | 0.05 | % (e) | 0.04 | % (e) | 0.03 | % (d) | 0.03 | % (d) | ||||||||||
Total net expenses to average daily net assets |
0.05 | % | 0.05 | % (c) | 0.04 | % (c) | 0.03 | % (c) | 0.03 | % (c) | ||||||||||
Net investment income (loss) to average daily net assets |
0.69 | % | 0.51 | % | 1.30 | % | 1.59 | % | 1.69 | % | ||||||||||
Portfolio turnover rate |
26 | % | 80 | % | 8 | % | 46 | % | 36 | % | ||||||||||
Fees and expenses reimbursed by GMO to average daily net assets |
0.08 | % | 0.04 | % | 0.04 | % | 0.04 | % | 0.04 | % |
(a) | The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any. |
(b) | Ratio is less than 0.01%. |
(c) | The net expense ratio does not include the effect of expense reductions. |
(d) | Interest expense incurred as a result of entering into reverse repurchase agreements and/or payables owed to Lehman Brothers in connection with the termination of derivative contracts in 2008 is included in the Funds net expenses. Income earned on investing proceeds from reverse repurchase agreements is included in interest income. |
(e) | Interest expense incurred as a result of entering into reverse repurchase agreements and/or margin on cleared swap contracts, if any, is included in the Funds net expenses. Income earned on investing proceeds from reverse repurchase agreements, if any, is included in interest income. |
| Calculated using average shares outstanding throughout the period. |
68
GMO Debt Opportunities Fund. GMO Debt Opportunities Fund (Debt Opportunities Fund), a series of the Trust, is not offered by this Private Placement Memorandum. Debt Opportunities Fund is managed by GMO.
Debt Opportunities Fund pays an investment management fee to GMO at the annual rate of 0.25% of Debt Opportunities Funds average daily net assets for each class of shares. Debt Opportunities Fund offers Class III and Class VI shares, which pay shareholder service fees to GMO at the annual rate, respectively, of 0.15% and 0.055% of the classs average daily net assets.
Debt Opportunities Funds investment objective is positive total return.
Debt Opportunities Fund invests primarily in debt investments (including both direct and indirect investments) and is not restricted in its exposure to any type of debt investment. Debt Opportunities Fund may invest in securities of any credit quality and has no limit on how much it may invest in below investment grade securities (commonly referred to as junk bonds). Debt Opportunities Funds debt investments may include all types of interest rate, payment, and reset terms, including fixed rate, adjustable rate, zero coupon, contingent, deferred, payment-in-kind, and auction rate features.
Debt Opportunities Fund may invest in debt investments issued by a wide range of U.S. and non-U.S. private issuers and by federal, state, local, and non-U.S. governments (whether or not guaranteed or insured by those governments). Debt Opportunities Fund may invest in asset-backed securities (including, but not limited to, securities backed by pools of residential and commercial mortgages (including sub-prime mortgages), credit-card receivables, home equity loans, automobile loans, educational loans, corporate and sovereign bonds, and bank loans made to corporations), corporate debt securities, money market instruments, and commercial paper. As of the date of this Private Placement Memorandum, Debt Opportunities Fund has invested a substantial portion of its assets in asset-backed securities, many of which are below investment grade.
In selecting debt investments for Debt Opportunities Funds portfolio, GMO uses analytical techniques to evaluate the relative attractiveness of particular sectors and securities. The factors considered and investment methods used by GMO can change over time.
Debt Opportunities Fund does not maintain a specified interest rate duration for its portfolio.
Under normal circumstances, Debt Opportunities Fund invests directly and indirectly (e.g., through other GMO Funds or derivatives) at least 80% of its assets in debt investments.
From time to time, Debt Opportunities Fund may have some direct or indirect exposure to equities.
Debt Opportunities Fund also may invest in exchange-traded and over-the-counter (OTC) derivatives, including swap contracts (such as credit default swaps, swaps on securities and securities indices, total return swaps, interest rate swaps, currency swaps, variance swaps, commodity swaps, inflation swaps, municipal swaps, correlation swaps, and other types of swaps), reverse repurchase agreements, and repurchase agreements. Debt Opportunities Fund is not limited in its use of derivatives or in the total notional value of its derivative positions. As a result of its derivative positions, Debt Opportunities Fund may have gross investment exposures in excess of its net assets (i.e., Debt Opportunities Fund may be leveraged) and therefore is subject to heightened risk of loss. Debt Opportunities Funds performance can depend substantially, if not primarily, on the performance of assets or indices underlying its derivatives even though it does not own those assets or indices.
Debt Opportunities Fund also may invest in GMO U.S. Treasury Fund and in money market funds unaffiliated with GMO.
69
Debt Opportunities Fund may, but is not required to, hedge part or all of its net foreign currency exposure into U.S. dollars.
If deemed prudent by GMO, Debt Opportunities Fund may take temporary defensive positions.
A GMO Fund that invests in Debt Opportunities Fund is subject to all of the risks to which Debt Opportunities Fund is exposed. The principal risks of an investment in Debt Opportunities Fund include Credit Risk, Market Risk Asset-Backed Securities, Illiquidity Risk, Focused Investment Risk, Management and Operational Risk, Market Risk Fixed Income Investments, Derivatives and Short Sales Risk, Leveraging Risk, Counterparty Risk, Fund of Funds Risk, Market Disruption and Geopolitical Risk, Market Risk Equities, Smaller Company Risk, Large Shareholder Risk, Non-U.S. Investment Risk, and Currency Risk. Debt Opportunities Fund is a non-diversified investment company under the Investment Company Act of 1940, as amended, and therefore a decline in the market price of a particular security held by Debt Opportunities Fund may affect Debt Opportunities Funds performance more than if Debt Opportunities Fund were a diversified investment company. Shareholders of each GMO Fund investing in Debt Opportunities Fund are indirectly exposed to these risks.
GMO U.S. Treasury Fund. GMO U.S. Treasury Fund (U.S. Treasury Fund), a series of the Trust, is not offered by this Private Placement Memorandum. U.S. Treasury Fund is managed by GMO.
U.S. Treasury Fund pays an investment management fee to GMO at the annual rate of 0.08% of U.S. Treasury Funds average daily net assets. As of the date of this Private Placement Memorandum, GMO has voluntarily waived U.S. Treasury Funds entire management fee. GMO may change or terminate this waiver at any time. U.S. Treasury Fund does not pay shareholder services fees to GMO. U.S. Treasury Fund offers a single class of shares.
U.S. Treasury Funds investment objective is liquidity and safety of principal with current income as a secondary objective.
GMO pursues investment strategies for U.S. Treasury Fund that are intended to complement the strategies it is pursuing in other funds or accounts managed by GMO. Accordingly, U.S. Treasury Fund is not a standalone investment.
Under normal circumstances, U.S. Treasury Fund invests at least 80% of its assets in Direct U.S. Treasury Obligations and repurchase agreements collateralized by these Obligations. Direct U.S. Treasury Obligations include U.S. Treasury bills, bonds and notes and other securities issued by the U.S. Treasury, as well as Separately Traded Registered Interest and Principal Securities (STRIPS) and other zero-coupon securities. GMO normally seeks to maintain an interest rate duration of one year or less for U.S. Treasury Funds portfolio.
U.S. Treasury Fund also may enter into repurchase agreements, under which U.S. Treasury Fund purchases a security backed by the full faith and credit of the U.S. government from a seller who simultaneously commits to repurchase, on an agreed upon date in the future, the security from U.S. Treasury Fund at the original purchase price plus an agreed upon amount representing the original purchase price plus interest. The counterparties in repurchase agreements are typically brokers and banks, and the safety of the arrangement depends on, among other things, U.S. Treasury Funds having an interest in the security that it can realize in the event of the insolvency of the counterparty.
In addition to Direct U.S. Treasury Obligations, U.S. Treasury Fund may invest in other fixed income securities that are backed by the full faith and credit of the U.S. government, such as fixed income securities issued by the Government National Mortgage Association (GNMA) and the Federal Deposit Insurance Corporation (FDIC) that are guaranteed by the U.S. government. U.S. Treasury Fund also may invest in money market funds unaffiliated with GMO.
Although the fixed income securities purchased by U.S. Treasury Fund normally will have a stated or remaining maturity of one year or less, Direct U.S. Treasury Obligations purchased pursuant to
70
repurchase agreements may not, and, therefore, if the counterparty to the repurchase agreement defaults, U.S. Treasury Fund may end up owning a security with a stated or remaining maturity of more than one year.
U.S. Treasury Fund is not a money market fund and is not subject to the duration, quality, diversification and other requirements applicable to money market funds.
In selecting U.S. Treasury securities for U.S. Treasury Funds portfolio, GMO focuses primarily on the relative attractiveness of different obligations (such as bonds, notes, or bills), which can vary depending on the general level of interest rates as well as supply and demand imbalances and other market conditions. The factors considered and investment methods used by GMO can change over time.
Other GMO Funds may invest in U.S. Treasury Fund.
A GMO Fund that invests in U.S. Treasury Fund is subject to all of the risks to which U.S. Treasury Fund is exposed. The principal risks of an investment in U.S. Treasury Fund include Market Risk Fixed Income Investments, Credit Risk, Focused Investment Risk, Large Shareholder Risk, Management and Operational Risk, and Market Disruption and Geopolitical Risk. Shareholders of each GMO Fund investing in U.S. Treasury Fund are indirectly exposed to these risks.
71
GMO TRUST
Each Funds annual and semiannual reports to shareholders contain additional information about the Funds investments. Each Funds annual report contains a discussion of the market conditions and investment strategies that significantly affected the Funds performance during its last fiscal year. Each Funds annual and semiannual reports are, and the Funds SAI is, available free of charge by writing to Shareholder Services at GMO, 40 Rowes Wharf, Boston, Massachusetts 02110 or by calling collect at 1-617-346-7646. Because the Funds do not publicly offer their shares, their shareholder reports and SAI are not available on GMOs website. The SAI contains more detailed information about each Fund and is incorporated by reference into this Private Placement Memorandum, which means that it is legally considered to be part of this Private Placement Memorandum.
You can review and copy the Private Placement Memorandum, SAI, and reports at the SECs Public Reference Room in Washington, D.C. Information regarding the operation of the Public Reference Room may be obtained by calling the SEC at 1-202-551-8090. Reports and other information about the Funds are available on the EDGAR database on the SECs Internet site at http://www.sec.gov. Copies of this information may be obtained, upon payment of a duplicating fee, by electronic request at the following e-mail address: publicinfo@sec.gov, or by writing the Public Reference Section of the SEC, Washington, D.C. 20549-1520.
Shareholders who wish to communicate with the Trustees must do so by mailing a written communication, addressed as follows: To the Attention of the Board of Trustees, c/o GMO Trust Chief Compliance Officer, 40 Rowes Wharf, Boston, Massachusetts 02110. The shareholder communication must (i) be in writing and be signed by the shareholder, (ii) identify the Fund to which it relates, and (iii) identify the class and number of shares held beneficially or of record by the shareholder.
Shareholders may request additional
information from and direct inquiries to:
Shareholder Services at
Grantham, Mayo, Van Otterloo & Co. LLC
40 Rowes Wharf, Boston, Massachusetts 02110
1-617-346-7646 (call collect)
1-617-439-4192 (fax)
SHS@GMO.com
website: http://www.gmo.com
Funds Distributor, LLC
3 Canal Plaza
Suite 100
Portland, Maine 04101
Investment Company Act File No. 811-04347
72
GMO TRUST
GMO GAAR Implementation Fund |
GMO Systematic Global Macro Opportunity Fund Class III |
|
GMO High Quality Short-Duration Bond Fund Class III, Class VI |
GMO World Opportunity Overlay Fund |
June 26, 2015
STATEMENT OF ADDITIONAL INFORMATION
This Statement of Additional Information (SAI) is not a prospectus. It relates to the Private Placement Memorandum for GMO GAAR Implementation Fund, GMO High Quality Short-Duration Bond Fund, GMO Systematic Global Macro Opportunity Fund, and GMO World Opportunity Overlay Fund, dated June 26, 2015, as amended and revised from time to time (the Private Placement Memorandum), and should be read in conjunction therewith. GMO GAAR Implementation Fund, GMO High Quality Short-Duration Bond Fund, GMO Systematic Global Macro Opportunity Fund, and GMO World Opportunity Overlay Fund (each a Fund, and collectively, the Funds, and together with other series of the Trust not offered in the Private Placement Memorandum, each a GMO Fund, and collectively, the GMO Funds) are each a series of GMO Trust (the Trust). Information from the Private Placement Memorandum is, and the Trusts audited financial statements, financial highlights, and report of the independent registered public accounting firm of the Funds, which are included in the annual report to shareholders of each Fund, are (or, in the case of GMO GAAR Implementation Fund and GMO High Quality Short-Duration Bond Fund, will be, when available), incorporated by reference into this SAI. The Private Placement Memorandum and the annual report to shareholders of each Fund may be obtained (in the case of the annual report to shareholders of GMO GAAR Implementation Fund and GMO High Quality Short-Duration Bond Fund, when available) free of charge from GMO Trust, 40 Rowes Wharf, Boston, Massachusetts 02110, or by calling the Trust collect at 1-617-346-7646.
Grantham, Mayo, Van Otterloo & Co. LLC (GMO) is not offering or placing interests in the Funds to or with or otherwise promoting the Funds to any natural or legal persons domiciled or with a registered office in any European Economic Area (EEA) Member State where the Alternative Investment Fund Managers Directive (Directive 2011/61/EU) is in force and effect. GMO, in its discretion, may accept any such investor into a Fund, but only if it is satisfied that, by accepting such investor, it would not be in breach of any law, rule, regulation or other legislative or administrative measure in or otherwise applicable to the relevant EEA Member State and such investor is otherwise eligible under the laws of such EEA Member State to invest in the Fund. None of the Funds, GMO, their respective affiliates, or any natural or legal person acting on their behalf have been registered with, have been approved by, or have made a notification to any EEA Member State, European Union, or other regulatory, governmental, or similar body with respect to the Funds, and no such body has approved, endorsed, reviewed, acquiesced, or taken any similar action with respect to any offering, marketing, or other promotional materials relating to the Funds.
Page | ||||
1 | ||||
1 | ||||
3 | ||||
57 | ||||
59 | ||||
63 | ||||
66 | ||||
67 | ||||
68 | ||||
TAXES: SYSTEMATIC GLOBAL MACRO OPPORTUNITY FUND AND WORLD OPPORTUNITY OVERLAY FUND |
84 | |||
110 | ||||
121 | ||||
126 | ||||
129 | ||||
130 | ||||
133 | ||||
136 | ||||
136 | ||||
137 | ||||
138 | ||||
A-1 | ||||
B-1 | ||||
C-1 |
-i-
Each Fund is a series of the Trust. The Trust is a series investment company that consists of separate series of investment portfolios (the Series), each of which is represented by a separate series of shares of beneficial interest. Each Series manager is GMO. Shares of the other Series of the Trust are offered pursuant to separate prospectuses or private placement memoranda, as applicable, and statements of additional information.
INVESTMENT OBJECTIVES AND POLICIES
The investment objectives, principal strategies of, and risks of investing in each Fund are described in the Private Placement Memorandum. Unless otherwise indicated in the Private Placement Memorandum or this SAI, the investment objective and policies of the Funds may be changed without shareholder approval.
The chart on the following page indicates the types of investments that each Fund is generally permitted (but not required) to make. A Fund may, however, make other types of investments, provided the investments are consistent with the Funds investment objective and policies and the Funds investment restrictions do not expressly prohibit it from so doing.
Investors should note that, when used in this SAI, the term invest includes both direct and indirect investing and the term investments includes both direct and indirect investments. For instance, a Fund may invest indirectly or make indirect investments by investing in another investment company or in derivatives and synthetic instruments with economic characteristics similar to the underlying asset. Accordingly, the following chart indicates the types of investments that a Fund is directly or indirectly permitted to make.
1
GAAR
Implementation Fund |
High Quality
Short-Duration Bond Fund |
Systematic
Global Macro Opportunity Fund |
World
Opportunity Overlay Fund |
|||||
U.S. Equity Securities 1 |
X | X | X | X | ||||
Non-U.S. Investments Non-U.S. Issuers 2 |
X | X | X | X | ||||
Non-U.S. Investments Non-U.S. Issuers (Traded on U.S. Exchanges) 2 |
X | X | X | X | ||||
Non-U.S. Investments Emerging Countries 2 |
X | X | X | |||||
Securities Lending |
X | X | X | X | ||||
Depositary Receipts |
X | X | ||||||
Convertible Securities |
X | X | X | |||||
Preferred Stocks |
X | X | ||||||
Master Limited Partnerships |
X | |||||||
Income Trusts |
X | |||||||
Warrants and Rights |
X | X | X | X | ||||
Non-Standard Warrants (LEPOs and P-Notes) |
X | X | ||||||
Options, Futures, and Forward Contracts |
X | X | X | X | ||||
Swap Contracts and Other Two-Party Contracts |
X | X | X | X | ||||
Foreign Currency Transactions |
X | X | X | X | ||||
Repurchase Agreements |
X | X | X | X | ||||
Debt and Other Fixed Income Securities |
X | X | X | X | ||||
Debt and Other Fixed Income Securities Long- and Medium-Term Corporate & Government Bonds 3 |
X | X | X | X | ||||
Debt and Other Fixed Income Securities Short-Term Corporate & Government Bonds 2 |
X | X | X | X | ||||
Debt and Other Fixed Income Securities Municipal Securities 4 |
X | X | X | X | ||||
Cash and Other High Quality Investments |
X | X | X | X | ||||
U.S. Government Securities and Foreign Government Securities |
X | X | X | X | ||||
Auction Rate Securities |
X | X | X | X | ||||
Real Estate Investment Trusts and Other Real Estate-Related Investments |
X | X | ||||||
Asset-Backed and Related Securities |
X | X | X | X | ||||
Adjustable Rate Securities |
X | X | X | X | ||||
Below Investment Grade Securities |
X | X | X | X | ||||
Distressed or Defaulted Debt Securities |
X | X | X | X | ||||
Brady Bonds |
X | X | ||||||
Euro Bonds |
X | X | X | X | ||||
Zero Coupon Securities |
X | X | X | X | ||||
Indexed Investments |
X | X | X | X | ||||
Structured Notes |
X | X | X | X | ||||
Firm Commitments, When-Issued Securities, and TBAs |
X | X | X | X | ||||
Loans, Loan Participations, and Assignments |
X | X | X | X | ||||
Reverse Repurchase Agreements and Dollar Roll Agreements |
X | X | X | X | ||||
Commodity-Related Investments |
X | X | ||||||
Illiquid Securities, Private Placements, Restricted Securities, and IPOs and Other Limited Opportunities |
X | X | X | X | ||||
Investments in Other Investment Companies or Other Pooled Investments |
X | X | X | X | ||||
Investments in Other Investment Companies Shares of Other GMO Trust Funds |
X | X | X | |||||
Investments in Other Investment Companies Shares of GMO U.S. Treasury Fund |
X | X | X | X | ||||
Investments in Subsidiary Companies Shares of Wholly-Owned Subsidiary 5 |
X | X |
2
Footnotes to Fund Investments Chart
1 | For more information, see, among other sections, Description of Principal Risks Market Risk Equities in the Private Placement Memorandum. |
2 | For more information, see, among other sections, Additional Information About the Funds Investment Strategies, Risks and Expenses and Description of Principal Risks Non-U.S. Investment Risk in the Private Placement Memorandum and Descriptions and Risks of Fund Investments Risks of Non-U.S. Investments herein. |
3 | For more information, see, among other sections, Descriptions and Risks of Fund Investments U.S. Government Securities and Foreign Government Securities herein. |
4 | For more information, see, among other sections, Descriptions and Risks of Fund Investments Municipal Securities herein. |
5 | For more information, see, among other sections, Descriptions and Risks of Fund Investments Investments in Wholly-Owned Subsidiaries herein. |
( Note : Some of the footnotes to the above chart refer investors to various risks described in the Additional Information About the Funds Investment Strategies, Risks and Expenses Description of Principal Risks section of the Private Placement Memorandum for more information relating to a particular type of investment listed in the chart. The presence of such a risk cross-reference for a particular Fund investment is not intended to indicate that such risk is a principal risk of that Fund, and instead is intended to provide more information regarding the risks associated with the particular investment. Please refer to the Additional Information About the Funds Investment Strategies, Risks and Expenses and Description of Principal Risks sections of the Private Placement Memorandum for a description of each Funds principal risks.)
DESCRIPTIONS AND RISKS OF FUND INVESTMENTS
The following is a description of investment practices in which the Funds may engage and the risks associated with their use. As noted in the Private Placement Memorandum or in Fund Investments above, GAAR Implementation Fund, High Quality Short-Duration Bond Fund, and Systematic Global Macro Opportunity Fund may invest in other GMO Funds or other investment companies and World Opportunity Overlay Fund may invest in GMO U.S. Treasury Fund or other investment companies (such other GMO Funds and other investment companies, the Underlying Funds), and GAAR Implementation Fund and Systematic Global Macro Opportunity Fund may invest in wholly-owned subsidiaries. Each of the Funds is indirectly exposed to the investment practices of the wholly-owned subsidiary or Underlying Funds in which it invests, and is therefore subject to all risks associated with the practices of the wholly-owned subsidiary or Underlying Funds. UNLESS OTHERWISE NOTED HEREIN, THE INVESTMENT PRACTICES AND ASSOCIATED RISKS DETAILED BELOW ALSO INCLUDE THOSE TO WHICH A FUND INDIRECTLY MAY BE EXPOSED THROUGH ITS INVESTMENT IN SUBSIDIARIES AND THE UNDERLYING FUNDS. ANY REFERENCES TO INVESTMENTS MADE BY A FUND INCLUDE THOSE THAT MAY BE MADE BOTH DIRECTLY BY THE FUND AND INDIRECTLY BY THE FUND (E.G., THROUGH ITS INVESTMENTS IN SUBSIDIARIES AND THE UNDERLYING FUNDS OR THROUGH ITS INVESTMENTS IN DERIVATIVES OR SYNTHETIC INSTRUMENTS).
A Fund may achieve exposure to a particular investment, industry, country, or geographic region by investing in a wholly-owned subsidiary or Underlying Funds. In particular, GAAR
3
Implementation Fund and Systematic Global Macro Opportunity Fund, through their investment in wholly-owned foreign subsidiaries, may have indirect exposure to a wide variety of investments, including, but not limited to, forward foreign-exchange contracts; futures contracts in the global equity, bond, and currency markets; investments in wholly-owned subsidiaries; futures and forward contracts on various commodities or commodity indices; commodity swaps on one or more broad-based commodities indices (e.g., the Dow Jones-UBS Commodity Index); and commodity swaps on individual commodities or baskets of commodities. See Commodity-Related Investments below for more discussion of the Funds use of commodity futures and swap contracts and other related types of derivatives.
Not all Funds may engage in all practices described below. Please refer to Additional Information About the Funds Investment Strategies, Risks and Expenses in the Private Placement Memorandum and Fund Investments above for additional information regarding the practices in which a particular Fund may engage.
Portfolio Turnover
Based on GMOs assessment of market conditions, GMO may trade a Funds investments more frequently at some times than at others, resulting in a higher portfolio turnover rate. Increased portfolio turnover involves correspondingly greater brokerage commissions and other transaction costs, which will be borne directly by a Fund and which may adversely affect the Funds performance. It also may give rise to additional taxable income for shareholders, including through the realization of capital gains or other types of income that are taxable to Fund shareholders when distributed by a Fund to them, in the case of a Fund that is a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended (the Code), when allocated by a Fund to them, in the case of a Fund that is a partnership for U.S. federal income tax purposes, or when realized by the Fund, in the case of a Fund that is a disregarded entity for U.S. federal income tax purposes, in each case unless those shareholders are themselves exempt from taxation or otherwise investing in the Fund through a tax-advantaged account. Because for U.S. federal income tax purposes GAAR Implementation Fund will be an entity disregarded as separate from its sole shareholder, GMO Benchmark-Free Fund (BFF), another series of the Trust offered in a separate prospectus, a higher portfolio turnover rate may result in higher transaction costs and higher taxes for BFF shareholders that hold BFF shares in a taxable account. If portfolio turnover results in the recognition of short-term capital gains, those gains typically are taxed to shareholders at ordinary income tax rates when those gains are either distributed or allocated, as applicable, to them. The after-tax impact of portfolio turnover is not considered when making investment decisions for a Fund. See the Taxes section in the Private Placement Memorandum and below for more information.
The historical portfolio turnover rate for each Fund (other than High Quality Short-Duration Bond Fund and GAAR Implementation Fund, which did not commence operations prior to the end of the most recent fiscal year) is shown under the heading Financial Highlights in the Private Placement Memorandum. Changes in portfolio turnover rates were generally the result of active trading strategies employed by such Funds portfolio manager(s) in response to market conditions, and not reflective of a material change in investment strategy.
Non-Diversified Portfolios
As stated in the Private Placement Memorandum, each Fund, is a non-diversified fund under the Investment Company Act of 1940, as amended (the 1940 Act), and as such is not required
4
to satisfy the requirements for diversified funds, which require that at least 75% of the value of a diversified funds total assets must be represented by cash and cash items (including receivables), government securities, securities of other investment companies, and other securities that for the purposes of this calculation are limited in respect of any one issuer to not greater than 5% of the value of the funds total assets and not more than 10% of the outstanding voting securities of any single issuer. As a non-diversified fund, a Fund is permitted (but is not required) to invest a higher percentage of its assets in the securities of fewer issuers. That concentration could increase the risk of loss to a Fund resulting from a decline in the market value of particular portfolio securities. Investment in a non-diversified fund may entail greater risks than investment in a diversified fund.
High Quality Short-Duration Bond Fund must meet diversification standards to qualify as a regulated investment company under the Code. See the Taxes: High Quality Short-Duration Bond Fund section below for a description of these diversification standards.
Accelerated Transactions
For a Fund to take advantage of certain available investment opportunities, GMO may need to make investment decisions on an expedited basis. In such cases, the information available to GMO at the time of an investment decision may be limited. GMO may not, therefore, have access to the detailed information necessary for a full analysis and evaluation of the investment opportunity.
Risks of Non-U.S. Investments
General. Investment in non-U.S. issuers or securities principally traded outside the United States may involve special risks due to non-U.S. economic, political, and legal developments, including favorable or unfavorable changes in currency exchange rates, exchange control regulations (including currency blockage), expropriation, nationalization or confiscatory taxation of assets, other government involvement in the economy or in the affairs of specific companies or industries (including in the case of wholly or partially state-owned enterprises) and possible difficulty in obtaining and enforcing judgments against non-U.S. entities. A Fund and/or its shareholders, as applicable (see the Taxes section for each Fund below for more information), may be subject to non-U.S. taxes, including potentially on a retroactive basis, on (i) capital gains it realizes or dividends, interest or other amounts it realizes or accrues in respect of non-U.S. investments; (ii) transactions in those investments; and (iii) repatriation of proceeds generated from the sale or other disposition of those investments. Any taxes or other charges paid or incurred by a Fund in respect of its non-U.S. investments will reduce its return thereon. A Fund may seek a refund in respect of taxes paid to a foreign country. In those cases, all or a portion of those taxes could ultimately be recovered by a Fund. However, the recovery process could take several years and the Fund will incur expenses in its efforts to collect the refund, which will reduce the benefit of any recovery. A Funds efforts to collect a refund may not be successful, in which case the Fund will have incurred additional expenses for no economic benefit. A Funds decision to seek a refund is in its sole discretion, and it may decide not to seek a refund, even if eligible. The outcome of a Funds efforts to obtain a refund is not predictable, and some refunds may not be reflected in a Funds net asset value. See the Taxes section for each Fund below for more information about other special tax considerations applicable to non-U.S. investments. In addition, for information on possible Australian or Singapore tax consequences of an investment in Systematic Global Macro Opportunity Fund, see the Taxes For Systematic Global Macro Opportunity Fund section in the Funds Private Placement Memorandum.
5
In addition, the tax laws of some non-U.S. jurisdictions in which a Fund may invest are unclear and interpretations of such laws can change over time, including on a retroactive basis in which case a Fund and/or its shareholders could potentially incur non-U.S. taxes on a retroactive basis. Moreover, in order to comply with guidance related to the accounting and disclosure of uncertain tax positions under U.S. generally accepted accounting principles (GAAP), a Fund may be required to accrue for book purposes certain non-U.S. taxes in respect of its non-U.S. securities or other non-U.S. investments that it may or may not ultimately pay. Such tax accruals will reduce a Funds net asset value at the time accrued, even though, in some cases, the Fund ultimately will not pay the related tax liabilities. Conversely, a Funds net asset value will be increased by any tax accruals that are ultimately reversed.
Issuers of non-U.S. securities are subject to different, often less comprehensive, accounting, custody, reporting, and disclosure requirements than U.S. issuers. The securities of some foreign governments, companies, and securities markets are less liquid, and at times more volatile, than comparable U.S. securities and securities markets. Non-U.S. brokerage commissions and related fees also are generally higher than in the United States. Funds that invest in non-U.S. securities also may be affected by different custody and/or settlement practices or delayed settlements in some non-U.S. markets. The laws of some foreign countries may limit a Funds ability to invest in securities of certain issuers located in those countries. Foreign countries may have reporting requirements with respect to the ownership of securities, and those reporting requirements may be subject to interpretation or change without prior notice to investors. While the Funds make reasonable efforts to stay informed of foreign reporting requirements relating to the Funds non-U.S. portfolio securities (e.g., through the Funds brokerage contacts, publications of the Investment Company Institute, which is the national association of U.S. investment companies, the Funds custodial network, and, to the extent deemed appropriate by the Funds under the circumstances, local counsel in the relevant foreign country), no assurance can be given that the Funds will satisfy applicable foreign reporting requirements at all times.
Emerging Countries. The risks described above apply to an even greater extent to investments in emerging countries. The securities markets of emerging countries are generally smaller, less developed, less liquid, and more volatile than the securities markets of the United States and other developed countries, and disclosure and regulatory standards in many respects are less stringent. In addition, the securities markets of emerging countries are typically subject to a lower level of monitoring and regulation. Government enforcement of existing securities regulations is limited, and any such enforcement may be arbitrary and the results may be difficult to predict. In addition, reporting requirements of emerging countries with respect to the ownership of securities are more likely to be subject to interpretation or changes without prior notice to investors than more developed countries.
Many emerging countries have experienced substantial, and in some periods extremely high, rates of inflation for many years. Inflation and rapid fluctuations in inflation rates have had and may continue to have negative effects on such countries economies and securities markets.
Economies of emerging countries generally are heavily dependent on international trade and, accordingly, have been and may continue to be affected adversely by trade barriers, exchange controls, managed adjustments in relative currency values, and other protectionist measures imposed or negotiated by the countries with which they trade. Economies of emerging countries also have been and may continue to be adversely affected by economic conditions in the countries with which they trade. The economies of emerging countries may be predominantly
6
based on only a few industries or dependent on revenues from particular commodities. In many cases, governments of emerging countries continue to exercise significant control over their economies, and government actions relative to the economy, as well as economic developments generally, may affect the capacity of creditors in those countries to make payments on their debt obligations, regardless of their financial condition.
Custodial services are often more expensive and other investment-related costs higher in emerging countries than in developed countries, which could reduce a Funds income from investments in securities or debt instruments of emerging country issuers.
Emerging countries are more likely than developed countries to experience political uncertainty and instability, including the risk of war, terrorism, nationalization, limitations on the removal of funds or other assets, or diplomatic developments that affect U.S. investments in these countries. No assurance can be given that adverse political changes will not cause a Fund to suffer a loss of any or all of its investments (or, in the case of fixed income securities, interest) in emerging countries.
Special Risks of Investing in Asian Securities. In addition to the risks of non-U.S. investments and emerging countries investments described above, investments in Asia are subject to other risks. The economies of Asian countries are at varying levels of development. Markets of countries whose economies are in the early stages of development typically exhibit a high concentration of market capitalization and have less trading volume, lower liquidity, and more volatility than more developed markets. Some Asian countries depend heavily on foreign trade and can be adversely affected by trade barriers, exchange controls, and other measures imposed or negotiated by the countries with which they trade. The economies of some Asian countries are not diversified and are based on only a few commodities or industries. Financial imbalances among various economic sectors, fueled by rising asset prices, strong credit growth, and relatively easy financing conditions in certain economies in Asia may also negatively impact those economies.
Investments in Asia also are susceptible to social, political, legal, and operational risks. Some countries have authoritarian or relatively unstable governments. Certain Asian countries have experienced violence, terrorism, armed conflict, and social instability, which has negatively impacted their economies. Some governments in the region provide less supervision and regulation of their financial markets and in some countries less financial information is available than is typical of more developed markets. Some governments in the region exercise considerable influence on their respective economies and, as a result, companies in the region may be subject to government interference and nationalization. Some Asian countries restrict direct foreign investment in securities markets, and investments in securities traded on those markets may be made, if at all, only indirectly (e.g., through Depositary Receipts, as defined below under Depositary Receipts, derivatives, etc.). Some countries in the region require foreign investors to be registered with local authorities prior to investing in the securities markets and impose limitations on the amount of investments that may be made by foreign investors and the repatriation of the proceeds from investments.
Asian countries periodically experience increases in market volatility and declines in foreign currency exchange rates. Currency fluctuations affect the value of securities because the prices of these securities are generally denominated or quoted in currencies other than the U.S. dollar. Fluctuations in currency exchange rates can also affect a countrys or companys ability to service its debt. The governments of certain Asian countries also maintain their currencies at
7
artificial levels in relation to the U.S. dollar rather than at levels determined by the market, which may have an adverse impact on foreign investors.
Investment in particular Asian countries is subject to unique risks, yet the political and economic prospects of one country or group of countries can affect other countries in the region. For example, the economies of some Asian countries are directly affected by Japanese capital investment in the region and by Japanese consumer demands. In addition, a recession, debt crisis, or decline in currency valuation in one Asian country may spread to other Asian countries. The economies of Asian countries are also vulnerable to effects of natural disasters occurring within the region, including droughts, floods, tsunamis, and earthquakes. Disaster recovery in Asia can be poorly coordinated, and the economic impact of natural disasters is significant at both the country and company levels.
Special Risks of Investing in Russian Securities . Certain of the Funds may invest directly in the securities of Russian issuers. Certain other Funds may have indirect exposure to Russian securities through their investment in one or more of the GMO Funds with direct investments in Russia. Investment in those securities presents many of the same risks as investing in the securities of emerging country issuers, as described in the preceding sections.
The social, political, legal, and operational risks of investing in Russian issuers, and of having assets held in custody within Russia, however, may be particularly pronounced relative to investments in more developed countries.
Russias system of share registration and custody creates certain risks of loss (including the risk of total loss) that are not normally associated with investments in other securities markets. The recent formation of the Russian securities markets and the underdeveloped state of Russias banking system subjects settlement, clearing, and registration of securities transactions to significant risks. Prior to 2013, there was no central registration system for equity share registration in Russia and registration was carried out by either the issuers themselves or by registrars located throughout Russia. Such registrars were not necessarily subject to effective state supervision, nor were they licensed with any governmental entity, thereby increasing the risk that a Fund could lose ownership of its securities through fraud, negligence, or even mere oversight. With the implementation of the National Settlement Depository (NSD) in Russia as a recognized central securities depository, title to Russian equities is now based on the records of the NSD and not the registrars. Although the implementation of the NSD is generally expected to decrease the risk of loss in connection with recording and transferring title to securities, issues resulting in loss still may occur. In addition, issuers and registrars are still prominent in the validation and approval of documentation requirements for corporate action processing in Russia. Because the documentation requirements and approval criteria vary between registrars and/or issuers, there remain unclear and inconsistent market standards in the Russian market with respect to the completion and submission of corporate action elections. To the extent that a Fund suffers a loss relating to title or corporate actions relating to its portfolio securities, it may be difficult for the Fund to enforce its rights or otherwise remedy the loss.
In addition, as a result of political and military actions undertaken by Russia, the United States and the European Union have instituted sanctions against certain Russian officials and institutions. These sanctions and any additional sanctions or other intergovernmental actions that may be undertaken against Russia in the future may result in the devaluation of Russian currency, a downgrade in the countrys credit rating, and a decline in the value and liquidity of Russian securities. Such actions could result in a freeze of Russian securities, impairing the ability of a Fund to buy, sell, receive, or deliver those securities. Retaliatory action by the
8
Russian government could involve the seizure of U.S. and/or European residents assets, and any such actions are likely to impair the value and liquidity of such assets. Any or all of these potential results could have an adverse/recessionary effect on Russias economy. All of these factors could have a negative effect on the performance of Funds that have significant exposure to Russia.
Securities Lending
A Fund may make secured loans of its portfolio securities amounting to not more than one-third of its total assets. For these purposes, total assets include the proceeds of such loans. The risks in lending portfolio securities, as with other extensions of credit, consist of possible delay in recovery of the securities or possible loss of rights in the collateral should the borrower fail financially, including possible impairment of the Funds ability to vote the securities. However, securities loans will be made to brokers that GMO believes to be of relatively high credit standing pursuant to agreements requiring that the loans be collateralized by cash, liquid securities, or shares of other investment companies with a value at least equal to the market value of the loaned securities (marked to market daily). If a loan is collateralized by U.S. government or other securities, the Fund receives a fee from the borrower. If a loan is collateralized by cash, the Fund typically invests the cash collateral for its own account in one or more money market funds (in which case the Fund will bear its pro rata share of such money market funds fees and expenses), or directly in interest-bearing, short-term securities, and typically pays a fee to the borrower that normally represents a portion of the Funds earnings on the collateral. As with other extensions of credit, the Fund bears the risk of delay in the recovery of loaned securities and of loss of rights in the collateral should the borrower fail financially. The Fund also bears the risk that the value of investments made with collateral may decline. The Fund bears the risk of total loss with respect to the investment of collateral.
Voting rights or rights to consent with respect to the loaned securities pass to the borrower. The Fund has the right to call loans at any time on reasonable notice and will do so if both (i) GMO receives adequate notice of a proposal upon which shareholders are being asked to vote, and (ii) GMO believes that the benefits to the Fund of voting on such proposal outweigh the benefits to the Fund of having the security remain out on loan. However, the Fund bears the risk of delay in the return of the security, impairing the Funds ability to vote on such matters. GMO has retained lending agents on behalf of several of the Funds that are compensated based on a percentage of the Funds return on its securities lending. The Funds also may pay various fees in connection with securities loans, including shipping fees and custodian fees.
Depositary Receipts
Many of the Funds invest in American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs), and European Depositary Receipts (EDRs) or other similar securities representing ownership of non-U.S. securities (collectively, Depositary Receipts) if issues of such Depositary Receipts are available that are consistent with the Funds investment objective. Depositary Receipts generally evidence an ownership interest in a corresponding non-U.S. security on deposit with a financial institution. Transactions in Depositary Receipts usually do not settle in the same currency as the underlying non-U.S. securities are denominated or traded. Generally, ADRs are designed for use in the U.S. securities markets and EDRs are designed for use in European securities markets. GDRs may be traded in any public or private securities market and may represent securities held by institutions located anywhere in the world. GDRs and other types of Depositary Receipts are typically issued by foreign banks or trust companies,
9
although they may be issued by U.S. financial institutions, and evidence ownership interests in a security or pool of securities issued by either a U.S. or foreign corporation.
Because the value of a Depositary Receipt is dependent upon the market price of an underlying non-U.S. security, Depositary Receipts are subject to most of the risks associated with investing in non-U.S. securities directly. Depositary Receipts may be issued as sponsored or unsponsored programs. See Risks of Non-U.S. Investments above. Depositary Receipts also may be subject to illiquidity risk.
Convertible Securities
A convertible security is a security (a bond or preferred stock) that may be converted at a stated price within a specified period into a specified number of shares of common stock of the same or a different issuer. Convertible securities are senior to common stock in a corporations capital structure, but are usually subordinated to senior debt obligations of the issuer. Convertible securities provide holders, through their conversion feature, an opportunity to participate in increases in the market prices of their underlying securities. The price of a convertible security is influenced by the market price of the underlying security, and tends to increase as the market price rises and decrease as the market price declines. GMO regards convertible securities as a form of equity security.
The value of a convertible security is a function of its investment value (determined by its yield in comparison with the yields of other securities of comparable maturity and quality that do not have a conversion privilege) and its conversion value (the securitys worth, at market value, if converted into the underlying common stock). The investment value of a convertible security is influenced by changes in interest rates, with investment value declining as interest rates increase and increasing as interest rates decline. The credit standing of the issuer and other factors also may have an effect on the convertible securitys investment value. The conversion value of a convertible security is determined by the market price of the underlying common stock. If the conversion value is low relative to the investment value, as in the case of broken or busted convertibles, the price of the convertible security is governed principally by its investment value. To the extent the market price of the underlying common stock approaches or exceeds the conversion price, the price of the convertible security will be increasingly influenced by its conversion value. A convertible security generally will sell at a premium over its conversion value by the extent to which investors place value on the right to acquire the underlying common stock while holding a fixed income security. Generally, the amount of the premium decreases as the convertible security approaches maturity.
A convertible security may be subject to redemption at the option of the issuer at a price established in the convertible securitys governing instrument. If a convertible security held by a Fund is called for redemption, the Fund will be required to permit the issuer to redeem the security, convert it into the underlying common stock or sell it to a third party.
Preferred Stocks
Preferred stocks include convertible and non-convertible preferred and preference stocks that are senior to common stock. Preferred stocks are equity securities that are senior to common stock with respect to the right to receive dividends and a fixed share of the proceeds resulting from the issuers liquidation. Some preferred stocks also entitle their holders to receive additional liquidation proceeds on the same basis as holders of the issuers common stock, and thus
10
represent an ownership interest in the issuer. Depending on the features of the particular security, holders of preferred stock may bear the risks disclosed in the Private Placement Memorandum or this SAI regarding equity or fixed income securities.
Investment in preferred stocks involves certain risks. Certain preferred stocks contain provisions that allow an issuer under certain conditions to skip or defer distributions. If a Fund owns a preferred stock that is deferring its distribution, it may be required to report income for tax purposes despite the fact that it is not receiving current income on this position. Preferred stocks often are subject to legal provisions that allow for redemption in the event of certain tax or legal changes or at the issuers call. In the event of redemption, a Fund may not be able to reinvest the proceeds at comparable rates of return. Preferred stocks are subordinated to bonds and other debt securities in an issuers capital structure in terms of priority for corporate income and liquidation payments, and therefore will be subject to greater credit risk than those debt securities. Preferred stocks may trade less frequently and in a more limited volume and may be subject to more abrupt or erratic price movements than many other securities, such as common stocks, corporate debt securities and U.S. government securities.
Master Limited Partnerships
A master limited partnership (MLP) generally is a publicly traded company organized as a limited partnership or limited liability company and treated as a partnership for U.S. federal income tax purposes. MLPs may derive income and gains from, among other things, the exploration, development, mining or production, processing, refining, transportation (including pipelines transporting gas, oil, or products thereof), or the marketing of any mineral or natural resources. MLPs generally have two classes of owners, the general partner and limited partners. The general partner of an MLP is typically owned by one or more of the following: a major energy company, an investment fund, or the direct management of the MLP. The general partner may be structured as a private or publicly traded corporation or other entity. The general partner typically controls the operations and management of the MLP through an up to 2% equity interest in the MLP plus, in many cases, ownership of common units and subordinated units. Limited partners own the remainder of the partnership through ownership of common units and have a limited role in the partnerships operations and management. For purposes of qualifying as a regulated investment company under the Code, the extent to which a Fund can invest in MLPs is limited.
MLP securities in which a Fund may invest can include, but are not limited to: (i) equity securities of MLPs, including common units, preferred units or convertible subordinated units; (ii) debt securities of MLPs, including debt securities rated below investment grade; (iii) securities of MLP affiliates; (iv) securities of open-end funds, closed-end funds or exchange-traded funds (ETFs) that invest primarily in MLP securities; or (v) exchange-traded notes whose returns are linked to the returns of MLPs or MLP indices.
The risks of investing in an MLP are generally those inherent in investing in a partnership as opposed to a corporation. For example, state law governing partnerships is often less restrictive than state law governing corporations. Accordingly, there may be fewer protections afforded investors in an MLP than investors in a corporation. Additional risks involved with investing in an MLP are risks associated with the specific industry or industries in which the partnership invests.
11
Income Trusts
Income trusts are investment trusts that hold income-producing assets and distribute income generated by such assets to the unitholders of the trust, which are entitled to participate in the trusts income and capital as its beneficiaries.
Income trusts generally invest in assets that provide a return to the trust and its unitholders based on the cash flows of an underlying business. Such assets may include equity and debt instruments, royalty interests or real properties. The income trust can receive interest, royalty or lease payments from an operating entity carrying on a business, as well as dividends and a return of capital.
Income trusts also may include royalty trusts, a particular type of income trust whose securities are listed on a stock exchange and which controls an underlying company whose business relates to, without limitation, the acquisition, exploitation, production and sale of oil and natural gas.
Investments in income trusts (including royalty trusts) are subject to operating risk based on the income trusts underlying assets and their respective businesses. Such risks may include lack of or limited operating histories. Income trusts are particularly subject to interest rate risk and increases in interest rates offered by competing investments may diminish the value of trust units. Changes in the interest rate also may affect the value of future distributions from the income trusts underlying assets or the value of the underlying assets themselves. Interest rate risk is also present within the income trusts themselves because they often hold very long-term capital assets, and much of the excess distributable income is derived from a maturity (or duration) mismatch between the life of the asset and the life of the financing associated with it. In an increasing interest rate environment, the income trusts distributions to its unitholders may decrease. Income trusts also may be subject to additional risk, including, without limitation, limited access to debt markets.
Income trusts do not guarantee minimum distributions or returns of capital to unitholders. The amount of distributions paid on a trusts units will vary from time to time based on production levels, commodity prices, royalty rates and certain expenses, deductions and costs, as well as on the distribution payout ratio policy adopted. The reduction or elimination of distributions to unitholders may decrease the value of trust units. Income trusts generally pay out to unitholders the majority of the cash flow that they receive from the production and sale of underlying assets. As a result of distributing the bulk of their cash flow to unitholders, the ability of a trust to finance internal growth is limited. Therefore, income trusts typically grow through acquisition of additional assets, funded through the issuance of additional equity or, where the trust is able, additional debt. Because an income trust may make distributions to unitholders in excess of its net income, unitholder equity may decline over time.
Finally, for purposes of qualifying as a regulated investment company under the Code, the extent to which the Funds can invest in a particular income trust may be limited, depending, for instance, on the trusts treatment for U.S. federal income tax purposes and its underlying assets.
Warrants and Rights
Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a stated price. Funds typically use warrants and rights in a manner similar to their use of options on securities, as described in Options, Futures, and Forward Contracts below. Risks
12
associated with the use of warrants and rights are generally similar to risks associated with the use of options. Unlike most options, however, warrants and rights are issued in specific amounts, and warrants generally have longer terms than options. Warrants and rights are not likely to be as liquid as exchange-traded options backed by a recognized clearing agency. In addition, the terms of warrants or rights may limit a Funds ability to exercise the warrants or rights at such time, or in such quantities, as the Fund would otherwise wish.
Non-Standard Warrants. From time to time, certain Funds may use non-standard warrants, including low exercise price warrants or low exercise price options (LEPOs) and participatory notes (P-Notes), to gain exposure to issuers in certain countries. LEPOs are different from standard warrants in that they do not give their holders the right to receive a security of the issuer upon exercise. Rather, LEPOs pay the holder the difference in price of the underlying security between the date the LEPO was purchased and the date it is sold. P-Notes are a type of equity-linked derivative that generally are traded over-the-counter and constitute general unsecured contractual obligations of the banks or brokers that issue them. Generally, banks and brokers associated with non-U.S.-based brokerage firms buy securities listed on certain non-U.S. exchanges and then issue P-Notes that are designed to replicate the performance of certain issuers and markets. The performance results of P-Notes will not replicate exactly the performance of the issuers or markets that the notes seek to replicate due to transaction costs and other expenses. The return on a P-Note that is linked to a particular underlying security generally is increased to the extent of any dividends paid in connection with the underlying security. However, the holder of a P-Note typically does not receive voting or other rights as it would if it directly owned the underlying security, and P-Notes present similar risks to investing directly in the underlying security. Additionally, LEPOs and P-Notes entail the same risks as other over-the-counter (OTC) derivatives. These include the risk that the counterparty or issuer of the LEPO or P-Note may not be able to fulfill its obligations, that the holder and counterparty or issuer may disagree as to the meaning or application of contractual terms, or that the instrument may not perform as expected. See Additional Information About the Funds Investment Strategies, Risks and Expenses and Description of Principal Risks Derivatives and Short Sales Risk and Counterparty Risk in the Private Placement Memorandum and Uses of Derivatives below. Additionally, while LEPOs or P-Notes may be listed on an exchange, there is no guarantee that a liquid market will exist or that the counterparty or issuer of a LEPO or P-Note will be willing to repurchase such instrument when a Fund wishes to sell it.
Options, Futures, and Forward Contracts
Certain Funds may use options, futures, and forward contracts for various purposes, including for investment purposes and as a means to hedge other investments. See Uses of Derivatives below for more information regarding the various derivatives strategies those Funds may employ using options, futures, and forward contracts. The use of options contracts, futures contracts, forward contracts, and options on futures contracts involves risk. Thus, while a Fund may benefit from the use of options, futures, forward contracts, and options on futures, unanticipated changes in interest rates, securities prices, currency exchange rates, or other underlying assets or reference rates may adversely affect a Funds performance.
Options on Securities and Indices. Certain Funds may purchase and sell put and call options on equity, fixed income, or other securities or indices in standardized exchange-traded contracts. An option on a security or index is a contract that gives the holder of the option, in return for a premium, the right (but not the obligation) to buy from (in the case of a call) or sell to (in the case of a put) the writer of the option the security underlying the option (or the cash value of the
13
index underlying the option) at a specified price. Upon exercise, the writer of an option on a security has the obligation to deliver the underlying security upon payment of the exercise price or to pay the exercise price upon delivery of the underlying security. Upon exercise, the writer of an option on an index is required to pay the difference between the cash value of the index and the exercise price multiplied by the specified multiplier for the index option.
Purchasing Options on Securities and Indices. Among other reasons, a Fund may purchase a put option to hedge against a decline in the value of a portfolio security. If such a decline occurs, the put option will permit the Fund to sell the security at the higher exercise price or to close out the option at a profit. By using put options in this manner, the Fund will reduce any profit it might otherwise have realized in the underlying security by the amount of the premium paid for the put option and by its transaction costs. In order for a put option purchased by a Fund to be profitable, the market price of the underlying security must decline sufficiently below the exercise price to cover the premium paid by the Fund and transaction costs.
Among other reasons, a Fund may purchase call options to hedge against an increase in the price of securities the Fund anticipates purchasing in the future. If such a price increase occurs, a call option will permit the Fund to purchase the securities at the exercise price or to close out the option at a profit. The premium paid for the call option, plus any transaction costs, will reduce the benefit, if any, that the Fund realizes upon exercise of the option and, unless the price of the underlying security rises sufficiently, the option may expire worthless to the Fund. Thus, for a call option purchased by a Fund to be profitable, the market price of the underlying security must rise sufficiently above the exercise price to cover the premium paid by the Fund to the writer and transaction costs.
In the case of both call and put options, the purchaser of an option risks losing the premium paid for the option plus related transaction costs if the option expires worthless.
Writing Options on Securities and Indices. Because a Fund receives a premium for writing a put or call option, a Fund may seek to increase its return by writing call or put options on securities or indices. The premium a Fund receives for writing an option will increase the Funds return in the event the option expires unexercised or is closed out at a profit. The size of the premium a Fund receives reflects, among other things, the relationship of the market price and volatility of the underlying security or index to the exercise price of the option, the remaining term of the option, supply and demand, and interest rates.
A Fund may write a call option on a security or other instrument held by the Fund (commonly known as writing a covered call option). In such case, the Fund limits its opportunity to profit from an increase in the market price of the underlying security above the exercise price of the option. Alternatively, a Fund may write a call option on securities in which it may invest but that are not currently held by the Fund (commonly known as writing a naked call option). During periods of declining securities prices or when prices are stable, writing these types of call options can be a profitable strategy to increase a Funds income with minimal capital risk. However, when securities prices increase, the Fund is exposed to an increased risk of loss, because if the price of the underlying security or instrument exceeds the options exercise price, the Fund will suffer a loss equal to the amount by which the market price exceeds the exercise price at the time the call option is exercised, minus the premium received. Calls written on securities that the Fund does not own are riskier than calls written on securities owned by the Fund because there is no underlying security held by the Fund that can act as a partial hedge. When such a call is exercised, the Fund must purchase the underlying security to meet its call obligation or make a
14
payment equal to the value of its obligation in order to close out the option. Calls written on securities that the Fund does not own have speculative characteristics and the potential for loss is theoretically unlimited. There is also a risk, especially with less liquid preferred and debt securities, that the securities may not be available for purchase.
A Fund also may write a put option on a security. In so doing, the Fund assumes the risk that it may be required to purchase the underlying security for an exercise price higher than its then-current market price, resulting in a loss on exercise equal to the amount by which the market price of the security is below the exercise price minus the premium received.
OTC Options . A Fund also may invest in OTC options. OTC options differ from exchange-traded options in that they are two-party contracts, with price and other terms negotiated between the buyer and seller, and generally do not have as much market liquidity as exchange-traded options.
Closing Options Transactions . The holder of an option may terminate its position in a put or call option it has purchased by allowing it to expire or by exercising the option. If an option is American-style, it may be exercised on any day up to its expiration date. In contrast, a European-style option may be exercised only on its expiration date.
In addition, a holder of an option may terminate its obligation prior to the options expiration by effecting an offsetting closing transaction. In the case of exchange-traded options, a Fund, as a holder of an option, may effect an offsetting closing sale transaction by selling an option of the same series as the option previously purchased. A Fund realizes a loss from a closing sale transaction if the premium received from the sale of the option is less than the premium paid to purchase the option (plus transaction costs). Similarly, a Fund that has written an option may effect an offsetting closing purchase transaction by buying an option of the same series as the option previously written. A Fund realizes a loss from a closing purchase transaction if the cost of the closing purchase transaction (option premium plus transaction costs) is greater than the premium received from writing the option. If a Fund desires to sell a security on which it has written a call option, it will effect a closing purchase prior to or concurrently with the sale of the security. There can be no assurance, however, that a closing purchase or sale can be effected when a Fund desires to do so.
Risk Factors in Options Transactions. The market price of an option is affected by many factors, including changes in the market prices or dividend rates of underlying securities (or in the case of indices, the securities in such indices); the time remaining before expiration; changes in interest rates or exchange rates; and changes in the actual or perceived volatility of the relevant stock market and underlying securities. The market price of an option also may be adversely affected if the market for the option becomes less liquid. In addition, since an American-style option allows the holder to exercise its rights any time before the options expiration, the writer of an American-style option has no control over when it will be required to fulfill its obligations as a writer of the option. (The writer of a European-style option is not subject to this risk because the holder may only exercise the option on its expiration date.)
The Funds ability to use options as part of their investment programs depends on the liquidity of the options market. In addition, that market may not exist when a Fund seeks to close out an option position. If a Fund were unable to close out an option that it had purchased on a security, it would have to exercise the option in order to realize any profit or the option may expire worthless. As the writer of a call option on a portfolio security, during the options life, the Fund
15
foregoes the opportunity to profit from increases in the market value of the security underlying the call option above the sum of the premium and the strike price of the call, but retains the risk of loss (net of premiums received) should the price of the underlying security decline. Similarly, as the writer of a call option on a securities index, a Fund foregoes the opportunity to profit from increases in the index over the strike price of the option, though it retains the risk of loss (net of premiums received) should the price of the Funds portfolio securities decline. If a Fund writes a call option and does not hold the underlying security or instrument, the amount of the Funds potential loss is theoretically unlimited.
An exchange-traded option may be closed out by means of an offsetting transaction only on a national securities exchange (Exchange), which provides a secondary market for an option of the same series. If a liquid secondary market for an exchange-traded option does not exist, a Fund might not be able to effect an offsetting closing transaction for a particular option. Reasons for the absence of a liquid secondary market on an Exchange include the following: (i) insufficient trading interest in some options; (ii) restrictions by an Exchange on opening or closing transactions, or both; (iii) trading halts, suspensions, or other restrictions on particular classes or series of options or underlying securities; (iv) unusual or unforeseen interruptions in normal operations on an Exchange; (v) inability to handle current trading volume; or (vi) discontinuance of options trading (or trading in a particular class or series of options) (although outstanding options on an Exchange that were issued by the Options Clearing Corporation should continue to be exercisable in accordance with their terms). In addition, the hours of trading for options on an Exchange may not conform to the hours during which the securities held by a Fund are traded. To the extent that the options markets close before the markets for the underlying securities, significant price and rate movements can take place in the markets for underlying securities that are not immediately reflected in the options markets.
The Exchanges generally have established limits on the maximum number of options an investor or group of investors acting in concert may write. The Funds, GMO, and other funds advised by GMO may constitute such a group. These limits could restrict a Funds ability to purchase or write options on a particular security.
An OTC option may be closed only with the consent of the counterparty, although either party may engage in an offsetting transaction that puts that party in the same economic position as if it had closed out the option with the counterparty; however, the exposure to counterparty risk may differ. No guarantee exists that a Fund will be able to effect a closing purchase or a closing sale with respect to a specific option at any particular time. See Swap Contracts and Other Two-Party Contracts Risk Factors in Swap Contracts, OTC Options, and Other Two-Party Contracts below for a discussion of counterparty risk and other risks associated with investing in OTC options.
Currency Options and Quantity-Adjusting (Quanto) Options. Certain Funds may purchase and sell options on currencies. Options on currencies possess many of the same characteristics as options on securities and generally operate in a similar manner. Funds that are permitted to invest in securities denominated in foreign currencies may purchase or sell options on currencies. In addition, a Fund may purchase and sell quanto options, which are cash-settled options in which the underlying asset (often an index) is denominated in a currency other than the currency in which the option is settled. See Foreign Currency Transactions below for more information on those Funds use of currency options.
16
Futures. To the extent consistent with applicable law and its investment restrictions, a Fund permitted to invest in futures contracts may invest in futures contracts on, among other things, financial instruments (such as a U.S. government security or other fixed income security), individual equity securities (single stock futures), securities indices, interest rates, currencies, inflation indices, and (to the extent a Fund is permitted to invest in commodities and commodity-related derivatives (as defined in Commodity-Related Investments below)) commodities or commodities indices. Futures contracts on securities indices are referred to herein as Index Futures. The purchase of futures contracts can serve as a long hedge, and the sale of futures contracts can serve as a limited short hedge. The purchase and sale of futures contracts also may be used for speculative purposes.
Certain futures contracts are physically settled (i.e., involve the making and taking of delivery of a specified amount of an underlying security or other asset). For instance, the sale of futures contracts on foreign currencies or financial instruments creates an obligation of the seller to deliver a specified quantity of an underlying foreign currency or financial instrument called for in the contract for a stated price at a specified time. Conversely, the purchase of such futures contracts creates an obligation of the purchaser to pay for and take delivery of the underlying foreign currency or financial instrument called for in the contract for a stated price at a specified time. In some cases, the specific instruments delivered or taken, respectively, on the settlement date are not determined until on or near that date. That determination is made in accordance with the rules of the exchange on which the sale or purchase was made.
Some futures contracts are cash settled (rather than physically settled), which means that the purchase price is subtracted from the current market value of the instrument and the net amount, if positive, is paid to the purchaser by the seller of the futures contract and, if negative, is paid by the purchaser to the seller of the futures contract. In particular, Index Futures are agreements pursuant to which two parties agree to take or make delivery of an amount of cash equal to the difference between the value of a securities index at the close of the last trading day of the contract and the price at which the index contract was originally written. Although the value of a securities index might be a function of the value of certain specified securities, no physical delivery of these securities is made.
The purchase or sale of a futures contract differs from the purchase or sale of a security or option in that no price or premium is paid or received. Instead, an amount of cash, U.S. government securities, or other liquid assets equal in value to a percentage of the face amount of the futures contract must be deposited with the broker. This amount is known as initial margin. The amount of the initial margin is generally set by the market on which the contract is traded (margin requirements on non-U.S. exchanges may be different than those on U.S. exchanges). Subsequent payments to and from the broker, known as variation margin, are made on a daily basis as the price of the underlying futures contract fluctuates, making the long and short positions in the futures contract more or less valuable, a process known as marking to the market. Prior to the settlement date of the futures contract, the position may be closed by taking an opposite position. A final determination of variation margin is then made, additional cash is required to be paid to or released by the broker, and the purchaser realizes a loss or gain. In addition, a commission is paid to the broker on each completed purchase and sale.
Although some futures contracts call for making or taking delivery of the underlying securities, currencies, commodities, or other underlying instrument, in most cases futures contracts are closed before the settlement date without the making or taking of delivery by offsetting purchases or sales of matching futures contracts (i.e., with the same exchange, underlying
17
financial instrument, currency, commodity, or index, and delivery month). If the price of the initial sale exceeds the price of the offsetting purchase, the seller is paid the difference and realizes a gain. Conversely, if the price of the offsetting purchase exceeds the price of the initial sale, the seller realizes a loss. Similarly, a purchase of a futures contract is closed out by selling a corresponding futures contract. If the offsetting sale price exceeds the original purchase price, the purchaser realizes a gain, and, if the original purchase price exceeds the offsetting sale price, the purchaser realizes a loss. Any transaction costs must also be included in these calculations.
In the United States, futures contracts are traded only on commodity exchanges or boards of trade known as contract markets approved by the Commodity Futures Trading Commission (CFTC), and must be executed through a futures commission merchant or brokerage firm that is a member of the relevant market. Certain Funds also may purchase futures contracts on non-U.S. exchanges or similar entities, which are not regulated by the CFTC and may not be subject to the same degree of regulation as the U.S. contract markets. See Additional Risks of Options on Securities, Futures Contracts, and Options on Futures Contracts Traded on Non-U.S. Exchanges below.
Index Futures. To the extent consistent with applicable law and investment restrictions, a Fund may purchase or sell Index Futures. A Fund may close open positions on a contract market on which Index Futures are traded at any time up to and including the expiration day. In general, all positions that remain open at the close of business on that day must be settled on the next business day (based on the value of the relevant index on the expiration day). Additional or different margin requirements as well as settlement procedures may apply to non-U.S. stock Index Futures.
Interest Rate Futures. Some Funds may engage in transactions involving the use of futures on interest rates. These transactions may be in connection with investments in U.S. government securities and other fixed income securities.
Inflation-Linked Futures. Inflation-linked futures, including Consumer Price Index (CPI) futures, are exchange-traded futures contracts that represent the inflation on a notional value of $1,000,000 for a period of three months, as implied by the CPI. Inflation-linked futures may be used by the Fund to hedge the inflation risk in nominal bonds (i.e., non-inflation-indexed bonds) thereby creating synthetic inflation-indexed bonds. A Fund also may combine inflation-linked futures with U.S. Treasury futures contracts to create synthetic inflation-indexed bonds issued by the U.S. Treasury. See Indexed Investments Inflation-Indexed Bonds below for a discussion of inflation-indexed bonds.
Currency Futures. Funds that are permitted to invest in securities denominated in foreign currencies may buy and sell futures contracts on currencies. See Foreign Currency Transactions below for a description of those Funds use of currency futures.
Options on Futures Contracts. Options on futures contracts give the purchaser the right in return for the premium paid to assume a long position (in the case of a call option) or a short position (in the case of a put option) in a futures contract at the option exercise price at any time during the period of the option (in the case of an American-style option) or on the expiration date (in the case of European-style option). Upon exercise of a call option, the holder acquires a long position in the futures contract and the writer is assigned the opposite short position. In the case of a put option, the holder acquires a short position and the writer is assigned the opposite long position in the futures contract. Accordingly, in the event that an option is exercised, the parties
18
will be subject to all the risks associated with the trading of futures contracts, such as payment of initial and variation margin deposits.
Funds may use options on futures contracts in lieu of writing or buying options directly on the underlying securities or purchasing and selling the underlying futures contracts. For example, to hedge against a possible decrease in the value of its portfolio securities, a Fund may purchase put options or write call options on futures contracts rather than selling futures contracts. Similarly, a Fund may hedge against a possible increase in the price of securities the Fund expects to purchase by purchasing call options or writing put options on futures contracts rather than purchasing futures contracts. In addition, a Fund may purchase and sell interest rate options on U.S. Treasury or Eurodollar futures to take a long or short position on interest rate fluctuations. Options on futures contracts generally operate in the same manner as options purchased or written directly on the underlying investments. See Foreign Currency Transactions below for a description of some Funds use of options on currency futures.
A Fund is also required to deposit and maintain margin with respect to put and call options on futures contracts written by it. Such margin deposits may vary depending on the nature of the underlying futures contract (and the related initial margin requirements), the current market value of the option, and other futures positions held by the Fund.
A position in an option on a futures contract may be terminated by the purchaser or seller prior to expiration by effecting a closing purchase or sale transaction, subject to the availability of a liquid secondary market, which is the purchase or sale of an option of the same type (i.e., the same exercise price and expiration date) as the option previously purchased or sold. The difference between the premiums paid and received represents the Funds profit or loss on the transaction.
Commodity Futures and Options on Commodity Futures. A futures contract on a commodity is an agreement between two parties in which one party agrees to purchase a commodity, such as an energy, agricultural, or metal commodity, from the other party at a later date at a price and quantity agreed upon when the contract is made. Futures contracts on commodities indices operate in a manner similar to Index Futures. While commodity futures on individual commodities are physically settled, GMO intends to close out those futures contracts before the settlement date without the making or taking of delivery. See also Commodity-Related Investments below.
Forward Contracts. A forward contract is a contract to buy or sell an underlying security or currency at a pre-determined price on a specific future date. The initial terms of the contract are set so that the contract has no value at the outset. Forward prices are obtained by taking the spot price of a security or currency and adding to it the cost of carry. No money is transferred upon entering into a forward contract and the trade is delayed until the specified date when the underlying security or currency is exchanged for cash. Subsequently, as the price of the underlying security or currency moves, the value of the contract also changes, generally in the same direction.
Forward contracts involve a number of the same characteristics and risks as futures contracts but there also are several differences. Forward contracts are not market traded, and are not necessarily marked to market on a daily basis. They settle only at the pre-determined settlement date. This can result in deviations between forward prices and futures prices, especially in circumstances where interest rates and futures prices are positively correlated. Second, in the
19
absence of exchange trading and involvement of clearing houses, there are no standardized terms for forward contracts. Accordingly, the parties are free to establish such settlement times and underlying amounts of a security or currency as desirable, which may vary from the standardized provisions available through any futures contract. Finally, forward contracts, as two party obligations for which there is no secondary market, involve counterparty credit risk not present with futures.
Forward currency contracts are contracts between two parties to purchase and sell a specific quantity of a particular currency at a specified price, with delivery and settlement to take place on a specified future date. Currency transactions involve significant risk. Currency exchange rates may fluctuate significantly over short periods of time. They generally are determined by the forces of supply and demand in the foreign exchange markets, the relative merits of investments in different countries, actual or perceived changes in interest rates and other complex factors. Currency exchange rates also can be affected unpredictably as a result of intervention (or the failure to intervene) by U.S. governments or foreign governments or central banks, or by currency controls or political developments in the United States or abroad, including repatriation limitations. A Funds exposure to foreign dollar currencies means that a change in the value of any such currency against the U.S. dollar will result in a change in the U.S. dollar value of a Funds assets.
Risk Factors in Futures and Futures Options Transactions . Investment in futures contracts involves risk. A purchase or sale of futures contracts may result in losses in excess of the amount invested in the futures contract. If a futures contract is used for hedging, an imperfect correlation between movements in the price of the futures contract and the price of the security, currency, or other investment being hedged creates risk. Correlation is higher when the investment being hedged underlies the futures contract. Correlation is lower when the investment being hedged is different than the security, currency, or other investment underlying the futures contract, such as when a futures contract on an index of securities or commodities is used to hedge a single security or commodity, a futures contract on one security (e.g., U.S. Treasury bonds) or commodity (e.g., gold) is used to hedge a different security (e.g., a mortgage-backed security) or commodity (e.g., copper), or when a futures contract in one currency is used to hedge a security denominated in another currency. In the case of Index Futures and futures on commodity indices, changes in the price of those futures contracts may not correlate perfectly with price movements in the relevant index due to market distortions. In the event of an imperfect correlation between a futures position and the portfolio position (or anticipated position) intended to be hedged, the Fund may realize a loss on the futures contract at the same time the Fund is realizing a loss on the portfolio position intended to be hedged. To compensate for imperfect correlations, a Fund may purchase or sell futures contracts in a greater amount than the hedged investments if the volatility of the price of the hedged investments is historically greater than the volatility of the futures contracts. Conversely, a Fund may purchase or sell fewer futures contracts if the volatility of the price of the hedged investments is historically less than that of the futures contract. The successful use of transactions in futures and related options for hedging also depends on the direction and extent of exchange rate, interest rate and asset price movements within a given time frame. For example, to the extent equity prices remain stable during the period in which a futures contract or option is held by a Fund investing in equity securities (or such prices move in a direction opposite to that anticipated), the Fund may realize a loss on the futures transaction, which is not fully or partially offset by an increase in the value of its portfolio securities. As a result, the Funds total return for such period may be less than if it had not engaged in the hedging transaction.
20
All participants in the futures market are subject to margin deposit and maintenance requirements. Instead of meeting margin calls, investors may close futures contracts through offsetting transactions, which could distort normal correlations. The margin deposit requirements in the futures market are less onerous than margin requirements in the securities market, allowing for more speculators who may cause temporary price distortions. Furthermore, the low margin deposits normally required in futures trading permit a high degree of leverage. Accordingly, a relatively small price movement in a futures contract can result in immediate and substantial losses. Trading hours for non-U.S. stock Index Futures may not correspond perfectly to the trading hours of the non-U.S. exchange to which a particular non-U.S. stock Index Future relates. As a result, the lack of continuous arbitrage may cause a disparity between the price of non-U.S. stock Index Futures and the value of the relevant index.
A Fund may purchase futures contracts (or options on them) as an anticipatory hedge against a possible increase in the price of a currency in which securities the Fund anticipates purchasing is denominated. In such instances, the currency may instead decline. If the Fund does not then invest in those securities, the Fund may realize a loss on the futures contract that is not offset by a reduction in the price of the securities purchased.
The Funds ability to engage in the futures and options on futures strategies described above depends on the liquidity of those instruments. Trading interest in various types of futures and options on futures cannot be predicted. Therefore, no assurance can be given that a Fund will be able to utilize these instruments at all or that their use will be effective. In addition, a liquid market may not exist at a time when a Fund seeks to close out a futures or option on a futures contract position, and that Fund would remain obligated to meet margin requirements until the position is closed. The liquidity of a secondary market in a futures contract may be adversely affected by daily price fluctuation limits established by commodity exchanges to limit the amount of fluctuation in a futures contract price during a single trading day. Once the daily limit has been reached, no trades of the contract may be entered at a price beyond the limit, thus preventing the liquidation of open futures positions. In the past, prices have exceeded the daily limit on several consecutive trading days. Short (and long) positions in Index Futures or futures on commodities indices may be closed only by purchasing (or selling) a futures contract on the exchange on which the Index Futures or commodity futures, as applicable, are traded.
As discussed above, if a Fund purchases or sells a futures contract, it is only required to deposit initial and variation margin as required by relevant CFTC regulations and the rules of the contract market. The Funds net asset value will generally fluctuate with the value of the security or other instrument underlying a futures contract as if it were already in the Funds portfolio. Futures transactions can have the effect of investment leverage. Furthermore, if a Fund combines short and long positions, in addition to possible declines in the values of its investment securities, the Fund will incur losses if the index underlying the long futures position underperforms the index underlying the short futures position.
In addition, if a futures broker of a Fund becomes bankrupt or insolvent, or otherwise defaults on its obligations to the Fund, the Fund may not receive all amounts owing to it in respect of its trading, despite the futures clearing house fully discharging all of its obligations. In the event of the bankruptcy of a futures broker, a Fund could be limited to recovering only a pro rata share of all available funds segregated on behalf of the futures brokers combined customer accounts. Also, in contrast to the treatment of margin provided for cleared derivatives, the futures broker does not typically notify the futures clearing house of the amount of margin provided by the futures broker to the futures clearing house that is attributable to each customer. Therefore, a
21
Fund is subject to the risk that its margin will be used by the futures clearing house to satisfy the obligations of another customer of its futures broker. In addition, in the event of the bankruptcy or insolvency of a clearing house, a Fund might experience a loss of funds deposited through its futures broker as margin with the clearing house, a loss of unrealized profits on its open positions, and the loss of funds owed to it as realized profits on closed positions. Such a bankruptcy or insolvency might also cause a substantial delay before a Fund could obtain the return of funds owed to it by a futures broker who was a member of such clearing house. Furthermore, if a futures broker does not comply with the applicable regulations or its agreement with a Fund, or in the event of fraud or misappropriation of customer assets by a futures broker, a Fund could have only an unsecured creditor claim in an insolvency of the futures broker with respect to the margin held by the futures broker.
Additional Risk Associated with Commodity Futures Transactions. Several additional risks are associated with transactions in commodity futures contracts.
Physical Delivery Risk. A Fund may trade in physical commodities and/or invest in certain futures contracts on commodities that are not required to be cash settled. In such cases, a Fund may take physical delivery of commodities. Such commodities may be subject to the risk of theft, spoilage, destruction and similar risks. In addition, storage, insurance, and other costs associated with holding commodities will affect the value of such contracts. In the event that a Fund holds physical commodities and one or more of the foregoing risks materialize, and in light of the costs associated with holding commodities, the Funds may suffer losses.
Reinvestment Risk. In the commodity futures markets, producers of an underlying commodity may sell futures contracts to lock in the price of the commodity at delivery. To induce speculators to purchase the other side (the long side) of the contract, the commodity producer generally must sell the contract at a lower price than the expected futures spot price. Conversely, if most purchasers of the underlying commodity purchase futures contracts to hedge against a rise in commodity prices, then speculators will only sell the contract at a higher price than the expected future spot price of the commodity. The changing nature of the hedgers and speculators in the commodity markets will influence whether futures prices are above or below the expected futures spot price. As a result, when GMO reinvests the proceeds from a maturing contract, it may purchase a new futures contract at a higher or lower price than the expected futures spot prices of the maturing contract or choose to pursue other investments.
Additional Economic Factors. The value of the commodities underlying commodity futures contracts may be subject to additional economic and non-economic factors, such as drought, floods or other weather conditions, livestock disease, trade embargoes, competition from substitute products, transportation bottlenecks or shortages, fluctuations in supply and demand, tariffs, and international economic, political, and regulatory developments.
See also Commodity-Related Investments below for more discussion of the special risks of investing in commodity futures, options on commodity futures, and related types of derivatives, including certain tax-related risks.
Additional Risks of Options on Securities, Futures Contracts, and Options on Futures Contracts Traded on Non-U.S. Exchanges. Options on securities, futures contracts, options on futures contracts, and options on currencies may be traded on non-U.S. exchanges. Such transactions may not be regulated as effectively as similar transactions in the United States (which are regulated by the CFTC) and may be subject to greater risks than trading on U.S.
22
exchanges. For example, some non-U.S. exchanges may be principal markets so that no common clearing facility exists and a trader may look only to the broker for performance of the contract. The lack of a common clearing facility creates counterparty risk. If a counterparty defaults, a Fund will have contractual remedies against that counterparty, but may be unsuccessful in enforcing those remedies. When seeking to enforce a contractual remedy, a Fund also is subject to the risk that the parties may interpret contractual terms (e.g., the definition of default) differently. Counterparty risk is greater for derivatives with longer maturities where events may intervene to prevent settlement. Counterparty risk is also greater when a Fund has entered into derivatives contracts with a single or small group of counterparties as it sometimes does as a result of its use of swaps and other OTC derivatives. If a dispute occurs, the cost and unpredictability of the legal proceedings required for the Fund to enforce its contractual rights may lead the Fund to decide not to pursue its claims against the counterparty. A Fund thus assumes the risk that it may be unable to obtain payments owed under foreign futures contracts or that those payments may be delayed or made only after the Fund has incurred the costs of litigation. To the extent that GMOs view with respect to a particular counterparty changes adversely (whether due to external events or otherwise), a Funds existing transactions with that counterparty will not necessarily be required to be terminated or modified. In addition, a Fund may enter into new transactions with a counterparty that GMO no longer considers a desirable counterparty if the transaction is primarily designed to reduce the Funds overall risk of potential exposure to that counterparty (for example, re-establishing the transaction with a lower notional amount). In addition, unless a Fund hedges against fluctuations in the exchange rate between the currencies in which trading is done on non-U.S. exchanges and other currencies, any profits that a Fund might realize in trading could be offset (or worse) by adverse changes in the exchange rate. The value of non-U.S. options and futures also may be adversely affected by other factors unique to non-U.S. investing. See Risks of Non-U.S. Investments above.
Swap Contracts and Other Two-Party Contracts
Swap Contracts. The Funds may directly or indirectly use various different swaps, such as swaps on securities and securities indices, total return swaps, interest rate swaps, basis swaps, currency swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps, municipal swaps, dividend swaps, volatility swaps, correlation swaps, and other types of available swap agreements, depending on a Funds investment objective and policies. Swap contracts are two-party contracts entered into primarily by institutional investors for periods ranging from a few weeks to a number of years. Under a typical swap, one party may agree to pay a fixed rate or a floating rate determined by reference to a specified instrument, rate, or index, multiplied in each case by a specified amount (notional amount), while the other party agrees to pay an amount equal to a different floating rate multiplied by the same notional amount. On each payment date, the parties obligations are netted, with only the net amount paid by one party to the other.
Swap contracts are typically individually negotiated and structured to provide exposure to a variety of different types of investments or market factors. Swap contracts may be entered into for hedging or non-hedging purposes and therefore may increase or decrease a Funds exposure to the underlying instrument, rate, asset or index. Swaps can take many different forms and are known by a variety of names. A Fund is not limited to any particular form or variety of swap agreement if GMO determines it is consistent with the Funds investment objective and policies.
In the case of an interest rate swap, the Fund may agree with a counterparty to pay a fixed rate (multiplied by a notional amount) and the counterparty pay a floating rate multiplied by the same
23
notional amount. To the extent the floating rate exceeds or falls short of the offsetting fixed rate obligation of the Fund, the Fund will receive a payment from or make a payment to the counterparty, respectively.
A Fund may enter into swaps on securities, baskets of securities or securities indices. For example, the parties to a swap contract may agree to exchange returns calculated on a notional amount of a security, basket of securities, or securities index (e.g., S&P 500 Index). Additionally, a Fund may use total return swaps, which typically involve commitments to pay amounts computed in the same manner as interest in exchange for a market-linked return, both based on notional amounts. A Fund may use such swaps to gain investment exposure to the underlying security or securities where direct ownership is either not legally possible or is economically unattractive. To the extent the total return of the security, basket of securities, or index underlying the transaction exceeds or falls short of the offsetting interest rate obligation, a Fund will receive a payment from or make a payment to the counterparty, respectively.
In addition, a Fund may enter into interest rate swaps (including municipal swaps) in order to protect against declines in the value of fixed income securities held by the Fund. In such an instance, the Fund may agree with a counterparty to pay a fixed rate (multiplied by a notional amount) and the counterparty pay a floating rate multiplied by the same notional amount. If interest rates rise, resulting in a diminution in the value of the Funds portfolio, the Fund would receive payments under the swap that would offset, in whole or in part, such diminution in value. A Fund also may enter into swaps to modify its exposure to particular currencies using currency swaps. For instance, a Fund may enter into a currency swap between the U.S. dollar and the Japanese Yen in order to increase or decrease its exposure to each such currency. A Fund may also enter into basis swaps in order to limit interest-rate risk as a result of the difference between borrowing and lending rates. Basis swaps are interest rate swaps that involve the exchange of two floating interest rate payments and may involve the exchange of two different currencies.
A Fund may use inflation swaps (including inflation swaps tied to the CPI), which involve commitments to pay a regular stream of inflation-indexed cash payments in exchange for receiving a stream of nominal interest payments (or vice versa), where both payment streams are based on a notional amount. The nominal interest payments may be based on either a fixed interest rate or variable interest rate, such as LIBOR. Inflation swaps may be used to hedge the inflation risk in nominal bonds (i.e., non-inflation-indexed bonds), thereby creating synthetic inflation-indexed bonds, or combined with U.S. Treasury futures contracts to create synthetic inflation-indexed bonds issued by the U.S. Treasury. See Indexed Investments Inflation-Indexed Bonds below.
In addition, a Fund may directly or indirectly use credit default swaps to take an active long or short position with respect to the likelihood of default by a corporate or sovereign issuer of fixed income securities (including asset-backed securities). In a credit default swap, one party pays, in effect, an insurance premium through a stream of payments to another party in exchange for the right to receive a specified return in the event of default (or similar events) by one or more third parties on their obligations. For example, in purchasing a credit default swap, a Fund may pay a premium in return for the right to put specified bonds or loans to the counterparty, such as a U.S. or non-U.S. issuer or basket of such issuers, upon issuer default (or similar events) at their par (or other agreed-upon) value. A Fund, as the purchaser in a credit default swap, bears the risk that the investment might expire worthless. It also would be subject to counterparty risk the risk that the counterparty may fail to satisfy its payment obligations to the Fund in the event of a
24
default (or similar event) (see Swap Contracts and Other Two-Party Contracts Risk Factors in Swap Contracts, OTC Options, and Other Two-Party Contracts below). In addition, as a purchaser in a credit default swap, the Funds investment would only generate income in the event of an actual default (or similar event) by the issuer of the underlying obligation. A Fund also may invest in credit default indices, which are indices that reflect the performance of a basket of credit default swaps.
A Fund also may use credit default swaps for investment purposes by selling a credit default swap, in which case the Fund will receive a premium from its counterparty in return for the Funds taking on the obligation to pay the par (or other agreed-upon) value to the counterparty upon issuer default (or similar events). As the seller in a credit default swap, a Fund effectively adds economic leverage to its portfolio because, in addition to its total net assets, the Fund is subject to investment exposure on the notional amount of the swap. If no event of default (or similar event) occurs, the Fund would keep the premium received from the counterparty and generally would have no payment obligations, with the exception of an initial payment made on the credit default swap or any margin requirements with the credit default swap counterparty. For credit default swap agreements, trigger events for payment under the agreement vary by the type of underlying investment (e.g., corporate and sovereign debt, asset-backed securities, and credit default swap indices) and by jurisdiction (e.g., United States, Europe and Asia).
A Fund may use dividend swaps. Under a dividend swap, one party pays to the other party the dividends paid with respect to a notional amount of a security (or a basket or index of securities) during the term of the swap, in exchange for interest rate or other payments. To the extent the dividends paid on the security, basket of securities, or index underlying the transaction exceeds or falls short of the offsetting obligation, a Fund will receive a payment from or make a payment to the counterparty, respectively.
In addition, a Fund may use volatility swaps. Volatility swaps involve the exchange of forward contracts on the future realized volatility of a given underlying asset, and allow the Fund to take positions on the volatility of that underlying asset. A Fund also may use a particular type of volatility swap, known as a variance swap agreement, which involves an agreement by two parties to exchange cash flows based on the measured variance (volatility squared) of a specified underlying asset. One party agrees to exchange a fixed rate or strike price payment for the floating rate or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount paid by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would receive a payment when the realized price variance of the underlying asset is greater than the strike price and would make a payment when that variance is less than the strike price. A payer of the realized price variance would make a payment when the realized price variance of the underlying asset is greater than the strike price and would receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
A Fund may use correlation swaps, which provide exposure to increases or decreases in the correlation between the prices of different assets or market rates. Correlation swaps involve receiving a stream of payments based on the actual average correlation between or among the price movements of two or more underlying variables over a period of time, in exchange for
25
making a regular stream of payments based on a fixed strike correlation level (or vice versa), where both payment streams are based on a notional amount. The underlying variables may include, without limitation, commodity prices, exchange rates, interest rates and stock indices.
Contracts for Differences. Contracts for differences are swap arrangements in which the parties agree that their return (or loss) will be based on the relative performance of two different groups or baskets of securities. Often, one or both baskets will be an established securities index. The Funds return will be based on changes in value of theoretical long futures positions in the securities comprising one basket (with an aggregate face value equal to the notional amount of the contract for differences) and theoretical short futures positions in the securities comprising the other basket. A Fund also may use actual long and short futures positions and achieve similar market exposure by netting the payment obligations of the two contracts. A Fund will only enter into contracts for differences (and analogous futures positions) when GMO believes that the basket of securities constituting the long position will outperform the basket constituting the short position. If the short basket outperforms the long basket, the Fund will realize a loss even in circumstances when the securities in both the long and short baskets appreciate in value. In addition, GAAR Implementation Fund and Systematic Global Macro Opportunity Fund may use contracts for differences that are based on the relative performance of two different groups or baskets of commodities. Often, one or both baskets is a commodities index. Contracts for differences on commodities operate in a similar manner to contracts for differences on securities described above.
Interest Rate Caps, Floors, and Collars. The Funds may use interest rate caps, floors, and collars for the same or similar purposes as they use interest rate futures contracts and related options and, as a result, will be subject to similar risks. See Options, Futures, and Forward Contracts Risk Factors in Options Transactions and Risk Factors in Futures and Futures Options Transactions above. Like interest rate swap contracts, interest rate caps, floors, and collars are two-party agreements in which the parties agree to pay or receive interest on a notional principal amount and are generally individually negotiated with a specific counterparty. The purchaser of an interest rate cap receives interest payments from the seller to the extent that the return on a specified index exceeds a specified interest rate. The purchaser of an interest rate floor receives interest payments from the seller to the extent that the return on a specified index falls below a specified interest rate. The purchaser of an interest rate collar receives interest payments from the seller to the extent that the return on a specified index falls outside the range of two specified interest rates.
Swaptions. An option on a swap agreement, also called a swaption, is an OTC option that gives the buyer the right, but not the obligation, to enter into a swap on a specified future date in exchange for paying a market-based premium. A receiver swaption gives the owner the right to receive the total return of a specified asset, reference rate, or index (such as a call option on a bond). A payer swaption gives the owner the right to pay the total return of a specified asset, reference rate, or index (such as a put option on a bond). Swaptions also include options that allow one of the counterparties to terminate or extend an existing swap.
Risk Factors in Swap Contracts, OTC Options, and Other Two-Party Contracts. A Fund may only close out a swap, contract for differences, cap, floor, collar, or OTC option (including swaption) with its particular counterparty, and may only transfer a position with the consent of that counterparty. If a counterparty fails to meet or disputes its contractual obligations, goes bankrupt, or otherwise experiences a business interruption, the Fund could miss investment opportunities or otherwise hold investments it would prefer to sell, resulting in losses for the
26
Fund. If the counterparty defaults, a Fund will have contractual remedies, but there can be no assurance that the counterparty will be able to meet its contractual obligations or that the Fund will be able to enforce its rights. For example, because the contract for each OTC derivatives transaction is individually negotiated with a specific counterparty, a Fund is subject to the risk that a counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund. The cost and unpredictability of the legal proceedings required for the Fund to enforce its contractual rights may lead it to decide not to pursue its claims against the counterparty. Counterparty risk is greater for derivatives with longer maturities where events may intervene to prevent settlement. Counterparty risk is also greater when a Fund has concentrated its derivatives with a single or small group of counterparties as it sometimes does as a result of its use of swaps and other OTC derivatives. To the extent a Fund has significant exposure to a single counterparty, this risk will be particularly pronounced for the Fund. The Fund, therefore, assumes the risk that it may be unable to obtain payments GMO believes are owed under an OTC derivatives contract or that those payments may be delayed or made only after the Fund has incurred the costs of litigation. In addition, counterparty risk is pronounced during unusually adverse market conditions and is particularly acute in environments (like those of 2008) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions.
The credit rating of a counterparty may be adversely affected by greater-than-average volatility in the markets, even if the counterpartys net market exposure is small relative to its capital.
Counterparty risk with respect to derivatives has been and will continue to be affected by new rules and regulations relating to the derivatives market. Some derivatives transactions are required to be centrally cleared, and a party to a cleared derivatives transaction is subject to the credit risk of the clearing house and the clearing member through which it holds its cleared position. Credit risk of market participants with respect to derivatives that are centrally cleared is concentrated in a few clearing houses, and it is not clear how an insolvency proceeding of a clearing house would be conducted and what impact an insolvency of a clearing house would have on the financial system. A clearing member is obligated by contract and regulation to segregate all funds received from customers with respect to cleared derivatives positions from the clearing members proprietary assets. However, all funds and other property received by a clearing member from its customers with respect to cleared derivatives are generally held by the clearing member on a commingled basis in an omnibus account (which can be invested in instruments permitted under the regulations). Therefore, a Fund might not be fully protected in the event of the bankruptcy of a Funds clearing member because the Fund would be limited to recovering only a pro rata share of the funds held by the clearing member on behalf of customers, with a claim against the clearing member for any deficiency. Also, the clearing member is required to transfer to the clearing house the amount of margin required by the clearing house for cleared derivatives, which amount is generally held in an omnibus account at the clearing house for all customers of the clearing member. Regulations promulgated by the CFTC require that the clearing member notify the clearing house of the initial margin provided by the clearing member to the clearing house that is attributable to each customer. However, if the clearing member does not accurately report a Funds initial margin, the Fund is subject to the risk that a clearing house will use the assets attributable to it in the clearing houses omnibus account to satisfy payment obligations a defaulting customer of the clearing member has to the clearing house. In addition, clearing members generally provide the clearing house the net amount of variation margin required for cleared swaps for all of its customers, rather than individually for each customer. The Funds are therefore subject to the risk that a clearing house will not make variation margin payments owed to a Fund if another customer of the clearing
27
member has suffered a loss and is in default, and the risk that a Fund will be required to provide additional variation margin to the clearing house before the clearing house will move the Funds cleared derivatives positions to another clearing member. In addition, if a clearing member does not comply with the applicable regulations or its agreement with the Funds, or in the event of fraud or misappropriation of customer assets by a clearing member, a Fund could have only an unsecured creditor claim in an insolvency of the clearing member with respect to the margin held by the clearing member.
Additional Risk Factors in OTC Derivatives Transactions. OTC derivatives are also subject to documentation risk, which is the risk that ambiguities, inconsistencies, or errors in the documentation relating to a derivative transaction lead to a dispute with the counterparty or unintended investment results.
Additionally, participants in OTC derivatives markets typically are not subject to the same level of credit evaluation and regulatory oversight as are members of exchange-based markets and, therefore, OTC derivatives generally expose a Fund to greater counterparty risk than exchange-traded derivatives.
Among other trading agreements, certain Funds are party to International Swaps and Derivatives Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements with select counterparties that generally govern OTC derivative transactions entered into by such Funds. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of a Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse impact on a Funds operations.
Additional Risk Factors in Cleared Derivatives Transactions. Under recently adopted rules and regulations, transactions in some types of swaps (including interest rate swaps and credit default swaps on North American and European indices) are required to be centrally cleared. In a transaction involving those swaps (cleared derivatives), a Funds counterparty is a clearing house, rather than a bank or broker. Since the Funds are not members of clearing houses and only members of a clearing house (clearing members) can participate directly in the clearing house, the Funds hold cleared derivatives through accounts at clearing members. In cleared derivatives positions, the Funds make payments (including margin payments) to and receive payments from a clearing house through their accounts at clearing members. Clearing members guarantee performance of their clients obligations to the clearing house.
In some ways, cleared derivative arrangements are less favorable to mutual funds than bilateral arrangements, for example, by requiring that funds provide more margin for their cleared derivatives positions. Also, as a general matter, in contrast to a bilateral derivatives position, following a period of notice to a Fund, a clearing member at any time can require termination of an existing cleared derivatives position or an increase in margin requirements above those required at the outset of a transaction. Clearing houses also have broad rights to increase margin requirements for existing positions or to terminate those positions at any time. Any increase in margin requirements or termination of existing cleared derivatives positions by the clearing member or the clearing house could interfere with the ability of a Fund to pursue its investment strategy. Further, any increase in margin requirements by a clearing member could expose a
28
Fund to greater credit risk to its clearing member because margin for cleared derivatives positions in excess of a clearing houses margin requirements typically is held by the clearing member. Also, a Fund is subject to risk if it enters into a derivatives transaction that is required to be cleared (or that GMO expects to be cleared), and no clearing member is willing or able to clear the transaction on the Funds behalf. While the documentation in place between the Funds and their clearing members generally provides that the clearing members will accept for clearing all cleared derivatives transactions that are within credit limits (specified in advance) for each Fund, the Funds are still subject to the risk that no clearing member will be willing or able to clear a transaction. In those cases, the position might have to be terminated, and the Fund could lose some or all of the benefit of the position, including loss of an increase in the value of the position and/or loss of hedging protection. In addition, the documentation governing the relationship between the Funds and clearing members is drafted by the clearing members and generally is less favorable to the Funds than typical bilateral derivatives documentation. For example, documentation relating to cleared derivatives generally includes a one-way indemnity by the Funds in favor of the clearing member for losses the clearing member incurs as the Funds clearing member and typically does not provide the Funds any remedies if the clearing member defaults or becomes insolvent. While futures contracts entail similar risks, the risks likely are more pronounced for cleared swaps due to their more limited liquidity and market history.
Some types of cleared derivatives are required to be executed on an exchange or on a swap execution facility. A swap execution facility is a trading platform where multiple market participants can execute derivatives by accepting bids and offers made by multiple other participants in the platform. While this execution requirement is designed to increase transparency and liquidity in the cleared derivatives market, trading on a swap execution facility can create additional costs and risks for the Funds. For example, swap execution facilities typically charge fees, and if a Fund executes derivatives on a swap execution facility through a broker intermediary, the intermediary may impose fees as well. Also, a Fund may indemnify a swap execution facility, or a broker intermediary who executes cleared derivatives on a swap execution facility on the Funds behalf, against any losses or costs that may be incurred as a result of the Funds transactions on the swap execution facility. If a Fund wishes to execute a package of transactions that include a swap that is required to be executed on a swap execution facility as well as other transactions (for example, a transaction that includes both a security and an interest rate swap that hedges interest rate exposure with respect to such security), the Fund may be unable to execute all components of the package on the swap execution facility. In that case, the Fund would need to trade some components of the package on the swap execution facility and other components in another manner, which could subject the Fund to the risk that some of the components would be executed successfully and others would not, or that the components would be executed at different times, leaving the Fund with an unhedged position for a period of time.
These and other new rules and regulations could, among other things, further restrict a Funds ability to engage in, or increase the cost to the Fund of, derivatives transactions, for example, by making some types of derivatives no longer available to the Fund or otherwise limiting liquidity. The implementation of the clearing requirement has increased the costs of derivatives transactions for the Funds since the Funds have to pay fees to their clearing members and are typically required to post more margin for cleared derivatives than they have historically posted for bilateral derivatives. The costs of derivatives transactions are expected to increase further as clearing members raise their fees to cover the costs of additional capital requirements and other regulatory changes applicable to the clearing members, and when rules imposing mandatory minimum margin requirements on bilateral swaps become effective. These rules and regulations are new and evolving, so their potential impact on the Funds and the financial system are not yet
29
known. While the new rules and regulations and central clearing of some derivatives transactions are designed to reduce systemic risk (i.e., the risk that the interdependence of large derivatives dealers could cause them to suffer liquidity, solvency or other challenges simultaneously), there is no assurance that they will achieve that result, and in the meantime, as noted above, central clearing and related requirements expose the Funds to new kinds of costs and risks.
Use of Futures and Related Options, Interest Rate Floors, Caps and Collars, Certain Types of Swap Contracts and Related Instruments Commodity Pool Operator Status. Each of GAAR Implementation Fund, Systematic Global Macro Opportunity Fund, and World Opportunity Overlay Fund, together with GMO Alpha Only Fund, GMO Asset Allocation Bond Fund, GMO Benchmark-Free Allocation Fund, GMO Benchmark-Free Bond Fund, GMO Benchmark-Free Fund, GMO Core Plus Bond Fund, GMO Currency Hedged International Bond Fund, GMO Emerging Country Debt Fund, GMO Global Asset Allocation Fund, GMO Global Bond Fund, GMO Implementation Fund, GMO International Bond Fund, GMO Special Opportunities Fund, and GMO Strategic Opportunities Allocation Fund (each a series of the Trust offered through a separate prospectus), is a commodity pool under the Commodity Exchange Act (the CEA) and GMO is registered as a commodity pool operator under the CEA with respect to these Funds. As a result, additional CFTC-mandated disclosure, reporting and recordkeeping obligations apply to these Funds and compliance with the CFTCs regulatory requirements could increase Fund expenses, adversely affecting a Funds total return.
The Trust, with respect to each GMO Fund not listed in the previous paragraph (the Excluded Funds), has claimed an exclusion from the definition of commodity pool operator under the CEA pursuant to CFTC Rule 4.5 (the exclusion). Accordingly, neither the Excluded Funds nor the Trust (with respect to the Excluded Funds) are subject to registration or regulation as a commodity pool operator under the CEA. To remain eligible for the exclusion, each Excluded Fund will be limited in its ability to use certain financial instruments regulated under the CEA (commodity interests), including futures and options on futures and certain swaps transactions. In the event that an Excluded Funds investments in commodity interests are not within the thresholds set forth in the exclusion, GMO may be required to register as a commodity pool operator with the CFTC with respect to that Excluded Fund. The eligibility of the Trust to claim the exclusion with respect to an Excluded Fund will be based upon, among other things, the level and scope of the funds investment in commodity interests, the purposes of such investments, and the manner in which the Excluded Fund holds out its use of commodity interests. An Excluded Funds ability to invest in commodity interests (including, but not limited to, futures and swaps on broad-based securities indexes and interest rates) is limited by the requirements of Rule 4.5, which may adversely affect the Excluded Funds total return. In the event the Trust becomes unable to rely on the exclusion in Rule 4.5 with respect to an Excluded Fund and GMO is required to register with the CFTC as a commodity pool operator with respect to an Excluded Fund, the Excluded Funds expenses may increase, adversely affecting that Funds total return.
Foreign Currency Transactions
Currency exchange rates may fluctuate significantly over short periods of time. They generally are determined by the forces of supply and demand in the currency exchange markets, trade balances, the relative merits of investments in different countries, actual or perceived changes in interest rates, differences in relative values of similar assets in different currencies, long-term opportunities for investment and capital appreciation, and other complex factors. Currency
30
exchange rates also can be affected unpredictably as a result of intervention (or the failure to intervene) by the U.S. or foreign governments, central banks, or supranational agencies such as the International Monetary Fund, or by currency or exchange controls or political and economic developments in the United States or abroad. Currencies in which a Funds assets are denominated, or in which a Fund has taken a long position, may be devalued against other currencies, resulting in a loss to the Fund. Similarly, currencies in which a Fund has taken a short position may increase in value relative to other currencies, resulting in a loss to the Fund.
In addition, some currencies are illiquid (e.g., emerging country currencies), and a Fund may not be able to convert these currencies into U.S. dollars, in which case GMO may decide to purchase U.S. dollars in a parallel market with an unfavorable exchange rate. Exchange rates for many currencies (e.g., emerging country currencies) are particularly affected by exchange control regulations.
Funds that are permitted to invest in securities denominated in foreign currencies may buy or sell foreign currencies or deal in forward foreign currency contracts, currency futures contracts and related options, and options on currencies. Those Funds may use such currency instruments for hedging, investment, and/or currency risk management. Currency risk management may include taking overweighted or underweighted currency positions relative to both the securities portfolio of a Fund and the Funds performance benchmark or index. Those Funds also may purchase forward foreign currency contracts in conjunction with U.S. dollar-denominated securities in order to create a synthetic foreign currency-denominated security that approximates desired risk and return characteristics when the non-synthetic securities either are not available in non-U.S. markets or possess undesirable characteristics.
Forward foreign currency contracts are contracts between two parties to purchase and sell a specified quantity of a particular currency at a specified price, with delivery and settlement to take place on a specified future date. A forward foreign currency contract can reduce a Funds exposure to changes in the value of the currency it will deliver and can increase its exposure to changes in the value of the currency it will receive for the duration of the contract. The effect on the value of a Fund is similar to the effect of selling securities denominated in one currency and purchasing securities denominated in another currency. Contracts to sell a particular foreign currency would limit any potential gain that might be realized by a Fund if the value of the hedged currency increases. In addition, it is not always possible to hedge fully or perfectly against currency fluctuations affecting the value of the securities denominated in foreign currencies because the value of such securities also is likely to fluctuate because of independent factors not related to currency fluctuations. If a forward foreign currency contract is used for hedging, an imperfect correlation between movements in the price of the forward foreign currency contract and the price of the currency or other investment being hedged creates risk.
Forward foreign currency contracts involve a number of the same characteristics and risks as currency futures contracts (discussed below) but there also are several differences. Forward foreign currency contracts settle only at the pre-determined settlement date. This can result in deviations between forward foreign currency prices and currency futures prices, especially in circumstances where interest rates and currency futures prices are positively correlated. Second, in the absence of exchange trading and involvement of clearing houses, there are no standardized terms for forward currency contracts. Accordingly, the parties are free to establish such settlement times and underlying amounts of a currency as desirable, which may vary from the standardized provisions available through any currency futures contract.
31
A Fund also may purchase or sell currency futures contracts and related options. Currency futures contracts are contracts to buy or sell a standard quantity of a particular currency at a specified future date and price. However, currency futures can be and often are closed out prior to delivery and settlement. In addition, a Fund may use options on currency futures contracts, which give their holders the right, but not the obligation, to buy (in the case of a call option) or sell (in the case of a put option) a specified currency futures contract at a fixed price during a specified period. See Options, Futures, and Forward Contracts Futures above for more information on futures contracts and options on futures contracts.
A Fund also may purchase or sell options on currencies. Options on currencies possess many of the same characteristics as options on securities and generally operate in a similar manner. They may be traded on an exchange or in the OTC markets. Options on currencies traded on U.S. or other exchanges may be subject to position limits, which may limit the ability of a Fund to reduce foreign currency risk using options. See Options, Futures, and Forward Contracts Currency Options above for more information on currency options.
Repurchase Agreements
A Fund may enter into repurchase agreements with banks and brokers. A repurchase agreement is a contract under which the Fund acquires a security (usually an obligation of the government in the jurisdiction where the transaction is initiated or in whose currency the agreement is denominated) for a relatively short period (usually less than a week) for cash and subject to the commitment of the seller to repurchase the security for an agreed-upon price on a specified date. The repurchase price exceeds the acquisition price and reflects an agreed-upon market rate unrelated to the coupon rate on the purchased security. Repurchase agreements afford a Fund the opportunity to earn a return on temporarily available cash without market risk, although the Fund bears the risk of a sellers failure to meet its obligation to pay the repurchase price when it is required to do so. Such a default may subject the Fund to expenses, delays, and risks of loss including: (i) possible declines in the value of the underlying security while the Fund seeks to enforce its rights thereto; (ii) possible reduced levels of income and lack of access to income during this period; and (iii) the inability to enforce its rights and the expenses involved in attempted enforcement. Entering into repurchase agreements entails certain risks, which include the risk that the counterparty to the repurchase agreement may not be able to fulfill its obligations, as discussed above, that the parties may disagree as to the meaning or application of contractual terms, or that the instrument may not perform as expected. See Description of Principal Risks Counterparty Risk in the Private Placement Memorandum.
Debt and Other Fixed Income Securities Generally
Debt and other fixed income securities include fixed and floating rate securities of any maturity. Fixed rate securities pay a specified rate of interest or dividends. Floating rate securities pay a rate that is adjusted periodically by reference to a specified index or market rate. Fixed and floating rate securities include securities issued by federal, state, local, and foreign governments and related agencies, and by a wide range of private issuers, and generally are referred to in this SAI as fixed income securities. Indexed bonds are a type of fixed income security whose principal value and/or interest rate is adjusted periodically according to a specified instrument, index, or other statistic (e.g., another security, inflation index, currency, or commodity). See Adjustable Rate Securities and Indexed Investments below. In addition, the Funds may create synthetic bonds which approximate desired risk and return profiles. This may be done where a non-synthetic security having the desired risk/return profile either is unavailable (e.g.,
32
short-term securities of certain foreign governments) or possesses undesirable characteristics (e.g., interest payments on the security would be subject to foreign withholding taxes). See, for example, Options, Futures, and Forward Contracts Inflation-Linked Futures above.
Holders of fixed income securities are exposed to both market and credit risk. Market risk (or interest rate risk) relates to changes in a securitys value as a result of changes in interest rates. In general, the values of fixed income securities increase when interest rates fall and decrease when interest rates rise. Credit risk relates to the ability of an issuer to make payments of principal and interest. Obligations of issuers are subject to bankruptcy, insolvency and other laws that affect the rights and remedies of creditors. Fixed income securities denominated in foreign currencies also are subject to the risk of a decline in the value of the denominating currency.
Because interest rates vary, the future income of a Fund that invests in floating rate fixed income securities cannot be predicted with certainty. To the extent a Fund invests in indexed securities, the future income of the Fund also will be affected by changes in those securities indices over time (e.g., changes in inflation rates, currency rates, or commodity prices).
The Funds may invest in a wide range of debt and fixed income instruments, including, but not limited to, Asset-Backed and Mortgage-Backed Securities, Brady Bonds, Euro Bonds, U.S. Government and Foreign Government Securities and Zero Coupon Securities, each of which is described below.
Cash and Other High Quality Investments
The Funds may temporarily invest a portion of their assets in cash or cash items pending other investments or to maintain liquid assets required in connection with some of the Funds investments. These cash items and other high quality debt securities may include money market instruments, such as securities issued by the U.S. government and its agencies, bankers acceptances, commercial paper, and bank certificates of deposit. If a custodian holds cash on behalf of a Fund, the Fund may be an unsecured creditor in the event of the insolvency of the custodian. In addition, the Fund will be subject to credit risk with respect to such a custodian, which may be heightened to the extent the Fund takes a temporary defensive position.
U.S. Government Securities and Foreign Government Securities
U.S. government securities include securities issued or guaranteed by the U.S. government or its authorities, agencies, or instrumentalities. Foreign government securities include securities issued or guaranteed by foreign governments (including political subdivisions) or their authorities, agencies, or instrumentalities or by supra-national agencies. Different kinds of U.S. and foreign government securities have different kinds of government support. For example, some U.S. government securities (e.g., U.S. Treasury bonds) are supported by the full faith and credit of the United States. Other U.S. government securities are issued or guaranteed by federal agencies or government-chartered or -sponsored enterprises but are neither guaranteed nor insured by the U.S. government (e.g., debt securities issued by the Federal Home Loan Mortgage Corporation (Freddie Mac), Federal National Mortgage Association (Fannie Mae), and Federal Home Loan Banks (FHLBs)). Similarly, some foreign government securities are supported by the full faith and credit of a foreign national government or political subdivision and some are not. Foreign government securities of some countries may involve varying degrees of credit risk as a result of financial or political instability in those countries or the possible
33
inability of a Fund to enforce its rights against the foreign government. As with issuers of other fixed income securities, sovereign issuers may be unable or unwilling to satisfy their obligations to pay principal or interest payments.
Supra-national agencies are agencies whose member nations make capital contributions to support the agencies activities. Examples include the International Bank for Reconstruction and Development (the World Bank), the Asian Development Bank, and the Inter-American Development Bank.
As with other fixed income securities, U.S. and foreign government securities expose their holders to market risk because their values typically change as interest rates fluctuate. For example, the value of U.S. or foreign government securities may fall during times of rising interest rates. Yields on U.S. and foreign government securities tend to be lower than those of corporate securities of comparable maturities. Generally, when interest rates on short-term U.S. Treasury obligations equal or approach zero, a Fund that invests a substantial portion of its assets in U.S. Treasury obligations will have a negative return unless GMO waives or reduces its management fees.
In addition to investing directly in U.S. and foreign government securities, a Fund may purchase certificates of accrual or similar instruments evidencing undivided ownership interests in interest payments and/or principal payments of U.S. government securities and foreign government securities. A Fund also may invest in Separately Traded Registered Interest and Principal Securities (STRIPS), which are interests in separately traded interest and principal component parts of U.S. Treasury obligations that represent future interest payments, principal payments, or both, are direct obligations of the U.S. government, and are transferable through the federal reserve book-entry system. Certificates of accrual and similar instruments may be more volatile than other government securities.
Municipal Securities
Municipal obligations are issued by or on behalf of states, territories and possessions of the United States and their political subdivisions, agencies and instrumentalities and the District of Columbia to obtain funds for various public purposes. Municipal obligations are subject to more credit risk than U.S. government securities that are supported by the full faith and credit of the United States. The ability of municipalities to meet their obligations will depend on the availability of tax and other revenues, economic, political, and other conditions within the state and municipality, and the underlying fiscal condition of the state and municipality. As with other fixed income securities, municipal securities also expose their holders to market risk because their values typically change as interest rates fluctuate. The two principal classifications of municipal obligations are notes and bonds.
Municipal notes are generally used to provide for short-term capital needs, such as to finance working capital needs of municipalities or to provide various interim or construction financing, and generally have maturities of one year or less. They are generally payable from specific revenues expected to be received at a future date or are issued in anticipation of long-term financing to be obtained in the market to provide for the repayment of the note.
Municipal bonds, which meet longer-term capital needs and generally have maturities of more than one year when issued, have two principal classifications: general obligation bonds and revenue bonds. Issuers of general obligation bonds, the proceeds of which are used to fund a
34
wide range of public projects including the construction or improvement of schools, highways and roads, water and sewer systems and a variety of other public purposes, include states, counties, cities, towns and regional districts. The basic security behind general obligation bonds is the issuers pledge of its full faith, credit, and taxing power for the payment of principal and interest.
Revenue bonds have been issued to fund a wide variety of capital projects including: electric, gas, water and sewer systems; highways, bridges and tunnels; port and airport facilities; colleges and universities; and hospitals. The principal security for a revenue bond is generally the net revenues derived from a particular facility or group of facilities or, in some cases, from the proceeds of a special excise or other specific revenue source. Although the principal security behind these bonds varies widely, many provide additional security in the form of a debt service reserve fund whose monies also may be used to make principal and interest payments on the issuers obligations. In addition to a debt service reserve fund, some authorities provide further security in the form of a states ability (without obligation) to make up deficiencies in the debt reserve fund.
Securities purchased for a Fund may include variable/floating rate instruments, variable mode instruments, put bonds, and other obligations that have a specified maturity date but also are payable before maturity after notice by the holder. There are, in addition, a variety of hybrid and special types of municipal obligations as well as numerous differences in the security of municipal obligations both within and between the two principal classifications (i.e., notes and bonds). A Fund also may invest in credit default swaps on municipal securities. See Swap Contracts and Other Two-Party Contracts Swap Contracts above.
See the Taxes section for each Fund below for a discussion of the tax treatment of municipal obligations at the Fund and shareholder level.
Auction Rate Securities
Auction rate securities consist of auction rate municipal securities and auction rate preferred securities sold through an auction process issued by closed-end investment companies, municipalities and governmental agencies. Provided that the auction mechanism is successful, auction rate securities usually permit the holder to sell the securities in an auction at par value at specified intervals. The dividend is reset by Dutch auction in which bids are made by brokers and other institutions for a certain amount of securities at a specified minimum yield. The dividend rate set by the auction is the lowest interest or dividend rate that covers all securities offered for sale. While this process is designed to permit auction rate securities to be traded at par value, there is the risk that an auction will fail due to insufficient demand for the securities.
Real Estate Investment Trusts and Other Real Estate-Related Investments
Certain Funds may invest in pooled real estate investment vehicles (so-called real estate investment trusts or REITs) and other real estate-related investments such as securities of companies principally engaged in the real estate industry. In addition to REITs, companies in the real estate industry and real estate-related investments may include, for example, entities that either own properties or make construction or mortgage loans, real estate developers, and companies with substantial real estate holdings. Each of these types of investments is subject to risks similar to those associated with direct ownership of real estate. Factors affecting real estate values include the supply of real property in particular markets, overbuilding, changes in zoning
35
laws, casualty or condemnation losses, delays in completion of construction, changes in operations costs and property taxes, levels of occupancy, adequacy of rent to cover operating expenses, possible environmental liabilities, regulatory limitations on rent, fluctuations in rental income, increased competition, and other risks related to local and regional market conditions. The value of real estate-related investments also may be affected by changes in interest rates, macroeconomic developments, and social and economic trends. For instance, during periods of declining interest rates, certain mortgage REITs may hold mortgages that the mortgagors elect to prepay, which prepayment may diminish the yield on securities issued by those REITs. Some REITs have relatively small market capitalizations, which can tend to increase the volatility of the market prices of their securities.
REITs are pooled investment vehicles that invest in real estate or real estate-related companies. The Funds may invest in different types of REITs, including equity REITs, mortgage REITs, and hybrid REITs. Equity REITs, which invest in and own real estate directly, generally invest a majority of their assets in income-producing properties to generate cash flow from rental income and gradual asset appreciation. The income-producing properties in which equity REITs invest typically include land, office, retail, industrial, hotel and apartment buildings, self storage, specialty and diversified and healthcare facilities. Equity REITs can realize capital gains (or losses) by selling properties that have appreciated (or depreciated) in value. Mortgage REITs, which make construction, development, or long-term mortgage loans, generally invest the majority of their assets in real estate mortgages or mortgage-backed securities and derive their income primarily from interest payments on the mortgages. Hybrid REITs share characteristics of equity REITs and mortgage REITs.
REITs can be listed and traded on national securities exchanges or can be traded privately between individual owners. An exchange-traded REIT is generally more liquid than a REIT that is not traded on a securities exchange. The Funds may invest in both exchange-traded and privately traded REITs.
In general, the value of a REITs shares changes in light of factors affecting the real estate industry. In addition, equity REITs may be affected by any changes in the value of the underlying property owned by the trusts, while mortgage REITs may be affected by the quality of any credit extended. REITs are also subject to the risk of fluctuations in income from underlying real estate assets, poor performance by the REITs manager and the managers inability to manage cash flows generated by the REITs assets, prepayments and defaults by borrowers, self-liquidation, adverse changes in the tax laws, and, with regard to real estate investment trusts (as defined in Section 856 of the Code) qualifying for the special tax treatment under Subchapter M of the Code (U.S. REITs), the risk of failing to qualify for tax-free pass-through of income under the Code and/or to maintain exempt status under the 1940 Act. If a REIT were not to qualify as such for federal income tax purposes, it would be subject to federal income tax, thus reducing its value.
By investing in REITs indirectly through a Fund, an investor will bear not only his or her proportionate share of the expenses of the Fund, but also, indirectly, similar expenses of REITs. In addition, REITs depend generally on their ability to generate cash flow to make distributions to investors. Investments in REITs are subject to risks associated with the direct ownership of real estate.
36
Asset-Backed and Related Securities
An asset-backed security is a fixed income security that predominantly derives its creditworthiness from cash flows relating to a pool of assets. There are a number of different types of asset-backed and related securities, including mortgage-backed securities, securities backed by other pools of collateral (such as automobile loans, student loans, sub-prime mortgages, and credit card receivables), collateralized mortgage obligations, and collateralized debt obligations, each of which is described in more detail below. Investments in asset-backed securities are subject to all of the market risks for fixed income securities described in the Private Placement Memorandum under Description of Principal Risks Market Risk Fixed Income Investments and elsewhere in this SAI.
Mortgage-Backed Securities. Mortgage-backed securities are asset-backed securities backed by pools of residential and commercial mortgages, which may include sub-prime mortgages. Mortgage-backed securities may be issued by agencies or instrumentalities of the U.S. government (including those whose securities are neither guaranteed nor insured by the U.S. government, such as Freddie Mac, Fannie Mae, and FHLBs), foreign governments (or their agencies or instrumentalities), or non-governmental issuers. Interest and principal payments (including prepayments) on the mortgage loans underlying mortgage-backed securities pass through to the holders of the mortgage-backed securities. Prepayments occur when the mortgagor on an individual mortgage loan prepays the remaining principal before the loans scheduled maturity date. Unscheduled prepayments of the underlying mortgage loans may result in early payment of the applicable mortgage-backed securities held by a Fund. The Fund may be unable to invest prepayments in an investment that provides as high a yield as the mortgage-backed securities. Consequently, early payment associated with mortgage-backed securities may cause these securities to experience significantly greater price and yield volatility than traditional fixed income securities. Many factors affect the rate of mortgage loan prepayments, including changes in interest rates, general economic conditions, further deterioration of worldwide economic and liquidity conditions, the location of the property underlying the mortgage, the age of the mortgage loan, governmental action, including legal impairment of underlying home loans, changes in demand for products financed by those loans, the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages), and social and demographic conditions. During periods of falling interest rates, the rate of mortgage loan prepayments usually increases, which tends to decrease the life of mortgage-backed securities. During periods of rising interest rates, the rate of mortgage loan prepayments usually decreases, which tends to increase the life of mortgage-backed securities.
Mortgage-backed securities are subject to varying degrees of credit risk, depending on whether they are issued by agencies or instrumentalities of the U.S. government (including those whose securities are neither guaranteed nor insured by the U.S. government) or by non-governmental issuers. Securities issued by private organizations may not be readily marketable, and since the deterioration of worldwide economic and liquidity conditions that became acute in 2008, mortgage-backed securities have been subject to greater illiquidity risk. These conditions may occur again. Also, government actions and proposals affecting the terms of underlying home loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages), have had, and may continue to have, adverse valuation and liquidity effects on mortgage-backed securities. Although liquidity of mortgage-backed securities has improved recently, there can be no assurance that in the future the market for mortgage-backed securities will continue to improve and become more liquid. In addition, mortgage-backed securities are subject to the risk of loss
37
of principal if the obligors of the underlying obligations default in their payment obligations, and to certain other risks described in Other Asset-Backed Securities below. The risk of defaults associated with mortgage-backed securities is generally higher in the case of mortgage-backed investments that include sub-prime mortgages. See Description of Principal Risks Market Risk Asset-Backed Securities and Credit Risk in the Private Placement Memorandum for more information regarding credit and other risks associated with investments in asset-backed securities.
Mortgage-backed securities may include Adjustable Rate Securities as such term is defined in Adjustable Rate Securities below.
Other Asset-Backed Securities. Similar to mortgage-backed securities, other types of asset-backed securities may be issued by agencies or instrumentalities of the U.S. government (including those whose securities are neither guaranteed nor insured by the U.S. government), foreign governments (or their agencies or instrumentalities), or non-governmental issuers. These securities include securities backed by pools of automobile loans, educational loans, home equity loans, and credit card receivables. The underlying pools of assets are securitized through the use of trusts and special purpose entities. These securities may be subject to risks associated with changes in interest rates and prepayment of underlying obligations similar to the risks of investment in mortgage-backed securities described immediately above. Similar to mortgage-backed securities, other asset-backed securities face illiquidity risk from worldwide economic and liquidity conditions as described above in Mortgage-Backed Securities. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions referred to above.
Payment of interest on asset-backed securities and repayment of principal largely depends on the cash flows generated by the underlying assets backing the securities and, in certain cases, may be supported by letters of credit, surety bonds, or other credit enhancements. The amount of market risk associated with asset-backed securities depends on many factors, including the deal structure (e.g., the amount of underlying assets or other support available to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets, the level of credit support, if any, provided for the securities, and the credit quality of the credit-support provider, if any. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default in payment of the obligations and the defaulted obligations exceed the securities credit support. The obligations of issuers (and obligors of underlying assets) may be subject to bankruptcy, insolvency and other laws affecting the rights and remedies of creditors. In addition, the existence of insurance on an asset-backed security does not guarantee that principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
The market value of an asset-backed security may be affected by the factors described above and other factors, such as the availability of information concerning the pool and its structure, the creditworthiness of the servicing agent for the pool, the originator of the underlying assets, or the entities providing the credit enhancement. The market value of asset-backed securities also can depend on the ability of their servicers to service the underlying collateral and is, therefore, subject to risks associated with servicers performance. In some circumstances, a servicers or originators mishandling of documentation for underlying assets (e.g., failure to properly
38
document a security interest in the underlying collateral) may affect the rights of the holders of those underlying assets. In addition, the insolvency of an entity that generated the assets underlying an asset-backed security is likely to result in a decline in the market price of that security as well as costs and delays.
Certain types of asset-backed securities present additional risks that are not presented by mortgage-backed securities. In particular, certain types of asset-backed securities may not have the benefit of a security interest in the related assets. For example, many securities backed by credit card receivables are unsecured. In addition, a Fund may invest in securities backed by pools of corporate or sovereign bonds, bank loans to corporations, or a combination of bonds and loans, many of which may be unsecured (commonly referred to as collateralized debt obligations or collateralized loan obligations) (see Collateralized Debt Obligations (CDOs) below). Even when security interests are present, the ability of an issuer of certain types of asset-backed securities to enforce those interests may be more limited than that of an issuer of mortgage-backed securities. For instance, automobile receivables generally are secured by automobiles rather than by real property. Most issuers of automobile receivables permit loan servicers to retain possession of the underlying assets. In addition, because of the large number of underlying vehicles involved in a typical issue of asset-backed securities and technical requirements under state law, the trustee for the holders of the automobile receivables may not have a proper security interest in all of the automobiles. Therefore, recoveries on repossessed automobiles may not be available to support payments on these securities.
In addition, certain types of asset-backed securities may experience losses on the underlying assets as a result of certain rights provided to consumer debtors under federal and state law. In the case of certain consumer debt, such as credit card debt, debtors are entitled to the protection of a number of state and federal consumer credit laws, many of which give such debtors the right to set off certain amounts owed on their credit cards (or other debt), thereby reducing their balances due. For instance, a debtor may be able to offset certain damages for which a court has determined that the creditor is liable to the debtor against amounts owed to the creditor by the debtor on his or her credit card.
Collateralized Mortgage Obligations (CMOs); Residuals and Strips. A CMO is a debt obligation backed by a portfolio of mortgages or mortgage-backed securities held under an indenture. The issuer of a CMO generally pays interest and prepaid principal on a monthly basis. These payments are secured by the underlying portfolio, which typically includes mortgage pass-through securities guaranteed by Freddie Mac, Fannie Mae, or the Government National Mortgage Association (Ginnie Mae) and their income streams, and which also may include whole mortgage loans and private mortgage bonds.
CMOs are issued in multiple classes, often referred to as tranches. Each class has a different maturity and is entitled to a different schedule for payments of principal and interest, including pre-payments.
In a typical CMO transaction, the issuer of the CMO bonds uses proceeds from the CMO offering to buy mortgages or mortgage pass-through certificates (the Collateral). The issuer then pledges the Collateral to a third party trustee as security for the CMOs. The issuer uses principal and interest payments from the Collateral to pay principal on the CMOs, paying the tranche with the earliest maturity first. Thus, the issuer pays no principal on a tranche until all other tranches with earlier maturities are paid in full. The early retirement of a particular class or
39
series has the same effect as the prepayment of mortgage loans underlying a mortgage-backed pass-through security.
CMOs may be less liquid and may exhibit greater price volatility than other types of mortgage- or other asset-backed securities.
The Funds also may invest in CMO residuals, which are issued by agencies or instrumentalities of the U.S. government or by private lenders of, or investors in, mortgage loans, including savings and loan associations, homebuilders, mortgage banks, commercial banks, and investment banks. A CMO residual represents excess cash flow generated by the Collateral after the issuer of the CMO makes all required principal and interest payments and after the issuers management fees and administrative expenses have been paid. Thus, CMO residuals have value only to the extent income from the Collateral exceeds the amount necessary to satisfy the issuers debt obligations on all other outstanding CMOs. The amount of residual cash flow resulting from a CMO will depend on, among other things, the characterization of the mortgage assets, the coupon rate of each class of CMO, prevailing interest rates, the amount of administrative expenses, and the pre-payment experience on the mortgage assets.
CMOs also include certificates representing undivided interests in payments of interest-only or principal-only (IO/PO Strips) on the underlying mortgages.
IO/PO Strips and CMO residuals tend to be more volatile than other types of securities. If the underlying securities are prepaid, holders of IO/PO Strips and CMO residuals may lose a substantial portion or the entire value of their investment. In addition, if a CMO pays interest at an adjustable rate, the cash flows on the related CMO residual will be extremely sensitive to rate adjustments.
Collateralized Debt Obligations (CDOs). A Fund may invest in CDOs, which include collateralized bond obligations (CBOs), collateralized loan obligations (CLOs), and other similarly structured securities. CBOs and CLOs are asset-backed securities. A CBO is an obligation of a trust or other special purpose vehicle backed by a pool of fixed income securities. A CLO is an obligation of a trust or other special purpose vehicle typically collateralized by a pool of loans, which may include U.S. and non-U.S. senior secured and unsecured loans, and subordinate corporate loans, including loans that may be rated below investment grade, or equivalent unrated loans.
For both CBOs and CLOs, the cash flows from the trust are split into two or more portions, called tranches, which vary in risk and yield. The riskier portions are the residual, equity, and subordinate tranches, which bear some or all of the risk of default by the bonds or loans in the trust, and therefore protect the other, more senior tranches from default in all but the most severe circumstances. Since it is partially protected from defaults, a senior tranche from a CBO trust or CLO trust typically has higher ratings and lower yields than its underlying securities, and can be rated investment grade. Despite the protection from the riskier tranches, senior CBO or CLO tranches can experience substantial losses due to actual defaults(including collateral default), the total loss of the riskier tranches due to losses in the collateral, market anticipation of defaults, fraud by the trust, and the illiquidity of CBO or CLO securities.
The risks of an investment in a CDO largely depend on the type of underlying collateral securities and the tranche in which a Fund invests. The Funds may invest in any tranche of a CBO or CLO. Typically, CBOs, CLOs and other CDOs are privately offered and sold, and thus,
40
are not registered under the securities laws. As a result, a Fund may characterize its investments in CDOs as illiquid, unless an active dealer market for a particular CDO allows the CDO to be purchased and sold in Rule 144A transactions. CDOs are subject to the typical risks associated with debt instruments discussed elsewhere in this SAI and the Private Placement Memorandum, including interest rate risk (which may be exacerbated if the interest rate payable on a structured financing changes based on multiples of changes in interest rates or inversely to changes in interest rates), default risk, prepayment risk, credit risk, illiquidity risk, market risk, structural risk, and legal risk. Additional risks of CDOs include: (i) the possibility that distributions from collateral securities will be insufficient to make interest or other payments; (ii) the possibility that the quality of the collateral may decline in value or default, due to factors such as the availability of any credit enhancement, the level and timing of payments and recoveries on and the characteristics of the underlying receivables, loans, or other assets that are being securitized, remoteness of those assets from the originator or transferor, the adequacy of and ability to realize upon any related collateral, and the capability of the servicer of the securitized assets; (iii) market and illiquidity risks affecting the price of a structured finance investment, if required to be sold, at the time of sale; and (iv) if the particular structured product is invested in a security in which a Fund is also invested, this would tend to increase the Funds overall exposure to the credit of the issuer of such securities, at least on an absolute, if not on a relative basis. In addition, due to the complex nature of a CDO, an investment in a CDO may not perform as expected. An investment in a CDO also is subject to the risk that the issuer and the investors may interpret the terms of the instrument differently, giving rise to disputes.
The Funds may invest in covered bonds, which are debt securities issued by banks or other credit institutions that are backed by both the issuing institution and underlying pool of assets that compose the bond (a cover pool). The cover pool for a covered bond is typically composed of residential or commercial mortgage loans or loans to public sector institutions. A covered bond may lose value if the credit rating of the issuing bank or credit institution is downgraded or the quality of the assets in the cover pool deteriorates.
Adjustable Rate Securities
Adjustable rate securities are securities that have interest rates that reset at periodic intervals, usually by reference to an interest rate index or market interest rate. Adjustable rate securities include U.S. government securities and securities of other issuers. Some adjustable rate securities are backed by pools of mortgage loans. Although the rate adjustment feature may act as a buffer to reduce sharp changes in the value of adjustable rate securities, changes in market interest rates or changes in the issuers creditworthiness may still affect their value. Because the interest rate is reset only periodically, changes in the interest rates on adjustable rate securities may lag changes in prevailing market interest rates. Also, some adjustable rate securities (or, in the case of securities backed by mortgage loans, the underlying mortgages) are subject to caps or floors that limit the maximum change in interest rate during a specified period or over the life of the security. Because of the rate adjustments, adjustable rate securities are less likely than non-adjustable rate securities of comparable quality and maturity to increase significantly in value when market interest rates fall.
Below Investment Grade Securities
Some Funds may invest some or all of their assets in securities or instruments rated below investment grade (that is, rated below Baa3/P-2 by Moodys Investors Service, Inc. (Moodys) or below BBB-/A-2 by Standard & Poors (S&P) for a particular security/commercial paper, or
41
securities unrated by Moodys or S&P that are determined by GMO to be of comparable quality to securities so rated) at the time of purchase, including securities in the lowest rating categories and comparable unrated securities (Below Investment Grade Securities) (commonly referred to as junk bonds). In addition, some Funds may hold securities that are downgraded to below investment grade status after the time of purchase by the Funds. Many issuers of high yield debt are highly leveraged, and their relatively high debt-to-equity ratios create increased risks that their operations might not generate sufficient cash flow to service their debt obligations. In addition, many issuers of high yield debt may be (i) in poor financial condition; (ii) experiencing poor operating results; (iii) having substantial capital needs or negative net worth; or (iv) facing special competitive or product obsolescence problems, and may include companies involved in bankruptcy or other reorganizations or liquidation proceedings. Compared to higher quality fixed income securities, Below Investment Grade Securities offer the potential for higher investment returns but subject holders to greater credit and market risk. The ability of an issuer of Below Investment Grade Securities to meet principal and interest payments is considered speculative. A Funds investments in Below Investment Grade Securities are more dependent on GMOs own credit analysis than its investments in higher quality bonds. Certain of these securities may not be publicly traded, and therefore it may be difficult to obtain information as to the true condition of the issuers. The market for Below Investment Grade Securities may be more severely affected than other financial markets by economic recession or substantial interest rate increases, changing public perceptions, or legislation that limits the ability of certain categories of financial institutions to invest in Below Investment Grade Securities. In addition, the market may be less liquid for Below Investment Grade Securities than for other types of securities. Reduced liquidity can affect the values of Below Investment Grade Securities, make their valuation and sale more difficult, and result in greater volatility. Because Below Investment Grade Securities are difficult to value and are more likely to be fair valued (see Determination of Net Asset Value in the Private Placement Memorandum and herein), particularly during erratic markets, the values realized on their sale may differ from the values at which they are carried on the books of a Fund. Some Below Investment Grade Securities in which a Fund invests may be in poor standing or in default.
Securities in the lowest investment-grade category (BBB or Baa) also have some speculative characteristics. See Appendix B Commercial Paper and Corporate Debt Ratings for more information concerning commercial paper and corporate debt ratings.
Distressed or Defaulted Debt Securities
Some Funds may invest in securities, claims, and obligations of U.S. and non-U.S. issuers which are experiencing significant financial or business difficulties (including companies involved in bankruptcy or other reorganization and liquidation proceedings). A Fund may purchase distressed securities and instruments of all kinds, including equity and debt instruments and, in particular, loans, loan participations, claims held by trade or other creditors, bonds, notes, non-performing and sub-performing mortgage loans, beneficial interests in liquidating trusts or other similar types of trusts, fee interests and financial interests in real estate, partnership interests and similar financial instruments, executory contracts and participations therein, many of which are not publicly traded and which may involve a substantial degree of risk.
Investments in distressed or defaulted debt securities generally are considered speculative and may involve substantial risks not normally associated with investments in higher quality securities, including adverse business, financial or economic conditions that can lead to payment defaults and insolvency proceedings on the part of their issuers.
42
In particular, defaulted obligations might be repaid, if at all, only after lengthy workout or bankruptcy proceedings, during which the issuer might not make any interest or other payments. The amount of any recovery may be adversely affected by the relative priority of the Funds investment in the issuers capital structure. The ability to enforce obligations may be adversely affected by actions or omissions of predecessors in interest that give rise to counterclaims or defenses, including causes of action for equitable subordination or debt recharacterization. In addition, such investments, collateral securing such investments, and payments made in respect of such investments may be challenged as fraudulent conveyances or to be subject to avoidance as preferences under certain circumstances.
Investments in distressed securities inherently have more credit risk than do investments in similar securities and instruments of non-distressed companies, and the degree of risk associated with any particular distressed securities may be difficult or impossible for GMO to determine within reasonable standards of predictability. The level of analytical sophistication, both financial and legal, necessary for successful investment in distressed securities is unusually high.
If GMOs assessment of the eventual recovery value of a defaulted debt security proves incorrect, a Fund may lose a substantial portion or all of its investment or may be required to accept cash or instruments worth less than its original investment.
Investments in financially distressed companies domiciled outside the United States involve additional risks. Bankruptcy law and creditor reorganization processes may differ substantially from those in the United States, resulting in greater uncertainty as to the rights of creditors, the enforceability of such rights, reorganization timing and the classification, seniority and treatment of claims. In certain developing countries, although bankruptcy laws have been enacted, the process for reorganization remains highly uncertain.
In addition, investments in distressed or defaulted debt securities can present special tax issues for a Fund. See the Taxes section for each Fund below for more information.
Brady Bonds
Brady Bonds are securities created through the restructuring of commercial bank loans to public and private entities under a debt restructuring plan introduced by former U.S. Secretary of the Treasury Nicholas F. Brady (the Brady Plan). Brady Plan debt restructurings have been implemented in Mexico, Uruguay, Venezuela, Costa Rica, Argentina, Nigeria, the Philippines, and other emerging countries.
Brady Bonds may be collateralized, are issued in various currencies (but primarily the U.S. dollar), and are traded in OTC secondary markets. U.S. dollar-denominated, collateralized Brady Bonds, which may be fixed-rate bonds or floating-rate bonds, are generally collateralized in full as to principal by U.S. Treasury zero coupon bonds having the same maturity as the bonds.
The valuation of a Brady Bond typically depends on an evaluation of: (i) any collateralized repayments of principal at final maturity; (ii) any collateralized interest payments; (iii) the uncollateralized interest payments; and (iv) any uncollateralized repayments of principal at maturity (the uncollateralized amounts constitute the residual risk). In light of the history of prior defaults by the issuers of Brady Bonds, investments in Brady Bonds may be viewed as speculative regardless of the current credit rating of the issuer. There are very few remaining Brady Bonds in existence today.
43
Euro Bonds
Euro bonds are securities denominated in U.S. dollars or another currency and sold to investors outside of the country whose currency is used. Euro bonds may be issued by government or corporate issuers, and are typically underwritten by banks and brokerage firms in numerous countries. While Euro bonds often pay principal and interest in U.S. dollars held in banks outside of the United States (Eurodollars), some Euro bonds may pay principal and interest in other currencies. Euro bonds are subject to the same risks as other fixed income securities. See Debt and Other Fixed Income Securities Generally above.
Zero Coupon Securities
A Fund investing in zero coupon fixed income securities accrues interest income at a fixed rate based on initial purchase price and length to maturity, but the securities do not pay interest in cash on a current basis. In the case of a Fund that is a regulated investment company under Subchapter M of the Code, such Fund is required to distribute the accrued income to its shareholders, even though the Fund is not receiving the income in cash on a current basis. Thus, any such Fund may have to sell other investments to obtain cash to make income distributions (including at a time when it may not be advantageous to do so). In the case of a Fund treated as a partnership for U.S. federal income tax purposes, shareholders will be required to recognize taxable income in respect of their proportionate share of accrued income on these securities in a taxable year without regard to whether that income may be in excess of the cash generated by the Funds investments in those securities during that year or whether the Fund makes cash distributions to its shareholders in that year. See the Taxes section for each Fund below. The market value of zero coupon securities is often more volatile than that of non-zero coupon fixed income securities of comparable quality and maturity. Zero coupon securities include IO/PO Strips and STRIPS.
Indexed Investments
Each Fund may invest in various transactions and instruments that are designed to track the performance of an index (including, but not limited to, securities indices and credit default indices). Indexed securities are securities the redemption values and/or coupons of which are indexed to a specific instrument, group of instruments, index, or other statistic. Indexed securities typically, but not always, are debt securities or deposits whose value at maturity or coupon rate is determined by reference to other securities, securities or inflation indices, currencies, precious metals or other commodities, or other financial indicators. For example, the maturity value of gold-indexed securities depends on the price of gold and, therefore, their price tends to rise and fall with gold prices.
While investments that track the performance of an index may increase the number, and thus the diversity, of the underlying assets to which the Fund is exposed, such investments are subject to many of the same risks of investing in the underlying assets that comprise the index discussed elsewhere in this section, as well as certain additional risks that are not typically associated with investments in such underlying assets. An investment that is designed to track the performance of an index may not replicate and maintain exactly the same composition and relative weightings of the assets in the index. Additionally, the liquidity of the market for such investments may be subject to the same conditions affecting liquidity in the underlying assets and markets and could be relatively less liquid in certain circumstances. The performance of indexed securities depends on the performance of the security, security index, inflation index, currency, or other instrument
44
to which they are indexed. Interest rate changes in the United States and abroad also may influence performance. Indexed securities also are subject to the credit risks of the issuer, and their values are adversely affected by declines in the issuers creditworthiness.
A Funds investments in certain indexed securities, including inflation-indexed bonds, may be required to accrue income in excess of the cash interest the securities currently pay to the Fund (e.g., due to increases in the principal amount of a bond). In the case of a Fund treated as a regulated investment company under Subchapter M of the Code, the Fund is required to distribute any such accrued income to its shareholders, even though the Fund is not receiving the income in cash on a current basis. Thus, any such Fund may have to sell other investments to obtain cash to make income distributions to shareholders (including at a time when it may not be advantageous to do so). In the case of a Fund treated as a partnership for U.S. federal income tax purposes, shareholders will be required to recognize taxable income in respect of their proportionate share of any such accrued income on these securities in a taxable year without regard to whether that income may be in excess of the cash generated by the Funds investments in those securities during that year or to whether the Fund makes cash distributions to its shareholders in that year. See the Taxes section for each Fund below.
Currency-Indexed Securities. Currency-indexed securities have maturity values or interest rates determined by reference to the values of one or more foreign currencies. Currency-indexed securities also may have maturity values or interest rates that depend on the values of a number of different foreign currencies relative to each other.
Inverse Floating Obligations. Indexed securities in which a Fund may invest include so-called inverse floating obligations or residual interest bonds on which the interest rates typically decline as the index or reference rates, typically short-term interest rates, increase and increase as index or reference rates decline. An inverse floating obligation may have the effect of investment leverage to the extent that its interest rate varies by a magnitude that exceeds the magnitude of the change in the index or reference rate of interest. Generally, leverage will result in greater price volatility.
Inflation-Indexed Bonds. Some Funds may invest in inflation-indexed bonds and in futures contracts on inflation-indexed bonds. See Options, Futures, and Forward Contracts Inflation-Linked Futures above for a discussion of inflation-linked futures. Inflation-indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that accrues inflation into the principal value of the bond. Most other issuers pay out the CPI accruals as part of a semiannual coupon.
Inflation-indexed securities issued by the U.S. Treasury (or TIPS) have maturities of approximately three, five, ten, or thirty years, although it is possible that securities that have other maturities will be issued in the future. U.S. Treasury securities pay interest on a semi-annual basis equal to a fixed percentage of the inflation-adjusted principal amount. For example, if a Fund purchased an inflation-indexed bond with a par value of $1,000 and a 3% real rate of return coupon (payable 1.5% semi-annually), and the rate of inflation over the first six months was 1%, the mid-year par value of the bond would be $1,010 and the first semi-annual interest payment would be $15.15 ($1,010 times 1.5%). If inflation during the second half of the year resulted in the whole years inflation equaling 3%, the end-of-year par value of the bond would be $1,030 and the second semi-annual interest payment would be $15.45 ($1,030 times 1.5%).
45
If the periodic adjustment rate measuring inflation falls, the principal value of inflation-indexed bonds will be adjusted downward and, consequently, the interest they pay (calculated with respect to a smaller principal amount) will be reduced. The U.S. government guarantees the repayment of the original bond principal upon maturity (as adjusted for inflation) in the case of a TIPS, even during a period of deflation, although the inflation-adjusted principal received could be less than the inflation-adjusted principal that had accrued to the bond at the time of purchase. However, the current market value of the bonds is not guaranteed and will fluctuate. A Fund also may invest in other inflation-related bonds which may or may not provide a similar guarantee. If a guarantee of principal is not provided, the adjusted principal value of the bond repaid at maturity may be less than the original principal.
The market price of inflation-indexed bonds (including TIPS) normally changes when real interest rates change. Their value typically declines during periods of rising real interest rates (i.e., nominal interest rate minus inflation) and increases during periods of declining real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e., nominal interest rate minus inflation) might decline, leading to an increase in value of inflation-indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation-indexed bonds. In some interest rate environments, such as when real interest rates are rising faster than nominal interest rates, the market price of inflation-indexed bonds may decline more than the price of non-inflation-indexed (or nominal) fixed income bonds with similar maturities. Moreover, if the index measuring inflation falls, the principal value of inflation-indexed bond investments will be adjusted downward, and, consequently, the interest they pay (calculated with respect to a smaller principal amount) will be reduced.
Although inflation-indexed bonds protect their holders from long-term inflationary trends, short-term increases in inflation may result in a decline in value. In addition, inflation-indexed bonds do not protect holders from increases in interest rates due to reasons other than inflation (such as changes in currency exchange rates).
The periodic adjustment of U.S. inflation-indexed bonds is tied to the Consumer Price Index for Urban Consumers (CPI-U), which is calculated monthly by the U.S. Bureau of Labor Statistics. The CPI-U is a measurement of changes in the cost of living, made up of components such as housing, food, transportation, and energy. Inflation-indexed bonds issued by a foreign government are generally adjusted to reflect changes in a comparable inflation index calculated by the foreign government. No assurance can be given that the CPI-U or any foreign inflation index will accurately measure the real rate of inflation in the prices of goods and services. In addition, no assurance can be given that the rate of inflation in a foreign country will correlate to the rate of inflation in the United States.
Coupon payments received by a Fund from inflation-indexed bonds generally are included in the Funds gross income for the period in which they accrue. In addition, any increase in the principal amount of an inflation-indexed bond constitutes taxable ordinary income to investors in the Fund, even though principal is not paid until maturity.
46
Structured Notes
Similar to indexed securities, structured notes are derivative debt securities, the interest rate or principal of which is determined by reference to changes in the value of a specific asset, reference rate, or index (the reference) or the relative change in two or more references. The interest rate or the principal amount payable upon maturity or redemption may increase or decrease, depending upon changes in the reference. The terms of a structured note may provide that, in certain circumstances, no principal is due at maturity and, therefore, may result in a loss of invested capital. Structured notes may be indexed positively or negatively, so that appreciation of the reference may produce an increase or decrease in the interest rate or value of the principal at maturity. In addition, changes in the interest rate or the value of the principal at maturity may be fixed at a specified multiple of the change in the value of the reference, making the value of the note particularly volatile.
Structured notes may entail a greater degree of market risk than other types of debt securities because the investor bears the risk of the reference. Structured notes also may be more volatile, less liquid, and more difficult to price accurately than less complex securities or more traditional debt securities.
Firm Commitments, When-Issued Securities, and TBAs
Some Funds may enter into firm commitments and similar agreements with banks or brokers for the purchase or sale of securities at an agreed-upon price on a specified future date. For example, a Fund that invests in fixed income securities may enter into a firm commitment agreement if GMO anticipates a decline in interest rates and believes it is able to obtain a more advantageous future yield by committing currently to purchase securities to be issued later. A Fund generally does not earn income on the securities it has committed to purchase until after delivery. A Fund may take delivery of the securities or, if deemed advisable as a matter of investment strategy, may sell the securities before the settlement date. When payment is due on when-issued or delayed-delivery securities, the Fund makes payment from then-available cash flow or the sale of securities, or from the sale of the when-issued or delayed-delivery securities themselves (which may have a value greater or less than what the Fund paid for them).
Certain Funds may purchase or sell securities, including mortgage-backed securities, in the to-be-announced (TBA) market. A TBA purchase commitment is a security that is purchased or sold for a fixed price and the underlying securities are announced at a future date. The seller does not specify the particular securities to be delivered. Instead, a Fund agrees to accept any security that meets specified terms. For example, in a TBA mortgage-backed security transaction, a Fund and the seller would agree upon the issuer, interest rate and terms of the underlying mortgages. The seller would not identify the specific underlying mortgages until it issues the security. The purchaser of TBA securities generally is subject to increased market risk and interest rate risk because the delivered securities may be less favorable than anticipated by the purchaser.
Loans (Including Bank Loans), Loan Participations, and Assignments
Some Funds may invest in direct debt instruments, which are interests in amounts owed to lenders or lending syndicates, to suppliers of goods or services, or to other parties by a corporate, governmental, or other borrower. Such loans may include bank loans, promissory notes, and loan participations, or in the case of suppliers of goods or services, trade claims or other receivables. Investments in direct debt instruments are subject to a Funds policies regarding the
47
quality of debt investments generally. Such instruments may include term loans and revolving loans, may pay interest at a fixed or floating rate, and may be senior or subordinated. The Funds may acquire interests in loans either directly (by way of sale or assignment) or indirectly (by way of participation).
Purchases of loans and other forms of direct indebtedness depend primarily upon the creditworthiness of the borrower for payment of principal and interest, and adverse changes in the creditworthiness of the borrower may affect its ability to pay principal and interest. Direct debt instruments may not be rated by any rating agency. In the event of non-payment of interest or principal, loans that are secured offer a Fund more protection than comparable unsecured loans. However, no assurance can be given that the collateral for a secured loan can be liquidated or that the proceeds will satisfy the borrowers obligation. Investment in the indebtedness of borrowers with low creditworthiness involves substantially greater risks, and may be highly speculative. Borrowers that are in bankruptcy or restructuring may never pay off their indebtedness, or may pay only a small fraction of the amount owed. Investments in sovereign debt similarly involve the risk that the governmental entities responsible for repayment of the debt may be unable or unwilling to pay interest and repay principal when due. The bank loans acquired by a Fund may be below investment grade or unrated.
When investing in a loan participation, a Fund typically purchases participation interests in a portion of a lenders or participants interest in a loan but has no direct contractual relationship with the borrower. Participation interests in a portion of a debt obligation typically result in a contractual relationship only with the institution participating in the interest, not with the borrower. The Fund must rely on the seller of the participation interest not only for the enforcement of the Funds rights against the borrower but also for the receipt and processing of principal, interest, or other payments due under the loan. This may subject the Fund to greater delays, expenses, and risks than if the Fund could enforce its rights directly against the borrower. In addition, the Fund generally will have no rights of set-off against the borrower, and the Fund may not directly benefit from the collateral supporting the debt obligation in which it has purchased the participation. A participation agreement also may limit the rights of the Fund to vote on changes that may be made to the underlying loan agreement, such as waiving a breach of a covenant. In addition, under the terms of a participation agreement, the Fund may be treated as a creditor of the seller of the participation interest (rather than of the borrower), thus exposing the Fund to the credit risk of the seller in addition to the credit risk of the borrower. Additional risks include inadequate perfection of a loans security interest, the possible invalidation or compromise of an investment transaction as a fraudulent conveyance or preference under relevant creditors rights laws, the validity and seniority of bank claims and guarantees, environmental liabilities that may arise with respect to collateral securing the obligations, and adverse consequences resulting from participating in such instruments through other institutions with lower credit quality.
Bank loans and participation interests may not be readily marketable and may be subject to restrictions on resale. There can be no assurance that future levels of supply and demand in loan or loan participation trading will provide an adequate degree of liquidity and no assurance that the market will not experience periods of significant illiquidity in the future.
Investments in loans through direct assignment of a lenders interests may involve additional risks to a Fund. For example, if a secured loan is foreclosed, the Fund could become part owner of any collateral, and would bear the costs and liabilities associated with owning and disposing
48
of the collateral. In addition, under legal theories of lender liability, the Fund potentially might be held liable as a co-lender.
A loan is often administered by a bank or other financial institution that acts as agent for all holders. The agent administers the terms of the loan, as specified in the loan agreement. Unless, under the terms of the loan or other indebtedness a Fund has direct recourse against the borrower, it may have to rely on the agent to enforce its rights against the borrower.
GMO may, with respect to its management of investments in certain loans for a Fund, seek to remain flexible to purchase and sell other securities in the borrowers capital structure, by remaining public. In such cases, GMO will seek to avoid receiving material, non-public information about the borrowers to which the Fund may lend (through assignments, participations or otherwise). GMOs decision not to use material, non-public information about borrowers may place GMO at an information disadvantage relative to other lenders. Also, in instances where lenders are asked to grant amendments, waivers or consents in favor of the borrower, GMOs ability to assess the significance of the amendment, waiver or consent or its desirability from a Funds point of view may be materially and adversely affected.
When GMOs employees, on-site consultants, partners, members, directors, or officers come into possession of material, non-public information about the issuers of loans that may be held by a Fund or other accounts managed by GMO (either intentionally or inadvertently), or material, non-public information is otherwise attributed to GMO, GMOs ability to trade in other securities of the issuers of these loans for the account of GMO may be limited pursuant to applicable securities laws. Such limitations on GMOs ability to trade could have an adverse effect on a Fund. In many instances, these trading restrictions could continue in effect for a substantial period of time.
Direct indebtedness purchased by a Fund may include letters of credit, revolving credit facilities, or other standby financing commitments obligating the Fund to pay additional cash on demand. These commitments may have the effect of requiring the Fund to increase its investment in a borrower at a time when it would not otherwise have done so. A Fund is required to maintain liquid assets to cover the Funds potential obligations under standby financing commitments.
Trade Claims. The Funds may purchase trade claims against companies, including companies in bankruptcy or reorganization proceedings. Trade claims generally include claims of suppliers for goods delivered and not paid, claims for unpaid services rendered, claims for contract rejection damages and claims related to litigation. An investment in trade claims is very speculative and carries a high degree of risk. Trade claims are illiquid instruments which generally do not pay interest and there can be no guarantee that the debtor will ever be able to satisfy the obligation on the trade claim. Additionally, there can be restrictions on the purchase, sale, and/or transferability of trade claims during all or part of a bankruptcy proceeding. The markets in trade claims generally are not regulated by U.S. federal securities laws or the U.S. Securities and Exchange Commission (SEC).
Trade claims are typically unsecured and may be subordinated to other unsecured obligations of a debtor, and generally are subject to defenses of the debtor with respect to the underlying transaction giving rise to the trade claim. Although GMO endeavors to protect against such risks in connection with the evaluation and purchase of claims, trade claims are subject to risks not generally associated with standardized securities and instruments due to the idiosyncratic nature of the claims purchased. These risks include the risk that the debtor may contest the allowance
49
of the claim due to disputes the debtor has with the original claimant or the inequitable conduct of the original claimant, or due to administrative errors in connection with the transfer of the claim. Recovery on allowed trade claims also may be impaired if the anticipated dividend payable on unsecured claims in the bankruptcy is not realized or if the timing of the bankruptcy distribution is delayed. As a result of the foregoing factors, trade claims are also subject to the risk that if a Fund does receive payment, it may be in an amount less than what the Fund paid for or otherwise expects to receive in respect of the claim.
In addition, because they are not negotiable instruments, trade claims are typically less liquid than negotiable instruments. Given these factors, trade claims often trade at a discount to other pari passu instruments.
Reverse Repurchase Agreements and Dollar Roll Agreements
The Funds may enter into reverse repurchase agreements and dollar roll agreements with banks and brokers to enhance return. Reverse repurchase agreements involve sales by a Fund of portfolio securities concurrently with an agreement by the Fund to repurchase the same securities at a later date at a fixed price. During the reverse repurchase agreement period, the Fund continues to receive principal and interest payments on the securities and also has the opportunity to earn a return on the collateral furnished by the counterparty to secure its obligation to redeliver the securities.
Dollar rolls are transactions in which a Fund sells securities for delivery in the current month and simultaneously contracts to repurchase substantially similar (same type and coupon) securities on a specified future date. During the roll period, the Fund foregoes principal and interest paid on the securities. The Fund is compensated by the difference between the current sales price and the forward price for the future purchase (often referred to as the drop) as well as by the interest earned on the cash proceeds of the initial sale.
If the buyer in a reverse repurchase agreement or dollar roll agreement files for bankruptcy or becomes insolvent, a Funds use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Funds right to repurchase the securities. Furthermore, in that situation a Fund may be unable to recover the securities it sold in connection with a reverse repurchase agreement and as a result would realize a loss equal to the difference between the value of the securities and the payment it received for them. This loss would be greater to the extent the buyer paid less than the value of the securities the Fund sold to it (e.g., a buyer may only be willing to pay $95 for a bond with a market value of $100). A Funds use of reverse repurchase agreements also subjects the Fund to interest costs based on the difference between the sale and repurchase price of a security involved in such a transaction. Additionally, reverse repurchase agreements entail the same risks as OTC derivatives. These include the risk that the counterparty to the reverse repurchase agreement may not be able to fulfill its obligations, as discussed above, that the parties may disagree as to the meaning or application of contractual terms, or that the instrument may not perform as expected. See Additional Information About the Funds Investment Strategies, Risks and Expenses and Description of Principal Risks Derivatives and Short Sales Risk and Counterparty Risk in the Private Placement Memorandum and Uses of Derivatives below. Reverse repurchase agreements and dollar rolls are not considered borrowings by a Fund for purposes of a Funds fundamental investment restriction on borrowings.
50
Commodity-Related Investments
Commodity prices can be extremely volatile and may be directly or indirectly affected by many factors, including changes in overall market movements, real or perceived inflationary trends, commodity index volatility, changes in interest rates or currency exchange rates, population growth and changing demographics, and factors affecting a particular industry or commodity, such as drought, floods, or other weather conditions, livestock disease, trade embargoes, competition from substitute products, transportation bottlenecks or shortages, fluctuations in supply and demand, tariffs, and international regulatory, political, and economic developments (e.g., regime changes and changes in economic activity levels). In addition, some commodities are subject to limited pricing flexibility because of supply and demand factors, and others are subject to broad price fluctuations as a result of the volatility of prices for certain raw materials and the instability of supplies of other materials.
Actions of and changes in governments, and political and economic instability, in commodity-producing and -exporting countries may affect the production and marketing of commodities. In addition, commodity-related industries throughout the world are subject to greater political, environmental, and other governmental regulation than many other industries. Changes in government policies and the need for regulatory approvals may adversely affect the products and services of companies in the commodities industries. For example, the exploration, development, and distribution of coal, oil, and gas in the United States are subject to significant federal and state regulation, which may affect rates of return on coal, oil, and gas and the kinds of services that the federal and state governments may offer to companies in those industries. In addition, compliance with environmental and other safety regulations has caused many companies in commodity-related industries to incur production delays and significant costs. Government regulation also may impede the development of new technologies. The effect of future regulations affecting commodity-related industries cannot be predicted.
The value of commodity-related derivatives fluctuates based on changes in the values of the underlying commodity, commodity index, futures contract, or other economic variable to which they are related. Additionally, economic leverage will increase the volatility of these instruments as they may increase or decrease in value more quickly than the underlying commodity or other relevant economic variable. See Options, Futures, and Forward Contracts, Structured Notes, Swap Contracts and Other Two-Party Contracts, and Uses of Derivatives herein for more information on the Funds investments in derivatives, including commodity-related derivatives such as swap agreements, commodity futures contracts, and options on commodity futures contracts.
In general, in order to qualify as a regulated investment company (RIC) under Subchapter M of the Internal Revenue Code of 1986, as amended (the Code), a Fund must, among other things, derive at least 90% of its gross income from certain specified sources (qualifying income). A RIC should generally be entitled to treat income that it recognizes from Systematic Global Macro Opportunity Funds investment in its wholly-owned foreign subsidiary, as qualifying income for purposes of qualifying as a regulated investment company under the Code. Similarly, BFF, which is expected to be the sole shareholder of GAAR Implementation Fund, should generally be entitled to treat income that it recognizes from GAAR Implementation Funds investment in its wholly-owned foreign subsidiary as qualifying income. There is a risk, however, that the Internal Revenue Service (IRS) could determine that some or all of the gross income derived from GAAR Implementation Funds and Systematic Global Macro Opportunity Funds investments in their subsidiaries, respectively, is not qualifying income in the hands of its
51
shareholders or sole shareholder, as applicable, which might adversely affect its shareholders or sole shareholders, as applicable, ability to qualify as a regulated investment company under the Code. See Investments in Wholly-Owned Subsidiaries and the Taxes section for Systematic Global Macro Opportunity Fund below. The tax consequences to BFF from its investment in GAAR Implementation Fund are described in BFFs prospectus and statement of additional information.
Illiquid Securities, Private Placements, Restricted Securities, and IPOs and Other Limited Opportunities
At the time of purchase, each Fund may invest up to 15% of its net assets in illiquid securities. For this purpose, illiquid securities are securities that the Fund may not sell or dispose of within seven days in the ordinary course of business at approximately the amount at which the Fund has valued the securities.
A repurchase agreement maturing in more than seven days is considered illiquid, unless it can be terminated after a notice period of seven days or less.
Private Placements and Restricted Investments. Illiquid securities include securities of private issuers, securities traded in unregulated or shallow markets, securities issued by entities deemed to be affiliates of a Fund, and securities that are purchased in private placements and are subject to legal or contractual restrictions on resale. Because relatively few purchasers of these securities may exist, especially in the event of adverse economic and liquidity conditions or adverse changes in the issuers financial condition, a Fund may not be able to initiate a transaction or liquidate a position in such investments at a desirable price. Disposing of illiquid securities may involve time-consuming negotiation and legal expenses, and selling them promptly at an acceptable price may be difficult or impossible.
While private placements may offer attractive opportunities not otherwise available in the open market, the securities purchased are usually restricted securities or are not readily marketable. Restricted securities cannot be sold without being registered under the Securities Act of 1933, as amended (the 1933 Act), unless they are sold pursuant to an exemption from registration (such as Rules 144 or 144A). Securities that are not readily marketable are subject to other legal or contractual restrictions on resale. A Fund may have to bear the expense of registering restricted securities for resale and the risk of substantial delay in effecting registration. A Fund selling its securities in a registered offering may be deemed to be an underwriter for purposes of Section 11 of the 1933 Act. In such event, the Fund may be liable to purchasers of the securities under Section 11 if the registration statement prepared by the issuer, or the prospectus forming a part of it, is materially inaccurate or misleading, although the Fund may have a due diligence defense.
At times, the inability to sell illiquid securities can make it more difficult to determine their fair value for purposes of computing a Funds net asset value. The judgment of GMO normally plays a greater role in valuing these securities than in valuing publicly traded securities.
IPOs and Other Limited Opportunities . Certain Funds may purchase securities of companies that are offered pursuant to an initial public offering (IPO) or other similar limited opportunities. Although companies can be any age or size at the time of their IPO, they are often smaller and have a limited operating history, which involves a greater potential for the value of their securities to be impaired following the IPO. The price of a companys securities may be
52
highly unstable at the time of its IPO and for a period thereafter due to factors such as market psychology prevailing at the time of the IPO, the absence of a prior public market, the small number of shares available, and limited availability of investor information. Securities purchased in IPOs have a tendency to fluctuate in value significantly shortly after the IPO relative to the price at which they were purchased. These fluctuations could impact the net asset value and return earned on a Funds shares. Investors in IPOs can be adversely affected by substantial dilution in the value of their shares, by sales of additional shares, and by concentration of control in existing management and principal shareholders. In addition, all of the factors that affect the performance of an economy or equity markets may have a greater impact on the shares of IPO companies. IPO securities tend to involve greater risk due, in part, to public perception and the lack of publicly available information and trading history.
Investments in Other Investment Companies or Other Pooled Investments
Subject to applicable regulatory requirements, a Fund may invest in shares of both open- and closed-end investment companies (including other GMO Funds, money market funds, and ETFs). Investing in another investment company exposes a Fund to all the risks of that investment company and, in general, subjects it to a pro rata portion of the other investment companys fees and expenses. Many of the Funds also may invest in private investment funds, vehicles, or structures. A Funds investment in other investment companies or private investment funds, vehicles or structures could affect the amount, timing and character of distributions (or, in the case of a Fund treated as a partnership for tax purposes, allocations) to shareholders, and in certain circumstances could cause the Fund to recognize taxable income in excess of the cash generated by such investment, which could, in the case of a Fund treated as a RIC for tax purposes, require the Fund in turn to liquidate investments, including when it is not advantageous to do so, in order to make required distributions. See the Taxes section below.
ETFs are hybrid investment companies that are registered as open-end investment companies or unit investment trusts (UITs) but possess some of the characteristics of closed-end funds. ETFs in which a Fund may invest typically hold a portfolio of common stocks that is intended to track the price and dividend performance of a particular index. Unlike the index, an ETF incurs administrative expenses and transaction costs in trading securities. In addition, the timing and magnitude of cash inflows and outflows from and to investors buying and redeeming shares in the ETF could create cash balances that cause the ETFs performance to deviate from the index (which remains fully invested at all times). Performance of an ETF and the index it is designed to track also may diverge because the composition of the index and the securities held by the ETF may occasionally differ. The Funds also may invest in actively-managed ETFs. Common examples of ETFs include S&P Depositary Receipts (SPDRs), Vanguard ETFs, and iShares, which may be purchased from the UIT or investment company issuing the securities or in the secondary market (SPDRs, Vanguard ETFs, and iShares are predominantly listed on the NYSE Arca). The market price for ETF shares may be higher or lower than the ETFs net asset value. The sale and redemption prices of ETF shares purchased from the issuer are based on the issuers net asset value.
Because ETFs are investment companies, investments in ETFs would, absent exemptive relief, be limited under applicable statutory limitations. Those limitations restrict a Funds investment in the shares of an ETF or other investment company to up to 5% of the Funds assets (which may represent no more than 3% of the securities of such ETF or other investment company) and limit aggregate investments in all ETFs and other investment companies to 10% of the Funds assets. A Fund may invest in one or more ETFs beyond the statutory limitations pursuant to an
53
agreement with the ETF, provided that the Fund complies with the terms and conditions of the agreement and the conditions of the ETFs exemptive order.
Investments in Wholly-Owned Subsidiaries
To the extent that a Fund invests directly or indirectly in one or more wholly-owned foreign subsidiary companies, such Fund will be indirectly exposed to the risks of any such subsidiarys investments.
As of the date of this SAI, Systematic Global Macro Opportunity Fund invests in its foreign subsidiary, GMO Alternative Asset SPC Ltd. (Alternative Asset SPC) and GAAR Implementation Fund intends to invest in its foreign subsidiary, GMO GAAR Implementation SPC Ltd. (GAAR Implementation SPC). Each of Alternative Asset SPC and GAAR Implementation SPC is a controlled foreign corporation (CFC) for U.S. federal tax purposes. As described in the Private Placement Memorandum, each of Alternative Asset SPC and GAAR Implementation SPC invests primarily in swap contracts on commodities indices, commodities futures contracts, and other commodity-related derivatives, and in fixed income securities, but may also invest in any other investments in which Systematic Global Macro Opportunity Fund and GAAR Implementation Fund, respectively, may invest directly. Each of Systematic Global Macro Opportunity Fund and GAAR Implementation Fund is indirectly exposed to the risks of its subsidiarys investments. See Options, Futures, and Forward Contracts above and Uses of Derivatives below. GMO serves as the investment manager to each of Alternative Asset SPC and Implementation SPC, but does not receive any additional management or other fees in respect of such services. In addition, State Street Bank and Trust Company, One Lincoln Street, Boston, Massachusetts 02111, serves as Alternative Asset SPCs and GAAR Implementation SPCs custodian, transfer agent, and fund accounting agent.
To the extent a Fund invests in its wholly-owned foreign subsidiary, future changes in the securities, corporate, tax or other applicable laws of the United States and/or the jurisdiction in which the relevant subsidiary is organized could result in the inability of the Fund and/or its respective subsidiary to operate as described in the Private Placement Memorandum or this SAI and could adversely affect the Fund and its shareholders. In addition, a Fund that invests, including indirectly through another GMO Fund, in a foreign subsidiary that is a CFC can present special U.S. federal income tax issues under the Code. See Commodity-Related Investments above and the Taxes section for Systematic Global Macro Opportunity Fund below for more information.
Legal and Regulatory Risk
Legal, tax, and regulatory changes could occur during the term of a Fund that may adversely affect the Fund. New (or revised) laws or regulations or interpretations of existing law may be issued by the IRS or Treasury Department, the CFTC, the SEC, the U.S. Federal Reserve or other banking regulators, or other governmental regulatory authorities, or self-regulatory organizations that supervise the financial markets that could adversely affect the Funds. In particular, these agencies are empowered to promulgate a variety of new rules pursuant to recently enacted financial reform legislation in the United States. The Funds also may be adversely affected by changes in the enforcement or interpretation of existing statutes and rules by these governmental regulatory authorities or self-regulatory organizations. For example, there has been an increase in governmental, as well as self-regulatory, scrutiny of the alternative investment industry. It is impossible to predict what, if any, changes in regulations may occur,
54
but any regulation that restricts the ability of a Fund or any underlying Funds to trade in securities could have a material adverse impact on a Funds performance.
In addition, the securities and futures markets are subject to comprehensive statutes, regulations, and margin requirements. The CFTC, the SEC, the Federal Deposit Insurance Corporation, other regulators, and self-regulatory organizations and exchanges are authorized to take extraordinary actions in the event of market emergencies. The regulation of securitization and derivatives transactions and funds that engage in such transactions is an evolving area of law and is subject to modification by government and judicial action.
The U.S. government has enacted legislation that provides for new regulation of the derivatives market, including clearing, margin, reporting and registration requirements. The CFTC, SEC, and other federal regulators have been tasked with developing the rules and regulations enacting the provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act (the Dodd-Frank Act). The European Union (and some other countries) are implementing similar requirements, which will affect a Fund when it enters into derivatives transactions with a counterparty organized in that country or otherwise subject to that countrys derivatives regulations.
The U.S. government and the European Union have proposed mandatory minimum margin requirements for bilateral derivatives. Such requirements could increase the amount of margin required to be provided by a Fund in connection with its derivatives transactions and, therefore, make derivatives transactions more expensive.
While certain of the rules are not effective, other rules are not yet final, so their ultimate impact remains unclear. New regulations could, among other things, restrict a Funds ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions, and the Fund may be unable to execute its investment strategy as a result.
The CFTC and certain futures exchanges have established limits, referred to as position limits, on the maximum net long or net short positions which any person may hold or control in particular options and futures contracts. The CFTC has proposed position limits for certain swaps. All positions owned or controlled by the same person or entity, even if in different accounts, may be aggregated for purposes of determining whether the applicable position limits have been exceeded. Thus, even if a Fund does not intend to exceed applicable position limits, it is possible that different clients managed by GMO and its affiliates may be aggregated for this purpose. Although it is possible that the trading decisions of GMO may have to be modified and that positions held by the Funds may have to be liquidated in order to avoid exceeding such limits, GMO believes that this is unlikely. The modification of investment decisions or the elimination of open positions, if it occurs, may adversely affect the profitability of a Fund.
The SEC has in the past adopted interim rules requiring reporting of all short positions above a certain de minimis threshold and may adopt rules requiring monthly public disclosure in the future. In addition, other non-U.S. jurisdictions where a Fund may trade have adopted reporting requirements. If a Funds short positions or its strategy become generally known, it could have a significant effect on GMOs ability to implement its investment strategy. In particular, it would make it more likely that other investors could cause a short squeeze in the securities held short by a Fund forcing the Fund to cover its positions at a loss. Such reporting requirements also may limit GMOs ability to access management and other personnel at certain companies where
55
GMO seeks to take a short position. In addition, if other investors engage in copycat behavior by taking positions in the same issuers as a Fund, the cost of borrowing securities to sell short could increase drastically and the availability of such securities to the Fund could decrease drastically. Such events could make a Fund unable to execute its investment strategy. Short sales are also subject to certain SEC regulations. If the SEC were to adopt additional restrictions regarding short sales, they could restrict a Funds ability to engage in short sales in certain circumstances, and the Fund may be unable to execute its investment strategy as a result.
The SEC and regulatory authorities in other jurisdictions may adopt (and in certain cases, have adopted) bans on short sales of certain securities in response to market events. Bans on short selling may make it impossible for a Fund to execute certain investment strategies and may have a material adverse effect on the Funds ability to generate returns.
Recently adopted rules implementing the credit risk retention requirements of the Dodd-Frank Act for asset-backed securities require the sponsor of certain securitization vehicles to retain, and to refrain from transferring, selling, conveying to a third party, or hedging 5% of the credit risk in assets transferred, sold, or conveyed through the issuance of such vehicle, subject to certain exceptions. These requirements may increase the costs to originators, securitizers, and, in certain cases, collateral managers of securitization vehicles in which a Fund may invest, which costs could be passed along to such Fund as an investor in such transactions.
Investors should also be aware that some EU-regulated institutions (banks, certain investment firms, and authorized managers of alternative investment funds) are currently restricted from investing in securitizations (including U.S.-related securitizations), unless, in summary: (i) the institution is able to demonstrate that it has undertaken certain due diligence in respect of various matters, including its investment position, the underlying assets, and (in the case of authorized managers of alternative investment funds) the sponsor and the originator of the securitization; and (ii) the originator, sponsor, or original lender of the securitization has explicitly disclosed to the institution that it will retain, on an ongoing basis, a net economic interest of not less than five percent of specified credit risk tranches or asset exposures related to the securitization. In the future, EU insurance and reinsurance undertakings and UCITS funds are expected to become subject to similar restrictions. Although the requirements do not apply to any of the Funds directly, the costs of compliance, in the case of any securitization within the EU risk retention rules in which a Fund has invested or is seeking to invest, could be indirectly borne by the Fund and the other investors in the securitization.
Lack of Operating History
As of the date of this SAI, GAAR Implementation Fund and High Quality Short-Duration Bond Fund have no operating history. Therefore, there is no operating history to evaluate these Funds future performance. The past performance of other investment funds managed by GMO cannot be relied upon as an indicator of a Funds success, in part because of the unique nature of such Funds investment strategy. An investor in each Fund must rely upon the ability of GMO in identifying and implementing investments. There can be no assurance that such personnel will be successful in identifying and implementing investment opportunities for such Fund.
56
ADDITIONAL INVESTMENT STRATEGIES
Merger Arbitrage Transactions
Some Funds may engage in transactions in which a Fund purchases securities at prices below the value of the consideration GMO expects to be paid for them upon consummation of a proposed merger, exchange offer, tender offer, or other similar transaction (merger arbitrage transactions). The purchase price may substantially exceed the market prices of the securities before the announcement of the transaction.
If a Fund engages in a merger arbitrage transaction and that transaction later appears unlikely to be consummated or, in fact, is not consummated or is delayed, the market prices of the securities purchased by the Fund may decline sharply, resulting in losses to the Fund. The risk/reward payout of merger arbitrage strategies typically is asymmetric the losses in failed transactions often far exceeding the gains in successful transactions. A merger arbitrage transaction can fail for many reasons, including regulatory and antitrust restrictions, political motivations, industry weakness, stock specific events, failed financings, and general market declines.
Merger arbitrage strategies depend for success on the overall volume of merger activity, which has historically been cyclical. When merger activity is low, GMO may be unable to identify enough opportunities to provide sufficient diversification.
In conjunction with merger arbitrage transactions, a Fund may sell securities short in an effort to maximize risk-adjusted returns. For example, when the terms of a proposed acquisition call for an exchange of securities, a Fund may sell short the securities of the acquiring company to protect against a decline in the market value of those securities before the acquisitions completion. A Fund also may employ various hedging strategies to protect against market fluctuations or other risks, and also may use derivatives to increase, or reduce, long or short exposure to one or more asset classes or issuers.
Merger arbitrage strategies are subject to the risk of overall market movements, and the Fund may experience losses even if a transaction is consummated. A Funds investments in derivatives or short sales of securities to hedge or otherwise adjust long or short investment exposure in connection with a merger arbitrage transaction may not perform as expected or may otherwise reduce the Funds gains or increase its losses. At any given time, a Fund can become improperly hedged, which can lead to inadvertent market-related losses. Also, in certain transactions, a Fund may be unable to hedge against market fluctuations or other risks, and market movements can result in losses to the Fund even if the proposed transaction is consummated. In addition, a Fund that sells securities short that GMO expects it to receive upon consummation of a transaction but it does not actually receive (and thus has an unintended naked short position) may be required to cover its short position at a time when the securities sold short have appreciated in value, thus resulting in a loss.
A Funds merger arbitrage transactions could result in the realization of short-term capital gains by the Fund, which are generally taxed to shareholders at ordinary income tax rates when distributed.
Short Sales
Some Funds may sell securities or currencies short as part of their investment programs in an attempt to increase their returns or for hedging purposes. Many Funds may make short sales
57
against the box, meaning the Fund may make short sales where the Fund owns, or has the right to acquire at no added cost, securities or currencies identical to those sold short. If a Fund makes a short sale against the box, the Fund will not immediately deliver the securities or currencies sold and will not immediately receive the proceeds from the sale. However, with respect to securities, the Fund is required to hold securities equivalent in kind and amount to the securities sold short (or securities convertible or exchangeable into such securities) while the short sale is outstanding. Once the Fund closes out its short position by delivering the securities or currencies sold short, it will receive the proceeds of the sale. A Fund will incur transaction costs, including interest, in connection with opening, maintaining, and closing short sales against the box. Short sales expose a Fund to the risk that it will be required to acquire, convert, or exchange a security or currency to replace the borrowed security or currency when the security or currency sold short has appreciated in value, thus resulting in a loss to the Fund. In addition, GAAR Implementation Fund and Systematic Global Macro Opportunity Fund are permitted to engage in short sales of securities or currencies, including securities or currencies that they do not own (i.e., short sales that are not against the box), in anticipation of a decline in the market value of that security or currency. To do so, a Fund borrows a security (e.g., shares of an ETF) or currency from a broker and sells it to a third party, pays to borrow the security or currency, and agrees to pay the broker any dividends or interest it receives on the borrowed security or currency. Purchasing securities or currencies to close out a short position can itself cause the price of the securities or currencies to rise further, thereby exacerbating any losses. A Fund that sells short a security or currency it does not own also may have to pay borrowing fees to a broker and may be required to pay the broker any dividends or interest it receives on a borrowed security. To borrow the security or currency, the Fund also may be required to pay a premium, which would increase the cost of the security or currency sold. The net proceeds of the short sale will be retained by the broker, to the extent necessary to meet margin requirements, until the short position is closed out. The Fund also will incur transaction costs in effecting short sales that are not against the box.
GAAR Implementation Fund and Systematic Global Macro Opportunity Fund will incur a loss as a result of a short sale if the price of the security or index or currency increases between the date of the short sale and the date on which the Fund replaces the borrowed security or currency. The Fund will realize a gain if the price of the security or currency declines between those dates. The amount of any gain will be decreased, and the amount of any loss increased, by the amount of the premium, dividends or interest the Fund may be required to pay in connection with a short sale. Short sales that are not against the box involve a form of investment leverage, and the amount of the Funds loss on such a short sale is theoretically unlimited. Under adverse market conditions, the Fund may have difficulty purchasing securities or currencies to meet its short sale delivery obligations, and may have to sell portfolio securities or currencies to raise the capital necessary to meet its short sale obligations at a time when it would be unfavorable to do so. If a request for return of borrowed securities and/or currencies occurs at a time when other short sellers of the securities and/or currencies are receiving similar requests, a short squeeze can occur, and the Fund may be compelled to replace borrowed securities and/or currencies previously sold short with purchases on the open market at the most disadvantageous time, possibly at prices significantly in excess of the proceeds received in originally selling the securities and/or currencies short. In addition, the Fund may have difficulty purchasing securities and/or currencies to meet its delivery obligations in the case of less liquid securities and/or currencies sold short by the Fund, such as certain emerging market country securities or securities of companies with smaller market capitalizations. A Fund also may create short investment exposure by taking a derivative position in which the value of the derivative moves in the opposite direction from the price of an underlying investment, pool of investments, index or currency. These derivative positions will typically expose the Fund to economic risks similar to
58
those associated with shorting securities directly. Short sales of securities or currencies a Fund does not own and short derivative positions involve forms of investment leverage, and the amount of the Funds potential loss is theoretically unlimited.
There can be no assurance that the short positions that a Fund holds will act as an effective hedge against its long positions. Any decrease in negative correlation or increase in positive correlation between the positions GMO anticipated would be offsetting (such as short and long positions in securities or currencies held by a Fund) could result in significant losses for the Fund.
To the extent GMO employs a hedging strategy for a Fund, the success of any such hedging strategy will depend, in part, upon GMOs ability to correctly assess the degree of correlation between the performance of the instruments used in the hedging strategy and the performance of the investments being hedged.
Introduction and Overview
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease, or adjust elements of the investment exposures of a Funds portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities, and indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
It is the policy of each Fund to comply with Section 18(f) of the 1940 Act and the Funds are permitted to use any practices permitted by or consistent with relevant SEC releases, no-action letters, and other pronouncements.
This overview outlines various ways in which the Funds and any wholly-owned subsidiaries may use different types of exchange-traded and OTC derivatives in implementing their investment programs. It is intended to supplement the information included in the Private Placement Memorandum, including the risks associated with derivatives described under Additional Information About the Funds Investment Strategies, Risks and Expenses Description of Principal Risks in the Private Placement Memorandum, and the information provided in the Fund Investments and Descriptions and Risks of Fund Investments sections of this SAI. As indicated in the Private Placement Memorandum and above, each of GAAR Implementation Fund and Systematic Global Macro Opportunity Fund may use the derivatives and engage in the derivatives strategies described below directly and/or indirectly through their investments in Subsidiaries. This overview, however, is not intended to be exhaustive and a Fund may use types of derivatives and/or employ derivatives strategies not otherwise described in this SAI or the Private Placement Memorandum.
In addition, a Fund may decide not to employ any of the strategies described below, and no assurance can be given that any strategy used will succeed. Also, suitable derivatives transactions may not be available in all circumstances and there can be no assurance that a Fund will be able to identify or employ a desirable derivatives transaction at any time or from time to time, or that any such transactions will be successful.
59
Each Fund may take advantage of instruments and any security or synthetic or derivative instruments which are not presently contemplated for use by the Fund or which are not currently available, but which may be developed, to the extent such opportunities are both consistent with the Funds investment objective and legally permissible for the Fund. Each Fund may become a party to various other customized derivative instruments entitling the counterparty to certain payments on the gain or loss on the value of an underlying or referenced instrument.
Note : Unless otherwise noted below in this section, the uses of derivatives discussed herein with respect to a particular Fund only refer to the Funds direct use of such derivatives. As indicated in the Private Placement Memorandum and in the Fund Investments section above, certain Funds may invest in other Funds of the Trust, which, in turn, may use types of derivatives and/or employ derivatives strategies that differ from those described in this SAI or the Private Placement Memorandum.
Function of Derivatives in the Funds. The types of derivatives used and derivatives strategies employed by a Fund and the extent a Fund uses derivatives varies from Fund to Fund depending on the Funds specific investment objective and strategies. A Fund may use exchange-traded and OTC financial derivatives as an integral part of its investment program. Each of GAAR Implementation Fund and Systematic Global Macro Opportunity Fund uses exchange traded futures and forward contracts as an integral part of its investment program. In addition, specific market conditions may influence GMOs choice of derivatives and derivatives strategies for a particular Fund, in some cases to a significant extent.
Legal and Regulatory Risk Relating to Derivatives. As described above under Descriptions and Risks of Fund Investments Legal and Regulatory Risk, the U.S. government, the European Union, and some other countries have enacted legislation that includes provisions for new regulation of the derivatives market, including clearing, margin, reporting, and registration requirements. Because the legislation leaves much to rule making (and many of the rules are not yet final), its ultimate impact remains unclear. The regulatory changes could, among other things, restrict a Funds ability to engage in derivatives transactions (including because certain types of derivatives transactions may no longer be available to the Fund) and/or increase the costs of such derivatives transactions (including through increased margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result.
Use of Derivatives by GAAR Implementation Fund
The Fund may use derivatives to gain long investment exposure to securities, commodities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives to maintain equity exposure when it holds cash by equitizing its cash balances using futures contracts or other types of derivatives. The Fund also may use exchange traded futures and forward foreign exchange contracts to gain exposure to a range of global equity, bond, currency, and commodity markets and may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives, such as futures, related options, and swap contracts, in an attempt to reduce its investment exposures (which may result in a reduction below zero) or the investment exposures of BFF. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its
60
or BFFs portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that GMO believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its or BFFs investment exposures to individual commodities, various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund or BFF holds a large proportion of a certain type of security or commodity and GMO believes that another security or commodity will outperform such security or commodity, the Fund might use a short futures contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in combination with a long futures contract on another index (to synthetically buy exposure to that index). Long and short swap contracts and contracts for differences also may be used for these purposes. Derivatives used to effect synthetic sales and purchases will generally be unwound as actual portfolio securities are sold and purchased. In adjusting investment exposures, the Fund also may use currency derivatives, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its or BFFs portfolio. The Funds foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The Fund may use derivatives to effect transactions intended as substitutes for securities lending.
The Fund is not limited in its use of derivatives or in the total notional value of its derivative positions. As a result of its derivative positions, the Fund may have gross investment exposures in excess of its net assets (i.e., the Fund may be leveraged) and therefore is subject to heightened risk of loss. The Funds performance can depend substantially, if not primarily, on the performance of assets or indices underlying its derivatives even though it does not own those assets or indices.
Use of Derivatives by High Quality Short-Duration Bond Fund
The Fund may use derivatives to gain long investment exposure to securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce their investment exposures (which may result in a reduction below zero). For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that GMO believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of their investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, GMO may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Funds exposure to the credit of an issuer through the debt instrument but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter
61
duration versus longer duration exposure. In adjusting their investment exposures, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund is not limited in its use of derivatives or in the total notional value of their derivative positions. As a result of their respective derivative positions, The Fund will typically have gross investment exposures in excess of its net assets (i.e., the Fund will be leveraged), and therefore the Fund is subject to heightened risk of loss. The Funds performances can depend substantially, if not primarily, on the performance of assets or indices underlying its derivatives even though it does not own those assets or indices.
Use of Derivatives by Systematic Global Macro Opportunity Fund
The Fund may use derivatives to gain long and/or short investment exposure to global equities, bonds, currencies, commodities, or other assets. In particular, the Fund may use exchange traded futures and forward foreign exchange contracts to gain exposure to a range of global equity, bond, currency, and commodity markets. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to adjust its investment exposures. For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that GMO believes is highly correlated with the relevant currency.
The Fund may use derivatives, such as futures, related options, and swap contracts, in an attempt to adjust elements of its investment exposures to individual commodities, various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of a certain type of security or commodity and GMO believes that another security or commodity will outperform such security or commodity, the Fund might use a short futures contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in combination with a long futures contract on another index (to synthetically buy exposure to that index). Long and short swap contracts and contracts for differences also may be used for these purposes. Derivatives used to effect synthetic sales and purchases will generally be unwound as actual portfolio securities are sold and purchased. In addition, GMO may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Funds exposure to the credit of an issuer through the debt instrument but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currencies in which their equities are traded.
The Fund is not limited in its use of derivatives or in the total notional value of its derivative positions. As a result of its derivative positions, the Fund will typically have gross investment exposures in excess of its net assets (i.e., the Fund will be leveraged) and therefore is subject to
62
heightened risk of loss. The Funds performance can depend substantially, if not primarily, on the performance of assets or indices underlying its derivatives even though it does not own those assets or indices.
Use of Derivatives by World Opportunity Overlay Fund
The Fund may use derivatives to gain long investment exposure to securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). For example, the Fund may use a bond futures contract to short the bond market of particular country. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that GMO believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, GMO may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Funds exposure to the credit of an issuer through the debt instrument but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund is not limited in its use of derivatives or in the total notional value of its derivative positions. As a result of its derivative positions, the Fund will typically have gross investment exposures in excess of its net assets (i.e., the Fund will be leveraged) and therefore is subject to heightened risk of loss. The Funds performance can depend substantially, if not primarily, on the performance of assets or indices underlying its derivatives even though it does not own those assets or indices.
Fundamental Restrictions :
The following are Fundamental Investment Restrictions of the Funds, which may not be changed without shareholder approval:
(1) Each Fund may not borrow money except under the following circumstances: (i) Each Fund may borrow money from banks so long as after such a transaction, the total assets (including the amount borrowed) less liabilities other than debt obligations, represent at least 300% of outstanding debt obligations; (ii) Each Fund may also borrow amounts equal to an additional 5% of its total assets without regard to the foregoing limitation for temporary purposes, such as for
63
the clearance and settlement of portfolio transactions and to meet shareholder redemption requests; and (iii) Each Fund may enter into transactions that are technically borrowings under the 1940 Act because they involve the sale of a security coupled with an agreement to repurchase that security (e.g., reverse repurchase agreements, dollar rolls, and other similar investment techniques) without regard to the asset coverage restriction described in (i) above, so long as and to the extent that a Funds custodian earmarks and maintains cash and/or high-grade debt securities equal in value to its obligations in respect of these transactions.
Under current pronouncements of the SEC staff, the above types of transactions are not treated as involving senior securities so long as and to the extent that the Fund maintains liquid assets equal in value to its obligations in respect of these transactions.
(2) Each Fund may not underwrite securities issued by other persons except to the extent that, in connection with the disposition of its portfolio investments, it may be deemed to be an underwriter under federal securities laws.
(3) Each Fund may not purchase or sell real estate, although it may purchase securities of issuers which deal in real estate, including securities of real estate investment trusts, and may purchase securities which are secured by interests in real estate.
(4) Each Fund may not make loans, except by purchase of debt obligations or by entering into repurchase agreements or through the lending of the Funds portfolio securities. Loans of portfolio securities may be made with respect to up to 100% of a Funds total assets in the case of each of High Quality Short-Duration Bond Fund, and up to 33 1/3% of the Funds total assets in the case of each of GAAR Implementation Fund, Systematic Global Macro Opportunity Fund, and World Opportunity Overlay Fund.
(5) Each Fund may not concentrate more than 25% of the value of its total assets in any one industry.
For purposes of this Fundamental Restriction (5) the U.S. government and its agencies and instrumentalities shall not be considered to be an industry.
(6) With respect to High Quality Short-Duration Bond Fund and World Opportunity Overlay Fund, each Fund may not purchase or sell commodities or commodity contracts, except that the Fund may purchase and sell financial futures contracts and options thereon.
With respect to GAAR Implementation Fund and Systematic Global Macro Opportunity Fund, the Fund may not purchase commodities, except that the Fund may purchase and sell commodity contracts or any type of commodity-related derivatives (including, without limitation, all types of commodity-related swaps, futures contracts, forward contracts and options contracts).
For purposes of investment restriction (6) above, at the time of the establishment of the restriction, swap contracts on financial instruments or rates were not within the understanding of the terms commodities or commodity contracts, and not withstanding any federal legislation or regulatory action by the CFTC that subject such swaps to regulation by the CFTC, the Funds will not consider such instruments to be commodities or commodity contracts for purposes of this restriction.
64
(7) Each Fund may not issue senior securities, as defined in the 1940 Act and as amplified by rules, regulations and pronouncements of the SEC.
The SEC has concluded that even though reverse repurchase agreements, firm commitment agreements, and standby commitment agreements fall within the functional meaning of the term evidence of indebtedness, the issue of compliance with Section 18 of the 1940 Act will not be raised with the SEC by the Division of Investment Management if a Fund covers such obligations or maintains liquid assets equal in value to its obligations with respect to these transactions. Similarly, so long as such assets are maintained, the issue of compliance with Section 18 will not be raised with respect to any of the following: any swap contract or contract for differences; any pledge or encumbrance of assets permitted by Non-Fundamental Restriction (4) below; any borrowing permitted by Fundamental Restriction (1) above; any collateral arrangements with respect to initial and variation margin; and the purchase or sale of options, forward contracts, futures contracts or options on futures contracts.
Non-Fundamental Restrictions :
The following are Non-Fundamental Investment Restrictions of the Funds, which may be changed by the Trustees without shareholder approval:
(1) With respect to High Quality Short-Duration Bond Fund and World Opportunity Overlay Fund, each Fund may not buy or sell oil, gas, or other mineral leases, rights or royalty contracts, although it may purchase securities of issuers that deal in oil, gas, or other mineral leases, rights or royalty contracts, including securities of royalty trusts, and may purchase securities which are secured by, or otherwise hold or represent interests in, oil, gas, or other mineral leases, rights or royalty contracts.
(2) | Each Fund may not make investments for the purpose of gaining control of a companys management. |
With respect to each of GAAR Implementation Fund and Systematic Global Macro Opportunity Fund, this restriction shall not apply with respect to the Funds investments in one or more wholly-owned subsidiaries.
(3) With respect to GAAR Implementation Fund, High Quality Short-Duration Bond Fund, Systematic Global Macro Opportunity Fund, and World Opportunity Overlay Fund, each Fund may not invest more than 15% of its net assets in illiquid securities.
(4) With respect to each Fund which has adopted a non-fundamental investment policy pursuant to Rule 35d-1 under the 1940 Act (each, a Name Policy), the Fund may not change its Name Policy as set forth under the Funds Principal Investment Strategies in the Private Placement Memorandum without providing the Funds shareholders with a notice meeting the requirement of Rule 35d-1(c) at least 60 days prior to such change.
For purposes of each Name Policy, each Fund considers the term invest to include both direct and indirect investing and the term investments to include both direct and indirect investments (for instance, a Fund may invest indirectly or make indirect investments by investing in another GMO Fund or in derivatives and synthetic instruments with economic characteristics similar to the underlying asset), and a Fund may achieve exposure to a particular investment, industry,
65
country, or geographic region through direct investing or indirect investing and/or direct investments or indirect investments.
When used in connection with a Funds Name Policy, GMO uses the term assets and tied economically as defined in the Private Placement Memorandum.
Except as indicated above in Fundamental Restriction (1), all percentage limitations on investments set forth herein and in the Private Placement Memorandum will apply at the time of the making of an investment and shall not be considered violated unless an excess or deficiency occurs or exists immediately after and as a result of such investment.
With respect to GAAR Implementation Fund and Systematic Global Macro Opportunity Fund, for purposes of determining compliance with the Funds policy not to concentrate investments in a particular industry, futures contracts will be valued at current market value (not notional value).
The phrase shareholder approval, as used in the Private Placement Memorandum and in this SAI, and the phrases vote of a majority of the outstanding voting securities and the approval of shareholders, as used herein with respect to a Fund, mean the affirmative vote of the lesser of (1) more than 50% of the outstanding shares of that Fund, or (2) 67% or more of the shares of that Fund present at a meeting if more than 50% of the outstanding shares are represented at the meeting in person or by proxy. Except for policies and restrictions that are explicitly described as fundamental in the Private Placement Memorandum or this SAI, the investment policies and restrictions of each Fund may be changed by the Trusts Trustees without the approval of shareholders of that Fund. Policies and restrictions of a Fund that are explicitly described as fundamental in the Private Placement Memorandum or this SAI cannot be changed without the approval of shareholders of that Fund.
World Opportunity Overlay Fund typically will have exposure to a number of countries throughout the world, including exposure to the interest rate markets of those countries through the use of futures contracts, swap contracts, currency forwards, and other types of derivatives.
DETERMINATION OF NET ASSET VALUE
The net asset value (or NAV) of a Fund or each class of shares of a Fund, as applicable, is determined as of the close of regular trading on the New York Stock Exchange (NYSE), generally at 4:00 p.m. Eastern time.
The NAV per share of a class of shares of a Fund is determined by dividing the total value of the Funds portfolio investments and other assets, less any liabilities, allocated to that share class by the total number of outstanding shares of that class. NAV is not determined on any days when the NYSE is closed for business. In addition, in the case of High Quality Short-Duration Bond Fund, Systematic Global Macro Opportunity Fund, and World Opportunity Overlay Fund, NAV is not determined (and accordingly, transactions in shares of the Fund are not processed) on days when the U.S. bond markets are closed. For these purposes, the U.S. bond markets are deemed to be closed on the dates that the Securities Industry and Financial Markets Association recommends a full close for the trading of U.S. dollar-denominated fixed income securities in the United States.
A Fund also may elect not to determine NAV on days during which no share is tendered for redemption and no order to purchase or sell a share is received by that Fund. Please refer to
66
Determination of Net Asset Value in the Private Placement Memorandum for additional information. In addition, to the extent a Fund holds portfolio securities listed on non-U.S. exchanges that trade on days on which the NYSE or the U.S. bond markets are closed, the net value of those Funds assets may change significantly on days when shares cannot be redeemed.
Although GMO normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. GMO monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Alternative pricing sources are often but not always available for securities held by a Fund, although the prices supplied by those alternative sources do not necessarily align with the prices supplied by the primary pricing sources.
TAXES
Except as specifically noted below, the following discussion is a general summary of the principal U.S. federal income tax consequences to shareholders investing in the Funds who are U.S. citizens, residents, or corporations. The consequences under other tax laws may differ. This discussion does not address all aspects of taxation that may be relevant to particular shareholders in light of their own investment or tax circumstances, or to particular types of shareholders (including insurance companies, financial institutions, brokers, tax-exempt entities, foreign corporations, and persons who are not citizens or residents of the United States) subject to special treatment under the U.S. federal income tax laws. This summary is based on the Code, the Treasury regulations thereunder, published rulings and other IRS guidance, and court decisions, all as currently in effect. These laws and administrative guidance are subject to change, possibly on a retroactive basis. Shareholders should consult their own tax advisers about the precise tax consequences of an investment in a Fund in light of their particular tax situation, including possible foreign, state, local, or other applicable tax laws (including the federal alternative minimum tax) .
Special tax rules apply to investments through defined contribution plans and other tax-qualified plans. Shareholders should consult their tax advisers to determine the suitability of shares of the Fund as an investment through such plans. A Funds shareholders may include certain GMO Funds, including GMO Funds not offered in this SAI, some of which are RICs as defined by Subchapter M of the Code. The summary below does not address tax consequences to shareholders of those other GMO Funds. Shareholders of those other GMO Funds should refer to the prospectuses or private placement memoranda, as applicable, and statements of additional information for those GMO Funds for a summary of the tax consequences applicable to them.
TAXES: GAAR IMPLEMENTATION FUND
As described in the Funds Private Placement Memorandum, it is currently expected that GAAR Implementation Funds sole shareholder will be BFF. BFF intends each year to qualify and to be eligible to be treated as a regulated investment company (RIC) under Subchapter M of the Code. For U.S. federal income tax purposes, the Fund will be disregarded as an entity separate from it sole shareholder BFF. As a result, for federal income tax purposes, including for purposes of meeting the ongoing distribution, asset diversification, qualifying income, and other requirements applicable to RICs under Subchapter M of the Code (i) BFF will be treated as owning the Funds assets, including the wholly-owned subsidiary in which the Fund invests,
67
directly; (ii) any income, gain, loss, deduction or other tax items arising in respect of the Funds assets will be treated as if they are realized or incurred, as applicable, directly by BFF; and (iii) any distributions BFF receives from the Fund will have no effect on BFF for U.S. federal income tax purposes, including in respect of any liability or the requirements applicable to it for RIC treatment under the Code.
The tax consequences to BFF from an investment in the Fund and to shareholders of BFF are described in BFFs prospectus and statement of additional information.
TAXES: HIGH QUALITY SHORT-DURATION BOND FUND
The following section applies only to High Quality Short-Duration Bond Fund and its shareholders.
At this time, the Fund does not intend to offer its shares publicly or to make them available, other than to other Funds of the Trust and certain other accredited investors. The following summary does not discuss the tax consequences to the shareholders of those other Funds of the Trust, of distributions by those other Funds to their shareholders, or of the sale of shares of those other Funds by their shareholders. Shareholders of such Funds should consult the prospectuses and statements of additional information of those other Funds for a discussion of the tax consequences to them.
Tax Status and Taxation of the Fund
The Fund is treated as a separate taxable entity for U.S. federal income tax purposes. The Fund intends to elect to be treated and intends to qualify and to be eligible each year to be treated as a RIC under Subchapter M of the Code. In order to qualify for the special tax treatment accorded RICs and their shareholders, the Fund must, among other things:
(a) | derive at least 90% of its gross income for each taxable year from (i) dividends, interest, payments with respect to certain securities loans, and gains from the sale or other disposition of stock, securities, or foreign currencies, or other income (including but not limited to gains from options, futures, or forward contracts) derived with respect to its business of investing in such stock, securities, or currencies and (ii) net income derived from interests in qualified publicly traded partnerships (as defined below); |
(b) | diversify its holdings so that, at the end of each quarter of the Funds taxable year, (i) at least 50% of the market value of the Funds total assets consists of cash and cash items, U.S. government securities, securities of other RICs, and other securities limited in respect of any one issuer to a value not greater than 5% of the value of the Funds total assets and not more than 10% of the outstanding voting securities of such issuer, and (ii) not more than 25% of the value of the Funds total assets is invested in the securities (other than those of the U.S. government or RICs) of any one issuer or of two or more issuers which the Fund controls and which are engaged in the same, similar, or related trades or businesses, or in the securities of one or more qualified publicly traded partnerships (as defined below); and |
(c) | distribute with respect to each taxable year at least 90% of the sum of its investment company taxable income (as that term is defined in the Code without regard to the deduction for dividends paid generally, taxable ordinary income and the excess, if any, of net short-term capital gains over net long-term capital losses) and any net tax-exempt interest income for such year. |
68
In general, for purposes of the 90% gross income requirement described in paragraph (a) above, income derived from a partnership will be treated as qualifying income only to the extent such income is attributable to items of income of the partnership which would be qualifying income if realized directly by the RIC. However, 100% of the net income derived from an interest in a qualified publicly traded partnership (defined generally as a partnership (i) the interests in which are traded on an established securities market or are readily tradable on a secondary market or the substantial equivalent thereof; (ii) that derives at least 90% of its income from passive income sources defined in Section 7704(d) of the Code; and (iii) that derives less than 90% of its income from the qualifying income described in paragraph (a)(i) above) will be treated as qualifying income. Certain MLPs and natural resources-related ETFs (e.g., those investing substantially in commodities futures) may qualify as qualified publicly traded partnerships. In general, such entities will be treated as partnerships for federal income tax purposes because they meet the passive income requirement under Section 7704(c)(2) of the Code. In addition, although in general the passive loss rules of the Code do not apply to RICs, such rules do apply to a RIC with respect to items attributable to an interest in a qualified publicly traded partnership. Further, for the purposes of the diversification test in paragraph (b) above: (i) the term outstanding voting securities of such issuer will include the equity securities of a qualified publicly traded partnership, and (ii) identification of the issuer (or, in some cases, issuers) of a particular Fund investment can depend on the terms and conditions of that investment. In some cases, identification of the issuer (or issuers) is uncertain under current law, and an adverse determination or future guidance by the IRS with respect to issuer identification for a particular type of investment may adversely affect the Funds ability to meet the diversification test in (b) above.
If the Fund qualifies as a RIC that is accorded special tax treatment, the Fund will not be subject to U.S. federal income tax on income distributed in a timely manner to its shareholders in the form of dividends (including Capital Gain Dividends, as defined below).
As described above, the Fund intends generally to distribute at least annually to its shareholders its net investment income (including any net tax-exempt interest income), if any, and its net realized capital gains (including both net short-term and long-term capital gains), if any. Any net taxable investment income or net short-term capital gains (as reduced by any net long-term capital losses) retained by the Fund will be subject to tax at the Fund level at regular corporate rates. Although the Fund intends generally to distribute all of its net capital gain (i.e., the excess of any net long-term capital gains over net short-term capital losses) each year, the Fund reserves the right to retain for investment all or a portion of its net capital gain. If the Fund retains any net capital gain, it will be subject to tax at the Fund level at regular corporate rates on the amount retained. In that case, the Fund is permitted to designate the retained amount as undistributed capital gains in a timely notice to its shareholders, who would then, in turn, be (i) required to include in income for U.S. federal income tax purposes, as long-term capital gain, their shares of such undistributed amount, and (ii) entitled to credit their proportionate shares of the tax paid by the Fund on such undistributed amount against their U.S. federal income tax liabilities, if any, and to claim refunds on a properly filed U.S. tax return to the extent the credit exceeds such liabilities. If the Fund properly makes this designation, for U.S. federal income tax purposes, the tax basis of shares owned by a shareholder of the Fund would be increased by an amount equal under current law to the difference between the amount of undistributed capital gains included in the shareholders gross income under clause (i) of the preceding sentence and the tax deemed paid by the shareholder under clause (ii) of the preceding sentence. The Fund is not required to,
69
and there can be no assurance that the Fund will, make this designation if it retains all or a portion of its net capital gain in a taxable year.
In determining its net capital gain, including in connection with determining the amount available to support a Capital Gain Dividend (as defined below), its taxable income, and its earnings and profits, the Fund generally may elect to treat part or all of any post-October capital loss (defined as any net capital loss attributable to the portion of the taxable year after October 31 or, if there is no such loss, the net long-term capital loss or net short-term capital loss attributable to such portion of the taxable year), or late-year ordinary loss (generally, the sum of its (i) net ordinary loss from the sale, exchange or other taxable disposition of property, attributable to the portion of the taxable year after October 31, and its (ii) other net ordinary loss attributable to the portion of the taxable year after December 31) as if incurred in the succeeding taxable year.
If the Fund were to fail to distribute in a calendar year at least an amount generally equal to the sum of 98% of its ordinary income for such calendar year and 98.2% of its capital gain net income for the one-year period ending October 31 within that year, plus any such retained amounts from the prior year, the Fund would be subject to a nondeductible 4% excise tax on the undistributed amounts. The Fund intends generally to make distributions sufficient to avoid imposition of the 4% excise tax, although the Fund reserves the right to pay an excise tax rather than make an additional distribution when circumstances warrant (e.g., the payment of the excise tax amount is deemed by the Fund to be de minimis).
Realized capital losses in excess of realized capital gains (Net Capital Losses) are not permitted to be deducted against net investment income. Instead, potentially subject to the limitations described below, the Fund will carry Net Capital Losses forward from any taxable year to subsequent taxable years to offset capital gains, if any, realized during such subsequent taxable years. Distributions from capital gains are generally made after applying any available capital loss carryforwards. Capital loss carryforwards are reduced to the extent they offset current-year net realized capital gains, whether the Fund retains or distributes such gains.
Any Net Capital Losses will be carried forward to one or more subsequent taxable years, and will be treated as realized on the first day of the taxable year in which it is used to reduce capital gain, without expiration. Any such carryforward losses will generally retain their character as short-term or long-term and will be applied first against gains of the same character before offsetting gains of a different character (e.g., Net Capital Losses resulting from previously realized net long-term losses will first offset any long-term capital gain, with any remaining amounts available to offset any net short-term capital gain). The Funds available capital loss carryforwards, if any, will be set forth in its annual shareholder report for each fiscal year.
In addition, the Funds ability to use Net Capital Losses may be limited following the occurrence of certain (i) acquisitive reorganizations and (ii) shifts in the ownership of the Fund by a shareholder owning or treated as owning 5% or more of the shares of the Fund (each, an ownership change). The Code may similarly limit the Funds ability to use any of its other capital losses, or ordinary losses, that have accrued but have not been recognized (i.e., built-in losses) at the time of an ownership change to the extent they are realized within the five-year period following the ownership change.
70
Limitation on Deductibility of Fund Expenses
The Fund will be considered to be a nonpublicly offered RIC if it does not have at least 500 shareholders at all times during a taxable year. Very generally, pursuant to Treasury regulations, expenses of nonpublicly offered RICs, except those specific to their status as a RIC or separate entity (e.g., registration fees or transfer agency fees), are subject to special pass-through rules. The affected expenses (which include Management Fees) are treated as additional dividends to certain Fund shareholders (generally including individuals and entities that compute their taxable income in the same manner as individuals) and are deductible by those shareholders, subject to the 2% floor on miscellaneous itemized deductions and other significant limitations on itemized deductions set forth in the Code.
Transactions in Fund Shares
The sale, exchange, or redemption of Fund shares generally will give rise to a taxable gain or loss, generally equal to the difference between the amount realized by a shareholder on the disposition of the shares (that is, gross proceeds) and the shareholders adjusted basis in those shares. To the extent a shareholders account is subject to U.S. federal tax reporting (including an account for which a shareholder has informed the Fund that it would like to receive informational only U.S. federal tax reporting), the Fund generally will provide cost basis information (on an IRS Form 1099-B) to the IRS and to the shareholders with respect to Fund shares acquired and held in such accounts, when such shares are subsequently redeemed or exchanged. The Fund is required to use the particular cost basis reporting method (e.g., average cost basis, first in first out, specific share identification) selected by the shareholder in reporting such adjusted basis information, and if a shareholder fails to select a particular method, use the Funds default method. This reporting is generally not required for Fund shares held in a retirement or other tax-advantaged account, unless a shareholder has opted for informational only reporting as described above. Shareholders should contact the Trust for more information about how to select a particular cost basis accounting method, as well as for information about the Funds particular default method.
Shareholders also should consult their tax advisers concerning the application of these rules to their investment in the Fund, and for advice about selecting a cost basis accounting method suitable for them in light of their particular circumstances.
If a shareholder has purchased shares of the Fund through an intermediary, in general, the intermediary and not the Fund will be responsible for providing the cost basis and related reporting described above to the shareholder, including pursuant to the intermediarys available cost basis accounting methods. Thus, shareholders purchasing shares through an intermediary, should contact the intermediary for more information about how to select a particular cost basis accounting method, as well as for information about the intermediarys particular default method.
In general, any gain or loss realized upon a taxable disposition of shares will be treated as long-term capital gain if the shares have been held for more than one year and as short-term capital gain if the shares have been held for not more than one year. However, if the Fund is a nonpublicly offered RIC as described above under Limitation on Deductibility of Fund Expenses, depending on a shareholders percentage ownership in the Fund, a shareholders partial redemption of its Fund shares could cause the shareholder to be treated as receiving a so-called section 301 distribution, treated, to the extent of such distributions allocable share of
71
the Funds current and accumulated earnings and profits, as a dividend taxable under the rules applicable to dividends and distributions described below, rather than capital gain income received in exchange for Fund shares. In this case, a shareholder would generally not be able to recognize any losses on its redeemed Fund shares. Where a redeeming shareholder is treated as receiving a dividend, there is a risk that other shareholders of the Fund, whose percentage interests in the Fund increase as a result of such redemption, will be treated as having received a taxable distribution from the Fund. Shareholders should consult their tax advisers regarding the proper tax treatment of their redemptions from the Fund.
Any loss realized upon a taxable disposition of Fund shares held by a shareholder for six months or less generally will be treated as long-term capital loss to the extent of any Capital Gain Dividends, as defined below, received or deemed received by a shareholder with respect to those shares. Further, all or a portion of any loss realized upon a taxable disposition of Fund shares will be disallowed under the Codes wash-sale rules if other shares of the same Fund are purchased, including by means of dividend reinvestment, within 30 days before or after the disposition. In such a case, the basis of the newly purchased shares will be adjusted to reflect the disallowed loss.
Taxation of Fund Distributions
Fund distributions are taxable to shareholders under the rules described below whether received in cash or reinvested in additional Fund shares.
Dividends and distributions on the Funds shares are generally subject to U.S. federal income tax as described below to the extent they do not exceed the Funds realized income and gains, even though such dividends and distributions may economically represent a return of a particular shareholders investment. Such dividends and distributions are likely to occur in respect of shares purchased at a time when the Funds net asset value reflects unrealized gains, or realized but undistributed income or gains that were therefore included in the price the shareholder paid for its shares. Such distributions may reduce the net asset value of the Funds shares below the shareholders cost basis in those shares. Such realized income and gains may be required to be distributed even when the Funds net asset value also reflects unrealized losses.
For U.S. federal income tax purposes, distributions of investment income made by the Fund are generally taxable to shareholders as ordinary income. Taxes on distributions of capital gains are determined by how long the Fund owned the investments that generated them, rather than how long a shareholder may have owned shares in the Fund. In general, the Fund will recognize long-term capital gain or loss on investments it has owned for more than one year, and short-term capital gain or loss on investments it has owned for one year or less. Tax rules can alter the Funds holding period in investments and thereby affect the tax treatment of gain or loss on such investments. Distributions of net capital gains (that is, the excess of net long-term capital gain over net short-term capital loss, in each case determined with reference to capital loss carryforwards) that are properly reported by the Fund as capital gain dividends (Capital Gain Dividends) generally are taxable to shareholders as long-term capital gains. Distributions attributable to net short-term capital gain (as reduced by any net long-term capital loss for the taxable year, in each case determined with reference to capital loss carryforwards) generally are taxable to shareholders as ordinary income.
Distributions of investment income properly reported by the Fund as derived from qualified dividend income will be taxable to shareholders taxed as individuals at the rates applicable to
72
long-term capital gain, provided holding period and other requirements are met at both the shareholder and Fund levels.
In order for some portion of the dividends received by a Fund shareholder to be qualified dividend income, the Fund must meet holding period and other requirements with respect to some portion of the dividend-paying stocks in its portfolio and the shareholder must meet holding period and other requirements with respect to the Funds shares. In general, a dividend will not be treated as qualified dividend income (at either the Fund or shareholder level) (i) if the dividend is received with respect to any share of stock held for fewer than 61 days during the 121-day period beginning on the date which is 60 days before the date on which such share becomes ex-dividend with respect to such dividend (or, in the case of certain preferred stock, 91 days during the 181-day period beginning 90 days before such date); (ii) to the extent that the recipient is under an obligation (whether pursuant to a short sale or otherwise) to make related payments with respect to positions in substantially similar or related property; (iii) if the recipient elects to have the dividend income treated as investment income for purposes of the limitation on deductibility of investment interest; or (iv) if the dividend is received from a foreign corporation that is (A) not eligible for the benefits of a comprehensive income tax treaty with the United States (with the exception of dividends paid on stock of such a foreign corporation readily tradable on an established securities market in the United States) or (B) treated as a passive foreign investment company (as defined below).
In general, distributions of investment income reported by the Fund as derived from qualified dividend income will be treated as qualified dividend income in the hands of a shareholder taxed as an individual, provided the shareholder meets the holding period and other requirements described above with respect to the Funds shares. If the above described holding period and other requirements are met at both the shareholder and Fund level, qualified dividend income will be taxed in the hands of individuals at the rates applicable to long-term capital gain. If the aggregate qualified dividend income received by the Fund during any taxable year is 95% or more of its gross income, then 100% of the Funds dividends (other than Capital Gain Dividends) will be eligible to be treated as qualified dividend income. For this purpose, the only gain included in the term gross income is the excess of net short-term capital gain over net long-term capital loss.
If the Fund receives dividends from an Underlying Fund, including an ETF, that is treated as a RIC for U.S. federal income tax purposes (Underlying RIC), and the Underlying RIC reports such dividends as qualified dividend income, then the Fund is permitted, in turn, to report a portion of its distributions as qualified dividend income, provided that the Fund meets the holding period and other requirements with respect to shares of the Underlying RIC.
For corporate shareholders (other than S corporations), the 70% dividends-received deduction will generally apply (subject to holding period and other requirements imposed by the Code) to a Funds dividends paid from investment income to the extent derived from dividends received from U.S. corporations for the taxable year. A dividend received by the Fund from a U.S. corporation will not be treated as a dividend eligible for the dividends-received deduction (1) if it has been received with respect to any share of stock that the Fund has held for less than 46 days (91 days in the case of certain preferred stock) during the 91-day period beginning on the date which is 45 days before the date on which such share becomes ex-dividend with respect to such dividend (during the 181-day period beginning 90 days before such date in the case of certain preferred stock) or (2) to the extent that the Fund is under an obligation (pursuant to a short sale or otherwise) to make related payments with respect to positions in substantially similar or
73
related property. Moreover, the dividends received deduction may otherwise be disallowed or reduced (1) if the corporate shareholder fails to satisfy the foregoing requirements with respect to its shares of the Fund or (2) by application of various provisions of the Code (for instance, the dividends-received deduction is reduced in the case of a dividend received on debt-financed portfolio stock (generally, stock acquired with borrowed funds)).
If the Fund receives dividends from an Underlying RIC, and the Underlying RIC reports such dividends as eligible for the dividends-received deduction, then the Fund is permitted, in turn, to report a portion of its distributions as eligible for the dividends-received deduction, provided that the Fund meets the holding period and other requirements with respect to shares of the Underlying RIC.
A portion of the original issue discount (OID) accrued on certain high yield discount obligations may not be deductible to the issuer as interest and will instead be treated as a dividend for purposes of the corporate dividends-received deduction. In such cases, if the issuer of the high yield discount obligations is a domestic corporation, dividend payments by the Fund may be eligible for the dividends-received deduction to the extent attributable to the deemed dividend portion of such OID. See Tax Implications of Certain Investments below for more discussion of OID.
To the extent that the Fund makes a distribution of income that is attributable to (i) income received by the Fund in lieu of dividends with respect to securities on loan pursuant to a securities lending transaction or (ii) dividend income received by the Fund on securities it temporarily purchased from a counterparty pursuant to a repurchase agreement treated for U.S. federal income tax purposes as a loan, such distribution will not constitute qualified dividend income to individual shareholders and will not be eligible for the dividends-received deduction for corporate shareholders.
The Code generally imposes a 3.8% Medicare contribution tax on the net investment income of certain individuals, trusts, and estates to the extent their income exceeds certain threshold amounts. For these purposes, net investment income generally includes, among other things, (i) distributions paid by the Fund of ordinary dividends and capital gain dividends as described above, and (ii) any net gain from the sale, redemption or exchange of Fund shares. Shareholders are advised to consult their tax advisers regarding the possible implications of this additional tax on their investment in the Fund.
The Fund may make a distribution to its shareholders in excess of its earnings and profits in any taxable year (a Return of Capital Distribution), in which case the excess distribution will be treated as a return of capital to the extent of each shareholders tax basis in its shares, and thereafter as capital gain. A return of capital is not taxable to the extent such an amount does not exceed a shareholders tax basis. Return of Capital Distributions reduce a shareholders tax basis in its shares, thus reducing any loss or increasing any gain on a subsequent taxable disposition by such shareholder of the shares.
A distribution paid to shareholders by the Fund in January of a year generally is deemed to have been received by shareholders on December 31 of the preceding year, if the distribution was declared and payable to shareholders of record on a date in October, November, or December of that preceding year.
74
The Fund may make distributions in excess of net investment income and net realized capital gain for the taxable year that are nonetheless supported by earnings and profits. In such cases, the distributions will be taxable as ordinary dividends, even though the distributed excess amounts would not have been subject to tax if retained by the Fund.
Early each calendar year, the Trust will provide U.S. federal tax information, including information about the character and amount of dividends and distributions paid during the preceding year, to taxable investors and others requesting such information (generally on an IRS Form 1099). In certain cases, the Fund may be required to amend tax information reported to shareholders in respect of a particular year. In this event, shareholders may be required to file amended U.S. federal income or other tax returns in respect of such amended information and pay additional taxes (including potentially interest and penalties), and may incur other related costs. Shareholders should consult their tax advisers in this regard.
Tax Implications of Certain Investments
The Funds transactions in derivative instruments (e.g., swap agreements, options, futures or forward contracts), as well as any of its other hedging, short sales, or similar transactions, may be subject to one or more special tax rules (e.g., notional principal contract, straddle, constructive sale, wash-sale, and short-sale rules). These rules, the application of which in any given instance may not be clear, may affect whether gains and losses recognized by the Fund are treated as ordinary or capital and/or as short-term or long-term, accelerate the recognition of income or gains to the Fund, defer losses, and cause adjustments in the holding periods of the Funds investments. The rules could therefore affect the amount, timing, and/or character of distributions to shareholders.
The Fund may make extensive use of various types of derivative financial instruments to the extent consistent with its investment policies and restrictions. The tax rules applicable to swaps and other derivative financial instruments are in some cases uncertain under current law, including under Subchapter M of the Code. Accordingly, while the Funds intend to account for such transactions in a manner they deem to be appropriate, an adverse determination or future guidance by the IRS with respect to one or more of these rules (which determination or guidance could be retroactive) may adversely affect the Funds ability to meet one or more of the relevant requirements to maintain its qualification as a RIC, as well as to avoid a fund-level tax. See Loss of RIC Status below.
Certain investments made and investment practices engaged in by the Fund can produce a difference between its book income and its taxable income and net tax-exempt income (if any). These can include, but are not limited to, certain hedging activities, as well as investments in foreign currencies, foreign currency-denominated debt instruments, Section 1256 contracts (as defined below), passive foreign investment companies (as defined below), and debt obligations with discount or purchased at a premium. In addition, certain foreign currency transactions associated with the redemption of the Funds shares (in the case where the Fund permits redemption of its shares in foreign currencies) may produce a difference between the Funds book income and its taxable income. If the Funds book income exceeds the sum of its taxable income and net tax-exempt interest income (if any), the distribution (if any) of such excess generally will be treated as (i) a dividend to the extent of the Funds remaining earnings and profits (including earnings and profits arising from tax-exempt interest income (if any)); (ii) thereafter, as a return of capital to the extent of the recipients basis in its shares; and (iii) thereafter, as gain from the sale or exchange of a capital asset. If the Funds book income is less
75
than the sum of its taxable income and net tax-exempt income (if any), the Fund could be required to make distributions exceeding book income to qualify as a RIC that is accorded special tax treatment.
Any transactions by the Fund in foreign currencies, foreign currency-denominated debt obligations, or certain foreign currency options, futures contracts, or forward contracts (or similar instruments) may give rise to ordinary income or loss to the extent such income or loss results from fluctuations in the value of the foreign currency concerned and, as described above, can give rise to differences between the Funds book and taxable income. Such ordinary income treatment may accelerate Fund distributions to shareholders and increase the distributions taxed to shareholders as ordinary income. Any net ordinary losses so created cannot be carried forward by the Fund to offset income or gains earned in subsequent taxable years.
In general, option premiums received by the Fund are not immediately included in the income of the Fund. Instead, the premiums generally are recognized when the option contract expires, the option is exercised by the holder, or the Fund transfers or otherwise terminates the option (e.g., through a closing transaction). The remainder of this paragraph describes the general tax consequences to the Fund of writing a put or call option that is not subject to one or more of the special rules described in the immediately following paragraphs. If securities or other assets are purchased by the Fund pursuant to the exercise of a put option written by it, the Fund generally will subtract the premium received from its cost basis in the securities or other assets purchased. If a call option written by the Fund is exercised and the Fund sells or delivers the underlying securities or other assets, the Fund generally will recognize capital gain or loss equal to (i) the sum of the strike price and the option premium received by the Fund minus (ii) the Funds basis in the underlying securities or other assets. Such gain or loss generally will be short-term or long-term depending upon the holding period of the underlying securities or other assets. The gain or loss with respect to any termination of the Funds obligation under an option other than through the exercise of the option and related purchase, sale, or delivery of the underlying securities or other assets generally will be short-term gain or loss depending on whether the premium income received by the Fund is greater or less than the amount paid by the Fund (if any) in terminating the transaction. Thus, for example, if an option written by the Fund expires unexercised, the Fund generally will recognize short-term gain equal to the premium received.
Certain covered call writing activities and other option strategies of the Fund may trigger the U.S. federal income tax straddle rules of Section 1092 of the Code, requiring the deferral of losses and the termination of holding periods on offsetting positions in options and stocks deemed to constitute substantially similar or related property. Call options on stocks that are not deep in the money may qualify as qualified covered calls, which generally are not subject to the straddle rules; the holding period on stock underlying qualified covered calls that are in the money although not deep in the money will be suspended during the period that such calls are outstanding. Thus, the straddle rules and the rules governing qualified covered calls could cause gains that would otherwise constitute long-term capital gains to be treated as short-term capital gains, and distributions that would otherwise constitute qualified dividend income or qualify for the corporate dividends-received deduction to fail to satisfy the holding period requirements and therefore to be taxed as ordinary income or to fail to qualify for the dividends-received deduction, as the case may be.
The tax treatment of certain contracts entered into by a Fund (including regulated futures contracts and non-equity options) will be governed by Section 1256 of the Code (Section 1256 contracts). Gains or losses on Section 1256 contracts generally are considered 60% long-term
76
and 40% short-term capital gains or losses (60/40), although certain foreign currency gains and losses from such contracts may be treated as ordinary in character. Also, Section 1256 contracts held by the Fund at the end of each taxable year (and, for purposes of the 4% excise tax, on certain other dates as prescribed under the Code) are marked to market, with the result that unrealized gains or losses are treated as though they were realized and the resulting gain or loss is treated as ordinary or 60/40 gain or loss, as applicable.
Some debt obligations with a fixed maturity date of more than one year from the date of issuance (and zero-coupon debt obligations with a fixed maturity date of more than one year from the date of issuance) will be treated as debt obligations that are issued originally at a discount. Generally, the amount of the OID is treated as interest income and is included in a Funds taxable income on a current basis and thus allocated to Fund shareholders over the term of the debt security, even though payment of that amount is not received by the Fund until a later time, usually upon partial or full repayment or disposition of the debt security. In addition, payment-in-kind securities will give rise to income which is taxable even though the Fund holding the security receives no interest payment in cash on the security during the year.
Some debt obligations with a fixed maturity date of more than one year from the date of issuance that are acquired by the Fund in the secondary market may be treated as having market discount. Very generally, market discount is the excess of the stated redemption price of a debt obligation (or in the case of an obligation issued with OID, its revised issue price) over the purchase price of such obligation. Also very generally, any gain recognized on the disposition of, and any partial payment of principal on, a debt security having market discount is treated as ordinary income to the extent the gain, or principal payment, does not exceed the accrued market discount on such debt security. Alternatively, the Fund may elect to accrue market discount currently, in which case the Fund will be required to include the accrued market discount in the Funds income (as ordinary income) and thus distribute it over the term of the debt security, even though payment of that amount is not received until a later time, upon partial or full repayment or disposition of the debt security. The rate at which the market discount accrues, and thus is included in the Funds income, will depend upon which of the permitted accrual methods the Fund elects.
Some debt obligations with a fixed maturity date of one year or less from the date of issuance may be treated as having OID or, in certain cases, acquisition discount (very generally, the excess of the stated redemption price over the purchase price). Also very generally, the Fund will be required to include the OID or acquisition discount in income (as ordinary income) over the term of the debt security, even though payment of that amount is not received until a later time, usually when the debt security matures. The OID or acquisition discount accrues ratably in equal daily installments or, if the Fund so elects, at a constant (compound) interest rate. If the Fund elects the constant interest rate method, the character and timing of recognition of income by the Fund will differ from what they would have been under the default pro rata method.
Increases in the principal amount of an inflation-indexed bond will be treated as OID includible in income (as ordinary income) over the term of the bond, even though payment of that amount is not received until a later time. Decreases in the principal amount of an inflation-indexed bond generally will reduce the amount of interest from the debt instrument that would otherwise be includible in income by the Fund. In addition, if the negative inflation adjustment exceeds the income includible by the Fund with respect to the debt instrument (including any OID) for the taxable year, such excess will be an ordinary loss to the extent the Funds total interest inclusions on the debt instrument in prior taxable years exceed the total amount treated by the Fund as an
77
ordinary loss on the debt instrument in prior taxable years. Any remaining excess may be carried forward to reduce taxable income and/or gain from the instrument in subsequent years.
The Fund may also purchase contingent payment debt instruments. For U.S. federal income tax purposes, holders of contingent payment debt instruments generally have to include taxable income (as interest) on a constant yield basis without regard to whether cash is received with respect thereto. Gain on the disposition of contingent payment debt instruments generally will be treated for U.S. federal income tax purposes as ordinary interest income rather than as capital gain.
If the Fund holds the foregoing kinds of debt instruments, it may be required to pay out as an income distribution each year an amount which is greater than the total amount of cash interest the Fund actually received. Such distributions may be made from the cash assets of the Fund or, if necessary, by liquidation of portfolio investments including at a time when it may not be advantageous to do so. The Fund may realize gains or losses from such liquidations. In the event the Fund realizes net long-term or short-term capital gains from such transactions, its shareholders may receive a larger Capital Gain Dividend or ordinary dividend, respectively, than they would in the absence of such transactions.
Very generally, where the Fund purchases a bond at a price that exceeds the redemption price at maturity, that is, at a premium, the premium is amortizable over the remaining term of the bond. In the case of a taxable bond, if the Fund makes an election applicable to all such bonds it purchases, which election is irrevocable without the consent of the IRS, the Fund reduces the current taxable income from the bond by the amortized premium and reduces its tax basis in the bond by the amount of such offset; upon the disposition or maturity of such bonds acquired on or after January 4, 2013, the Fund is generally permitted to deduct any remaining premium allocable to a prior period. In the case of a tax-exempt bond, tax rules require the Fund to reduce its tax basis by the amount of amortized premium.
Investments in debt obligations that are at risk of or in default present special tax issues for the Fund. Tax rules are not entirely clear about issues such as whether and to what extent the Fund should recognize market discount on a debt obligation; when the Fund may cease to accrue interest, OID, or market discount; when and to what extent the Fund may take deductions for bad debts or worthless securities; and how the Fund should allocate payments received on obligations in default between principal and income. These and other related issues will be addressed by the Fund when, as, and if it invests in such securities, in order to seek to ensure that it distributes sufficient income to preserve its status as a RIC and does not become subject to U.S. federal income or excise tax.
Although the interest on municipal obligations is generally exempt from U.S. federal income tax, distributions from the Fund derived from interest on municipal obligations are taxable to shareholders of the Fund when received, and gains realized by the Fund on the sale or exchange of municipal obligations are taxable to shareholders of the Fund.
Income and gains from certain commodity-linked instruments generally would not constitute qualifying income to a RIC for purposes of the 90% gross income test described above if a RIC were to invest directly in such instruments.
To the extent the Fund invests in commodities-related entities that are partnerships (other than qualified publicly traded partnerships (as defined above)), income or other trusts, or other pass-
78
through structures for U.S. federal income tax purposes, including, for instance, certain royalty trusts and certain ETFs (e.g., ETFs investing in gold bullion), all or a portion of any income and gains from such entities could constitute non-qualifying income to the Fund for purposes of the 90% gross income requirement described above. Similarly, certain other income trusts in which the Fund may invest could be partnerships or other pass-through structures for U.S. federal income tax purposes, such that, depending on the specific assets held by the income trust, all or a portion of any income or gains from such investment could constitute non-qualifying income to the Fund. In any such cases, the Funds ability to pursue its investment strategy, including a strategy involving the ability to make investments in such entities, may be limited by the Funds intention to qualify as a RIC and the Funds strategy may bear adversely on the Funds ability to so qualify. See Loss of RIC Status below.
Backup Withholding
The Fund (or in the case of shares held through an intermediary, the intermediary) generally is required to withhold and remit to the U.S. Treasury a percentage of the taxable distributions and redemption proceeds paid to any individual shareholder who fails to properly furnish the Fund (or the intermediary) with a correct taxpayer identification number, who has under-reported dividend or interest income, or who fails to certify that he or she is not subject to such withholding. The backup withholding tax rate is 28%. Any tax withheld as a result of backup withholding does not constitute an additional tax imposed on the record owner of the account, and may be claimed as a credit on the record owners U.S. federal income tax return, provided the appropriate information is furnished to the IRS.
Distributions to Non-U.S. Investors
In general, absent a specific statutory exemption, the Funds ordinary dividends are subject to a U.S. withholding tax of 30% when paid to a shareholder that is not a U.S. person within the meaning of the Code (a Non-U.S. Shareholder). To the extent withholding is made on an ordinary dividend paid to a Non-U.S. Shareholder, persons who are resident in a country that has an income tax treaty with the United States may be eligible for a reduced withholding rate (upon filing of appropriate forms), and are urged to consult their tax advisers regarding the applicability and effect of such a treaty.
The Funds Capital Gain Dividends and Return of Capital Distributions are generally not subject to withholding when paid to a Non-U.S. Shareholder, as described more fully below.
In addition, for taxable years of a RIC beginning before January 1, 2015 (each a pre-2015 taxable year), the RIC is not required to withhold any amounts (i) with respect to distributions (other than distributions to a Non-U.S. Shareholder (A) that has not provided a satisfactory statement that the beneficial owner is not a U.S. person, (B) to the extent that the dividend is attributable to certain interest on an obligation if the Non-U.S. Shareholder is the issuer or is a 10% shareholder of the issuer, (C) that is within certain foreign countries that have inadequate information exchange with the United States, or (D) to the extent the dividend is attributable to interest paid by a person that is a related person of the Non-U.S. Shareholder and the Non-U.S. Shareholder is a controlled foreign corporation) from U.S.-source interest income of types similar to those not subject to U.S. federal income tax if earned directly by an individual Non-U.S. Shareholder, to the extent such distributions are properly reported as such by the RIC (interest-related dividends), and (ii) with respect to distributions (other than (A) distributions to an individual Non-U.S. Shareholder who was present in the United States for a period or
79
periods aggregating 183 days or more during the year of the distribution and (B) distributions subject to special rules regarding the disposition of U.S. real property interests (USRPIs) as described below) of net short-term capital gains in excess of net long-term capital losses, to the extent such distributions were properly reported as such by the RIC (short-term capital gain dividends). A RIC is permitted to report such parts of its dividends paid in respect of a pre-2015 taxable year as interest-related and/or short-term capital gain dividends as are eligible, but is not required to do so.
Additionally, if a RIC invests in an Underlying RIC that reports and pays such short-term capital gain or interest-related dividends to its shareholders in respect of a taxable year of the Underlying RIC beginning before January 1, 2015, such distributions generally remain not subject to withholding if properly reported as such in respect of distributions paid by the RIC to its shareholders for a pre-2015 taxable year of the RIC. Similarly, if a RIC invests in an Underlying Fund that is treated as a partnership for U.S. federal income tax purposes, then to the extent that the Underlying Fund has allocated to the RIC income that would have given rise to interest-related or short-term capital gain dividends if it had been earned directly by the RIC, the RIC generally is permitted to report any dividends attributable to such income in respect of a pre-2015 taxable year as interest-related or short-term capital gain dividends, as applicable.
The exemption from withholding for interest-related and short-term capital gain dividends has expired for distributions with respect to taxable years of a RIC beginning on or after January 1, 2015. It is currently unclear whether Congress will extend this exemption for distributions with respect to taxable years of a RIC beginning on or after January 1, 2015, and what the terms of any such extension will be, including whether any such extension will have retroactive effect.
In the case of shares held through an intermediary, the intermediary may withhold even if the RIC properly reports the payment as an interest-related or short-term capital gain dividend to shareholders in respect of a pre-2015 taxable year. Non-U.S. Shareholders should contact their intermediaries regarding the application of these rules to their accounts.
In certain circumstances, a Non-U.S. Shareholder may be required to file appropriate U.S. federal tax forms in order to receive the benefit of these exemptions.
Under U.S. federal tax law, a Non-U.S. Shareholder is not, in general, subject to U.S. federal income tax on gains (and is not allowed a deduction for losses) realized on the sale of shares of the Fund or on Capital Gain Dividends unless (i) such gain or Capital Gain Dividend is effectively connected with the conduct by the Non-U.S. Shareholder of a trade or business within the United States; (ii) in the case of a Non-U.S. Shareholder that is an individual, the shareholder is present in the United States for a period or periods aggregating 183 days or more during the year of the sale or the receipt of the Capital Gain Dividend and certain other conditions are met; or (iii) the special rules relating to gain attributable to the sale or exchange of USRPIs apply to the Non-U.S. Shareholders sale of shares of the Fund or to the Capital Gain Dividend received.
Also, Non-U.S. Shareholders with respect to whom income from a Fund is effectively connected with a U.S. trade or business carried on by such shareholder will in general be subject to U.S. federal income tax on the income derived from the Fund at the graduated rates applicable to U.S. citizens, residents, or domestic corporations, whether such income is received in cash or reinvested in shares, and, in the case of a foreign corporation, may also be subject to a branch profits tax. If a Non-U.S. Shareholder is eligible for the benefits of a tax treaty, any effectively connected income or gain will generally be subject to U.S. federal income tax on a
80
net basis only if it is also attributable to a permanent establishment maintained by the shareholder in the United States. Again, Non-U.S. Shareholders who are residents in a country with an income tax treaty with the United States may obtain different tax results, and are urged to consult their tax advisers.
Non-U.S. Shareholders should consult their tax advisers (and if holding shares through an intermediary, their intermediary) concerning the application of these rules to their investment in the Fund.
In order to qualify for any exemptions from withholding described above or for lower withholding tax rates under income tax treaties, or to establish an exemption from backup withholding, a Non-U.S. Shareholder must comply with special certification and filing requirements relating to its non-U.S. status (including, for example, furnishing an IRS Form W-8BEN or W-8BEN-E). A Non-U.S. Shareholder in the Fund should consult their tax advisers and, if holding shares through intermediaries, their intermediaries, in this regard.
Special rules (including withholding and reporting requirements) apply to foreign partnerships and those holding Fund shares through foreign partnerships. Also, additional considerations may apply to foreign trusts and estates. Investors holding Fund shares through foreign entities should consult their tax advisers about their particular situation.
A Non-U.S. Shareholder may be subject to state and local taxes and to the U.S. federal estate tax in addition to the U.S. federal income tax referred to above.
Non-U.S. shareholders described in section 892 of the Code should consult their tax advisers with respect to their investment in the Fund.
See also Other Reporting and Withholding Requirements below for information regarding the potential application of an additional withholding regime.
Non-U.S. Taxes
The Funds non-U.S. investments may be subject to foreign withholding and other taxes on dividends, interest, capital gains, or the proceeds of dispositions that will decrease the Funds return on its investments. The Fund may otherwise be subject to non-U.S. taxation on repatriation proceeds generated from those investments or to other transaction-based non-U.S. taxes on those investments, including potentially on a retroactive basis, which can also decrease the Funds return on its investments. Such non-U.S. withholding taxes and other taxes may be reduced or eliminated under income tax treaties between the United States and certain non-U.S. jurisdictions. In some cases, the Fund may seek to collect a refund in respect of taxes paid to a non-U.S. jurisdiction (see Descriptions and Risks of Fund InvestmentsRisks of Non-U.S. Investments above for more information). The non-U.S. withholding and other tax rates applicable to the Funds investments in certain non-U.S. jurisdictions may be higher, in certain circumstances, for instance, if the Fund has a significant number of Non-U.S. Shareholders, if the Fund owns a significant holding of a non-U.S. issuer, or if the Fund or Underlying Fund invests through a subsidiary.
If, at the end of the Funds taxable year, more than 50% of the value of the total assets of the Fund is represented by direct investments in stock or other securities of foreign corporations, the Fund may make an election that allows shareholders to claim a foreign tax credit or deduction
81
(but not both) on their U.S. income tax return in respect of non-U.S. taxes paid by or withheld from the Fund on its non-U.S. portfolio investments. Only non-U.S. taxes that meet certain qualifications are eligible for this pass-through treatment. If the Fund is eligible for and makes such an election, its shareholders generally will include in gross income from non-U.S. sources their pro rata shares of such taxes paid by the Fund. A shareholders ability to claim an offsetting foreign tax credit or deduction in respect of these taxes is subject to limitations imposed by the Code, which may result in the shareholders not receiving a full credit or deduction (if any) for the amount of such taxes. Shareholders who do not itemize deductions on their U.S. federal income tax returns may claim a credit (but not a deduction) for such non-U.S. taxes. Even if the Fund is eligible to make this election, it may determine not to do so in its sole discretion, in which case any such qualified non-U.S. taxes paid by the Fund cannot be given this special pass-through treatment by the Fund or its shareholders. Investors should consult their tax advisers for further information relating to the foreign tax credit and deduction. Shareholders that are not subject to U.S. federal income tax, and those who invest in the Fund through tax-advantaged accounts (including those who invest through individual retirement accounts or other tax-advantaged retirement plans), generally will receive no benefit from any tax credit or deduction passed through by the Fund.
Withholding taxes that are accrued on dividends in respect of (i) securities on loan pursuant to a securities lending transaction during the period that any such security was not directly held by the Fund or (ii) securities the Fund temporarily purchased from a counterparty pursuant to a repurchase agreement that is treated as a loan for U.S. federal income tax purposes generally will not qualify as a non-U.S. tax paid by the Fund, in which case they could not be passed through to shareholders even if the Fund meets the other requirements described above.
Shareholder Reporting Obligations With Respect to Foreign Bank and Financial Accounts
Shareholders that are U.S. persons and own, directly or indirectly, more than 50% of the Fund could be required to report annually their financial interest in the Funds foreign financial accounts, if any, on FinCEN Form 114, Report of Foreign Bank and Financial Accounts (FBAR). Shareholders should consult their intermediaries through which the Fund investment is made (if applicable), as well as a tax adviser, regarding the applicability to them of this reporting requirement.
Other Reporting and Withholding Requirements
Sections 1471-1474 of the Code and the U.S. Treasury Regulations and IRS guidance issued thereunder (collectively, FATCA) generally require the Fund to obtain information sufficient to identify the status of each of its shareholders under FATCA or under an applicable intergovernmental agreement (an IGA). If a shareholder fails to provide this information or otherwise fails to comply with FATCA or an IGA, the Fund or its agent may be required to withhold under FATCA 30% of the distributions, other than distributions properly reported as capital gain dividends, the Fund pays to that shareholder and, after December 31, 2016, 30% of the gross proceeds of the sale, redemption or exchange of Fund shares and certain Capital Gain Dividends the Fund pays to that shareholder. If a payment by the Fund is subject to FATCA withholding, the Fund or its agent is required to withhold even if the payment would otherwise be exempt from withholding under the rules applicable to Non-U.S. Shareholders described above (e.g., Capital Gain Dividends).
82
Payments to a shareholder will generally not be subject to FATCA withholding, provided the shareholder provides the Fund with such certifications, waivers or other documentation or information as the Fund requires, including, to the extent required, with regard to such shareholders direct and indirect owners, to establish the shareholders FATCA status and otherwise to comply with these rules. In order to avoid withholding, a shareholder that is a foreign financial institution (FFI) must either (i) become a participating FFI by entering into a valid U.S. tax compliance agreement with the IRS; (ii) qualify for an exception from the requirement to enter into such an agreement, for example by becoming a deemed compliant FFI; or (iii) be covered by and in compliance with an applicable intergovernmental agreement between the United States and a foreign government to implement FATCA. In any of these cases, the investing FFI generally will be required to provide the Fund with appropriate identifiers, certifications or documentation concerning its status. The IRS has issued guidance on how FATCA interacts with other U.S. withholding tax rules and, accordingly, the above-described withholding tax may apply differently in the event that income is subject to multiple types of withholding.
The Fund will disclose the information that it receives from (or concerning) its shareholders to the IRS, non-U.S. taxing authorities or other parties as necessary to comply with FATCA, related intergovernmental agreements or other applicable law or regulation.
If an Underlying Fund were to fail to comply with FATCA or were to be a member of an expanded affiliated group in which a member of such group causes other members to not be in compliance with FATCA, such non-compliance could reduce the Funds return on its investments.
Each prospective investor is urged to consult its tax adviser regarding the applicability and consequences of FATCA and any other reporting requirements with respect to the prospective investors own situation, including investments through an intermediary.
The Fund and its shareholders may be subject to certain other tax reporting requirements as a result of the investment strategy and activities of the Fund. Certain U.S. federal, state, local and non-U.S. tax reporting requirements may require the Fund to provide certain information about its shareholders to the IRS or other similar authorities responsible for tax matters in other jurisdictions (e.g., foreign countries).
Loss of RIC Status
If the Fund were to fail to meet the income, diversification, or distribution test described in Tax Status and Taxation of the Fund above, the Fund could in some cases cure such failure, including by paying a Fund-level tax, paying interest charges, making additional distributions, or disposing of certain assets. If the Fund were ineligible to or otherwise did not cure such failure for any year, or if the Fund were otherwise to not qualify for taxation as a RIC for such year, the Funds income would be taxed at the Fund level at regular corporate rates, and depending on when the Fund discovered its qualification failure for a particular taxable year, the Fund may be subject to penalties and interest on any late payments of its Fund-level taxes for such year. In addition, in the event of any such loss of RIC status, all distributions from earnings and profits, including distributions of net long-term capital gains and net tax-exempt income (if any), generally would be taxable to shareholders as ordinary income. Such distributions generally would be eligible (i) to be treated as qualified dividend income in the case of shareholders taxed as individuals and (ii) for the dividends-received deduction in the case of corporate shareholders,
83
provided, in both cases, the shareholder meets certain holding period and other requirements in respect of the Funds shares. In addition, in order to re-qualify for taxation as a RIC that is accorded special tax treatment, the Fund may be required to recognize unrealized gains, pay substantial taxes and interest on such gains, and make certain substantial distributions. If an Underlying RIC were to fail to qualify as a RIC in a particular taxable year, the Funds return on its investment in such Underlying RIC and, depending on the size of the Funds investment in such Underlying RIC, the Funds ability to qualify as a RIC, could be adversely affected.
Certain of the Funds investments could affect the amount, timing and character of the Funds income, gains and distributions, and could cause the Fund to recognize taxable income in excess of the cash generated by such investments which may require the Fund to liquidate investments, including when it is not advantageous to do so, in order to make required distributions. Further, the application of the requirements for treatment as a RIC under the Code can be unclear with respect to certain of these investments. As a result, certain of the Funds investments could cause the Fund to fail to qualify as a RIC.
Tax Shelter Reporting Regulations
Under Treasury regulations, if a shareholder recognizes a loss on disposition of the Funds shares of $2 million or more for an individual shareholder or $10 million or more for a corporate shareholder, the shareholder must file with the IRS a disclosure statement on Form 8886. Direct holders of portfolio securities are in many cases excepted from this reporting requirement, but under current guidance, shareholders of a RIC are not excepted. Future guidance may extend the current exception from this reporting requirement to shareholders of most or all RICs. The fact that a loss is reportable under these regulations does not affect the legal determination of whether the taxpayers treatment of the loss is proper. Shareholders should consult their tax advisers to determine the applicability of these regulations in light of their individual circumstances.
State and Local Tax Matters
Most states permit mutual funds, such as the Fund, to pass through to their shareholders the state tax exemption on income earned from investments in some direct U.S. Treasury obligations, as well as some limited types of U.S. government agency securities (such as Federal Farm Credit Bank and Federal Home Loan Bank securities), so long as the Fund meets all applicable state requirements. Therefore, shareholders in the Fund may be allowed to exclude from their state taxable income distributions made to them by the Fund that are attributable to interest the Fund directly or indirectly earned on such investments. The availability of these exemptions varies by state. Investments in securities of certain U.S. government agencies, including securities issued by Ginnie Mae, Fannie Mae, and Freddie Mac, and repurchase agreements collateralized by U.S. government securities generally do not qualify for these exemptions. Moreover, these exemptions may not be available to corporate shareholders. All shareholders should consult their tax advisers regarding the applicability of these exemptions to their situation.
TAXES: SYSTEMATIC GLOBAL MACRO OPPORTUNITY FUND AND WORLD OPPORTUNITY OVERLAY FUND
The following section applies only with respect to Systematic Global Macro Opportunity Fund and World Opportunity Overlay Fund (for purposes of this section Taxes: Systematic Global Macro Opportunity Fund and World Opportunity Fund, the Funds, and each a Fund).
84
The Funds shareholders are other Funds of the Trust and certain accredited investors. The following summary does not discuss the tax consequences to the shareholders of those other Funds of the Trust, of distributions by those other Funds to their shareholders, or of the sale of shares of those other Funds by their shareholders. Shareholders of such Funds should consult the prospectuses (or private placement memoranda) and statements of additional information of those other Funds for a discussion of the tax consequences applicable to them.
Fund Status
For U.S. federal income tax purposes, each Fund has elected to be treated as a partnership and not as an association taxable as a corporation. Consistent with the treatment of its assets and liabilities under the Trusts Amended and Restated Declaration of Trust and Massachusetts law regarding business trusts, each Fund considers itself to be a separate business entity from the other series of the Trust that should not be required to take into account the assets, operations, or shareholders of other series of the Trust for U.S. federal income tax purposes (e.g., for purposes of determining possible characterization as a publicly traded partnership). To each Funds knowledge, the IRS has not taken a definitive position with respect to the separate tax treatment of series of Massachusetts business trusts that are treated as partnerships.
An entity that would otherwise be treated as a partnership for U.S. federal income tax purposes may be taxable as a corporation if it is a publicly traded partnership under Section 7704 of the Code. In general, each Fund currently expects to be treated, and intends to operate so that it will be treated, as a partnership that is separate from each other series of the Trust and that is not a publicly traded partnership for U.S. federal income tax purposes. Currently, each Fund intends to monitor the number of its shareholders so as not to be treated as a publicly traded partnership. If, however, a Fund were determined to be a publicly traded partnership taxable as a corporation, it generally would be subject to tax at the Fund level on its earnings and profits at regular corporate income tax rates, and any distributions from earnings and profits generally would be taxable to shareholders as ordinary income. Such distributions generally would be eligible to (i) be treated as qualified dividend income in the case of shareholders taxed as individuals, and (ii) for the dividends-received deduction in the case of corporate shareholders, provided, in both cases, the shareholder meets certain holding period and other requirements in respect of the Funds shares. In addition, if a Fund were determined to be a publicly traded partnership, the Funds overall performance may be reduced. There can be no assurance that the IRS will not seek to challenge the tax status of a Fund, and there can be no assurance that the IRS would not prevail with respect to any such challenge.
The remainder of this discussion assumes that each Fund will be treated as a partnership for U.S. federal income tax purposes that is separate from each other series of the Trust and is not a publicly traded partnership.
In general, entities treated as partnerships are not subject to U.S. federal income tax. Instead, partners in a partnership will be subject to tax on their distributive shares of the partnerships taxable income, gains, losses, deductions, credits, items of tax preference and other tax items, as described more fully below.
Taxation of Shareholders
Each shareholder will be required to take into account in computing its U.S. federal income tax liability its allocable share of a Funds income, gains, losses, deductions, credits, and other tax
85
items for any taxable year of the Fund ending with or within the taxable year of the shareholder, without regard to whether it has received or will receive corresponding distributions from the Fund. See Distributions and Adjusted Basis below.
The amount of tax due, if any, with respect to gains and income of a Fund is determined separately for each shareholder. Each Fund will be required to file an information return on IRS Form 1065, and, to provide each shareholder with a Schedule K-l indicating the shareholders allocable share of the Funds income, gains, losses, deductions, credits, and other tax items following the close of the Funds taxable year. Each shareholder, however, is responsible for assessing the U.S. federal tax reporting information it receives and keeping its own records for determining its tax basis in its Fund shares and calculating and reporting any gain or loss resulting from a Fund distribution or redemption or other disposition of Fund shares.
In certain cases, a Fund may be required to amend tax information reported to shareholders on a Schedule K-1 or otherwise in respect of a particular year. In this event, shareholders may be required to file amended U.S. federal income or other tax returns in respect of such amended information and pay additional taxes (including potentially interest and penalties), and may incur other related costs. Shareholders should consult their tax advisers in this regard.
Each Fund will use the accrual method of accounting to determine its net profits or net losses for U.S. federal income tax purposes. To the extent consistent with applicable law, each Fund will adopt a taxable year ending on the 28th day (or 29th day, as applicable) of February as its taxable year for U.S. federal income tax purposes. In the event, however, that one or more shareholders having an aggregate interest in Fund profits and capital of more than 50% (majority interest partners), or all shareholders having a 5% or greater interest in Fund profits or capital (principal partners), have a different taxable year, a Fund may be required to adopt the taxable year of those shareholders. Further, if there is no majority interest partners taxable year or principal partners taxable year, then, under applicable Treasury regulations, a Fund may be required to adopt the taxable year of one or more of the Funds shareholders that results in the least aggregate deferral of income to the Funds shareholders (as described in the relevant Treasury regulations). Any change in a Funds taxable year under these rules may accelerate a shareholders recognition of its allocable share of a Funds income, gains, losses, deductions, credits, and other tax items.
Fund Allocations
For U.S. federal income tax purposes, the income, gains, losses, deductions, credits, and other tax items of each Fund are generally allocated among the shareholders so as to reflect, in the judgment of GMO, the interests of the shareholders in the Fund. GMO, in consultation with each Funds tax adviser, is authorized to select and modify allocations to comply with applicable tax regulations, including, without limitation, the income tax provisions under Sections 704, 706, 708, 734, 743, 754, and 755 of the Code and the regulations thereunder; to make all tax elections and determinations; and to make special allocations of specific items, including items of gross income, gain, loss, or deduction. In particular, a Fund or certain entities that are treated as partnerships for U.S. federal income tax purposes in which a Fund invests may elect to, or be required to, make adjustments to the basis of the Funds or such entities assets, which could affect the amount, timing or character of a shareholders allocable share of the Funds income, gain, loss, or deduction. In addition, allocations of income, gains, losses or deductions to or from redeeming shareholders could result in shareholders (including a redeeming shareholder) receiving more or less items of income, gain, loss, or deduction (and/or income, gains, losses, or
86
deductions of a different character) than they would in the absence of such allocations. Some or all of the Funds allocations may not (and allocations described in the prior sentence likely may not) have economic effect under the Treasury regulations, and a successful challenge by the IRS of such allocations may result in some shareholders (including, in the case of redemptions, redeeming shareholders and/or remaining shareholders) recognizing currently more income for tax purposes than otherwise would have been the case. Allocations of a Funds income, gain, loss and deduction for U.S. federal income tax purposes may not match the amounts of income, gain, loss or deduction reported for book purposes or the amount of economic gain or loss in any given year.
A Fund may revalue its assets to reflect unrealized gains and losses. Tax rules only permit such accounting in limited cases, including if the revaluations are made under generally accepted industry accounting practices, provided substantially all of the Funds property (excluding money) consists of stock, securities, commodities, options, warrants, futures, or similar instruments that are readily tradable on an established securities market. If a Fund were unable to qualify to use such revaluations, certain allocations to shareholders capital accounts could be deemed to be capital shifts, the treatment of which is in some cases unclear and which may constitute taxable income to the Fund or certain shareholders.
In addition, Treasury regulations permit certain securities partnerships to use an aggregate method for so-called reverse 704(c) allocations (but only with respect to qualified financial assets). A Fund or its assets may fail to qualify to use the aggregate method, which could result in incremental administrative expenses for the Fund, possible challenges by the IRS, and the possibility of some shareholders recognizing more income and/or gain for U.S. federal income tax purposes than would otherwise be the case.
Shareholders who contribute assets in-kind to a Fund in exchange for shares in the Fund (to the extent such investors do not recognize gains at the time of the contribution) generally will, at the time of disposition by the Fund of such shareholders contributed assets, be specially allocated gains or losses from such assets up to the amount of built-in gain or built-in loss, respectively, at the time of contribution. In addition, there may be circumstances in which shareholders who contribute appreciated assets to a Fund in-kind could recognize income up to the built-in gain in such assets at the time of contribution even in advance of a disposition of such assets.
By purchasing shares of a Fund, shareholders agree to be bound by the Funds allocations, elections, and determinations. The IRS may successfully challenge any of the foregoing, in which case a shareholder may be allocated more or less of any tax item.
Distributions and Adjusted Basis
In general, a shareholders adjusted basis in its shares will initially equal the amount of cash and, if any, the adjusted basis in other property the shareholder has contributed for the shares, and will be increased by the shareholders allocable share of Fund income and gains and decreased (but not below zero) by the amount of cash distributions and the adjusted basis of any property distributed from a Fund to the shareholder and the shareholders distributive share of certain Fund expenses and losses. In addition, a shareholders basis includes the shareholders share of a Funds liabilities, and decreases in the shareholders share of liabilities are treated as cash distributions.
87
In general, a shareholder that receives cash in connection with the shareholders complete withdrawal from a Fund will recognize capital gain or loss to the extent of the difference between the proceeds received by the shareholder and the shareholders adjusted tax basis in its shares immediately before the distribution. Gain or loss recognized as a result of a complete withdrawal from a Fund generally will be short-term or long-term capital gain or loss depending on the shareholders holding period for its shares in the Fund, except that a shareholder will generally recognize ordinary income (regardless of whether there would otherwise be net gain on the transaction and possibly in excess of net gain otherwise recognized) to the extent that the shareholder receives a cash distribution for the shareholders allocable share of (i) previously untaxed unrealized receivables (including any accrued but untaxed market discount), if any, or (ii) certain inventory (together, Hot Assets). A shareholders receipt of a non-liquidating cash distribution from a Fund generally will result in recognized gain (but not loss) only to the extent that the amount of the distribution exceeds the shareholders adjusted basis in its Fund shares before the distribution, except that the shareholder might recognize ordinary gain, regardless of whether the distribution exceeds its basis, in the event that a Fund holds Hot Assets under the rules described above. A shareholders basis in a Fund for purposes of calculating future gain or loss will be adjusted accordingly. If a shareholder acquired portions of its interest at different times or acquired its entire interest in a single transaction subject to different holding periods, such shareholders interest generally will have a divided holding period, which could cause such shareholder to recognize more or less short-term and long-term capital gain or loss than it would have with a single holding period.
A shareholder generally will not recognize gain or loss on an in-kind distribution of property from a Fund. If the distribution does not represent a complete liquidation of the shareholders shares, the shareholders basis in the distributed property generally will equal the Funds adjusted tax basis in the property, or, if less, the shareholders basis in its Fund shares before the distribution. If the distribution is made in complete liquidation of the shareholders Fund shares, the shareholder generally will take the assets with a tax basis equal to its adjusted tax basis in its shares. Special rules may apply to the distribution of property to a shareholder who contributed other property to a Fund and to the distribution of such contributed property to another shareholder. The tax law generally requires a partner in a partnership to recognize gain on a distribution by the partnership of marketable securities to the extent that the value of such securities exceeds the partners adjusted basis in its partnership interest. This requirement does not apply, however, to distributions to eligible partners of an investment partnership, as those terms are defined in the Code. If a Fund qualifies as an investment partnership, each shareholder should qualify as an eligible partner, provided that such investor contributes only cash and certain other property to the Fund.
To the extent a shareholder receives a distribution of Hot Assets in exchange for its share of Fund property, including money, or receives a distribution of property, including money, in exchange for its share of Hot Assets, the transaction may be treated as a sale or exchange between the distributee shareholder and the Fund. In general, any gain to the person deemed to be exchanging its pro rata share of Hot Assets for other property (including money) will be ordinary income to such person.
A shareholder cannot deduct losses from a Fund in an amount greater than the shareholders adjusted tax basis in its Fund shares as of the end of the Funds tax year. A shareholder may be able to deduct such excess losses in subsequent tax years to the extent that the shareholders adjusted tax basis for its shares exceeds zero in such years. See At Risk Rules, Limitations on a Shareholders Deduction of Investment Expenses 2% Floor, Limitations on
88
Shareholders Deduction of Interest, Effect of Ownership of Tax-Exempt Obligations on Interest Deductions, and Organizational Expenses below for other limitations on the deductibility of Fund losses and certain expenses.
Reimbursement of Fund Expenses
GMO has contractually agreed to reimburse each Fund for specified Fund expenses (as described in the Private Placement Memorandum under the heading Fees and expenses). Although each Fund expects to take the position that the reimbursement of Fund expenses by GMO does not result in income to the Fund, or indirectly to its shareholders, the IRS could challenge this position and prevail, with the result that shareholders would recognize more income for U.S. federal income tax purposes than would otherwise be the case.
Character and Timing of Income and Tax Implications of Certain Investments
A Funds income and gains, if any, may consist of ordinary income, short-term capital gains, and/or long-term capital gains. Accordingly, shareholders should not expect that any portion of any taxable income of a Fund will necessarily consist of long-term capital gains taxable to individuals at reduced rates or qualified dividend income to individuals at long-term capital gains rates. A Funds taxable losses (if any) may consist of long-term and short-term capital losses, the deductibility of which is subject to certain limitations.
A Funds transactions in derivative instruments (e.g., swap agreements, options, futures or forward contracts), as well as any of its other hedging, short sales, or similar transactions, may be subject to one or more special tax rules (e.g., notional principal contract, straddle, constructive sale, wash-sale, short-sale, and partner-to-partnership and partner-to-partner disguised sale rules). These rules may affect whether gains and losses recognized by Fund shareholders are treated as ordinary or capital and/or as short-term or long-term, accelerate the recognition of income or gains, defer losses, and cause adjustments in the holding periods of the Funds investments. The rules could therefore affect the amount, timing, and/or character of income, gains, deductions, losses, and other tax items that are allocable to shareholders and could cause shareholders to be taxed on amounts in excess of economic income. In addition, because the tax rules applicable to derivative financial instruments are in some cases uncertain under current law, an adverse determination or future guidance by the IRS with respect to these rules (which determination or guidance could be retroactive) may cause changes in a shareholders allocation of any tax item, possibly for prior tax years.
In general, option premiums received by a Fund are not immediately included in the income of the Fund. Instead, the premiums generally are recognized when the option contract expires, the option is exercised by the holder, or the Fund transfers or otherwise terminates the option (e.g., through a closing transaction). The remainder of this paragraph describes the general tax consequences to a Fund of writing a put or call option that is not subject to one or more of the special rules described in the immediately following paragraphs. If securities or other property are purchased by a Fund pursuant to the exercise of a put option written by it, the Fund generally will subtract the premium received from its cost basis in the securities or other property purchased. If a call option written by a Fund is exercised and the Fund sells or delivers the underlying securities or other property, Fund shareholders generally will recognize capital gain or loss equal to (i) the sum of the strike price and the option premium received by the Fund minus (ii) the Funds basis in the securities or other property. Such gain or loss generally will be short-term or long-term depending upon the holding period of the underlying securities or other property. The gain or loss with respect to any termination of a Funds obligation under an option other than through the exercise of the option and related purchase, sale or delivery of the underlying securities or other
89
property generally will be short-term gain or loss depending on whether the premium income received by the Fund is greater or less than the amount paid by the Fund (if any) in terminating the transaction. Thus, for example, if an option written by a Fund expires unexercised, Fund shareholders generally will recognize short-term gain equal to the premium received.
Certain covered call writing activities and other option strategies of a Fund may trigger the U.S. federal income tax straddle rules of Section 1092 of the Code, requiring the deferral of losses and the termination of holding periods on offsetting positions in options and stocks deemed to constitute substantially similar or related property. Call options on stocks that are not deep in the money may constitute qualified covered calls, which generally are not subject to the straddle rules; the holding period on stock underlying qualified covered calls that are in the money although not deep in the money will be suspended during the period that such calls are outstanding. Thus, the straddle rules and the rules governing qualified covered calls could cause gains that would otherwise constitute long-term capital gains to be treated as short-term capital gains, and distributions that would otherwise constitute qualified dividend income or qualify for the corporate dividends-received deduction to fail to satisfy the holding period requirements and therefore to be taxed as ordinary income or to fail to qualify for the dividends-received deduction, as the case may be.
The tax treatment of certain contracts entered into by a Fund (including regulated futures contracts and non-equity options) will be governed by Section 1256 of the Code (Section 1256 contracts). Gains or losses on Section 1256 contracts generally are considered 60% long-term and 40% short-term capital gains or losses (60/40), although certain foreign currency gains and losses from such contracts may be treated as ordinary in character. Also, Section 1256 contracts held by a Fund at the end of each taxable year are marked to market, with the result that unrealized gains or losses are treated as though they were realized and the resulting gain or loss is treated as ordinary or 60/40 gain or loss, as applicable.
A portion of a Funds income (including income from a U.S. REIT or allocated to a Fund from another pass-through entity) that is attributable to a residual interest in a REMIC (including by investing in residual interests in CMOs with respect to which an election to be treated as a REMIC is in effect) or an equity interest in a TMP (referred to in the Code as an excess inclusion) will be subject to federal income tax in all events. The excess inclusion income of a partnership, such as the Funds, will be allocated to shareholders of the partnership consistent with their allocation of other items of income, with the same consequences as if the shareholders held the related interest directly. As a result, a Fund investing in any such interests may not be a suitable investment for certain tax-exempt investors, as noted in U.S. Tax-Exempt Shareholders below.
In general, excess inclusion income allocated to shareholders (i) cannot be offset by net operating losses (subject to a limited exception for certain thrift institutions); (ii) will constitute UBTI (as defined below) to entities (including a qualified pension plan, an individual retirement account, a 401(k) plan, a Keogh plan, or other tax-exempt entity) subject to tax on UBTI, thereby potentially requiring such an entity that is allocated excess inclusion income to file a tax return and pay tax on such income; and (iii) in the case of a shareholder that is not a U.S. person within the meaning of the Code, will not qualify for any reduction in U.S. federal withholding tax. A shareholder will be subject to U.S. federal income tax on such inclusions notwithstanding any
90
exemption from such income tax otherwise available under the Code. See U.S. Tax-Exempt Shareholders below.
Some debt obligations with a fixed maturity date of more than one year from the date of issuance (and zero-coupon debt obligations with a fixed maturity date of more than one year from the date of issuance) will be treated as debt obligations that are issued originally at a discount. Generally, the amount of the OID is treated as interest income and is included in a Funds taxable income on a current basis and thus allocated to Fund shareholders over the term of the debt security, even though payment of that amount is not received by the Fund until a later time, usually upon partial or full repayment or disposition of the debt security. In addition, payment-in-kind securities will give rise to income which is taxable even though the Fund holding the security receives no interest payment in cash on the security during the year.
Some debt obligations with a fixed maturity date of more than one year from the date of issuance that are acquired by a Fund in the secondary market may be treated as having market discount. Very generally, market discount is the excess of the stated redemption price of a debt obligation (or in the case of an obligation issued with OID, its revised issue price) over the purchase price of such obligation. Also very generally, any gain recognized on the disposition of, and any partial payment of principal on, a debt security having market discount is treated as ordinary income to the extent the gain, or principal payment, does not exceed the accrued market discount on such debt security. Alternatively, the Fund may elect to accrue market discount currently, in which case the Fund will be required to include the accrued market discount in the Funds income (as ordinary income) on a current basis and thus allocate such accrued income to shareholders over the term of the debt security, even though payment of that accrued income is not received by the Fund until a later time, upon partial or full repayment or disposition of the debt security. The rate at which the market discount accrues, and thus is included in the Funds income and allocated to shareholders, will depend upon which of the permitted accrual methods the Fund elects.
Some debt obligations with a fixed maturity date of one year or less from the date of issuance may be treated as having OID or, in certain cases, acquisition discount (very generally, the excess of the stated redemption price over the purchase price). Generally, a Fund will be required to include the acquisition discount or OID in income (as ordinary income) on a current basis and thus allocate such income to Fund shareholders over the term of the debt security, even though payment of that amount is not received by the Fund until a later time, usually when the debt security matures. The OID or acquisition discount accrues ratably in equal daily installments or, if the Fund so elects, at a constant (compound) interest rate. If the Fund elects the constant interest rate method, the character and timing of recognition of income will differ from what they would have been under the default pro rata method.
Increases in the principal amount of an inflation-indexed bond will be treated as OID, includible in the Funds income (as ordinary income) and thus allocated to Fund shareholders over the term of the bond, even though payment of that amount is not received by the Fund until a later time. Generally, decreases in the principal amount of an inflation-indexed bond will reduce the amount of interest from the debt instrument that would otherwise be includible in income. In addition, if the negative inflation adjustment exceeds the income includible by a Fund with respect to the debt instrument (including any OID) for the taxable year, such excess will be an ordinary loss to the extent a Funds total interest inclusions on the debt instrument in prior taxable years exceed the total amount treated by the Fund as an ordinary loss on the debt instrument in prior taxable
91
years. Any remaining excess may be carried forward to reduce taxable income and/or gain from the instrument in subsequent years.
In addition, a Fund may purchase investment units and, if a portion of the purchase price is allocated to the non-debt portion of such units (e.g., warrants), the debt instrument purchased may also be deemed to have OID. Similar rules may apply to certain preferred stock (whether acquired as part of an investment unit or, in certain cases, otherwise). A Fund may also purchase contingent payment debt instruments. For U.S. federal income tax purposes, holders (including shareholders of a Fund) of OID or contingent payment debt instruments generally have to include taxable income (as interest) on a constant yield basis without regard to whether cash is received with respect thereto. Gain on the disposition of contingent payment debt instruments generally will be treated for U.S. federal income tax purposes as ordinary interest income rather than as capital gain. In addition, a Fund may engage in modifications of debt instruments and exchanges of debt instruments for new debt instruments, and it is possible that such transactions could give rise to taxable income without a corresponding receipt of cash. The modified or newly-issued debt instruments may have a significant amount of OID. In certain circumstances, a Fund may receive fee income in connection with modifications and exchanges of debt instruments which may be treated as ordinary income.
Very generally, where a Fund purchases a bond at a price that exceeds the redemption price at maturity, that is, at a premium, the premium is amortizable over the remaining term of the bond. In the case of a taxable bond, if a Fund makes an election applicable to all such bonds it purchases, which election is irrevocable without the consent of the IRS, the Fund reduces the current taxable income from the bond by the amortized premium and reduces its tax basis in the bond by the amount of such offset; upon the disposition or maturity of such bonds acquired on or after January 4, 2013, the Fund is generally permitted to deduct any remaining premium allocable to a prior period. In the case of a tax-exempt bond, tax rules require a Fund to reduce its tax basis by the amount of amortized premium.
Investments in debt obligations that are at risk of, or in, default present special tax issues for a Fund. Tax rules are not entirely clear about issues such as whether and to what extent the Fund should recognize market discount on a debt obligation; when the Fund may cease to accrue interest, OID, or market discount; when and to what extent the Fund may take deductions for bad debts or worthless securities; and how the Fund should allocate payments received on obligations in default between principal and income. These and other related issues will be addressed by a Fund when, as, and if it invests in such securities.
Certain of a Funds investments in instruments that are treated as debt for corporate law purposes or otherwise may be treated as equity for U.S. federal income tax purposes, in which case the U.S. federal income tax treatment of such instruments will generally differ from the treatment of debt instruments described above.
The Funds may engage in transactions where all or a portion of the income or loss attributable to currency fluctuations will be treated as ordinary income or loss. In general, where some or all of the amount that a Fund is entitled to receive or required to pay in a Section 988 Transaction is denominated in (or determined by reference to) a currency other than the U.S. dollar, the foreign currency gain or loss attributable to the transaction and allocated to shareholders is generally calculated separately from any gain or loss on the underlying transaction and treated as ordinary income or loss rather than capital gain or loss. These transactions include, but are not limited to, the following: acquiring or becoming the obligor under a debt instrument; accruing or otherwise
92
taking into account any item of expense or gross income or receipts that is to be paid or received at a later date; and entering into or acquiring any forward contract, futures contract, option, or similar financial instrument. In general, the gain or loss from the disposition of non-functional currency is also treated as gain or loss from a Section 988 Transaction. A Fund may elect to treat gains or losses from certain foreign currency contracts as capital gains or losses.
If a Fund invests in shares of Underlying RICs, its income and gains will normally consist, in part, of distributions from Underlying RICs and income, gains and losses on the disposition of shares of Underlying RICs. The amount of income and capital gains realized by a Funds shareholders in respect of the Funds investments in Underlying RICs may be greater than such amounts would have been had the Fund invested directly in the investments held by the Underlying RICs, rather than investing in shares of the Underlying RICs. Similarly, the character of such income and gains (e.g., long-term capital gain, eligibility for dividends-received deduction, etc.) will not necessarily be the same as it would have been had the Fund invested directly in the investments held by the Underlying RICs.
Depending on a Funds percentage ownership in an Underlying RIC both before and after a redemption of Underlying RIC shares, the Funds redemption of shares of such Underlying RIC may cause the Fund to be treated as receiving a dividend on the full amount of the redemption instead of being treated as realizing capital gain (or loss) on the redemption of the shares of the Underlying RIC. This could be the case where the Fund holds a significant interest in an Underlying RIC that is not a publicly offered RIC within the meaning of the Code where true, most likely because the Underlying RIC is offered only to upper-tier funds or other accredited investors and redeems only a small portion of such interest. Dividend treatment of a redemption by a Fund would affect the amount and character of income required to be distributed by the Underlying RIC for the year in which the redemption occurred, and could cause Fund shareholders to recognize higher amounts of ordinary income than if they held shares of the Underlying RICs directly.
Furthermore, certain of a Funds investments may be in entities that are treated as partnerships for U.S. federal income tax purposes, and as such, that Fund would be required to take into account its distributive share of such entities income, gains, losses, deductions, credits, and other tax items. Consequently, to the extent a Fund invests in other partnerships, the nature of that Funds income, gains, losses, deductions, credits, and other tax items will depend, in part, on the activities and holdings of such partnerships.
It is possible that a shareholders tax liability relating to a Fund in a taxable year will exceed amounts of cash (if any) distributed by the Fund to the shareholder in that year. This is particularly likely in the case of Funds that generally do not intend to make non-redeeming cash distributions to their shareholders (see Distributions in the Funds Private Placement Memorandum for each Funds distribution policy).
If eligible, a Fund, in the discretion of GMO, may make the election described in Section 475(f) of the Code (the mark-to-market election). If a Fund makes the mark-to-market election, the rules described in this section (and, potentially, certain of the rules described in the immediately following section) will generally not apply to the Funds transactions and the Fund instead will generally be required to recognize ordinary gain or loss on many (or all) of its investments at the end of each taxable year as if the Fund had sold such investments for their fair market value on the last business day of such taxable year. GMO currently does not expect to make the mark-to-market election, but may determine to do so in the future.
93
Effect of Straddle and Wash Sale Rules on Shareholders Securities Positions
The IRS may treat certain positions in securities held (directly or indirectly) by a shareholder and its indirect interest in similar securities held by reason of its investment in a Fund as straddles for U.S. federal income tax purposes. The application of the straddle rules in such a case could affect a shareholders holding period for the securities involved and may defer the recognition of losses with respect to such securities. A loss a shareholder otherwise would realize upon a disposition of securities held either directly or indirectly (including through a Fund) may be disallowed in part or in whole if substantially identical securities are purchased either directly by the shareholder or indirectly (including through the Fund) within 30 days before or after the disposition. In such a case, the basis of the newly purchased securities will be adjusted to reflect the loss. These rules generally also apply to direct or indirect interests in options, swaps and other derivatives.
At Risk Rules
The Code further limits the deductibility of losses by certain taxpayers (such as individuals and certain closely held corporations) from a given activity to the amount which the taxpayer is at risk in the activity. Losses which cannot be deducted by a shareholder because of the at risk rules may be carried forward to subsequent years until such time as they are allowable. The amount which a shareholder will be considered to have at risk generally will be the purchase price of its interest plus the shareholders cumulative share of Fund income and gains, and certain liabilities that are recourse to the shareholder, minus the shareholders cumulative share of Fund expenses, losses, and distributions. The at risk limitations may be applied on an activity-by-activity basis with limited or no aggregation. There can be no assurance that a Funds losses allocable to a shareholder which are suspended by the at risk rules will be available to offset a shareholders income and gains in subsequent years.
Passive Activity Loss Limitations
The Code further limits the deductibility of losses and expenses by certain taxpayers from activities in which the taxpayer does not materially participate. Generally, loss from such passive activities may not be deducted from non-passive income. To the extent that the total deductions from passive activities exceed the total income from passive activities for a tax year, the excess (the passive activity loss) is generally not allowed for that year and is carried forward as a deduction from income from passive activities in subsequent years. However, losses previously disallowed under passive activity loss rules may be used to offset non-passive income if a taxpayer disposes of its interest in a passive activity and meets certain other requirements. Furthermore, there may be additional limitations on some or all types of passive losses realized by a Fund.
Limitations on Dividends-Received Deduction and Qualified Dividend Income
For corporate shareholders (other than S corporations), the 70% dividends-received deduction will generally apply (subject to holding period and other requirements imposed by the Code) to their proportionate share of dividend income received by a Fund from its investments in U.S. corporations for the taxable year.
Qualified dividend income received by an individual is taxed at the rates applicable to long-term capital gain for such individual. An otherwise qualifying dividend will not constitute qualified
94
dividend income if certain holding period and other requirements are not met. Dividends paid by foreign corporations will not qualify as qualified dividend income unless, among other things, (i) the corporation paying the dividend is eligible for the benefits of a comprehensive income tax treaty with the United States or (ii) the dividend is paid on stock of such a foreign corporation that is readily tradable on an established securities market in the United States. In addition, dividends will not be qualified dividend income if paid by a foreign corporation that is a passive foreign investment company (PFIC). To the extent that dividends received by a Fund do not qualify as qualified dividend income, shareholders will generally be subject to tax at ordinary income tax rates with respect to their allocable share of such dividends received by the Fund.
Dividends received by a Fund from a U.S. REIT will not qualify for the dividends-received deduction and generally will not constitute qualified dividend income.
Limitations on Shareholders Deduction of Interest
Section 163(d) of the Code imposes limitations on the deductibility of investment interest by non-corporate taxpayers. Investment interest is defined as interest paid or accrued on indebtedness incurred or continued to purchase properties to be held for investment. Investment interest is deductible only to the extent of net investment income (i.e., investment income less investment expenses). For this purpose, any long-term capital gain and qualified dividend income are excluded from net investment income unless the taxpayer elects to pay tax on such amounts at ordinary income tax rates. Otherwise allowable deductions in connection with short sales generally are treated as investment interest for purposes of this limitation. In general, investment interest which cannot be deducted for any year because of the foregoing limitation may be carried forward and allowed as a deduction in a subsequent year to the extent the taxpayer has net investment income in such year. Because all or substantially all of the income or loss of a Fund is expected to be treated as arising from property held for investment, any interest expense incurred by a shareholder to purchase or carry its shares in the Fund and its allocable share of any interest expense incurred by the Fund may be subject to the investment interest limitations.
Limitations on a Shareholders Deduction of Investment Expenses 2% Floor
Depending on the nature of its activities, a Fund may be deemed to be either an investor or trader in securities, or both if the Fund engages in multiple activities. If a Fund is deemed to be an investor, certain Fund fees and expenses (including, without limitation, the Management Fees) will be treated as miscellaneous itemized deductions of the Fund for U.S. federal income tax purposes. An individual taxpayer and certain trusts or estates that hold interests in a Fund (directly or through certain pass-through entities, including a partnership, a nonpublicly offered RIC, a Subchapter S corporation, or a grantor trust) may deduct such fees and expenses in a taxable year only to the extent they exceed 2% of the taxpayers adjusted gross income, but only if the shareholder itemizes deductions. In addition, in the case of individuals whose adjusted gross income exceeds a certain inflation-adjusted threshold, the aggregate itemized deductions allowable for the year will be reduced, but not by more than 80%, by an amount equal to 3% of the excess of adjusted gross income over the applicable threshold (the overall limitation on itemized deductions) (this limitation being applied after giving effect to the 2% floor described above and any other applicable limitations). The U.S. Treasury Department has issued regulations prohibiting the deduction through the Funds (as partnerships) of amounts which would be nondeductible if paid directly by an individual.
95
In addition to the fees and expenses described above, these limitations also may apply to certain types of payments made by a Fund under certain swap agreements and certain other amounts. The amounts of these fees and expenses may be separately reported to the shareholders and, as indicated above, if the Fund is deemed an investor, will be deductible by an individual shareholder only to the extent that the shareholders miscellaneous deductions exceed 2% of the shareholders adjusted gross income, subject further, if applicable, to the overall limitation on itemized deductions described above.
If a Fund is deemed to be a trader in securities, the 2% floor and the overall limitation on itemized deductions will not apply (subject to the regulations described above). Whether a Fund will be treated as a trader or investor will be determined annually based upon an examination of the Funds trading practices.
Organizational Expenses
Certain organizational and offering expenses of a Fund are paid by GMO. Given this fact, the IRS could take the position that some portion of the Management Fee payable to GMO represents a reimbursement of such expenses paid by GMO and therefore require that such amounts be amortized or capitalized. If such expenses were treated as paid by the Fund, the Fund may be required to amortize the organizational expenses over a 180-month period. However, offering expenses must be capitalized and cannot be amortized or otherwise deducted. Shareholders are advised to consult their tax advisers regarding the application of these rules to their particular circumstances.
Sale or Exchange of Fund Property
Subject to the discussion above, gains or losses from the disposition of Fund property (including sales of a Funds interests in other pooled investment vehicles) not held primarily for sale to customers in the ordinary course of a trade or business generally should be treated as capital gains or losses, except to the extent that the Hot Assets rules apply, the property is otherwise subject to ordinary income recapture or in certain other cases. A Fund might also realize capital gains or losses upon the modification of a debt instrument or default of an issuer. These capital gains and losses may be long-term or short-term depending, in general, upon the length of time the Fund holds the property. Property held (or deemed held) for more than one year generally will be eligible for long-term capital gain or loss treatment. The deductibility of capital losses, however, may be limited.
In the case of individuals and other non-corporate taxpayers, long-term capital gains generally are taxed at a lower U.S. federal income tax rate than ordinary income. For corporations, net capital gains and ordinary income are currently taxed at the same rate. GMO does not have a duty to notify shareholders if this (or any other) law changes.
The distinction between capital gains and ordinary income is significant not only with respect to the maximum tax rate differential for individuals and other non-corporate taxpayers, but also with regard to the rules concerning the offsetting of capital gains and losses. In general, capital losses are allowed as an offset only against capital gains. If an individual (or other non-corporate taxpayer) has a net capital loss, the first $3,000 may generally offset ordinary income, and the excess may be carried forward (but not back) indefinitely and applied first against capital gains, and then against ordinary income up to $3,000, in each succeeding year. In general, corporations may only offset capital losses against capital gains and also may be subject to other rules that
96
limit the use of losses in a particular taxable year, and the excess may be carried back for three years and carried forward for up to five years.
Alternative Minimum Tax
Both individual and corporate taxpayers could be subject to an alternative minimum tax (AMT) if the AMT exceeds the income tax otherwise payable by the taxpayer for the year. Due to the complexity of the AMT calculations, investors should consult with their tax advisers as to whether the purchase of Fund shares might create or increase AMT liability.
Medicare Contribution Tax
The Code generally imposes a 3.8% Medicare contribution tax on the net investment income of certain individuals, trusts, and estates to the extent their income exceeds certain threshold amounts. Very generally, for this purpose, net investment income includes (i) a shareholders distributive share of a Funds gross investment income (e.g., dividends or interest income received by a Fund or any gains realized on the disposition of Fund property), and (ii) any net gain recognized by the shareholder on the redemption of shares of a Fund, and will be reduced by a shareholders distributive share of Fund deductions that are properly allocable to the type of gross income or gain described in (i) or (ii). Shareholders are advised to consult their tax advisers regarding the possible implications of this additional tax on their investment in a Fund in light of their particular circumstances.
Tax Implications of Investment in a Subsidiary (Systematic Global Macro Opportunity Fund only)
Systematic Global Macro Opportunity Fund invests a portion of its assets in one or more foreign subsidiaries that are (or will be) classified as corporations for U.S. federal income tax purposes. It is expected that each subsidiary will neither be subject to taxation on its net income in the same manner as a corporation formed in the United States nor subject to branch profits tax on the income and gain derived from its activities in the United States. A foreign corporation will generally not be subject to such taxation unless it is deemed to be engaged in a U.S. trade or business. Each subsidiary conducts (or intends to conduct) its activities in a manner so as to meet the requirements of a safe harbor under Section 864(b)(2) of the Code (the Safe Harbor), pursuant to which each subsidiary, provided it is not a dealer in securities or commodities, may engage in the following activities without being deemed to be engaged in a U.S. trade or business: (i) engage in the United States in trading securities (including contracts or options to buy or sell securities) for its own account; and (ii) engage in the United States in trading, for its own account, commodities that are of a kind customarily dealt in on an organized commodity exchange, if the transaction is of a kind customarily consummated at such place. If certain of a subsidiarys activities were determined to be not of the type described in the Safe Harbor, then the activities of such subsidiary may constitute a U.S. trade or business.
In addition, as described below, a foreign corporation is subject to U.S. federal income tax as if it earned income that is effectively connected with a U.S. trade or business (ECI) to the extent it realizes any gains from U.S. real property interests (USRPIs). It is not expected that a subsidiary will invest in any USRPI.
In general, a foreign corporation that does not conduct a U.S. trade or business is nonetheless subject to tax at a flat rate of 30% (or lower tax treaty rate), generally payable through withholding, on the gross amount of certain U.S.-source income that is not effectively connected
97
with a U.S. trade or business. There is presently no tax treaty in force between the United States and the jurisdiction in which any subsidiary is (or would be) resident that would reduce this rate of withholding tax. Income subject to such a flat tax is of a fixed or determinable annual or periodic nature and includes dividends and interest income. Certain types of income are specifically exempted from the 30% tax and thus withholding is not required on payments of such income to a foreign corporation. The 30% tax generally does not apply to capital gains (whether long-term or short-term) or to interest paid to a foreign corporation on its deposits with U.S. banks. The 30% tax also does not apply to interest which qualifies as portfolio interest. Very generally, the term portfolio interest includes U.S.-source interest (including OID) on an obligation in registered form, and with respect to which the person, who would otherwise be required to deduct and withhold the 30% tax, received the required statement that the beneficial owner of the obligation is not a U.S. person within the meaning of the Code.
As discussed in more detail below, FATCA (as defined below) generally imposes a reporting and 30% withholding tax regime (which is different from the withholding regime described above) with respect to certain U.S.-source income (withholdable payments) paid to foreign financial institutions and certain other non-U.S. entities when those entities fail to satisfy the applicable account documentation, information reporting, withholding, registration, certification and/or other requirements applicable to their status under FATCA. A subsidiary will be subject to the 30% withholding tax in respect of any withholdable payment it receives if it fails to satisfy these requirements, as may be applicable to the subsidiary. Each subsidiary expects to satisfy these requirements, as may be applicable to it, so as to avoid this additional 30% withholding. See Other Reporting and Withholding Requirements below for more discussion of these rules.
Each subsidiary is (or will be) wholly owned by the Fund. A U.S. person who owns (directly, indirectly or constructively) 10% or more of the total combined voting power of all classes of stock of a foreign corporation is a U.S. Shareholder for purposes of the CFC provisions of the Code. A CFC is a foreign corporation that, on any day of its taxable year, is owned (directly, indirectly, or constructively) more than 50% (measured by voting power or value) by U.S. Shareholders. Because Systematic Global Macro Opportunity Fund is a U.S. person that owns (or will own) all of the stock of a subsidiary, the Fund is a U.S. Shareholder and the subsidiary is (or will be) a CFC. As a U.S. Shareholder, in general, for each taxable year, the Fund is (or will be) required to include in its gross income for U.S. federal income tax purposes all of its subsidiarys subpart F income (defined, in part, below), whether or not such income is actually distributed by the subsidiary.
It is expected that all of each subsidiarys income will be subpart F income. Subpart F income generally includes interest, OID, dividends, net gains from the disposition of stocks or securities, receipts with respect to securities loans, and net payments received with respect to equity swaps and similar derivatives. In particular, subpart F income generally also includes the excess of gains over losses from transactions (including futures, forward, and similar transactions) in any commodities. Subpart F income is generally treated as ordinary income, regardless of the character of the subsidiarys underlying income. The Funds recognition of any subpart F income from an investment in any subsidiary treated as a CFC will increase the Funds tax basis in the subsidiary. Distributions by a subsidiary to the Fund, including distributions to the Fund by its subsidiary in partial redemption of the Funds interests in the subsidiary, generally will be tax-free to the Fund to the extent of the subsidiarys previously taxed but undistributed subpart F income, and will correspondingly reduce the Funds tax basis in the subsidiary (but not below zero), with any amount in excess of such basis generally taxable to the Fund as capital gain. Net losses incurred by a subsidiary during a tax year do not flow through to the Fund and thus will
98
not be available to offset income or capital gain generated from other investments. Any losses with respect to the Funds shares of its subsidiary will not be currently recognized. In addition, net losses incurred by a CFC during a tax year generally cannot be carried forward by the CFC to offset gains realized by it in subsequent taxable years.
In general, each U.S. Shareholder is required to file an IRS form providing information about its ownership of a CFC and about the CFC itself. In general, and subject to certain exceptions, these filing requirements will apply to shareholders of the Fund if a shareholder is a U.S. person who owns directly, indirectly, or constructively (within the meaning of Sections 958(a) and (b) of the Code) 10% or more of the total combined voting power of all classes of voting stock of a foreign corporation that is a CFC for an uninterrupted period of 30 days or more during any tax year of the foreign corporation, and who owned that stock on the last day of that year. Because the subsidiaries are (or will be) CFCs, shareholders such as Systematic Global Macro Opportunity Fund may have these filing and reporting obligations in respect of its investment in its subsidiary. In addition, a U.S. investor in the Fund may in certain other circumstances be required to report on this form certain direct or indirect purchases or dispositions of shares in a CFC or other foreign corporation. Shareholders should consult their tax advisers regarding these filing requirements in light of their particular situation. See also Certain U.S. Reporting Requirements below for additional possible U.S. shareholder tax reporting requirements.
Changes or modifications in existing judicial decisions or in the current positions of the IRS and the passage of new legislation could substantially modify the tax treatment of a subsidiary as outlined in this SAI, possibly on a retroactive basis. In particular, legislation has been proposed in Congress that could cause a subsidiary to be subject to U.S. federal income tax on its income and gains. It is not currently clear whether or in what form this or any other proposed legislation will be enacted.
Certain Tax Considerations Relating to Certain Non-U.S. Investments
Certain other non-U.S. investments of a Fund, including investments in CFCs and PFICs, may cause a U.S. shareholder to recognize taxable income prior to the Funds receipt of distributable proceeds, pay an interest charge on receipts that are deemed to have been deferred, or recognize ordinary income that otherwise would have been treated as capital gain. A Fund, in GMOs sole discretion, may make a mark-to-market or qualified electing fund election with respect to PFICs, in which case a different set of rules may apply to such investments. There can be no assurance, however, that a Fund will be able to obtain the information necessary to make a mark-to-market or qualified electing fund election with respect to any PFIC in which the Fund directly or indirectly invests, in the event a Fund makes either election. Even if the necessary information is available, the Fund may incur costs to obtain such information. In addition, whether a foreign corporation is a PFIC is not always entirely clear. Therefore, there is a risk, for example, that a Fund may not realize that a foreign corporation in which it invests is a PFIC for U.S. federal income tax purposes and thus the Fund may fail to timely make a mark-to-market or qualified electing fund election in respect of that corporation, in which event the Fund could be subject to the U.S. federal income taxes and interest charges described above. The lowest-tier U.S. shareholder of a PFIC (such as a Fund) is generally required to file an annual information return with the IRS on IRS Form 8621 (regardless of whether that U.S. shareholder has received a distribution from, disposed of an interest in, or made an election in respect of a PFIC). In certain circumstances a U.S. person who indirectly holds an interest in a Fund may also be required to file Form 8621 with the IRS. Shareholders are urged to consult their own tax
99
advisers with respect to this reporting requirement. See Certain U.S. Reporting Requirements below.
A Fund may make investments that subject the Fund and/or shareholders directly or indirectly to taxation and/or tax filing obligations in non-U.S. jurisdictions, including any taxes on (i) capital gains or gross proceeds the Fund realizes or dividends or interest it receives on those investments; (ii) transactions in those investments; or (iii) the repatriation of proceeds generated from the sale or other disposition of those investments. In particular, a Funds non-U.S. investments may cause some of the Funds income, gains or proceeds from dispositions to be subject to withholding or other taxes of non-U.S. jurisdictions, and could result in taxation on net income attributed to the jurisdiction if the Fund were considered to be conducting a trade or business in the applicable country through a permanent establishment or otherwise. Such non-U.S. taxes and/or tax filing obligations may be reduced or eliminated by applicable income tax treaties, although shareholders should be aware that a Fund may not be entitled to claim reduced rates on withholding or other non-U.S. taxes or may choose not to assert any such claim. The tax consequences to shareholders may depend in part on the direct and indirect activities and investments of a Fund. Accordingly, the Fund will be limited in its ability to avoid adverse non-U.S. tax consequences resulting from the Funds underlying investments. Furthermore, some shareholders may not be eligible for certain or any treaty benefits. Subject to applicable legal, regulatory or practical limitations, a shareholder may be entitled to claim, for U.S. federal income tax purposes, a credit for its allocable share of any non-U.S. tax incurred by a Fund, including withholding taxes, so long as such non-U.S. tax qualifies as a creditable income tax under the applicable Treasury regulations. Alternatively, a shareholder may elect to deduct (subject to certain limitations) its share of such non-U.S. taxes for U.S. federal income tax purposes. A Fund may be required to provide non-U.S. tax authorities with certain information about its shareholders in order to secure treaty benefits in those jurisdictions.
For information on possible Australian and Singapore tax consequences of an investment in Systematic Global Macro Opportunity Fund, see the Taxes For Systematic Global Macro Opportunity Fund section in the Private Placement Memorandum.
Certain U.S. Reporting Requirements
A shareholder may be subject to certain reporting requirements that require it to file information returns with the IRS with respect to certain direct or indirect transfers of cash or property by a Fund to a foreign partnership. In addition, in certain cases, a U.S. shareholder who owns or acquires, directly or indirectly through a Fund, a 10% or greater interest in a foreign partnership, or where a shareholder and persons related to such shareholder have transferred directly or indirectly, cash and/or property in excess of U.S. $100,000 to the non-U.S. partnership within a 12-month period, must report its interest in the foreign partnership and/or certain acquisitions, dispositions, or proportional changes in its interest in the foreign partnership.
A shareholder that is a U.S. person also may be required to report transfers of cash by a Fund to a foreign corporation (including a Funds wholly-owned subsidiary) if such shareholder holds, through the Fund as well as directly or by attribution, 10% or more of the voting power or value of the foreign corporation, or the shareholder and persons related to the shareholder have transferred, directly or indirectly, cash in excess of $100,000 to the foreign corporation within a 12-month period. Under current regulations, this reporting must be made by a Funds U.S. shareholders and may not be satisfied by the Fund. In addition, a shareholder that acquires, directly or indirectly through a Fund, 10% by vote or value of the stock of a foreign corporation
100
must report certain acquisitions or dispositions of, or proportional changes of, its interest in the foreign corporation. Certain other non-cash transfers by a Fund to foreign corporations also may trigger reporting requirements for shareholders. See also Tax Implications of Investment in a Subsidiary above for additional possible U.S. shareholder tax reporting requirements related to direct and indirect investments in foreign corporations.
Shareholders that are U.S. persons currently may also be subject to reporting and filing requirements with respect to a Funds direct or indirect investment in a PFIC, regardless of the size of the shareholders investment.
None of the Funds have committed to provide information (other than any information that the Fund is required to provide by U.S. law) about Fund investments that may be needed to complete any reporting requirements. The above discussion of U.S. reporting requirements is primarily directed at U.S. persons. Shareholders are urged to consult their own tax advisers with respect to these reporting requirements.
Effect of Ownership of Tax-Exempt Obligations on Interest Deductions
Section 265(a)(2) of the Code disallows any deductions for interest paid by a taxpayer on indebtedness incurred or continued for the purpose of purchasing or carrying tax-exempt obligations (e.g., certain municipal obligations). The IRS stated, in Revenue Procedure 72-18, 1972-1 C.B. 740, that indebtedness incurred to finance a portfolio investment when the taxpayers portfolio also includes tax-exempt assets, either directly or indirectly, will be deemed, in part, to be for the purpose of purchasing or carrying such tax-exempt obligation. Thus, if a shareholder holds tax-exempt obligations, either directly or indirectly through a Fund, the IRS might take the position that any interest paid, directly or indirectly, by the shareholder on indebtedness incurred to enable it to purchase investments should be viewed as incurred to enable the shareholder to continue carrying tax-exempt obligations. As a result, the IRS might argue that the shareholder should not be allowed to deduct the full amount of interest incurred. In addition, pursuant to Revenue Procedure 72-18, each shareholder will be treated as incurring its share of any indebtedness incurred by a Fund. Therefore, a shareholder owning tax-exempt obligations could be denied a deduction for its share of any interest expense incurred by a Fund to purchase securities or other portfolio investments. Other deductions relating to tax-exempt income also may be prohibited by Section 265(a).
U.S. Tax-Exempt Shareholders
Under current U.S. federal income tax law, U.S. tax-exempt shareholders are generally exempt from U.S. federal income tax except to the extent that they earn unrelated business taxable income (UBTI). A Fund may generate income or gain that is UBTI in the hands of U.S. tax-exempt shareholders. For instance, to the extent that a shareholder has borrowed to finance an interest in a Fund or a Fund holds property that constitutes debt-financed property (e.g., securities purchased on margin) or property primarily for sale to customers (dealer property), income or gain attributable to such property allocated to a shareholder that is an exempt organization may constitute UBTI (but only as to that portion of property that is treated as debt-financed or dealer property). Certain of a Funds other investments or activities may also generate UBTI (e.g., investments in operating pass-through entities or as a result of holding operating assets due to foreclosures). Furthermore, the IRS may take the position that certain of a Funds investments in derivative instruments should be reclassified in a manner that gives rise to UBTI. In addition, reverse repurchase agreements may, under certain conditions, be
101
characterized as secured loans, the proceeds of which could be used to acquire assets that would, therefore, give rise to debt-financed UBTI. Investments in so-called pension-held REITs also may result in the generation of UBTI. If a Fund generates UBTI, a U.S. tax-exempt shareholder of the Fund generally would be required to file a tax return and could incur tax liability on its allocable share of that UBTI. The characterization of certain income or gain of a Fund as UBTI may depend in part on the nature of the underlying investments made by entities treated as partnerships for U.S. federal income tax purposes in which the Fund may invest.
Moreover, a charitable remainder trust, as defined in Section 664 of the Code, that realizes UBTI during a taxable year must pay an excise tax annually of an amount equal to 100% of such UBTI.
U.S. tax-exempt shareholders should consult their own tax advisers concerning the possible effects of UBTI on their own tax situations as well as the general tax implications of an investment in a Fund.
Termination of a Fund
In general, if within a 12-month period there is a sale or exchange of 50% or more of the interests in a Funds capital and profits, a termination of the Fund will occur for U.S. federal income tax purposes, and the taxable year of the Fund will close. If such a termination were to occur, the Fund would be deemed to contribute all of its assets and liabilities to a new partnership, and, immediately thereafter, the Fund would be deemed to distribute interests in the new partnership to the purchasing shareholder and the continuing shareholders in proportion to their respective interests in the Fund in liquidation of the Fund. Such a termination could result in the acceleration of Fund income or gain for that year to shareholders whose taxable years differ from that of the Fund (and to other shareholders in certain cases) and could generate adverse tax consequences to some or all shareholders. Shareholders should refer to the above section titled Distributions and Adjusted Basis for a discussion of the treatment of distributions from the Fund.
Backup Withholding
Under the backup withholding rules, a Fund (or in the case of shares held through an intermediary, the intermediary) generally is required to withhold and remit to the U.S. Treasury a percentage of the taxable distributions paid to and proceeds of share sales, exchanges, or redemptions made by any individual shareholder (including any foreign individual) who fails to furnish the Fund (or the intermediary) with a correct taxpayer identification number, who has under-reported dividends or interest income, or who fails to certify that he or she is a U.S. person and is not subject to such withholding. The backup withholding tax rate is 28%. Any tax withheld as a result of backup withholding does not constitute an additional tax imposed on the record owner of the account, and may be claimed as a credit on the record owners U.S. federal income tax return, provided the appropriate information is furnished to the IRS.
In order to establish an exemption from backup withholding, a Non-U.S. Shareholder must comply with special certification and filing requirements relating to its non-U.S. status (including, for example, furnishing an IRS Form W-8BEN or W-8BEN-E). Non-U.S. investors in a Fund should consult their tax advisers and, if holding shares through intermediaries, their intermediaries, in this regard.
102
Tax Determinations, Requests for Information, Elections, and Tax Matters Partner
GMO will have considerable authority to make decisions affecting the tax treatment and procedural rights of shareholders. GMO, at its option, will make all tax determinations and oversee elections for each Fund, including, pursuant to Section 754 of the Code (as described more fully below), an election to adjust the basis of Fund property in the case of a distribution of Fund property or a transfer of an interest in a Fund. GMO will decide how to report Fund items on the tax returns of each Fund, and all shareholders are required under the Code to treat the items consistently on their own returns, unless they file a statement with the IRS disclosing the inconsistency, and, by purchasing shares of a Fund, agree to be bound by the Funds allocations, elections, and determinations.
At the request of a Fund, shareholders may be required to provide the Fund with information about the tax basis of their interest in the Fund upon a redemption or transfer of Fund shares.
GMO, or, in the event that GMO is not a shareholder of a Fund, such other shareholder of the Fund as may be designated from time to time by GMO, will be the Tax Matters Partner, as defined in Section 6231 of the Code, for the Fund. In the event the income tax returns of a Fund are audited by the IRS, the tax treatment of a Funds income and deductions generally is determined at the Fund level in unified proceedings before the IRS and the courts, rather than in separate proceedings involving each shareholder. The Tax Matters Partner generally will have the authority to negotiate, settle, or contest any proposed adjustments and, in most circumstances, these actions will be binding on shareholders. An audit at the Fund level may result in an extension of the three-year statute of limitations on assessments of deficiencies with respect to Fund items included in shareholders returns. There can be no assurance that a Fund will not be audited and that adjustments will not be made.
U.S. Tax Shelter Rules
A Fund may engage in transactions or make investments that would subject the Fund, its shareholders, and/or its material advisors, as defined in Treas. Reg. Sec. 301.6112-1(c)(1), to special rules requiring such transactions or investments by the Fund or investments in the Fund to be reported and/or otherwise disclosed to the IRS, including to the IRSs Office of Tax Shelter Analysis (the Tax Shelter Rules). A transaction may be subject to reporting or disclosure if it is described in any of several categories of reportable transactions, which include, among others, transactions that result in the incurrence of a loss or losses exceeding certain thresholds or that are offered under conditions of confidentiality. Although each Fund does not expect to engage in transactions solely or principally for the purpose of achieving a particular tax consequence, there can be no assurance that a Fund will not engage in transactions that trigger the Tax Shelter Rules. In addition, a shareholder may have disclosure obligations with respect to its shares in a Fund if the shareholder (or the Fund in certain cases) participates in a reportable transaction.
Shareholders should consult their own tax advisers about their obligation to report or disclose to the IRS information about their investment in a Fund and participation in a Funds income, gain, loss, deduction, or credit with respect to transactions or investments subject to these rules. In addition, pursuant to these rules, a Fund may provide to its material advisors identifying information about the Funds shareholders and their participation in the Fund and the Funds income, gain, loss, deduction, or credit from those transactions or
103
investments, and the Fund or its material advisors may disclose this information to the IRS upon its request. Significant penalties may apply for failure to comply with these rules.
Under U.S. federal tax law, if a Fund (or, in certain cases, any fund in which a Fund directly or indirectly invests) engages in certain tax shelter transactions, a U.S. tax-exempt shareholder could be subject to an excise tax equal to the highest corporate tax rate times the greater of (i) the shareholders net income from the transactions or (ii) 75% of the proceeds attributable to the shareholder from the transactions. If such a U.S. tax-exempt shareholder knew or had reason to know that a transaction was a prohibited tax shelter transaction, a substantially higher excise tax could be applicable. In addition, such U.S. tax-exempt shareholders could be subject to certain disclosure requirements, and penalties could apply if such U.S. tax-exempt shareholders do not comply with such disclosure requirements. There can be no assurance that the Funds (or any fund in which a Fund directly or indirectly invests) will not engage or be deemed to engage in prohibited tax shelter transactions. The excise tax does not apply to U.S. tax-exempt investors that are pension plans, although certain penalties applicable to entity managers (as defined in Section 4965(d) of the Code) might still apply. U.S. tax-exempt shareholders should consult their own tax advisers regarding these provisions.
In certain circumstances, a Fund and/or a Funds tax adviser may make special disclosures to the IRS or state tax authorities of certain positions taken by the Fund.
Shareholder Reporting Obligations with Respect to Foreign Bank and Financial Accounts
Shareholders that are U.S. persons and own, directly or indirectly, more than 50% of a Fund could be required to report annually their financial interest in the Funds foreign financial accounts (if any) on FinCEN Form 114, Report of Foreign Bank and Financial Accounts (FBAR) to report a shareholders financial interest in the Funds foreign financial accounts (if any).
Shareholders should consult their intermediaries through which a Fund investment is made (if applicable), as well as their tax advisers to determine the applicability of this reporting requirement in light of their individual circumstances.
Other Reporting and Withholding Requirements
Sections 1471-1474 of the Code and the U.S. Treasury Regulations, rules and IRS guidance issued thereunder (collectively, FATCA) generally require a Fund to obtain information sufficient to identify the status of each of its shareholders under FATCA or under an applicable intergovernmental agreement (an IGA). If a shareholder fails to provide this information or otherwise fails to comply with FATCA or an IGA, a Fund may be required to withhold under FATCA at a rate of 30% with respect to that shareholder on certain U.S-source income (including, among other types of income, dividends, interest and certain payments with respect to derivative instruments that are determined to be dividend equivalent payments) paid or allocated to that shareholder and, after December 31, 2016 30% of gross proceeds from the sale or other disposition of property that can produce U.S.-source dividends or interest paid or allocated to that shareholder (collectively, Withholdable Payments).
Payments to a shareholder will generally not be subject to FATCA withholding, provided the shareholder provides a Fund with such certifications, waivers or other documentation or information as the Fund requires, including, to the extent required, with regard to such
104
shareholders direct and indirect owners, to establish the shareholders FATCA status and otherwise to comply with these rules. In order to avoid withholding, a shareholder that is a foreign financial institution (FFI) must either (i) become a participating FFI by entering into a valid U.S. tax compliance agreement with the IRS; (ii) qualify for an exception from the requirement to enter into such an agreement, for example by becoming a deemed compliant FFI; or (iii) be covered by and in compliance with an applicable intergovernmental agreement between the United States and a foreign government to implement FATCA. In any of these cases, the investing FFI generally will be required to provide the Fund with appropriate identifiers, certifications or documentation concerning its status. The IRS has issued guidance on how FATCA interacts with other U.S. withholding tax rules and, accordingly, the above described withholding tax may apply differently in the event that income is subject to multiple types of withholding.
The Fund will disclose the information that it receives from (or concerning) its shareholders to the IRS, non-U.S. taxing authorities or other parties as necessary to comply with FATCA, related intergovernmental agreements or other applicable law or regulation.
If an Underlying Fund were to fail to comply with FATCA or were to be a member of an expanded affiliated group in which a member of such group causes other members to not be in compliance with FATCA, such non-compliance could reduce the Funds return on its investments.
If the Funds wholly owned foreign subsidiary were to become a member of an expanded affiliated group with respect to a direct or indirect investor in the Fund, this status could adversely affect the FATCA status of the subsidiary, or of such direct or indirect investor in the Fund, and reduce the subsidiarys return on its investments.
Each prospective investor is urged to consult its tax adviser regarding the applicability and consequences of FATCA and any other reporting requirements with respect to the prospective investors own situation, including investments through an intermediary.
The Fund and its shareholders may be subject to certain other tax reporting requirements as a result of the investment strategy and activities of the Fund. Certain U.S. federal, state, local and non-U.S. tax reporting requirements may require the Fund to provide certain information about its shareholders to the IRS or other similar authorities responsible for tax matters in other jurisdictions (e.g., non-U.S. countries).
Tax Elections
A Fund may make various elections for U.S. federal income tax purposes which could result in certain items of income, gain, loss, deduction, and credit being treated differently for tax and accounting purposes.
Under Section 754 of the Code, each Fund generally may elect to adjust the basis of its assets in the event of certain distributions to a shareholder, or a transfer of Fund shares from a shareholder to a new or existing shareholder. Such an election, if made, could either increase or decrease the future tax liability of the remaining shareholders or the transferee, respectively, because the election would increase or decrease the basis of the Funds assets for purposes of computing the shareholders or transferees distributive share of Fund income, gains, losses, and deductions.
105
Very generally, a Fund also must make these basis adjustments as though the Fund had made the Section 754 elections described above in the case of (i) a transfer of Fund shares, if the Funds assets have a built-in loss of more than $250,000 immediately following the transfer; or (ii) a distribution of Fund property, if the sum of (x) the excess of (I) the basis of such property in the hands of the distributee shareholder immediately after the distribution, over (II) the adjusted basis of such property to the partnership immediately before the distribution, and (y) any loss recognized by the distributee shareholder with respect to the distribution, exceeds $250,000. To determine whether the mandatory basis adjustment rules will be triggered upon a shareholders transfer or withdrawal from a Fund, the Fund may request that the shareholder provide certain information, including information regarding the shareholders tax basis in its interest in the Fund. Some or all of shareholders distributive shares of Fund income, gains, losses, and deductions may be adjusted in accordance with these rules.
Certain Tax Considerations for RIC Shareholders
Special tax considerations apply to Fund shareholders that intend to qualify for the special tax treatment accorded RICs (each, a RIC Shareholder) under Subchapter M of the Code. In order to qualify for the special tax treatment accorded RICs and their shareholders, a RIC Shareholder must, among other things:
(a) derive at least 90% of its gross income for each taxable year from (i) dividends, interest, payments with respect to certain securities loans, and gains from the sale or other disposition of stock, securities, or foreign currencies, or other income (including but not limited to gains from options, futures, or forward contracts) derived with respect to its business of investing in such stock, securities, or currencies and (ii) net income derived from interests in qualified publicly traded partnerships (as defined below); (b) diversify its holdings so that, at the end of each quarter of a Funds taxable year, (i) at least 50% of the market value of the RIC Shareholders total assets consists of cash and cash items, U.S. government securities, securities of other RICs, and other securities limited in respect of any one issuer to a value not greater than 5% of the value of the RIC Shareholders total assets and not more than 10% of the outstanding voting securities of such issuer, and (ii) not more than 25% of the value of the RIC Shareholders total assets is invested in the securities (other than those of the U.S. government or RICs) of any one issuer or of two or more issuers which the RIC Shareholder controls and which are engaged in the same, similar, or related trades or businesses, or in the securities of one or more qualified publicly traded partnerships (as defined below); and
(c) distribute with respect to each taxable year at least 90% of the sum of its investment company taxable income (as that term is defined in the Code without regard to the deduction for dividends paid generally, taxable ordinary income and the excess, if any, of net short-term capital gains over net long-term capital losses) and any net tax-exempt interest income for such year.
If a RIC Shareholder fails to distribute in a calendar year substantially all of its ordinary income for such year and substantially all of its capital gain net income for the one-year period ending October 31 (or later if a RIC Shareholder is permitted to elect and so elects), plus any retained amount from the prior year, the RIC Shareholder would be subject to a nondeductible 4% excise tax on the undistributed amounts (the Excise Tax).
In general, for purposes of the 90% gross income requirement described in paragraph (a) above, income derived from a Fund will be treated as qualifying income only to the extent such income
106
is attributable to items of income of the Fund which would be qualifying income if realized directly by the RIC Shareholder in the same manner as realized by the Fund. However, 100% of the net income derived by the Fund from an interest in a qualified publicly traded partnership (defined generally as a partnership (i) the interests in which are traded on an established securities market or are readily tradable on a secondary market or the substantial equivalent thereof; (ii) that derives at least 90% of its income from passive income sources defined in Section 7704(d) of the Code; and (iii) that derives less than 90% of its income from the qualifying income described in paragraph (a)(i) above) that is allocable to a RIC Shareholder will be treated as qualifying income for purposes of the RIC Shareholders 90% gross income requirement.
Income a Fund derives from certain of its direct investments, or indirect investments (made through certain types of pass-through vehicles that are, for instance, partnerships or grantor trusts for U.S. federal income tax purposes), in derivatives related to commodities and commodities indexes generally will not be considered qualifying income for the purposes of the 90% gross income requirement. This may limit the extent to which a Fund invests in such contracts.
Further, some Funds may make extensive use of various types of derivative financial instruments. The tax rules applicable to derivative financial instruments are in some cases uncertain under current law, including under Subchapter M of the Code. Accordingly, while the Funds intend to account for such transactions in a manner they deem to be appropriate, an adverse determination concerning a Funds or a RIC Shareholders treatment of such transactions or future guidance by the IRS with respect to one or more of these rules (which determination or guidance could be retroactive) could adversely affect a RIC Shareholders ability to meet one or more of the relevant requirements to maintain its qualification as a RIC, as well as to avoid a fund-level tax.
A RIC Shareholder will be required to include its distributive share, whether or not actually distributed by a Fund, of the Funds income, gains, losses, and other tax items for any Fund taxable year ending within the RIC Shareholders taxable year. In general, a RIC Shareholder will not recognize its distributive share of these tax items until the close of the Funds taxable year. However, absent the availability of an exception, a RIC Shareholder will recognize its distributive shares of these items as they are recognized by the Fund for purposes of determining its liability for the Excise Tax. If a Fund and a RIC Shareholder have different taxable years, the RIC Shareholder may be obligated to make distributions in excess of the net income and gains recognized from the Fund and yet be unable to avoid the Excise Tax because it is without sufficient earnings and profits at the end of its taxable year. In some cases, however, the RIC Shareholder can take advantage of certain safe harbors that would allow it to include in its income its distributive share of a Funds income, gains, losses, and certain other items at the close of the Funds taxable year for both Excise Tax purposes and general Subchapter M purposes, thus avoiding the potential complications arising from different taxable years.
With respect to shareholders in Systematic Global Macro Opportunity Fund only, RIC Shareholders should generally be entitled to treat the portion of income recognized by the Fund as a result of its investment in a subsidiary as qualifying income for purposes of the 90% qualifying income requirement, regardless of its underlying source (e.g., commodities-related derivatives held by the Fund). There is a risk, however, that the IRS could prevail, under one or more legal arguments, in asserting that some or all of the income derived from a Funds investment in a subsidiary should not be treated as qualifying income in the hands of a RIC
107
Shareholder, which might adversely affect a RIC Shareholders ability to qualify as a RIC in a particular year.
Certain Tax Considerations for Non-U.S. Investors
The U.S. federal income tax treatment of a nonresident alien, foreign corporation, foreign partnership, foreign estate, or foreign trust (non-U.S. investor) investing as a shareholder in a Fund is complex and will vary depending upon the circumstances of the shareholder and the activities of the Fund, GMO, and the Tax Matters Partner. This discussion does not address the tax considerations that may be relevant to non-U.S. investors who are subject to U.S. federal income tax independent of their direct or indirect investment in a Fund. Each non-U.S. investor is urged to consult with its own tax advisers regarding the U.S. federal, state, local, and non-U.S. tax treatment of its investment in a Fund.
In general, the U.S. federal income tax treatment of a non-U.S. investor depends upon whether a Fund is deemed to be engaged in a U.S. trade or business. There can be no assurance that the activities or investments of a Fund will not cause the Fund to be deemed engaged in a U.S. trade or business, and an investment in the Fund could cause a non-U.S. investor to recognize income that is or is treated as effectively connected with the conduct of a U.S. trade or business (ECI). If a Fund were treated as engaged in a U.S. trade or business, non-U.S. investors would be subject to U.S. federal income tax (generally, in the first instance, collected by means of withholding) on a net basis on ECI (including, for certain corporate non-U.S. investors, potentially an additional 30% branch profits tax, which is generally not collected by means of withholding) and to U.S. tax return filing obligations. A non-U.S. investors ability to pay such tax on a net, rather than gross, basis would generally depend on whether the non-U.S. investor properly files a U.S. tax return for the relevant year.
A Fund could be deemed to be engaged in a U.S. trade or business as a result of certain investments or activities. This could occur if it were determined to be a dealer or engaged in certain business activities such as lending or other financing transactions, to the extent such activities were not considered passive investing (or trading in stocks or securities). In this regard, rules distinguishing dealer activity and lending and other financing activities from passive investing (or trading in stocks or securities) are not clear under current law (e.g., repurchase agreements have generally been treated by the IRS as secured loans). Furthermore, writing protection pursuant to credit default swaps may be viewed as engaging in an insurance or similar business (although, if finalized, recently proposed Treasury Regulations would treat certain credit default swaps entered into on or after the date the regulations are finalized as notional principal contracts). Such a trade or business could also be deemed to exist as a result of the provision of certain services and other activities, if any, engaged in during the course of debt restructurings. Furthermore, a Fund may realize ECI from holding operating assets or USRPIs as a result of foreclosures or other investments or investments in U.S. REITs (as discussed below). Under proposed Treasury Regulations the term engaged in a trade or business in the United States does not include effecting transactions in derivatives (including hedging transactions for the taxpayers own account) but the exception does not apply to any non-U.S. person who is a dealer in stocks, securities, commodities, or derivatives. For this purpose derivative includes: (1) any interest rate, currency, equity, or commodity notional principal contract; and (2) any evidence of an interest, or a derivative financial instrument (including an option, forward contract, short position, and any similar interest), in any commodity, currency, share of stock, publicly traded or widely held partnership, evidence of indebtedness, or notional principal contract. The term currency is limited to those currencies
108
that are of a kind customarily dealt in on an organized commodity exchange. Also, generally, for this purpose, commodities are limited to those of a kind customarily dealt in on an organized commodity exchange and to a commodity transaction that is of a kind customarily consummated at such place. There can be no assurance that the IRS will not contend successfully that a Fund has been engaged (directly or indirectly) in a U.S. trade or business with respect to any taxable year.
A Fund may invest in equity interests in partnerships and other pass-through entities, and if any such entity (directly or indirectly through pass-through entities) is engaged in a U.S. trade or business (or is deemed to so engage), such trade or business will be attributed to the Fund and to its shareholders and may result in non-U.S. investors recognizing ECI (which, in the case of corporate non-U.S. investors, may be subject to the branch profits tax). Furthermore, a Fund (and, therefore, its shareholders) may be attributed certain tax statuses of such pass-through entities, such as dealer status, in which case foreign investors may be required to treat income as ECI.
Gain on the sale or other disposition of USRPIs will be treated as ECI and will generally subject non-U.S. investors to withholding tax at rates of 10% of the proceeds, or, in certain circumstances, the applicable tax rate on the gain resulting from such sale or other disposition. For example, if (i) the Fund were to acquire an interest (including stock or certain convertible debt) in a corporation, (ii) such corporation were a USRPHC at any time within the shorter of the five-year period preceding the disposition of such interest or the time the Fund held such an interest, and (iii) either (A) such corporation was not publicly traded (within the meaning of the tax rules) or (B) the Fund (at any time during the period described in (ii) above) owned (actually or constructively) either a regularly traded interest (other than an interest solely as a creditor) in such corporation which was more than 5% (by value) of such regularly traded class of stock, or any other interest (other than an interest solely as a creditor) if such interest was more than 5% (by value) of the regularly traded class with the lowest value or of the regularly traded class into which such interest was convertible, then gain on the sale of such stock (or such convertible interest) would be treated as ECI and, therefore, would potentially be subject to regular U.S. federal income tax. As noted above, gain from the sale of a USRPI (other than interests in USRPHCs) would subject a corporate non-U.S. investor to the branch profits tax.
A Fund may invest in U.S. REITs that, in turn, invest in U.S. or foreign real estate or mortgage interests. Dividends from a U.S. REIT which are not attributable to gains from the sale of USRPIs may be subject to U.S. federal withholding tax at a 30% rate. Dividends attributable to gains from the sale of USRPIs generally would be subject to a 35% withholding tax. Distributions from a U.S. REIT may also be subject to a 30% branch profits tax in the hands of a corporate non-U.S. investor. Liquidating distributions may result in the imposition of similar taxes. In general, gains on sale of stock in a REIT that is domestically controlled (as that term is defined in the Code) or certain positions in publicly traded REITs would not be subject to U.S. federal income tax in the hands of a non-U.S. investor.
Even if a Fund is not engaged in a U.S. trade or business, if the Fund receives certain types of investment income, such as dividends (including certain payments with respect to derivative instruments that are determined to be dividend equivalent payments) or interest other than portfolio interest from U.S. sources, to the extent such income is allocated to a non-U.S. investor, the Fund may be required to withhold at a rate of 30% (or lower applicable treaty rate). In order to obtain a lower applicable treaty rate, a shareholder must provide the Fund with a properly executed withholding certificate, generally on Form W-8BEN or W-8BEN-E, properly claiming
109
eligibility for applicable treaty benefits. A Fund may withhold and pay any taxes with respect to any non-U.S. investor, including any withholding taxes under FATCA. In order to obtain the cash to pay any such tax, the Fund may, among other things, withhold the amount of such tax from any distribution otherwise payable to such foreign investor or require the non-U.S. investor to reimburse the Fund for the amount of such tax.
Considerations Regarding Foreign Jurisdictions
Shareholders may become liable for non-U.S. tax and/or filing obligations in connection with the activities or investments of a Fund outside the United States or in connection with income and gain recognized by a Fund from foreign sources, whether or not shareholders receive any distributions with respect to such investments. In addition, some of a Funds income from non-U.S. sources may be subject to tax in the applicable jurisdiction(s). Any such taxes paid by or withheld from a Fund will reduce the value of the relevant shareholders capital accounts. Shareholders may in some circumstances be able to claim relief under a double taxation treaty between their country of residence and the applicable country of the non-U.S.-source investment. Shareholders subject to tax in jurisdictions outside the United States should consult their own tax advisers regarding the tax consequences of an investment in a Fund. All prospective shareholders should consult their own tax advisers regarding the non-U.S. tax implications of an investment in a Fund.
For information on possible Australian or Singapore tax consequences of an investment in Systematic Global Macro Opportunity Fund, see the Taxes For Systematic Global Macro Opportunity Fund section in the Private Placement Memorandum.
U.S. State and Local and Non-U.S. Taxes and Taxes Other Than Income Taxes
The foregoing discussion does not address the U.S. state or local or non-U.S. tax consequences, or the consequences of taxes (including U.S. taxes) other than income taxes, of an investment in a Fund. It is possible that a Funds activities might generate tax return filing, reporting, or tax payment obligations in Massachusetts or other U.S. state or local or non-U.S. jurisdictions. Prospective shareholders should consult their own tax advisers regarding U.S. state and local and non-U.S. tax matters, as well as taxes other than income taxes.
The following tables present information as of June 26, 2015 regarding each current Trustee and officer of the Trust. Each Trustees and officers year of birth (YOB) is set forth after his or her name. Unless otherwise noted, (i) each Trustee and officer has engaged in the principal occupation(s) noted in the table for at least the most recent five years, although not necessarily in the same capacity, and (ii) the address of each Trustee and officer is c/o GMO Trust, 40 Rowes Wharf, Boston, Massachusetts 02110. Each Trustee serves in office until the earlier of (a) the election and qualification of a successor at the next meeting of shareholders called to elect Trustees or (b) the Trustee dies, resigns, or is removed as provided in the Trusts governing documents. Each of the Trustees of the Trust, other than Mr. Kittredge, is not an interested person of the Trust, as such term is used in the 1940 Act (each, an Independent Trustee). Because the Funds do not hold annual meetings of shareholders, each Trustee will hold office for an indeterminate period. Each officer serves in office until his or her successor is elected and determined to be qualified to carry out the duties and responsibilities of the office, or until the officer resigns or is removed from office.
110
Name and Year of Birth |
Position(s) Held with the Trust |
Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Number of Portfolios in Fund Complex 1 Overseen |
Other Directorships Held in the Past Five Years |
|||||
INDEPENDENT TRUSTEES |
||||||||||
Donald W. Glazer YOB: 1944 |
Chairman of the Board of Trustees | Chairman of the Board of Trustees since March 2005; Lead Independent Trustee (September 2004-March 2005); Trustee since December 2000. | Consultant Law and Business 2 ; Author of Legal Treatises. | 40 | None. | |||||
Peter Tufano YOB: 1957 |
Trustee | Since December 2008. | Peter Moores Dean and Professor of Finance, University of Oxford Saïd Business School (as of July 1, 2011); Sylvan C. Coleman Professor of Financial Management, Harvard Business School (1989-2011). | 40 | Trustee of State Street Navigator Securities Lending Trust (5 Portfolios). | |||||
Paul Braverman YOB: 1949 |
Trustee | Since March 2010. | Director of Courier Corporation (a book publisher and manufacturer) (January 2008-present); Director of Claren Road Asset Management, LLC (hedge fund) (January 2011-present); Director of Leerink Swann Holdings, LLC (investment bank) (October 2013-present). | 40 | Trustee of HIMCO Variable Insurance Trust (27 Portfolios); Director of Courier Corporation (a book publisher and manufacturer). |
111
Name and Year of Birth |
Position(s) Held with the Trust |
Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Number of Portfolios in Fund Complex 1 Overseen |
Other Directorships Held in the Past Five Years |
|||||
INTERESTED TRUSTEE AND OFFICER |
||||||||||
Joseph B. Kittredge, Jr. 3 YOB: 1954 |
Trustee; President |
Trustee since March 2010; President since March 2009; Chief Executive Officer, March 2009-June 2015. | General Counsel, Grantham, Mayo, Van Otterloo & Co. LLC (October 2005-present); Partner, Ropes & Gray, LLP (1988-2005). | 52 | None. |
1 | The Fund Complex includes series of each of GMO Trust and GMO Series Trust. Mr. Kittredge also serves as a Trustee of GMO Series Trust. |
2 | As part of Mr. Glazers work as a consultant, he provides part-time consulting services to Goodwin Procter LLP (Goodwin). Goodwin has provided legal services to Renewable Resources, LLC, an affiliate of GMO; GMO, in connection with its relationship with Renewable Resources; and funds managed by Renewable Resources. Mr. Glazer has represented that he has no financial interest in, and is not involved in the provision of, such legal services. In the calendar years ended December 31, 2013 and December 31, 2014, these entities paid $2,005.60 and $1,194.25, respectively, in legal fees and disbursements to Goodwin. In correspondence with the staff of the SEC (the Staff) beginning in August 2006, the Independent Trustees legal counsel provided the Staff with information regarding Mr. Glazers relationship with Goodwin and his other business activities. On September 11, 2007, based on information that had been given to the Staff as of that date, the Staff provided oral no-action assurance consistent with the opinion of the Independent Trustees legal counsel that Mr. Glazer is not an interested person of the Trust. |
3 | Mr. Kittredge is an interested person of the Trust, as such term is used in the 1940 Act (an Interested Trustee), by virtue of his positions with the Trust and GMO indicated in the table above and his interest as a member of GMO. |
Information About Each Trustees Experience, Qualifications, Attributes, or Skills for Board Membership. As described in additional detail below under Committees, the Governance Committee, which is comprised solely of Independent Trustees, has responsibility for recommending to the Board of Trustees the nomination of candidates for election as Trustees, including identifying and evaluating the skill sets and qualifications of, potential candidates. In recommending the election of the current board members as Trustees, the Governance Committee generally considered the educational, business, and professional experience of each Trustee in determining his or her qualifications to serve as a Trustee of the Funds. The Governance Committee focuses on the complementary skills and experience of the Trustees as a group, as well as on those of any particular Trustee. With respect to Messrs. Glazer, Tufano, and Braverman, the Governance Committee noted that these Trustees all had considerable experience in overseeing investment management activities and/or related operations and in serving on the boards of other companies. In addition, the Committee also considered, among other factors, the particular attributes described below with respect to the various individual Trustees:
Donald W. Glazer Mr. Glazers experience serving as Chairman of the Board of Trustees and as a director of other companies, his professional training and his experience as a business lawyer, including as a partner at a leading law firm, and his business experience.
112
Peter Tufano Mr. Tufanos experience serving as Trustee of the Trust and as a director of other companies, and his professional training and his experience in business and finance, including as a dean of a leading business school.
Paul Braverman Mr. Bravermans experience as a director, his professional training and his experience as a certified public accountant and lawyer and his experience in the management of a leading investment management firm.
Joseph B. Kittredge, Jr. Mr. Kittredges experience serving as President of the Trust, President and Trustee of GMO Series Trust, and General Counsel and a Member of GMO, his professional training and his experience as a lawyer representing mutual funds and investment management firms, including as a partner at a leading law firm, and his perspective on Board matters as a senior executive of GMO.
Information relating to the experience, qualifications, attributes, and skills of the Trustees is required by the registration form adopted by the SEC, does not constitute holding out the Board or any Trustee as having any special expertise or experience, and does not impose any greater responsibility or liability on any such person or on the Board as a whole than would otherwise be the case.
Officers
Name and Year of Birth |
Position(s) Held with the
|
Length of Time Served |
Principal Occupation(s)
|
|||
Joseph B. Kittredge, Jr. YOB: 1954 |
Trustee; President |
Trustee since March 2010; President since March 2009; Chief Executive Officer, March 2009-June 2015. | General Counsel, Grantham, Mayo, Van Otterloo & Co. LLC (October 2005-present); Partner, Ropes & Gray LLP (1988-2005). | |||
Sheppard N. Burnett YOB: 1968 |
Chief Executive Officer | Chief Executive Officer since June 2015; Chief Financial Officer, March 2007-June 2015; Treasurer, November 2006-June 2015; Assistant Treasurer, September 2004-November 2006. | Head of Fund Treasury and Tax (December 2006-present), Grantham, Mayo, Van Otterloo & Co. LLC. | |||
Carly Condron YOB: 1984 |
Treasurer, Chief Financial Officer and Chief Accounting Officer | Treasurer and Chief Financial Officer since June 2015; Chief Accounting Officer since May 2014; Assistant Treasurer, September 2013-June 2015. | Fund Administrator, Grantham, Mayo, Van Otterloo & Co. LLC (December 2009-present); Senior Accountant, Renaissance HealthCare (February 2009-December 2009); Auditor/Senior Auditor, Deloitte & Touche (September 2006-February 2009). | |||
John L. Nasrah YOB: 1977 |
Assistant Treasurer and Chief Tax Officer | Since March 2007. | Fund Administrator, Grantham, Mayo, Van Otterloo & Co. LLC (September 2004-present). |
113
Name and Year of Birth |
Position(s) Held with the
|
Length of Time Served |
Principal Occupation(s)
|
|||
Betty Chang YOB: 1972 |
Assistant Treasurer | Since September 2013. | Fund Administrator, Grantham, Mayo, Van Otterloo & Co. LLC (July 2010-present); Assistant Treasurer (June 2009-July 2010), Manager, Fund Administration and Regulatory Affairs (2006-2009), Hambrecht & Quist Capital Management LLC. | |||
Mahmoodur Rahman YOB: 1967 |
Assistant Treasurer | Since September 2007. | Fund Administrator, Grantham, Mayo, Van Otterloo & Co. LLC (April 2007-present). | |||
Brian Kadehjian YOB: 1974 |
Assistant Treasurer and Treasury Officer | Assistant Treasurer since February 2015; Treasury Officer since September 2013. | Fund Administrator, Grantham, Mayo, Van Otterloo & Co. LLC (April 2002-present). | |||
Craig Parker YOB: 1982 |
Assistant Treasurer | Since February 2015. | Fund Administrator, Grantham, Mayo, Van Otterloo & Co. LLC (October 2010-present); Senior Associate, PricewaterhouseCoopers LLP (September 2009-October 2010). | |||
Megan Bunting YOB: 1978 |
Vice President and Assistant Clerk | Since September 2013. | Legal Counsel, Grantham, Mayo, Van Otterloo & Co. LLC (September 2006-present). | |||
Meta S. David YOB: 1982 |
Vice President and Assistant Clerk | Since September 2013. | Legal Counsel, Grantham, Mayo, Van Otterloo & Co. LLC (August 2012-present). | |||
Gregory L. Pottle YOB: 1971 |
Chief Compliance Officer, Vice President and Assistant Clerk | Chief Compliance Officer since May 2015; Vice President and Assistant Clerk since November 2006. | Chief Compliance Officer, Grantham, Mayo, Van Otterloo & Co. LLC (May 2015-present); Legal Counsel, Grantham, Mayo, Van Otterloo & Co. LLC (March 2000-May 2015). | |||
Kelly Hollister YOB: 1988 |
Anti-Money Laundering Officer | Since November 2014. | Compliance Associate, Grantham, Mayo, Van Otterloo & Co. LLC (May 2012-present). |
1 | Each officer of the Trust may also serve as an officer and/or director of certain pooled investment vehicles of which GMO or an affiliate of GMO serves as the investment adviser. With the exceptions of Messrs. Kittredge and Parker, each officer listed in the table above also serves as an officer of GMO Series Trust. |
Trustees Responsibilities. Under the provisions of the Declaration of Trust (as defined below under Description of the Trust and Ownership of Shares), the Trustees manage the business of the Trust, an open-end management investment company. The Trustees have all powers necessary or convenient to carry out that responsibility, including the power to engage in securities transactions on behalf of the Trust. Without limiting the foregoing, the Trustees may: adopt By-Laws not inconsistent with the Declaration of Trust providing for the regulation and management of the affairs of the Trust; amend and repeal By-Laws to the extent that such By-Laws do not reserve that right to the shareholders; fill vacancies in or remove members of the Board of Trustees (including any vacancies created by an increase in the number of Trustees); remove members of the Board of Trustees with or without cause; elect and remove such officers and appoint and terminate agents as they consider appropriate; appoint members of the Board of
114
Trustees to one or more committees consisting of two or more Trustees, which may exercise the powers and authority of the Trustees, and terminate any such appointments; employ one or more custodians of the assets of the Trust and authorize such custodians to employ subcustodians and to deposit all or any part of such assets in a system or systems for the central handling of securities or with a Federal Reserve Bank; retain a transfer agent or a shareholder servicing agent, or both; provide for the distribution of Shares by the Trust, through one or more principal underwriters or otherwise; set record dates for the determination of Shareholders with respect to various matters; and in general delegate such authority as they consider desirable to any officer of the Trust, to any committee of the Trustees, and to any agent or employee of the Trust or to any such custodian or underwriter.
Board Leadership Structure and Risk Oversight. The Board of Trustees is responsible for the general oversight of each GMO Funds affairs and for assuring that each GMO Fund is managed in the best interests of its shareholders. The Board regularly reviews each GMO Funds investment performance as well as the quality of services provided to each GMO Fund and its shareholders by GMO and its affiliates, including shareholder servicing. At least annually, the Board reviews and evaluates the fees and operating expenses paid by each GMO Fund for these services and negotiates changes that it deems appropriate. In carrying out these responsibilities, the Board is assisted by the GMO Funds auditors, independent counsel to the Independent Trustees and other persons as appropriate, who are selected by and responsible to the Board. In addition, the GMO Funds Chief Compliance Officer reports directly to the Board.
Currently, all but one of the Trustees are Independent Trustees. The Independent Trustees must vote separately to approve all financial arrangements and other agreements with the Funds investment adviser, GMO, and other affiliated parties. The role of the Independent Trustees has been characterized as that of a watchdog charged with oversight of protecting shareholders interests against overreaching and abuse by those who are in a position to control or influence a fund. The Independent Trustees meet regularly as a group in executive session without representatives of GMO present. An Independent Board Member currently serves as Chairman of the Board of Trustees.
Taking into account the number, diversity, and complexity of the GMO Funds overseen by the Board of Trustees and the aggregate amount of assets under management in the GMO Funds, the Board has determined that the efficient conduct of its affairs makes it desirable to delegate responsibility for certain specific matters to committees of the Board. These committees, which are described in more detail below, review and evaluate matters specified in their charters and make recommendations to the Board as they deem appropriate. Each committee may utilize the resources of the GMO Funds counsel and auditors as well as other persons. The committees meet from time to time, either in conjunction with regular meetings of the Board or otherwise. The membership and chair of each committee are appointed by the Board upon recommendation of the Governance Committee. The membership and chair of each committee other than the Risk Oversight Committee consists exclusively of Independent Trustees.
The Board of Trustees has determined that this committee structure also allows the Board to focus more effectively on the oversight of risk as part of its broader oversight of each GMO Funds affairs. While risk management is primarily the responsibility of the Funds investment adviser, GMO, the Board regularly receives reports, including reports from GMO and the GMO Funds Chief Compliance Officer, regarding investment risks, compliance risks, and certain other risks applicable to the GMO Funds. The Boards committee structure allows separate committees, such as the Audit Committee, Pricing Committee, and Governance Committee, which are discussed in more detail below under Committees, to focus on different aspects of
115
these risks within the scope of the committees authority and their potential impact on some or all of the GMO Funds, and to discuss with the GMO the ways in which GMO monitors and controls such risks. The Board has also established a separate Risk Oversight Committee to oversee the management of risks applicable to the Funds, to the extent such risks are not overseen by a separate standing committee of the Board or by the Board itself.
The Board recognizes that not all risks that may affect the GMO Funds can be identified, that it may not be practical or cost-effective to eliminate or mitigate certain risks, that it may be necessary to bear certain risks (such as investment-related risks) to achieve a GMO Funds goals, that reports received by the Trustees with respect to risk management matters are typically summaries of the relevant information, and that the processes, procedures and controls employed to address risks may be limited in their effectiveness. As a result of the foregoing and other factors, risk management oversight by the Board and by the Committees is subject to substantial limitations.
Committees
The Board of Trustees has the authority to establish committees, which may exercise the power and authority of the Trustees to the extent the Board determines. The committees assist the Board of Trustees in performing its functions and duties under the 1940 Act and Massachusetts law.
The Board of Trustees currently has established four standing committees: the Audit Committee, the Pricing Committee, the Risk Oversight Committee, and the Governance Committee. During the fiscal year ended February 28, 2015, the Audit Committee held five meetings; the Governance Committee held three meetings; the Pricing Committee held four meetings; and the Risk Oversight Committee held three meetings.
Audit Committee. The Audit Committee (i) oversees the Trusts accounting and financial reporting policies and practices and internal controls over financial reporting; (ii) oversees the quality and objectivity of the Trusts financial statements and the independent audit of those statements; (iii) appoints, determines the independence and compensation of, and oversees the work performed by the Trusts independent auditors in preparing or issuing an audit report or related work; (iv) approves all audit and permissible non-audit services provided to the Trust, and certain other persons by the Trusts independent auditors; and (v) acts as a liaison between the Trusts independent auditors and the Board of Trustees. Mr. Braverman and Mr. Tufano are members of the Audit Committee, and Mr. Glazer is an alternate member of the Audit Committee. Mr. Braverman is the Chairman of the Audit Committee.
Governance Committee. The Governance Committee oversees general GMO Fund governance-related matters, including making recommendations to the Board of Trustees relating to governance of the Trust, reviewing possible conflicts of interest and independence issues involving Trustees, considering the skill sets and qualifications of prospective Trustees and to propose to the Board candidates to serve as Trustees, overseeing the determination that any person serving as legal counsel for the Independent Trustees qualifies as independent legal counsel, as that term is defined in the 1940 Act, and performing any other functions delegated to it by the Board of Trustees. Mr. Glazer and Mr. Braverman are members of the Governance Committee, and Mr. Tufano is an alternate member of the Governance Committee. Mr. Glazer is the Chairman of the Governance Committee.
As described above under Information About Each Trustees Experience, Qualifications, Attributes or Skills for Board Membership, the Governance Committee has responsibility for
116
recommending to the Board of Trustees the nomination of candidates for election as Trustees, including identifying and evaluating the skill sets and qualifications of potential candidates. Prospective nominees may be recommended by the current Trustees, the Trusts Officers, GMO, current shareholders, or other sources that the Governance Committee deems appropriate. Candidates properly submitted by shareholders will be considered on the same basis as candidates recommended by other sources. The Governance Committee has full discretion to reject nominees.
The Governance Committee considers a variety of qualifications, skills, and other attributes in evaluating potential candidates for nomination to the Board of Trustees. The attributes considered may include, but are not limited to: (i) relevant industry and related experience, including experience serving on other boards; (ii) skill sets, areas of expertise, abilities and judgment; and (iii) availability and commitment to attend meetings and to perform the responsibilities of a Trustee. In evaluating potential candidates, the Governance Committee also considers the overall composition of the Board of Trustees and assesses the needs of the Board and its committees.
Shareholders may recommend nominees to the Board of Trustees by writing the Board of Trustees, c/o GMO Trust Chief Compliance Officer, GMO Trust, 40 Rowes Wharf, Boston, Massachusetts 02110. A recommendation must (i) be in writing and signed by the shareholder; (ii) identify the GMO Fund to which it relates; and (iii) identify the class and number of shares held by the shareholder.
Pricing Committee. The Pricing Committee oversees the valuation of the securities and other assets held by the GMO Funds, reviews and makes recommendations regarding the Trusts Pricing Policies, and, to the extent required by the Trusts Pricing Policies, determines the fair value of the securities or other assets held by the Funds. Mr. Tufano and Mr. Glazer are members of the Pricing Committee, and Mr. Braverman is an alternate member of the Pricing Committee. Mr. Tufano is the Chairman of the Pricing Committee.
Risk Oversight Committee. The Risk Oversight Committee assists the Board in overseeing the management of risks applicable to the Funds to the extent those risks are not overseen by another standing committee of the Board or by the Board itself (e.g., financial reporting and audit-related operational or compliance risks, which are overseen by the Audit Committee, valuation-related operational or compliance risks, which are overseen by the Pricing Committee, or legal risks, which are overseen by the Board as a whole) including, without limitation, investment, operational and compliance risks. All of the Trustees are members of the Risk Oversight Committee, and Messrs. Braverman and Tufano are Co-Chairmen of the Risk Oversight Committee.
Trustee Fund Ownership
The following table sets forth ranges of the current Trustees direct beneficial share ownership in the Funds and the aggregate dollar ranges of their direct beneficial share ownership in all series of GMO Trust and GMO Series Trust (the Family of Investment Companies) as of December 31, 2014.
117
Name/Funds |
Dollar Range of
Shares Directly Owned in the Funds |
Aggregate Dollar Range of Shares
Directly Owned in all Registered Investment Companies (whether or not offered in the Private Placement Memorandum) Overseen by Trustee in Family of Investment Companies |
||
INDEPENDENT TRUSTEES |
||||
Donald W. Glazer |
None | Over $100,000 | ||
Peter Tufano |
None | None | ||
Paul Braverman |
None | None | ||
INTERESTED TRUSTEE |
||||
Joseph B. Kittredge, Jr. |
None | None |
The following table sets forth ranges of the current Trustees indirect beneficial share ownership in the Funds and the aggregate dollar range of their indirect beneficial share ownership in the Family of Investment Companies as of December 31, 2014.
Name/Funds |
Dollar Range of
Shares Indirectly Owned in the Funds |
Aggregate Dollar Range of Shares
Indirectly Owned in all Registered Investment Companies (whether or not offered in the Private Placement Memorandum) Overseen by Trustee in Family of Investment Companies |
||
INDEPENDENT TRUSTEES |
||||
Donald W. Glazer |
None | Over $100,000 | ||
Peter Tufano |
None | None | ||
Paul Braverman |
None | None | ||
INTERESTED TRUSTEE |
||||
Joseph B. Kittredge, Jr. |
None | None |
118
Independent Trustee Ownership of Securities Issued by GMO or Principal Underwriter
None.
Independent Trustee Ownership of Related Companies
The following table sets forth information about securities owned by the current Independent Trustees and their family members, as of December 31, 2014, in GMO, Funds Distributor, LLC, the GMO Funds principal underwriter, or entities directly or indirectly controlling, controlled by, or under common control with GMO or Funds Distributor, LLC.
Name of Independent Trustee |
Name of
Owner(s) and Relationship to Trustee |
Company |
Title of
|
Value of
Securities² |
% of Class | |||||||
Donald W. Glazer |
Self | GMO Multi-Strategy Fund (Offshore), a private investment company managed by GMO. 1 | Limited partnership interest Class A | $ | 642,997.28 | 0.01% | ||||||
Peter Tufano |
N/A | None | N/A | N/A | N/A | |||||||
Paul Braverman |
N/A | None | N/A | N/A | N/A |
1 | GMO may be deemed to control this fund by virtue of its serving as investment manager of the fund and by virtue of its ownership interest in the fund. |
2 | Securities valued as of December 31, 2014. |
Remuneration. The Trust has adopted a compensation policy for its Independent Trustees. Each Independent Trustee receives an annual retainer from the Trust for his services. In addition, each Chairman of the Trusts standing committees and the Chairman of the Board of Trustees receive an annual fee. The Trust reimburses the Independent Trustees for travel expenses incurred in connection with attending Board and committee meetings. The Trust pays no additional compensation for travel time to meetings, attendance at directors educational seminars or conferences, service on industry or association committees, participation as speakers at directors conferences, or service on special director task forces or subcommittees, although the Trust does reimburse Independent Trustees for seminar or conference fees and for travel expenses incurred in connection with attendance at seminars or conferences. The Independent Trustees do not receive any employee benefits such as pension or retirement benefits or health insurance.
During the fiscal year ended February 28, 2015, other than as set forth in the table below, no Trustee of the Trust received any direct compensation from the Fund Complex or any Fund, and no officer of the Trust received aggregate compensation exceeding $60,000 from any Fund:
119
Donald W.
Glazer, Trustee |
Peter
Tufano, Trustee |
Paul
Braverman, Trustee |
||||||||||
Compensation from Each Fund: |
||||||||||||
GAAR Implementation Fund 1 |
$ | 5,979 | $ | 5,113 | $ | 5,092 | ||||||
High Quality Short-Duration Bond Fund 1 |
$ | 82 | $ | 69 | $ | 70 | ||||||
Systematic Global Macro Opportunity Fund |
$ | 4,814 | $ | 4,064 | $ | 4,084 | ||||||
World Opportunity Overlay Fund |
$ | 914 | $ | 771 | $ | 760 | ||||||
Pension or Retirement Benefits Accrued as Part of Fund Expenses: |
N/A | N/A | N/A | |||||||||
Estimated Annual Benefits Upon Retirement: |
N/A | N/A | N/A | |||||||||
Total Compensation from the Fund Complex: 2 |
$ | 385,367 | $ | 325,640 | $ | 328,241 |
1 | Reflects an estimate of the direct compensation to be paid to each Trustee for the Funds initial fiscal year ending February 28, 2016. Actual direct compensation paid to the Trustees will vary depending on the net assets of the Fund throughout its initial fiscal year. |
2 | Reflects actual direct compensation received during the fiscal year ended February 28, 2015 from series of the Fund Complex that had commenced operations on or before February 28, 2015, which consisted of 47 series of GMO Trust and GMO Series Trust. |
Mr. Kittredge does not receive any compensation from the Fund Complex, but as a member of GMO will benefit from management, shareholder servicing, administration, and any other fees paid to GMO and its affiliates by the Funds and various GMO Funds not offered through the Private Placement Memorandum. The officers of the Trust do not receive any employee benefits such as pension or retirement benefits or health insurance from the Trust.
As of June 11, 2015, the Trustees and officers of the Trust as a group owned less than 1% of the outstanding shares of each class of shares of each other Fund offered in the Private Placement Memorandum.
Code of Ethics. The Trust and GMO have each adopted a Code of Ethics pursuant to the requirements of the 1940 Act. Under each Code of Ethics, personnel are permitted to engage in personal securities transactions only in accordance with specified conditions relating to their position, the identity of the security, the timing of the transaction, and similar factors. Transactions in securities that may be purchased or held by the Funds are permitted, subject to compliance with each Code. Personal securities transactions must be reported quarterly and broker confirmations must be provided for review.
The independent Trustees of the Trust are subject to a separate Code of Ethics for the Independent Trustees pursuant to the requirements of the 1940 Act. Transactions by the Independent Trustees in securities, including securities that may be purchased or held by the Funds, are permitted, subject to compliance with the Code of Ethics. Pursuant to the Code of Ethics, an Independent Trustee ordinarily is not required to report his or her personal securities transactions or to identify his or her brokerage accounts to a Fund or its representatives, subject to certain limited exceptions specified in the Code of Ethics.
The Funds principal underwriter, which is not affiliated with the Funds or GMO, also has adopted a Code of Ethics pursuant to the requirements of the 1940 Act. Transactions in securities effected by the principal underwriters personnel who are designated as Access
120
Persons under the Code of Ethics, including securities that may be purchased or held by the Funds, are permitted, subject to compliance with the Code of Ethics.
INVESTMENT ADVISORY AND OTHER SERVICES
Management Contracts
As disclosed in the Private Placement Memorandum under the heading Management of the Fund, under separate Management Contracts (each, a Management Contract) between the Trust, on behalf of the Funds, and GMO, subject to such policies as the Trustees of the Trust may determine, GMO furnishes continuously an investment or asset allocation program, as applicable, for each Fund, and makes investment decisions on behalf of the Fund and places all orders for the purchase and sale of portfolio securities. Subject to the control of the Trustees, GMO also manages, supervises, and conducts the other affairs and business of the Trust, furnishes office space and equipment, provides bookkeeping and certain clerical services, and pays all salaries, fees, and expenses of officers and Trustees of the Trust who are affiliated with GMO. As indicated under Portfolio Transactions Brokerage and Research Services, the Trusts portfolio transactions may be placed with brokers who furnish GMO, at no cost, research, statistical and quotation services of value to GMO in advising the Trust or its other clients.
GMO does not charge GAAR Implementation Fund or World Opportunity Overlay Fund any management or shareholder service fees. In addition, GMO has contractually agreed to waive and/or reimburse each Fund for specified Fund expenses (as described in the Private Placement Memorandum under the heading Fees and expenses) through at least June 30, 2016.
Each Management Contract provides that GMO shall not be subject to any liability in connection with the performance of its services in the absence of willful misfeasance, bad faith, gross negligence, or reckless disregard of its obligations and duties.
Each Management Contract was approved by the Trustees of the Trust (including a majority of the Trustees who were not interested persons of GMO) and by the relevant Funds sole initial shareholder in connection with the organization of the Trust and the establishment of the Funds. Generally, each Management Contract continues in effect for a period of two years from the date of its execution and continuously thereafter so long as its continuance is approved at least annually by (i) the vote, cast in person at a meeting called for that purpose, of a majority of those Trustees who are not interested persons of GMO or the Trust, and by (ii) the majority vote of either the full Board of Trustees or the vote of a majority of the outstanding shares of the relevant Fund. Each Management Contract automatically terminates on assignment, and is terminable on not more than 60 days notice by the Trust to GMO. In addition, each Management Contract may be terminated on not more than 60 days written notice by GMO to the Trust.
With respect to World Opportunity Overlay Fund, since the commencement of the Funds operations, the Fund has not paid a Management Fee to GMO pursuant to the Management Contract. With respect to GAAR Implementation Fund and High Quality Short-Duration Bond Fund, these Funds have not yet commenced operations as of the date of this SAI. With respect to Systematic Global Macro Opportunity Fund, the Management Fee is calculated based on a fixed percentage of the Funds average daily net assets.
Pursuant to their Management Contracts, the Funds have paid the following amounts as Management Fees to GMO during the last three fiscal years:
121
Gross | Reduction | Net | ||||||||||
GAAR IMPLEMENTATION FUND 1 |
||||||||||||
Year ended 2/28/15 |
N/A | N/A | N/A | |||||||||
Year ended 2/28/14 |
N/A | N/A | N/A | |||||||||
Year ended 2/29/13 |
N/A | N/A | N/A | |||||||||
HIGH QUALITY SHORT-DURATION BOND FUND 2 |
||||||||||||
Year ended 2/28/15 |
N/A | N/A | N/A | |||||||||
Year ended 2/28/14 |
N/A | N/A | N/A | |||||||||
Year ended 2/29/13 |
N/A | N/A | N/A | |||||||||
SYSTEMATIC GLOBAL MACRO OPPORTUNITY FUND |
||||||||||||
Year ended 2/28/15 |
$ | 10,612,865 | $ | 1,184,588 | $ | 9,428,777 | ||||||
Year ended 2/28/14 |
11,288,705 | 2,068,353 | 9,220,352 | |||||||||
Year ended 2/29/13 |
3,133,713 | 743,265 | 2,390,448 | |||||||||
WORLD OPPORTUNITY OVERLAY FUND |
||||||||||||
Year ended 2/28/15 |
$ | 0 | $ | 0 | $ | 0 | ||||||
Year ended 2/28/14 |
0 | 0 | 0 | |||||||||
Year ended 2/29/13 |
0 | 0 | 0 |
1 | As of the date of this SAI, GAAR Implementation Fund has not yet commenced operations. |
2 | As of the date of this SAI, High Quality Short-Duration Bond Fund has not yet commenced operations. |
In the event that GMO ceases to be the manager of a Fund, the right of the Trust to use the identifying initials GMO and the name Grantham, Mayo, Van Otterloo & Co. LLC may be withdrawn.
Portfolio Management
Management of each Fund is the responsibility of one or more investment teams comprising investment professionals associated with GMO. Each teams members work collaboratively to manage a Funds portfolio, and no one person is primarily responsible for management of any Fund.
The following table sets forth information about accounts overseen or managed by the senior members of the teams as of February 28, 2015 (except as otherwise noted below).
122
Senior Member |
Registered investment companies managed
(including non-GMO mutual fund subadvisory relationships) |
Other pooled investment vehicles
managed (world-wide) |
Separate accounts managed
(world-wide) |
|||||||||
Number of
accounts |
Total assets 1 |
Number of
accounts |
Total assets |
Number of
accounts |
Total assets | |||||||
Joe Auth |
1 | $1,744,127,034 | 0 | 0 | 0 | 0 | ||||||
Michael Emanuel |
7 | $6,161,795,423 | 4 | $1,119,681,099 | 4 | $463,573,517 | ||||||
Jason Halliwell |
1 | $1,499,451,199 | 5 | $4,648,402,118 | 2 | $685,493,944 | ||||||
Ben Inker |
35 | $54,197,368,780 | 16 | $9,034,706,439 | 190 | $19,987,730,464 | ||||||
Greg Jones |
8 | $7,905,922,456 | 0 | 0 | 0 | 0 | ||||||
Sam Wilderman |
35 | $54,197,368,780 | 16 | $9,034,706,439 | 190 | $19,987,730,464 | ||||||
Senior Member |
Registered investment companies managed
for which GMO receives a performance- based fee (including non-GMO mutual fund subadvisory relationships) |
Other pooled investment vehicles
managed (world-wide) for which GMO receives a performance-based fee |
Separate accounts managed (world-wide)
for which GMO receives a performance- based fee |
|||||||||
Number of
accounts |
Total assets |
Number of
accounts |
Total assets |
Number of
accounts |
Total assets | |||||||
Joe Auth |
0 | 0 | 0 | 0 | 0 | 0 | ||||||
Michael Emanuel |
0 | 0 | 0 | 0 | 1 | $335,265,020 | ||||||
Jason Halliwell |
0 | 0 | 3 | $4,644,881,869 | 1 | $604,670,576 | ||||||
Ben Inker |
0 | 0 | 5 | $1,301,542,070 | 145 | $15,483,542,550 | ||||||
Greg Jones |
0 | 0 | 0 | 0 | 0 | 0 | ||||||
Sam Wilderman |
0 | 0 | 5 | $1,301,542,070 | 145 | $15,483,542,550 |
1 | For some senior members, Total assets includes assets invested by other GMO Funds (including GMO Funds not offered through the Private Placement Memorandum). |
123
Because each senior member manages other accounts, including accounts that pay higher fees or accounts that pay performance-based fees, potential conflicts of interest exist, including potential conflicts between the investment strategy of a Fund and the investment strategy of the other accounts managed by the senior member and potential conflicts in the allocation of investment opportunities between a Fund and the other accounts.
Senior members of each team are generally members (partners) of GMO. As of February 28, 2015, the compensation of each senior member consisted of a fixed annual base salary and, possibly, an additional, discretionary, bonus related to the senior members contribution to GMOs success and, in the case of partners, a partnership interest in the firms profits. The compensation program does not disproportionately reward outperformance by higher-fee/performance-fee products. Base salary is determined by taking into account current industry norms and market data to ensure that GMO pays a competitive base salary. A discretionary bonus may be paid to recognize specific business contributions and to ensure that the total level of compensation is competitive with the market. The level of partnership interest is determined by taking into account the individuals contribution to GMO and its mission statement. Because each persons compensation is based on his or her individual performance, GMO does not have a typical percentage split among base salary, bonus and other compensation. A GMO partnership interest is the primary incentive for persons to maintain employment with GMO. GMO believes this is the best incentive to maintain stability of portfolio management personnel.
Senior Member Fund Ownership. None of the senior members, as of February 28, 2015, had any direct beneficial share ownership in the Funds that are overseen or managed by the senior member as of the date of this SAI.
The following table sets forth the dollar range of each senior members indirect beneficial share ownership, as of February 28, 2015 (except as otherwise noted below), in the Funds offered in the Private Placement Memorandum that are overseen or managed by the senior member as of the date of this SAI, by virtue of the senior members direct ownership of shares of certain other Funds of the Trust that invest in the Funds:
124
Custodial Arrangements and Fund Accounting Agents . As described in the Private Placement Memorandum, State Street Bank and Trust Company (State Street Bank), One Lincoln Street, Boston, Massachusetts 02111, serves as the Trusts custodian, fund accounting agent and FATCA compliance services provider on behalf of the Funds. As such, State Street Bank holds in safekeeping certificated securities and cash belonging to a Fund and, in such capacity, is the registered owner of securities in book-entry form belonging to a Fund. Upon instruction, State Street Bank receives and delivers cash and securities of a Fund in connection with Fund transactions and collects all dividends and other distributions made with respect to Fund portfolio securities. State Street Bank also maintains certain accounts and records of the Trust and calculates the total net asset value, total net income and net asset value per share of each Fund on a daily basis.
Shareholder Service Arrangements . As disclosed in the Private Placement Memorandum, pursuant to the terms of an amended and restated servicing and supplemental support agreement (the Servicing Agreement) with the Funds of the Trust, GMO provides direct client service, maintenance, and reporting to shareholders of High Quality Short-Duration Bond Fund and Systematic Global Macro Opportunity Fund. The Servicing Agreement was approved by the Trustees of the Trust (including a majority of the Trustees who are not interested persons of GMO or the Trust). The Servicing Agreement will continue in effect for a period of more than one year from the date of its execution only so long as its continuance is approved at least annually by (i) the vote, cast in person at a meeting called for the purpose, of a majority of those Trustees who are not interested persons of GMO or the Trust, and (ii) the majority vote of the full Board of Trustees. The Servicing Agreement automatically terminates on assignment (except as specifically provided in the Servicing Agreement) and is terminable by either party upon not more than 60 days written notice to the other party.
The Trust entered into the Servicing Agreement with GMO on May 30, 1996. Pursuant to the terms of the Servicing Agreement, High Quality Short-Duration Bond Fund and Systematic Global Macro Opportunity Fund paid GMO the following amounts (after reimbursement by GMO) during the last three fiscal years:
March 1, 2012
Through February 28, 2013 |
March 1, 2013
Through February 28, 2014 |
March 1, 2014
Through February 28, 2015 |
||||||||||
High Quality Short-Duration Bond Fund 1 |
N/A | N/A | N/A | |||||||||
Systematic Global Macro Opportunity Fund |
$ | 671,509 | $ | 2,419,008 | $ | 2,272,572 |
1 | As of the date of this SAI, High Quality Short-Duration Bond Fund has not yet commenced operations. |
125
Independent Registered Public Accounting Firm . The Trusts independent registered public accounting firm is PricewaterhouseCoopers LLP, 125 High Street, Boston, Massachusetts 02110. PricewaterhouseCoopers LLP conducts annual audits of the Trusts financial statements, assists in the preparation of each Funds federal and state income tax returns, consults with the Trust as to matters of accounting and federal and state income taxation, provides assistance in connection with the preparation of various SEC filings, and consults with the Trust as to certain non-U.S. tax matters.
Placement Agent . Funds Distributor, LLC, 3 Canal Plaza, Suite 100, Portland, Maine 04101, serves as the Trusts placement agent on behalf of the Funds. GMO pays all expenses related to the placement of shares of the Funds. Funds Distributor, LLC sells shares of each Fund on a private placement basis pursuant to an exemption from registration by Regulation D under the Securities Act of 1933, as amended, and will use reasonable efforts in connection with the placement of shares of the Funds.
Counsel . Ropes & Gray LLP, Prudential Tower, 800 Boylston Street, Boston, Massachusetts 02199, serves as counsel to the Trust. Morgan, Lewis & Bockius LLP, 225 Franklin Street, Boston, Massachusetts 02110, serves as independent counsel to the independent Trustees of the Trust.
Transfer Agent. State Street Bank serves as the Trusts transfer agent on behalf of the Funds.
Decisions to buy and sell portfolio securities for each Fund and for each of its other investment advisory clients are made by GMO with a view to achieving each clients investment objectives taking into consideration other account-specific factors such as, without limitation, cash flows into or out of the account, current holdings, the accounts benchmark(s), if any, applicable regulatory limitations, liquidity, cash restrictions, applicable transaction documentation requirements, market registration requirements, and/or time constraints limiting GMOs ability to confirm adequate transaction documentation or seek interpretation of investment guideline ambiguities. Therefore, a particular security may be bought or sold only for certain clients of GMO even though it could have been bought or sold for other clients at the same time. Also, a particular security may be bought/sold for one or more clients when one or more other clients are selling/buying the security or taking a short position in the security, including clients invested in the same investment strategy. Additionally, one of GMOs investment teams may share investment ideas with one or more other investment teams and/or may manage a portion of another investment teams client accounts.
To the extent permitted by applicable law, GMOs compliance policies and procedures and a clients investment guidelines, GMO may engage in cross trades where, as investment manager to a client account, GMO causes that client account to purchase a security directly from (or sell a security directly to) another client account.
In certain cases, GMO may identify investment opportunities that are suitable for the Funds and one or more private investment companies for which GMO or one of its affiliates serves as investment manager, general partner, and/or managing member (GMO Private Funds). In
126
most cases, GMO receives greater compensation in respect of a GMO Private Fund (including incentive-based compensation) than it receives in respect of a GMO Fund. In addition, senior members or other portfolio managers frequently have a personal investment in a GMO Private Fund that is greater than such persons investment in a similar GMO Fund (or, in some cases, may have no investment in the similar GMO Fund). GMO itself also makes investments in GMO Private Funds. To help manage these potential conflicts, GMO has developed and reviewed with the Trusts Board of Trustees trade allocation policies that establish a framework for allocating IPOs and other limited opportunities that take into account the needs and objectives of each GMO Fund and the other GMO clients.
Transactions involving the issuance of Fund shares for securities or assets other than cash will be limited to a bona fide reorganization or statutory merger and to other acquisitions of portfolio securities that meet all of the following conditions: (i) such securities meet the investment objectives and policies of the Fund; (ii) such securities are acquired for investment and not for resale; and (iii) such securities can be valued pursuant to the Trusts pricing policies.
Brokerage and Research Services . Orders for the purchase or sale of securities may be placed on a principal or agency basis with brokers, in GMOs discretion. In selecting brokers and dealers to effect portfolio transactions for each Fund, GMO seeks best execution and also takes into account the research services provided by the broker. Best execution is not based solely on the explicit commission charged by the broker and, consequently, a broker effecting a transaction may be paid a commission higher than that charged by another broker for the same transaction. Seeking best execution involves the weighing of qualitative as well as quantitative factors, and evaluations of best execution are, to a large extent, possible, if at all, only after multiple trades have been completed. GMO does place trades with brokers that provide investment ideas and other research services, even if the relevant broker has not yet demonstrated an ability to effect best execution; however, trading with such a broker (as with any and all brokers) will typically be curtailed or suspended, in due course, if GMO is not reasonably satisfied with the quality of particular trade executions, unless or until the broker has altered its execution capabilities in such a way that GMO can reasonably conclude that the broker is capable of achieving best execution.
The determination of what may constitute best execution involves a number of considerations in varying degrees of emphasis, including, without limitation, the overall net economic result to a Fund; the efficiency with which the transaction is effected; access to order flow; the ability of the executing broker to effect the transaction where a large block is involved; reliability (e.g., lack of failed trades); availability of the broker to stand ready to execute possibly difficult transactions in the future; technological capabilities of the broker, including but not limited to execution technology; the brokers inventory of securities sought; reported broker flow; post-transaction reporting capabilities; the financial strength and stability of the broker; past bids and willingness to commit capital in the case of principal trades; and the relative weighting of opportunity costs (i.e., timeliness of execution) by different trading strategies. Due to the similarities among brokers in technological execution capabilities and commissions paid, GMO often allocates program or algorithmic developed market equity trades across multiple brokers. Additionally, regulations in certain markets, particularly emerging markets, require GMO to identify and trade with one or a limited number of brokers. Most of the foregoing are subjective considerations made in advance of the trade and are not always borne out by the actual execution.
127
GMOs broker selection may, in addition to the factors listed above, also be based on research services provided by the broker. In seeking best execution and in determining the overall reasonableness of brokerage commissions, GMO may consider research services received by brokers and therefore, may select or recommend a broker based on GMOs interest in receiving the research, rather than on the lowest commission charged. GMO may also direct trades to brokers based in part on the brokers history of providing, and capability to continue providing, pricing information for securities purchased.
Generally, GMO determines the overall reasonableness of brokerage commissions paid upon consideration of the relative merits of a number of factors, which may include: (i) the net economic effect to the particular Fund; (ii) historical and current commission rates; (iii) the kind and quality of the execution services rendered; (iv) the size and nature of the transactions effected; and (v) research services received. These factors are considered mostly over multiple transactions covering extended periods of time in varying degrees of emphasis. In some instances, GMO may evaluate best execution on principal bids based on the total commissions charged (the bid for handling a trade as a principal trade) because the trades were filled at the price set at an agreed upon time (e.g., previous nights close). In those cases, any additional impact or cost is represented by the cents per share or basis points paid in addition to a typical commission rate.
GMO relies on the statutory safe harbor in Section 28(e) of the Securities Exchange Act of 1934, as amended (the 1934 Act) because GMO will frequently use brokers that provide research in all markets and that research is a factor in evaluating brokers. However, GMO does not participate in any formal soft dollar arrangements involving third party research (i.e., research provided by someone other than the executing broker) or the payment of GMOs out-of-pocket expenses for data or other research services. The research services received by GMO are limited to the types of research contemplated by Section 28(e) of the 1934 Act. Research services provided by brokers take various forms, including personal interviews with analysts, written reports, pricing services in respect of securities, and meetings arranged with various sources of information regarding particular issuers (including, where permissible, company management), industries, governmental policies, specific information about local markets and applicable regulations, economic trends, and other matters. To the extent that services of value are received by GMO, GMO receives a benefit because it does not have to produce or pay for the services itself. Such services furnished to GMO may be used in furnishing investment or other advice to all or some subset of GMOs clients, including the Funds, and services received from a broker that executed transactions for a particular Fund will not necessarily be used by GMO specifically in providing investment advice to that particular Fund.
The Trust paid, on behalf of the Funds that commenced operations prior to the end of the most recent fiscal year, the following amounts in brokerage commissions during the three most recent fiscal years:
128
March 1, 2012
Through February 28, 2013 |
March 1, 2013
Through February 28, 2014 |
March 1, 2014
Through February 28, 2015 |
||||||||||
Systematic Global Macro Opportunity Fund (a) |
$ | 97,127 | $ | 414,973 | $ | 517,175 | ||||||
World Opportunity Overlay Fund |
$ | 105,613 | $ | 117,582 | $ | 41,417 |
(a) | Brokerage commissions include commissions paid by the Fund and its wholly-owned subsidiary. |
Differences in the amount of brokerage commissions paid by a Fund during a Funds three most recent fiscal years (as disclosed in the table above) are generally the result of (i) active trading strategies employed by GMO when responding to changes in market conditions; (ii) management of cash flows into and out of a Fund as a result of shareholder purchases and redemptions; (iii) rebalancing portfolios to reflect the results of GMOs portfolio management models; (iv) changes in commission rates in the relevant markets; or (v) the use of principal trades. Changes in the amount of brokerage commissions paid by a Fund do not reflect material changes in the Funds investment objective or strategies.
None of the Funds acquired securities of their regular brokers or dealers (as defined in the 1940 Act) or of their parents during the fiscal year ended February 28, 2015.
Due to restrictions under the 1940 Act, it is possible that, as the result of certain affiliations between a broker or its affiliates and a Fund, GMO or the Funds distributor, all of the GMO Funds may refrain, or be required to refrain, from engaging in principal trades with such broker. Additionally, the GMO Funds may be restricted in their ability to purchase securities issued by affiliates of the Funds distributor.
PROXY VOTING POLICIES AND PROCEDURES
The Trust has adopted a proxy voting policy under which responsibility to vote proxies related to its portfolio securities has been delegated to GMO. The Board of Trustees of the Trust has reviewed and approved the proxy voting policies and procedures GMO follows when voting proxies on behalf of the Funds. The Trusts proxy voting policy and GMOs proxy voting policies and procedures are attached to this SAI as Appendix C .
GMOs proxy voting policies on a particular issue may or may not reflect the views of individual members of the Board of Trustees of the Trust, or a majority of the Board of Trustees.
Information regarding how the Funds voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 will be available on the Trusts website at www.gmo.com and on the SECs website at www.sec.gov no later than August 31 of each year.
129
DISCLOSURE OF PORTFOLIO HOLDINGS
The policy of the Trust is to protect the confidentiality of each Funds portfolio holdings and to prevent inappropriate selective disclosure of those holdings. The Board of Trustees has approved this policy and material amendments require its approval.
Registered investment companies that are sub-advised by GMO may be subject to different portfolio holdings disclosure policies, and neither GMO nor the Board of Trustees exercises control over those policies. In addition, separate account clients of GMO have access to their portfolio holdings and are not subject to the Funds portfolio holdings disclosure policies. Some of the funds that are sub-advised by GMO and some of the separate accounts managed by GMO have substantially similar investment objectives and strategies and, therefore, potentially similar portfolio holdings.
Information regarding the composition of a Funds portfolio is the property of that Fund. Neither GMO nor any Fund will receive any compensation or other consideration in connection with its disclosure of a Funds portfolio holdings.
GMO may disclose a Funds portfolio holdings (together with any other information from which the Funds portfolio holdings could reasonably be derived, as reasonably determined by GMO) (the Portfolio Holdings Information) to shareholders (including shareholders of record of indirect investments in a Fund through another fund managed by GMO), qualified potential shareholders as determined by GMO (including qualified potential shareholders of record who are considering an indirect investment in a Fund through another fund managed by GMO), and their consultants and agents (collectively, Permitted Recipients). GMO may disclose Portfolio Holdings Information to Permitted Recipients by means of the GMO website, by e-mail, and by any other means in such scope and form and with such frequency as GMO may reasonably determine, no earlier than the next day following the day on which the Portfolio Holdings Information is posted on the GMO website.
Except as otherwise noted, to receive Portfolio Holdings Information, Permitted Recipients must enter into a confidentiality agreement with GMO that requires that the Portfolio Holdings Information be used solely for purposes determined by senior management of GMO to be lawful and in the best interest of the shareholders of the Fund to which the information relates. Any exception must be approved in advance as described below.
The Funds Private Placement Memorandum describes the type of information disclosed on GMOs website, as well as the frequency with which it is disclosed and the lag between the date of the information and the date of its disclosure. Up to the largest fifteen holdings of some GMO Funds are posted monthly on GMOs website and typically are available to shareholders without a confidentiality agreement. In addition, position attribution information regarding one or more Funds may be posted monthly to GMOs website (e.g., best/worst performing positions in the Fund over a specified time period). Such information is available without a confidentiality agreement to registered users of GMOs website.
GMO also may make Portfolio Holdings Information available to Permitted Recipients without a confidentiality agreement, by e-mail, or by any other means in such scope and form and with
130
such frequency as GMO may reasonably determine, (i) on any day following the day on which the Portfolio Holdings Information is posted on the GMO website (provided that the Private Placement Memorandum describes the nature and scope of the Portfolio Holdings Information that will be available on the GMO website, when the information will be available and the period for which the information will remain available, and the location on the Funds website where the information will be made available) or (ii) on the same day or any day after the day such Portfolio Holdings Information is made available through a publicly available, routine filing with the SEC.
GMO also may from time to time disclose Portfolio Holdings Information to all shareholders of a Fund and, as applicable, their consultants and agents (including shareholders of record of indirect investments in a Fund through another fund managed by GMO). Such disclosure may be made by e-mail, written notice or any other means in such scope and form as GMO may reasonably determine, and generally will not be subject to a confidentiality agreement and will not be required to be posted to GMOs website in advance.
In some cases, GMO may disclose to a third party Portfolio Holdings Information that has not been made available to Permitted Recipients on the GMO website or in a publicly available, routine filing with the SEC. That disclosure may only be made if GMO determines that it is in the best interests of the shareholders of the Fund to which the information relates. That determination may be made by either GMOs General Counsel (or persons designated by GMOs General Counsel) or GMOs Chief Compliance Officer, in consultation with the relevant portfolio manager. The third party receiving the Portfolio Holdings Information must be, and shall be informed that it is, under a duty not to trade on such information or disclose it to others and shall agree in writing not to do so. In addition, the third party receiving the Portfolio Holdings Information must enter into a confidentiality agreement with GMO that requires that the Portfolio Holdings Information be used solely for purposes determined by GMO senior management to be in the best interest of the Funds shareholders.
The procedures pursuant to which GMO may disclose to a third party Portfolio Holdings Information that has not been made available to Permitted Recipients do not apply to Portfolio Holdings Information provided to entities who provide on-going services to the Funds in connection with their day-to-day operations and management, including GMO, GMOs affiliates, the Funds custodians and auditors, the Funds pricing service vendors, brokers when requesting bids for or price quotations on securities, brokers in the normal course of trading on a Funds behalf, and persons assisting the Funds in the voting of proxies. In addition, (i) when an investor indicates that it wants to purchase shares of a Fund in exchange for securities acceptable to GMO, GMO may make available a list of securities that it would be willing to accept for the Fund, and, from time to time, the securities on the list may overlap with securities currently held by the Fund; and (ii) when the Fund determines to pay redemption proceeds wholly or partly in-kind with securities, GMO may make available a list of securities it intends to deliver from the Fund.
No provision of this policy is intended to restrict or prevent the disclosure of Portfolio Holdings Information as may be required by applicable law, rules or regulations.
131
GMOs General Counsel or Chief Compliance Officer may authorize exceptions to these procedures. Exceptions must be disclosed to the Chief Compliance Officer of the Trust or his designee.
If GMO becomes aware that a recipient has or is likely to violate the terms of a confidentiality agreement regarding Portfolio Holdings Information, GMO shall cease providing such information to such recipient.
If senior management of GMO identifies a potential conflict with respect to the disclosure of Portfolio Holdings Information between the interest of a Funds shareholders, on the one hand, and GMO or an affiliated person of GMO or the Fund, on the other, GMO is required to inform the Trusts Chief Compliance Officer of the potential conflict, and the Trusts Chief Compliance Officer has the power to decide whether, in light of the potential conflict, disclosure should be permitted under the circumstances. The Trusts Chief Compliance Officer also is required to report his decision to the Board of Trustees.
GMO periodically reports the following information to the Board of Trustees:
| Determinations made by senior management of GMO relating to the use of Portfolio Holdings Information by Permitted Recipients and third parties; |
| The nature and scope of disclosure of Portfolio Holdings Information to third parties; |
| Exceptions to the disclosure policy authorized by GMOs General Counsel or Chief Compliance Officer; and |
| Any other information the Trustees may request relating to the disclosure of Portfolio Holdings Information. |
Ongoing Arrangements to Make Portfolio Holdings Available . Senior management of GMO has authorized disclosure of Portfolio Holdings Information on an on-going basis (generally, daily, except with respect to PricewaterhouseCoopers LLP, which receives holdings semi-annually and as necessary in connection with the services it provides to the Funds) to the following entities that provide on-going services to the Funds in connection with their day-to-day operations and management, provided that they agree to, or have a duty to, maintain this information in confidence:
Name of Recipient |
Funds |
Purpose of Disclosure |
||
State Street Bank and Trust Company |
All Funds | Custodial services, fund accounting services and compliance testing | ||
PricewaterhouseCoopers LLP |
All Funds | Independent registered public accounting firm | ||
Institutional Shareholder Services Inc. (formerly known as RiskMetrics Group, Inc.) |
All Funds | Corporate actions services |
132
Name of Recipient |
Funds |
Purpose of Disclosure |
||
Super Derivatives, Inc. |
All Funds | Derivative valuations | ||
TriOptima AB | All Funds | Portfolio derivative reconciliations | ||
FactSet | All Funds | Data service provider | ||
Ernst & Young | All Funds | Consulting and local tax services | ||
Goldman, Sachs & Co. and affiliates |
GAAR Implementation Fund |
Prime brokerage arrangement |
Senior management of GMO has authorized disclosure of Portfolio Holdings Information on an on-going basis (daily) to the following recipients, provided that they agree or have a duty to maintain this information in confidence and are limited to using the information for the specific purpose for which it was provided:
Name of Recipient |
Funds |
Purpose of Disclosure |
||
Epstein & Associates, Inc. | All Funds | Software provider for Code of Ethics monitoring system |
DESCRIPTION OF THE TRUST AND OWNERSHIP OF SHARES
The Trust, an open-end management investment company, is organized as a Massachusetts business trust under the laws of Massachusetts by an Agreement and Declaration of Trust (Declaration of Trust) dated June 24, 1985, as amended and restated September 10, 2009, and as such Declaration of Trust may be amended from time to time. A copy of the Declaration of Trust is on file with the Secretary of The Commonwealth of Massachusetts. The Trust operates as a series investment company that consists of separate series of investment portfolios, each of which is represented by a separate series of shares of beneficial interest. Each Fund is a series of the Trust. The fiscal year for each Fund ends on the last day of February.
Pursuant to the Declaration of Trust, the Trustees have currently authorized the issuance of an unlimited number of full and fractional shares of forty series: Alpha Only Fund; Asset Allocation Bond Fund; Benchmark-Free Allocation Fund; Benchmark-Free Fund; Benchmark-Free Bond Fund; Core Plus Bond Fund; Currency Hedged International Bond Fund; Debt Opportunities Fund; Developed World Stock Fund; Emerging Countries Fund; Emerging Country Debt Fund; Emerging Domestic Opportunities Fund; Emerging Markets Fund; Foreign Fund; Foreign Small Companies Fund; GAAR Implementation Fund; Global Asset Allocation Fund; Global Bond Fund; Global Developed Equity Allocation Fund; Global Equity Allocation Fund; Global Focused Equity Fund; High Quality Short-Duration Bond Fund; Implementation Fund; International Bond Fund; International Developed Equity Allocation Fund; International Equity Allocation Fund; International Equity Fund; International Large/Mid Cap Equity Fund; International Small Companies Fund; Quality Fund; Resources Fund; Risk Premium Fund;
133
Special Opportunities Fund; Strategic Opportunities Allocation Fund; Systematic Global Macro Opportunity Fund; Taiwan Fund; Tax-Managed International Equities Fund; U.S. Equity Allocation Fund; U.S. Treasury Fund; and World Opportunity Overlay Fund.
Interests in each portfolio (GMO Fund) are represented by shares of the corresponding series. Each share of each series represents an equal proportionate interest, together with each other share, in the corresponding GMO Fund. The shares of such series do not have any preemptive rights. Upon liquidation of a GMO Fund, shareholders of the corresponding series are entitled to share pro rata in the net assets of the GMO Fund available for distribution to shareholders. The Declaration of Trust also permits the Trustees to charge shareholders directly for custodial, transfer agency, and servicing expenses, but the Trustees have no present intention to make such charges.
The Declaration of Trust also permits the Trustees, without shareholder approval, to subdivide any series of shares into various sub-series or classes of shares with such dividend preferences and other rights as the Trustees may designate. This power is intended to allow the Trustees to provide for an equitable allocation of the effect of any future regulatory requirements that might affect various classes of shareholders differently. The Trustees have currently authorized the establishment and designation of up to ten classes of shares for each series of the Trust: Class I Shares, Class II Shares, Class III Shares, Class IV Shares, Class V Shares, Class VI Shares, Class VII Shares, Class VIII Shares, Class M Shares, and Class MF Shares.
The Trustees also may, without shareholder approval, establish one or more additional separate portfolios for investments in the Trust or merge two or more existing portfolios (i.e., a new fund). Shareholders investments in such a portfolio would be evidenced by a separate series of shares.
The Declaration of Trust provides for the perpetual existence of the Trust. The Trust, however, may be terminated at any time by vote of at least two-thirds of the outstanding shares of the Trust. While the Declaration of Trust further provides that the Trustees also may terminate the Trust upon written notice to the shareholders, the 1940 Act requires that the Trust receive the authorization of a majority of its outstanding shares in order to change the nature of its business so as to cease to be an investment company.
134
On June 2, 2015, the following shareholders held beneficially (unless otherwise indicated) greater than 25% of the outstanding shares of a Fund offered in the Private Placement Memorandum. For each shareholder listed that is not an individual, the jurisdiction under the laws of which the shareholder is organized (if applicable) and any parent company of the shareholder are listed, if known:
Fund* |
Shareholders |
Jurisdiction of
Organization |
Parent
Company |
|||
GMO Systematic Global Macro Opportunity Fund |
GMO Benchmark-Free Allocation Fund c/o GMO LLC 40 Rowes Wharf Boston, MA 02110 |
MA | N/A | |||
GMO World Opportunity Overlay Fund |
J.P. Morgan Chase Bank As Directed Trustee For The IBM Personal Pension Plan Trust One Beacon Street, Floor 20 Boston, MA 02108 |
MA | N/A | |||
GMO Core Plus Bond Fund c/o GMO LLC 40 Rowes Wharf Boston, MA 02110 |
MA | N/A |
* | GAAR Implementation Fund and High Quality Short-Duration Bond Fund have not yet commenced operations as of the date of this SAI and, therefore, have not yet offered any shares for sale. |
The above shareholders may be deemed to control their respective series as such term is defined in the 1940 Act.
Shareholders should be aware that to the extent a shareholders investment in a Fund exceeds certain threshold amounts or percentages, the investment may constitute a reportable acquisition under the Hart-Scott-Rodino Act (HSR) and the shareholder may be required to make a corresponding filing under HSR. HSR regulations are complex and shareholders should consult their legal advisers about the precise HSR filing consequences of an investment in a Fund.
As of June 4, 2015, substantially all of the shares of Systematic Global Macro Opportunity Fund and World Opportunity Overlay Fund were held by accounts for which GMO has investment discretion.
135
Shareholders are entitled to one vote for each full share held (with fractional votes for fractional shares held) and to vote by individual GMO Fund (to the extent described below) in the election of Trustees and the termination of the Trust and on other matters submitted to the vote of shareholders. Shareholders vote by individual GMO Fund on all matters except (i) when required by the 1940 Act, shares are voted in the aggregate and not by individual GMO Fund, and (ii) when the Trustees have determined that the matter affects the interests of more than one GMO Fund, then shareholders of the affected GMO Funds are entitled to vote. Shareholders of one GMO Fund are not entitled to vote on matters exclusively affecting another GMO Fund including, without limitation, such matters as the adoption of or change in the investment objectives, policies, or restrictions of the other GMO Fund and the approval of the investment advisory contract of the other GMO Fund. Shareholders of a particular class of shares do not have separate class voting rights except for matters that affect only that class of shares and as otherwise required by law.
Normally the Trust does not hold meetings of shareholders to elect Trustees except in accordance with the 1940 Act (i) the Trust will hold a shareholders meeting for the election of Trustees at such time as less than a majority of the Trustees holding office have been elected by shareholders, and (ii) if, as a result of a vacancy in the Board of Trustees, less than two-thirds of the Trustees holding office have been elected by the shareholders, that vacancy may only be filled by a vote of the shareholders. In addition, Trustees may be removed from office by a written consent signed by the holders of two-thirds of the outstanding shares and filed with the Trusts custodian or by a vote of the holders of two-thirds of the outstanding shares at a meeting duly called for that purpose, which meeting shall be held upon the written request of the holders of not less than 10% of the outstanding shares. Upon written request by the holders of at least 1% of the outstanding shares stating that such shareholders wish to communicate with the other shareholders for the purpose of obtaining the signatures necessary to demand a meeting to consider removal of a Trustee, the Trust has undertaken to provide a list of shareholders or to disseminate appropriate materials (at the expense of the requesting shareholders). Except as set forth above, the Trustees will continue to hold office and may appoint successor Trustees. Voting rights are not cumulative.
No amendment may be made to the Declaration of Trust without the affirmative vote of a majority of the outstanding shares of the Trust except (i) to change the Trusts name or to cure technical problems in the Declaration of Trust and (ii) to establish, designate, or modify new and existing series or sub-series of Trust shares or other provisions relating to Trust shares in response to applicable laws or regulations.
SHAREHOLDER AND TRUSTEE LIABILITY
Under Massachusetts law, shareholders could, under some circumstances, be held personally liable for the obligations of the Trust. However, the Declaration of Trust disclaims shareholder liability for acts or obligations of the Trust and requires that notice of that disclaimer be given in each agreement, obligation, or instrument entered into or executed by the Trust or the Trustees. The Declaration of Trust provides for indemnification out of all the property of a Fund for all loss and expense of any shareholder of the Fund held personally liable for the obligations of the
136
Trust. Thus, the risk of a shareholder incurring financial loss on account of shareholder liability is limited to circumstances in which the disclaimer is inoperative and the Fund in which the shareholder holds shares is unable to meet its obligations.
The Declaration of Trust further provides that the Trustees will not be liable for errors of judgment or mistakes of fact or law. However, nothing in the Declaration of Trust protects a Trustee against any liability to which the Trustee would otherwise be subject by reason of willful misfeasance, bad faith, gross negligence, or reckless disregard of the duties involved in the conduct of his office. The By-Laws of the Trust provide for indemnification by the Trust of the Trustees and the officers of the Trust except for any matter as to which any such person did not act in good faith in the reasonable belief that his action was in or not opposed to the best interests of the Trust. Trustees and officers may not be indemnified against any liability to the Trust or the Trust shareholders to which they would otherwise be subject by reason of willful misfeasance, bad faith, gross negligence, or reckless disregard of the duties involved in the conduct of their office.
BENEFICIAL OWNERS OF 5% OR MORE OF THE FUNDS SHARES
The following chart sets forth the names, addresses and percentage ownership of those shareholders owning beneficially 5% or more of the outstanding Class III Shares of GMO Systematic Global Macro Opportunity Fund as of June 2, 2015:
Name and Address |
% Ownership | |
GMO Benchmark Free Allocation Fund
c/o GMO
LLC
|
73.9 | |
GMO Benchmark-Free Fund
c/o GMO LLC
|
14.1 | |
GMO Global Asset Allocation Fund
c/o GMO
LLC
|
8.3 |
137
The following chart sets forth the names, addresses and percentage ownership of those shareholders owning beneficially 5% or more of the outstanding shares of GMO World Opportunity Overlay Fund as of June 2, 2015:
Name and Address |
% Ownership | |
J.P. Morgan Chase Bank As Directed Trustee For The IBM Personal Pension Plan Trust One Beacon Street, Floor 20 Boston, MA 02108 |
48.7 | |
GMO Core Plus Bond Fund c/o GMO LLC 40 Rowes Wharf Boston, MA 02110 |
34.9 | |
GMO Currency Hedged International Bond Fund c/o GMO LLC 40 Rowes Wharf Boston, MA 02110 |
10.5 | |
GMO Global Bond Fund c/o GMO LLC 40 Rowes Wharf Boston, MA 02110 |
5.9 |
The Trusts audited financial statements, financial highlights, and report of the independent registered public accounting firm of the Funds, included in the Annual Report for the fiscal year ended February 28, 2015 for each of Systematic Global Macro Opportunity Fund and World Opportunity Overlay Fund and filed with the SEC pursuant to Section 30(d) of the 1940 Act and the rules promulgated thereunder, are hereby incorporated in this SAI by reference. Such Funds Annual Reports for the fiscal year ended February 28, 2015 were filed electronically with the SEC on Form N-CSR on May 1, 2015 (Accession No. 0001193125-15-165975).
138
GMO TRUST
SPECIMEN PRICE MAKE-UP SHEETS
Following are computations for each Fund of the total offering price per share of each class of shares of beneficial interest of the Fund that are offered through the Private Placement Memorandum and that had shares of beneficial interest outstanding as of February 28, 2015, in each case based upon their respective net asset values and shares of beneficial interest outstanding as of the close of business on February 28, 2015. GAAR Implementation Fund and High Quality Short-Duration Bond Fund will commence operations following the date of this SAI; therefore, such Funds do not yet have any shares of beneficial interest outstanding.
GMO Systematic Global Macro Opportunity Fund Class III | ||||
Net Assets at Value (Equivalent to $33.80 per share based on 44,362,462 shares of beneficial interest outstanding) |
$ | 1,499,442,615 | ||
Offering Price |
$ | 33.80 | ||
GMO World Opportunity Overlay Fund |
||||
Net Assets at Value (Equivalent to $25.50 per share based on 7,058,123 shares of beneficial interest outstanding) |
$ | 179,956,708 | ||
Offering Price |
$ | 25.50 |
A-1
COMMERCIAL PAPER AND CORPORATE DEBT RATINGS
Commercial Paper Ratings
Standard & Poors . Standard & Poors short-term ratings are generally assigned to those obligations considered short-term in the relevant market. In the U.S., for example, that means obligations with an original maturity of no more than 365 days including commercial paper. The following are excerpts from Standard & Poors short-term issue credit ratings definitions:
A-1 A short-term obligation rated A-1 is rated in the highest category by Standard & Poors. The obligors capacity to meet its financial commitment on the obligation is strong. Within this category, certain obligations are designated with a plus sign (+). This indicates that the obligors capacity to meet its financial commitment on these obligations is extremely strong.
A-2 A short-term obligation rated A-2 is somewhat more susceptible to the adverse effects of changes in circumstances and economic conditions than obligations in higher rating categories. However, the obligors capacity to meet its financial commitment on the obligation is satisfactory.
A-3 A short-term obligation rated A-3 exhibits adequate protection parameters. However, adverse economic conditions or changing circumstances are more likely to lead to a weakened capacity of the obligor to meet its financial commitment on the obligation.
B A short-term obligation rated B is regarded as vulnerable and has significant speculative characteristics. The obligor currently has the capacity to meet its financial commitments; however, it faces major ongoing uncertainties which could lead to the obligors inadequate capacity to meet its financial commitments.
C A short-term obligation rated C is currently vulnerable to nonpayment and is dependent upon favorable business, financial, and economic conditions for the obligor to meet its financial commitment on the obligation.
D A short-term obligation rated D is in default or in breach of an imputed promise. For non-hybrid capital instruments, the D rating category is used when payments on an obligation are not made on the date due, unless Standard & Poors believes that such payments will be made within any stated grace period. However, any stated grace period longer than five business days will be treated as five business days. The D rating also will be used upon the filing of a bankruptcy petition or the taking of a similar action and where default on an obligation is a virtual certainty, for example due to automatic stay provisions. An obligations rating is lowered to D if it is subject to a distressed exchange offer.
Moodys . Moodys short-term ratings are assigned to obligations with an original maturity of thirteen months or less and reflect the likelihood of a default on contractually promised payments. The following are excerpts from Moodys short-term ratings definitions:
P-1 Issuers (or supporting institutions) rated Prime-1 have a superior ability to repay short-term debt obligations.
B-1
P-2 Issuers (or supporting institutions) rated Prime-2 have a strong ability to repay short-term debt obligations.
P-3 Issuers (or supporting institutions) rated Prime-3 have an acceptable ability to repay short-term obligations.
NP Issuers (or supporting institutions) rated Not Prime do not fall within any of the Prime rating categories.
Corporate Debt Ratings
Standard & Poors . A Standard & Poors issue credit rating is a forward-looking opinion about the creditworthiness of an obligor with respect to a specific financial obligation, a specific class of financial obligations, or a specific financial program. The following are excerpts from Standard & Poors long-term issue credit ratings definitions:
AAA An obligation rated AAA has the highest rating assigned by Standard & Poors. The obligors capacity to meet its financial commitment on the obligation is extremely strong.
AA An obligation rated AA differs from the highest-rated obligations only to a small degree. The obligors capacity to meet its financial commitment on the obligation is very strong.
A An obligation rated A is somewhat more susceptible to the adverse effects of changes in circumstances and economic conditions than obligations in higher-rated categories. However, the obligors capacity to meet its financial commitment on the obligation is still strong.
BBB An obligation rated BBB exhibits adequate protection parameters. However, adverse economic conditions or changing circumstances are more likely to lead to a weakened capacity of the obligor to meet its financial commitment on the obligation.
BB, B, CCC, CC, and C Obligations rated BB, B, CCC, CC, and C are regarded as having significant speculative characteristics. BB indicates the least degree of speculation and C the highest. While such obligations will likely have some quality and protective characteristics, these may be outweighed by large uncertainties or major exposures to adverse conditions.
BB An obligation rated BB is less vulnerable to nonpayment than other speculative issues. However, it faces major ongoing uncertainties or exposure to adverse business, financial, or economic conditions, which could lead to the obligors inadequate capacity to meet its financial commitment on the obligation.
B An obligation rated B is more vulnerable to nonpayment than obligations rated BB, but the obligor currently has the capacity to meet its financial commitment on the obligation. Adverse business, financial, or economic conditions will likely impair the obligors capacity or willingness to meet its financial commitment on the obligation.
CCC An obligation rated CCC is currently vulnerable to nonpayment, and is dependent upon favorable business, financial, and economic conditions for the obligor to meet its financial commitment on
B-2
the obligation. In the event of adverse business, financial, or economic conditions, the obligor is not likely to have the capacity to meet its financial commitment on the obligation.
CC An obligation rated CC is currently highly vulnerable to nonpayment. The CC rating is used when a default has not yet occurred, but Standard & Poors expects default to be a virtual certainty, regardless of the anticipated time to default.
C An obligation rated C is currently highly vulnerable to nonpayment, and the obligation is expected to have lower relative seniority or lower ultimate recovery compared to obligations that are rated higher.
D An obligation rated D is in default or in breach of an imputed promise. For non-hybrid capital instruments, the D rating category is used when payments on an obligation are not made on the date due, unless Standard & Poors believes that such payments will be made within five business days, in the absence of a stated grace period or within the earlier of the stated grace period or 30 calendar days. The D rating also will be used upon the filing of a bankruptcy petition or the taking of similar action and where default on an obligation is a virtual certainty, for example due to automatic stay provisions. An obligations rating is lowered to D if it is subject to a distressed exchange offer.
Plus (+) or Minus (-) The ratings from AA to CCC may be modified by the addition of a plus (+) or minus (-) sign to show relative standing within the major rating categories.
NR This indicates that no rating has been requested, or that there is insufficient information on which to base a rating, or that Standard & Poors does not rate a particular obligation as a matter of policy.
Moodys . Moodys long-term ratings are assigned to issuers or obligations with an original maturity of one year or more and reflect both on the likelihood of a default on contractually promised payments and expected financial loss suffered in the event of default. The following are excerpts from Moodys long-term obligation ratings definitions:
Aaa Obligations rated Aaa are judged to be of the highest quality, subject to the lowest level of credit risk.
Aa Obligations rated Aa are judged to be of high quality and are subject to very low credit risk.
A Obligations rated A are judged to be upper-medium grade and are subject to low credit risk.
Baa Obligations rated Baa are judged to be medium grade and subject to moderate credit risk and as such may possess certain speculative characteristics.
Ba Obligations rated Ba are judged to be speculative and are subject to substantial credit risk.
B Obligations rated B are considered speculative and are subject to high credit risk.
Caa Obligations rated Caa are judged to be speculative and of poor standing and are subject to very high credit risk.
B-3
Ca Obligations rated Ca are highly speculative and are likely in, or very near, default, with some prospect of recovery of principal and interest.
C Obligations rated C are the lowest rated and are typically in default, with little prospect for recovery of principal or interest.
Note: Moodys appends numerical modifiers 1, 2, and 3 to each generic rating classification from Aa through Caa. The modifier 1 indicates that the obligation ranks in the higher end of its generic rating category; the modifier 2 indicates a mid-range ranking; and the modifier 3 indicates a ranking in the lower end of that generic rating category. Additionally, a (hyb) indicator is appended to all ratings of hybrid securities issued by banks, insurers, finance companies, and securities firms.*
* | By their terms, hybrid securities allow for the omission of scheduled dividends, interest, or principal payments, which can potentially result in impairment if such an omission occurs. Hybrid securities may also be subject to contractually allowable write-downs of principal that could result in impairment. Together with the hybrid indicator, the long-term obligation rating assigned to a hybrid security is an expression of the relative credit risk associated with that security. |
B-4
GMO TRUST
PROXY VOTING POLICY
Adopted September 16, 2003, Revised March 11, 2010
I. Statement of Policy
GMO Trust (the Trust) delegates the authority and responsibility to vote proxies related to portfolio securities held by the series of the Trust (each, a Fund, and collectively, the Funds) to Grantham, Mayo, Van Otterloo & Co. LLC, its investment adviser (the Adviser).
The Board of Trustees (the Board) of the Trust has reviewed and approved the use of the proxy voting policies and procedures of the Adviser (Proxy Voting Procedures) on behalf of the Funds when exercising voting authority on behalf of the Funds.
II. Standard
The Adviser shall vote proxies related to portfolio securities in the best interests of the Funds and their shareholders. In the event of any conflicts of interest between the Adviser and the Funds, the Adviser shall follow procedures that enable it to cause the proxy to be voted in the best interests of the Funds and their shareholders, which may include (1) causing the proxy to be voted pursuant to the recommendation of an independent third party, pursuant to pre-established proxy voting guidelines, or (2) seeking instructions from the Board on the manner in which the proxy should be voted.
III. Review of Proxy Voting Procedures
The Board shall periodically review the Proxy Voting Procedures presented by the Adviser.
The Adviser shall provide periodic reports to the Board regarding any proxy votes where a material conflict of interest was identified except in circumstances where the Adviser caused the proxy to be voted consistent with the recommendation of the independent third party.
The Adviser shall notify the Board promptly of any material change to its Proxy Voting Procedures.
IV. Securities Lending
When a Fund lends its portfolio securities, the Adviser pursuant to the authority delegated to it by the Fund retains an obligation with respect to voting proxies relating to such securities. However, while such securities are on loan, a Fund will not have the right to vote the proxies relating to those securities. As a result, a Fund will only loan its portfolio securities pursuant to securities lending arrangements that permit the Fund to recall a loaned security or to exercise voting rights associated with the security. However, the Adviser generally will not arrange to have a security recalled or to exercise voting rights associated with a security unless the Adviser
C-1
both (1) receives adequate notice of a proposal upon which shareholders are being asked to vote (which the Adviser often does not receive, particularly in the case of non-U.S. issuers) and (2) the Adviser believes that the benefits to the Fund of voting on such proposal outweigh the benefits to the Fund of having the security remain out on loan. The Adviser may use third party service providers to assist it in identifying and evaluating proposals, and to assist it in recalling loaned securities for proxy voting purposes.
V. Certain Non-U.S. Markets
In certain non-U.S. markets, shareholders who vote proxies of a non-U.S. issuer may not be able to trade in the issuers stock for a period of time around the shareholder meeting date. In addition, there may be other costs or impediments to voting proxies in certain non-U.S. markets (e.g., receiving adequate notice, arranging for a proxy, and re-registration requirements). In non-U.S. markets with the foregoing attributes, the Adviser generally will determine not to vote proxies unless it believes that the potential benefits to the Fund of voting outweigh the impairment of portfolio management flexibility and the expected costs/impediments associated with voting.
VI. Disclosure
The following disclosure shall be provided:
A. | Each Funds proxy voting record shall annually be included in the Funds Form N-PX. |
B. | The Adviser shall cause each Fund to include the Trusts proxy voting policies and procedures in the Trusts statement of additional information. |
C. | Each Funds shareholder report shall include a statement that a description of the Funds proxy voting policies and procedures is available (i) without charge, upon request, by calling a specified toll-free or collect telephone number; (ii) on the Funds website, if applicable; and (iii) on the Commissions website at http://www.sec.gov. |
D. | The Trusts statement of additional information and each Funds shareholder report shall include a statement that information regarding how the Fund voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available (i) without charge, upon request, by calling a specified toll-free or collect telephone number, or on or through the Funds website, or both; and (ii) on the Commissions website at http://www.sec.gov. |
C-2
GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC
GMO AUSTRALIA LTD.
GMO EUROPE LLC
GMO SINGAPORE PTE LTD.
(TOGETHER GMO)
PROXY VOTING POLICIES AND PROCEDURES
Amended and Restated as of May 12, 2011
Amended as of December 12, 2011, October 22, 2013, and June 25, 2014
I. | Introduction and General Principles |
GMO provides investment advisory services primarily to institutional, including both ERISA and non-ERISA clients, and commercial clients. GMO understands that proxy voting is an integral aspect of security ownership. Accordingly, in cases where GMO has been delegated authority to vote proxies, that function must be conducted with the same degree of prudence and loyalty accorded any fiduciary or other obligation of an investment manager.
This policy permits clients of GMO to: (1) delegate to GMO the responsibility and authority to vote proxies on their behalf according to GMOs proxy voting polices and guidelines; (2) delegate to GMO the responsibility and authority to vote proxies on their behalf according to the particular clients own proxy voting policies and guidelines; or (3) elect to vote proxies themselves. In instances where clients elect to vote their own proxies, GMO shall not be responsible for voting proxies on behalf of such clients.
GMO believes that the following policies and procedures are reasonably designed to ensure that proxy matters are conducted in the best interest of its clients, in accordance with GMOs fiduciary duties, applicable rules under the Investment Advisers Act of 1940 and fiduciary standards and responsibilities for ERISA clients set out in the Department of Labor interpretations.
II. | Proxy Voting Guidelines |
GMO has engaged Institutional Shareholder Services Group, Inc. (ISS) as its proxy voting agent to:
(1) | research and make voting recommendations or, for matters for which GMO has so delegated, to make the voting determinations; |
(2) | ensure that proxies are voted and submitted in a timely manner; |
(3) | handle other administrative functions of proxy voting; |
(4) | maintain records of proxy statements received in connection with proxy votes and provide copies of such proxy statements promptly upon request; |
(5) | maintain records of votes cast; and |
(6) | provide recommendations with respect to proxy voting matters in general. |
C-3
Proxies generally will be voted in accordance with the voting recommendations contained in the applicable ISS Regional Proxy Voting Policy, as in effect from time to time, subject to such modifications as may be determined by GMO (as described below). Copies of concise summaries of the current ISS regional proxy voting guidelines are available through ISS Policy Gateway at http://www.issgovernance.com. To the extent GMO determines to adopt proxy voting guidelines that differ from the ISS proxy voting recommendations, such guidelines will be set forth on Exhibit A and proxies with respect to such matters will be voted in accordance with the guidelines set forth on Exhibit A. GMO reserves the right to modify any of the recommendations set forth in the ISS Proxy Voting Manual in the future. If any such changes are made, an amended Exhibit A to these Proxy Voting Policies and Procedures will be made available for clients.
Except in instances where a GMO client retains voting authority, GMO will instruct custodians of client accounts to forward all proxy statements and materials received in respect of client accounts to ISS.
In certain non-U.S. markets, shareholders who vote proxies of a non-U.S. issuer may not be able to trade in the issuers stock for a period of time around the shareholder meeting date. In addition, there may be other costs or impediments to voting proxies in certain non-U.S. markets (e.g., receiving adequate notice, arranging for a proxy, and re-registration requirements). In non-U.S. markets with the foregoing attributes, GMO generally will determine to not vote proxies unless it believes that the potential benefits to the client of voting outweigh the impairment of portfolio management flexibility and the expected costs/impediments associated with voting. In addition, if a portfolio security is out on loan, GMO generally will not arrange to have the security recalled or to exercise voting rights associated with the security unless GMO both (1) receives adequate notice of a proposal upon which shareholders are being asked to vote (which GMO often does not receive, particularly in the case of non-U.S. issuers) and (2) GMO believes that the benefits to the client of voting on such proposal outweigh the benefits to the client of having the security remain out on loan. GMO may use third-party service providers to assist it in identifying and evaluating proposals, and to assist it in recalling loaned securities for proxy voting purposes.
III. | Proxy Voting Procedures |
GMO has a Corporate Actions Group with responsibility for administering the proxy voting process, including:
1. | Implementing and updating the applicable ISS regional proxy voting guidelines set forth in the ISS Proxy Voting Manual, as modified from time to time by Exhibit A hereto; |
2. | Overseeing the proxy voting process; and |
3. | Providing periodic reports to GMOs Compliance Department and clients as requested. |
C-4
There may be circumstances under which a portfolio manager or other GMO investment professional (GMO Investment Professional) believes that it is in the best interest of a client or clients to vote proxies in a manner inconsistent with the proxy voting guidelines described in Section II. In such an event, the GMO Investment Professional will inform GMOs Corporate Actions Group of its decision to vote such proxy in a manner inconsistent with the proxy voting guidelines described in Section II.
IV. | Conflicts of Interest |
As ISS will vote proxies in accordance with the proxy voting guidelines described in Section II, GMO believes that this process is reasonably designed to address conflicts of interest that may arise between GMO and a client as to how proxies are voted.
In addition, if GMO is aware that one of the following conditions exists with respect to a proxy, GMO shall consider such event a potential material conflict of interest:
1. | GMO has a business relationship or potential relationship with the issuer; |
2. | GMO has a business relationship with the proponent of the proxy proposal; or |
3. | GMO members, employees or consultants have a personal or other business relationship with the participants in the proxy contest, such as corporate directors or director candidates. |
In the event of a potential material conflict of interest, GMO will (i) vote such proxy according to Exhibit A (if applicable) or the specific recommendation of ISS; (ii) seek instructions from the client or request that the client votes such proxy; or (iii) abstain. All such instances shall be reported to GMOs Compliance Department at least quarterly.
V. | Special Procedures for Voting Shares of GMO Trust |
GMOs responsibility and authority to vote proxies on behalf of its clients for shares of GMO Trust, a family of registered mutual funds for which GMO serves as the investment adviser, may give rise to conflicts of interest. Accordingly, GMO will (i) vote such proxies in the best interests of its clients with respect to routine matters, including proxies relating to the election of Trustees; and (ii) with respect to matters where a conflict of interest exists between GMO and GMO Trust, such as proxies relating to a new or amended investment management contract between GMO Trust and GMO, or a re-organization of a series of GMO Trust, GMO will either (a) vote such proxies in the same proportion as the votes cast with respect to that proxy, (b) seek instructions from its clients and vote on accordance with those instructions, or (c) take such other action as GMO deems appropriate in consultation with the Trusts Chief Compliance Officer.
VI. | Special Procedures for Voting Shares of GMO Series Trust |
GMO also serves as investment adviser for the GMO Series Trust family of registered mutual funds. Each series of GMO Series Trust is a Feeder Fund investing substantially of its assets in shares of a corresponding series of GMO Trust (each a Master Fund) in reliance on Section 12(d)(1)(E) of the Investment Company Act of 1940 (the 1940 Act). In accordance with
C-5
Section 12(d)(1)(E) of the 1940 Act, GMO will either (i) seek instructions from a Feeder Funds holders with regard to the voting of all proxies with respect to the Feeder Funds shares in the corresponding Master Fund and vote such proxies only in accordance with such instructions, or (ii) vote the shares of the corresponding Master Fund held by a Feeder Fund in the same proportion as the vote of all other holders of the Master Fund.
VII. | Recordkeeping |
GMO will maintain records relating to the implementation of these proxy voting policies and procedures, including:
(1) | a copy of these policies and procedures which shall be made available to clients, upon request; |
(2) | a record of each vote cast (which ISS maintains on GMOs behalf); and |
(3) | each written client request for proxy records and GMOs written response to any client request for such records. |
Such proxy voting records shall be maintained for a period of five years.
VIII. | Disclosure |
Except as otherwise required by law, GMO has a general policy of not disclosing to any issuer or third party how GMO or its voting delegate voted a clients proxy.
C-6
Exhibit A (as amended February 2, 2009)
Modifications to recommendations set forth in the ISS Proxy Voting Manual
Shareholder Ability to Act by Written Consent
Vote FOR proposals to restrict or prohibit shareholder activity to take action by written consent.
Vote AGAINST proposals to allow or make easier shareholder action by written consent.
Cumulative Voting
Vote FOR proposals to eliminate cumulative voting.
Vote AGAINST proposals to restore or provide for cumulative voting.
Incumbent Director Nominees
Vote WITH managements recommendations regarding incumbent director nominees.
C-7
GMO TRUST
PART C. OTHER INFORMATION
Item 28. | Exhibits |
(a) 1. | Amended and Restated Agreement and Declaration of Trust of GMO Trust (the Trust or Registrant), dated September 10, 2009 (the Declaration of Trust); 19 |
2. | Amendment No. 1 to the Declaration of Trust; 20 |
3. | Amendment No. 2 to the Declaration of Trust; 22 |
4. | Amendment No. 3 to the Declaration of Trust; 24 |
5. | Amendment No. 4 to the Declaration of Trust; 25 |
6. | Amendment No. 5 to the Declaration of Trust; 27 |
7. | Amendment No. 6 to the Declaration of Trust; 27 |
8. | Amendment No. 7 to the Declaration of Trust; 27 |
9. | Amendment No. 8 to the Declaration of Trust; 30 |
10. | Amendment No. 9 to the Declaration of Trust; 31 |
11. | Amendment No. 10 to the Declaration of Trust; 32 |
12. | Amendment No. 11 to the Declaration of Trust; 33 |
13. | Amendment No. 12 to the Declaration of Trust; 34 |
14. | Amendment No. 13 to the Declaration of Trust; 37 |
15. | Amendment No. 14 to the Declaration of Trust; 38 |
16. | Amendment No. 15 to the Declaration of Trust; 38 |
17. | Amendment No. 16 to the Declaration of Trust; 40 |
18. | Amendment No. 17 to the Declaration of Trust; 41 and |
19. | Amendment No. 18 to the Declaration of Trust. 41 |
(b) | Amended and Restated By-laws of the Trust, effective as of March 1, 2007 (the By-laws). 13 |
(c) 1. | Please refer to Article III (Shares) and Article V (Shareholders Voting Powers and Meetings) of the Declaration of Trust, which is hereby incorporated by reference; 20 and |
2. | Please refer to Article 11 (Meetings of Shareholders) of the By-laws, which is hereby incorporated by reference. 13 |
(d) 1. | Amended and Restated Management Contract, dated as of June 30, 2008, between the Trust, on behalf of GMO International Equity Fund (formerly GMO International Intrinsic Value Fund and GMO International Core Fund), and GMO; 15 |
2. | Management Contract, dated October 15, 1991, between the Trust, on behalf of GMO International Small Companies Fund, and GMO; 38 |
3. | Form of Management Contract between the Trust, on behalf of GMO Emerging Countries Fund (formerly GMO Evolving Countries Fund), and GMO; 12 |
1
4. | Form of Management Contract between the Trust, on behalf of GMO International Bond Fund, and GMO; 12 |
5. | Management Contract, dated June 24, 1994, between the Trust, on behalf of GMO Currency Hedged International Bond Fund, and GMO; 38 |
6. | Form of Management Contract between the Trust, on behalf of GMO Emerging Country Debt Fund, and GMO; 12 |
7. | Management Contract, dated June 25, 1994, between the Trust, on behalf of GMO Alpha Only Fund (formerly GMO Global Hedged Equity Fund), and GMO; 38 |
8. | Amended and Restated Management Contract, dated as of January 1, 2012, between the Trust, on behalf of GMO Benchmark-Free Allocation Fund, and GMO; 29 |
9. | Form of Management Contract between the Trust, on behalf of GMO Taiwan Fund, and GMO; 12 |
10. | Management Contract, dated December 20, 1995, between the Trust, on behalf of GMO Global Bond Fund, and GMO; 38 |
11. | Management Contract, dated June 27, 1995, between the Trust, on behalf of GMO Foreign Fund, and GMO; 38 |
12. | Form of Management Contract between the Trust, on behalf of GMO International Equity Allocation Fund, and GMO; 1 |
13. | Form of Management Contract between the Trust, on behalf of GMO Global Asset Allocation Fund (formerly GMO Global Balanced Asset Allocation Fund, GMO World Balanced Allocation Fund, and GMO World Equity Allocation Fund), and GMO; 2 |
14. | Form of Management Contract between the Trust, on behalf of GMO Global Equity Allocation Fund (formerly GMO Global (U.S.+) Equity Allocation Fund), and GMO; 2 |
15. | Form of Management Contract between the Trust, on behalf of GMO Core Plus Bond Fund (formerly GMO U.S. Bond/Global Alpha A Fund and GMO Global Fund), and GMO; 12 |
16. | Amended and Restated Management Contract, dated as of June 30, 2008, between the Trust, on behalf of GMO Tax-Managed International Equities Fund, and GMO; 15 |
17. | Form of Management Contract between the Trust, on behalf of GMO Foreign Small Companies Fund, and GMO; 3 |
18. | Amended and Restated Management Contract, dated February 12, 2014, between the Trust, on behalf of GMO Debt Opportunities Fund (formerly GMO Short-Duration Collateral Fund), and GMO; 37 |
19. | Form of Management Contract between the Trust, on behalf of GMO Quality Fund (formerly GMO U.S. Quality Equity Fund), and GMO; 7 |
20. | Form of Management Contract between the Trust, on behalf of GMO World Opportunity Overlay Fund, and GMO; 8 |
21. | Form of Management Contract between the Trust, on behalf of GMO Strategic Opportunities Allocation Fund (formerly GMO Strategic Balanced Allocation Fund), and GMO; 9 |
2
22. | Form of Management Contract between the Trust, on behalf of GMO Global Developed Equity Allocation Fund (formerly GMO World Opportunities Equity Allocation Fund), and GMO; 9 |
23. | Amended and Restated Management Contract, dated as of June 30, 2008, between the Trust, on behalf of GMO Developed World Stock Fund, and GMO; 15 |
24. | Form of Management Contract between the Trust, on behalf of GMO U.S. Equity Allocation Fund (formerly GMO U.S. Core Equity Fund), and GMO; 10 |
25. | Form of Management Contract between the Trust, on behalf of GMO International Large/Mid Cap Equity Fund (formerly GMO International Core Equity Fund), and GMO; 10 |
26. | Management Contract between the Trust, on behalf of GMO International Developed Equity Allocation Fund (formerly GMO International Opportunities Equity Allocation Fund), and GMO; 11 |
27. | Management Contract between the Trust, on behalf of GMO U.S. Treasury Fund, and GMO; 17 |
28. | Management Contract between the Trust, on behalf of GMO Asset Allocation Bond Fund, and GMO; 17 |
29. | Amended and Restated Management Contract, dated as of August 12, 2009, between the Trust, on behalf of GMO Emerging Markets Fund, and GMO; 19 |
30. | Amended and Restated Management Contract, dated as of June 25, 2010, between the Trust, on behalf of GMO Systematic Global Macro Opportunity Fund (formerly GMO Alternative Asset Opportunity Fund), and GMO; 21 |
31. | Management Contract, dated as of December 2, 2009, between the Trust, on behalf of GMO Debt Opportunities Fund, and GMO; 20 |
32. | Management Contract, dated as of December 2, 2009, between the Trust, on behalf of GMO High Quality Short-Duration Bond Fund, and GMO; 20 |
33. | Management Contract, dated as of August 2, 2010, between the Trust, on behalf of GMO Emerging Domestic Opportunities Fund, and GMO; 22 |
34. | Management Contract, dated as of May 20, 2011, between the Trust, on behalf of GMO Benchmark-Free Fund, and GMO; 24 |
35. | Management Contract, dated as of September 12, 2011, between the Trust, on behalf of GMO Global Focused Equity Fund, and GMO; 26 |
36. | Management Contract, dated as of December 6, 2011, between the Trust, on behalf of GMO Resources Fund, and GMO; 27 |
37. | Management Contract, dated as of December 5, 2011, between the Trust, on behalf of GMO Implementation Fund, and GMO; 28 |
(i) | Management Contract, dated as of February 23, 2015, between GMO Implementation SPC Ltd. and GMO. 41 |
38. | Management Contract, dated as of June 27, 2014, between the Trust, on behalf of GMO Special Opportunities Fund, and GMO; 39 |
(i) | Management Contract, dated as of July 9, 2014, between GMO Special Opportunities SPC Ltd. and GMO. 39 |
3
39. | Management Contract, dated as of September 15, 2014, between the Trust, on behalf of GMO Benchmark-Free Bond Fund, and GMO; 40 |
40. | Management Contract, dated as of April 13, 2015, between the Trust, on behalf of GMO GAAR Implementation Fund, and GMO; 41 |
(i) | Management Contract, dated as of April 13, 2015, between GMO GAAR Implementation SPC Ltd. and GMO. 41 |
41. | Sub-Advisory Agreement, dated as of December 30, 2013, among GMO, GMO Singapore Pte. Limited (GMO Singapore), and the Trust, on behalf of GMO Systematic Global Macro Opportunity Fund; 36 and |
42. | Sub-Advisory Agreement, dated as of December 30, 2013, among GMO, GMO Singapore, and the Trust, on behalf of GMO Emerging Domestic Opportunities Fund. 36 |
(e) 1. | Amended and Restated Distribution Agreement (the Distribution Agreement), effective June 30, 2012, between the Trust, on behalf of the Funds listed on Schedule A thereto, as Schedule A may be amended from time to time, and Funds Distributor, LLC; 34 and |
2. | Master Placement Agency Agreement between the Trust, on behalf of the Funds listed on Schedule A thereto, as Schedule A may be amended from time to time, and Funds Distributor, LLC, dated September 8, 2014. 40 |
(f) | None. |
(g) 1. | Form of Custodian Agreement (the IBT Custodian Agreement), dated August 1, 1991, among the Trust, on behalf of certain Funds listed therein, GMO and Investors Bank & Trust Company (IBT), as amended from time to time to include GMO International Bond Fund, GMO Currency Hedged International Bond Fund, GMO Emerging Country Debt Fund, GMO Benchmark-Free Allocation Fund, GMO Global Bond Fund, GMO International Equity Allocation Fund, GMO Global Asset Allocation Fund, GMO Global Equity Allocation Fund, GMO Core Plus Bond Fund, GMO Emerging Country Debt Share Fund, GMO Debt Opportunities Fund, GMO Quality Fund, GMO World Opportunity Overlay Fund, GMO Strategic Opportunities Allocation Fund, GMO Global Developed Equity Allocation Fund, GMO U.S. Equity Allocation Fund, GMO International Developed Equity Allocation Fund, GMO U.S. Treasury Fund, GMO Asset Allocation Bond Fund, GMO Debt Opportunities Fund, GMO High Quality Short-Duration Bond Fund, GMO Benchmark-Free Fund, GMO Implementation Fund, GMO Risk Premium Fund, GMO Special Opportunities Fund, GMO Benchmark-Free Bond Fund, and GMO GAAR Implementation Fund; 12 |
4
(i) | Letter Amendment to the IBT Custodian Agreement, dated May 30, 2003, among the Trust, GMO and IBT; 6 |
(ii) | Letter Amendment to the IBT Custodian Agreement, dated March 10, 2009, among the Trust, on behalf of GMO U.S. Treasury Fund and GMO Asset Allocation Bond Fund, GMO and State Street Bank (as successor by merger to IBT); 17 |
(iii) | Form of Letter Amendment to the IBT Custodian Agreement, dated November 25, 2009, among the Trust, on behalf of GMO Debt Opportunities Fund and GMO High Quality Short-Duration Bond Fund, GMO and State Street Bank (as successor by merger to IBT); 20 |
(iv) | Form of Letter Amendment to the IBT Custodian Agreement, dated May 20, 2011, among the Trust, on behalf of GMO Benchmark-Free Fund, GMO and State Street Bank (as successor by merger to IBT); 24 |
(v) | Form of Letter Amendment to the IBT Custodian Agreement, dated December 2011, among the Trust, on behalf of GMO Implementation Fund, GMO and State Street Bank (as successor by merger to IBT); 28 |
(vi) | Form of Letter Amendment to the IBT Custodian Agreement, dated September 2012, among the Trust, on behalf of GMO Risk Premium Fund, GMO and State Street Bank (as successor by merger to IBT); 33 |
(vii) | Letter Amendment to the IBT Custodian Agreement, dated July 1, 2014, among the Trust, on behalf of GMO Special Opportunities Fund, GMO and State Street Bank (as successor by merger to IBT); 39 |
(viii) | Letter Amendment to the IBT Custodian Agreement, dated September 8, 2014, among the Trust, on behalf of GMO Benchmark-Free Bond Fund, GMO and State Street Bank (as successor by merger to IBT); 40 |
(ix) | Amendment to the IBT Custodian Agreement, dated February 17, 2015, among the Trust, GMO and State Street Bank (as successor by merger to IBT); 41 and |
(x) | Letter Amendment to the IBT Custodian Agreement, dated April 13, 2015, among the Trust, on behalf of GMO GAAR Implementation Fund, GMO and State Street Bank (as successor by merger to IBT). 42 |
2. | Form of Custodian Agreement (the BBH Custodian Agreement), dated June 29, 2001, between the Trust, on behalf of certain Funds listed on Schedule I thereto, and Brown Brothers Harriman & Co. (BBH), as amended from time to time to include GMO Taiwan Fund, GMO Developed World Stock Fund, GMO International Large/Mid Cap Equity Fund, GMO Emerging Domestic Opportunities Fund, GMO Global Focused Equity Fund, and GMO Resources Fund; 5 |
5
(i) | Letter Amendment to the BBH Custodian Agreement, dated June 4, 2003, among the Trust and BBH; 6 |
(ii) | Amendment to the BBH Custodian Agreement, dated June 30, 2009, among the Trust and BBH; 18 |
(iii) | Letter Amendment to the BBH Custodian Agreement, dated May 21, 2010, between the Trust, on behalf of GMO Emerging Domestic Opportunities Fund, and BBH; 22 |
(iv) | Form of Letter Amendment to the BBH Custodian Agreement, dated September 12, 2011 among the Trust, on behalf of GMO Global Focused Equity Fund, and BBH; 26 and |
(v) | Form of Letter Amendment to the BBH Custodian Agreement, dated December 2011 among the Trust, on behalf of GMO Resources Fund, and BBH. 27 |
3. | Form of Accounting Agency Agreement (the Accounting Agency Agreement), dated June 29, 2001, between the Trust, on behalf of certain Funds listed on Schedule I thereto, and BBH, as amended to include GMO Taiwan Fund, GMO Emerging Domestic Opportunities Fund, GMO Global Focused Equity Fund, and GMO Resources Fund; 5 |
(i) | Form of Second Amendment to the Accounting Agency Agreement, dated November 22, 2005, between the Trust, on behalf of the Funds listed on Schedule I thereto, and BBH; 12 |
(ii) | Letter Amendment to the Accounting Agency Agreement, dated May 21, 2010, between the Trust, on behalf of GMO Emerging Domestic Opportunities Fund, and BBH; 22 |
(iii) | Form of Letter Amendment to the Accounting Agency Agreement, dated September 12, 2011 among the Trust, on behalf of GMO Global Focused Equity Fund and BBH; 26 and |
(iv) | Form of Letter Amendment to the Accounting Agency Agreement, dated December 2011 among the Trust, on behalf of GMO Resources Fund, and BBH. 27 |
4. | Form of 17f-5 Delegation Schedule (the Delegation Schedule), dated June 29, 2001, between the Trust, on behalf of certain Funds listed on Schedule 1 thereto, and BBH, as amended from time to time to include GMO Taiwan Fund, GMO Developed World Stock Fund, GMO International Large/Mid Cap Equity Fund, GMO Emerging Domestic Opportunities Fund, GMO Global Focused Equity Fund, and GMO Resources Fund; 5 |
(i) | Letter Amendment to the Delegation Schedule, dated May 21, 2010, between the Trust, on behalf of GMO Emerging Domestic Opportunities Fund, and BBH; 22 |
(ii) | Form of Letter Amendment to the Delegation Schedule, dated September 12, 2011, among the Trust, on behalf of GMO Global Focused Equity Fund and BBH; 26 and |
(iii) | Form of Letter Amendment to the Delegation Schedule, dated December 2011, among the Trust, on behalf of GMO Resources Fund, and BBH. 27 |
6
5. | Form of Amended and Restated Delegation Agreement (the Delegation Agreement), dated June 29, 2001, between the Trust, on behalf of GMO Core Plus Bond Fund, GMO International Bond Fund, GMO Currency Hedged International Bond Fund, GMO Global Bond Fund, GMO Emerging Country Debt Fund, and GMO Emerging Country Debt Share Fund, and IBT, as amended from time to time to include GMO Debt Opportunities Fund, GMO Systematic Global Macro Opportunity Fund, GMO Strategic Opportunities Allocation Fund, GMO Global Developed Equity Allocation Fund, GMO U.S. Equity Allocation Fund, GMO International Developed Equity Allocation Fund, GMO U.S. Treasury Fund, GMO Asset Allocation Bond Fund, GMO Debt Opportunities Fund, GMO High Quality Short-Duration Bond Fund, GMO Benchmark-Free Fund, GMO Implementation Fund, GMO Risk Premium Fund, GMO Special Opportunities Fund, GMO Benchmark-Free Bond Fund, and GMO GAAR Implementation Fund; 5 |
(i) | Letter Amendment to the Delegation Agreement, dated March 10, 2009, among the Trust, on behalf of GMO U.S. Treasury Fund and GMO Asset Allocation Bond Fund, GMO and State Street Bank (as successor by merger to IBT); 17 |
(ii) | Form of Letter Amendment to the Delegation Agreement, dated November 25, 2009, among the Trust, on behalf of GMO Debt Opportunities Fund and GMO High Quality Short-Duration Bond Fund, GMO and State Street Bank (as successor by merger to IBT); 20 |
(iii) | Form of Letter Amendment to the Delegation Agreement, dated May 20, 2011, among the Trust, on behalf of GMO Benchmark-Free Fund, GMO and State Street Bank (as successor by merger to IBT); 24 |
(iv) | Form of Letter Amendment to the Delegation Agreement, dated December 2011, among the Trust, on behalf of GMO Implementation Fund, GMO and State Street Bank (as successor by merger to IBT); 28 |
(v) | Form of Letter Amendment to the Delegation Agreement, dated September 2012, among the Trust, on behalf of GMO Risk Premium Fund, GMO and State Street Bank (as successor by merger to IBT); 33 |
(vi) | Letter Amendment to the Delegation Agreement, dated July 1, 2014, among the Trust, on behalf of GMO Special Opportunities Fund, GMO and State Street Bank (as successor by merger to IBT); 39 |
(vii) | Letter Amendment to the Delegation Agreement, dated September 8, 2014, among the Trust, on behalf of GMO Benchmark-Free Bond Fund, GMO and State Street Bank (as successor by merger to IBT); 40 and |
(viii) | Letter Amendment to the Delegation Agreement, dated April 13, 2015, among the Trust, on behalf of GMO GAAR Implementation Fund, GMO and State Street Bank (as successor by merger to IBT). 42 |
7
(h) 1. | Form of Transfer Agency and Service Agreement (the Transfer Agency and Service Agreement), dated August 1, 1991, among the Trust, on behalf of certain Funds listed therein, GMO and IBT, as amended from time to time to include GMO Global Bond Fund, GMO Foreign Fund, GMO International Equity Allocation Fund, GMO Global Asset Allocation Fund, GMO Global Equity Allocation Fund, GMO Core Plus Bond Fund, GMO Tax-Managed International Equities Fund, GMO Emerging Country Debt Share Fund, GMO Foreign Small Companies Fund, GMO Debt Opportunities Fund, GMO Quality Fund, GMO World Opportunity Overlay Fund, GMO Strategic Opportunities Allocation Fund, GMO Global Developed Equity Allocation Fund, GMO Developed World Stock Fund, GMO International Large/Mid Cap Equity Fund, GMO U.S. Equity Allocation Fund, GMO International Developed Equity Allocation Fund, GMO U.S. Treasury Fund, GMO Asset Allocation Bond Fund, GMO Debt Opportunities Fund, GMO High Quality Short-Duration Bond Fund, GMO Emerging Domestic Opportunities Fund, GMO Benchmark-Free Fund, GMO Global Focused Equity Fund, GMO Resources Fund, GMO Implementation Fund, GMO Risk Premium Fund, GMO Special Opportunities Fund, GMO Benchmark-Free Bond Fund, and GMO GAAR Implementation Fund; 12 |
(i) | Letter Amendment to the Transfer Agency and Service Agreement, dated March 10, 2009, among the Trust, on behalf of GMO U.S. Treasury Fund and GMO Asset Allocation Bond Fund, GMO and State Street Bank (as successor by merger to IBT); 17 |
(ii) | Form of Letter Amendment to the Transfer Agency and Service Agreement, dated November 25, 2009, among the Trust, on behalf of GMO Debt Opportunities Fund and GMO High Quality Short-Duration Bond Fund, GMO and State Street Bank (as successor by merger to IBT); 20 |
(iii) | Form of Letter Amendment to the Transfer Agency and Service Agreement, dated July 30, 2010, among the Trust, on behalf of GMO Emerging Domestic Opportunities Fund, GMO and State Street Bank (as successor by merger to IBT); 22 |
(iv) | Form of Letter Amendment to the Transfer Agency and Service Agreement, dated May 20, 2011 among the Trust, on behalf of GMO Benchmark-Free Fund, GMO and State Street Bank (as successor by merger to IBT); 24 |
(v) | Form of Letter Amendment to the Transfer Agency and Service Agreement, dated September 12, 2011 among the Trust, on behalf of GMO Global Focused Equity Fund, GMO and State Street Bank (as successor by merger to IBT); 26 |
(vi) | Letter Amendment Regarding Fund of Fund Procedures to the Transfer Agency and Service Agreement, dated June 1, 2010, among the Trust, GMO, and State Street Bank (as successor by merger to IBT); 27 |
8
(vii) | Letter Amendment to the Transfer Agency and Service Agreement, dated November 17, 2011 among the Trust, on behalf of GMO Resources Fund, GMO and State Street Bank (as successor by merger to IBT); 27 |
(viii) | Form of Letter Amendment to the Transfer Agency and Service Agreement, dated December 2011, among the Trust, on behalf of GMO Implementation Fund, GMO and State Street Bank (as successor by merger to IBT); 28 |
(ix) | Form of Letter Amendment to the Transfer Agency and Service Agreement, dated September 2012, among the Trust, on behalf of GMO Risk Premium Fund, GMO and State Street Bank (as successor by merger to IBT); 33 |
(x) | Letter Amendment to the Transfer Agency and Service Agreement, dated July 1, 2014, among the Trust, on behalf of GMO Special Opportunities Fund, GMO and State Street Bank (as successor by merger to IBT); 40 |
(xi) | Letter Amendment to the Transfer Agency and Service Agreement, dated September 8, 2014, among the Trust, on behalf of GMO Benchmark-Free Bond Fund, GMO and State Street Bank (as successor by merger to IBT); 40 |
(xii) | Letter Amendment to the Transfer Agency and Service Agreement, dated April 13, 2015, among the Trust, on behalf of GMO GAAR Implementation Fund, GMO and State Street Bank (as successor by merger to IBT); 42 and |
(xiii) | FATCA Support Services Amendment to the Transfer Agency and Service Agreement, dated May 22, 2015, among the Trust, GMO and State Street Bank (as successor by merger to IBT)Exhibit (h)(1)(xiii). |
2. | Form of Notification of Undertaking to Reimburse Selected Fund Expenses and Waive Selected Fees by GMO to the Trust, dated as of June 30, 2015Exhibit (h)(2). |
3. | Amended and Restated Servicing and Supplemental Support Agreement, dated May 30, 1996, as amended and restated effective September 15, 2014, between the Trust, on behalf of certain Funds listed on Exhibit I thereto, and GMO; 40 |
9
(i) | Form of Notification of Undertaking to Reduce Supplemental Support Fees by GMO to the Trust, dated as of June 30, 2015Exhibit (h)(3)(i). |
4. | Distribution Agreement, dated as of February 27, 2015, between the Trust and GMO U.K. Limited. 41 |
(i) | Opinion and Consent of Ropes & Gray LLP previously filed with the Securities and Exchange Commission (SEC). |
(j) | Consent of Independent Registered Public Accounting FirmExhibit (j). |
(k) | Financial Statements Not applicable. |
(l) | None. |
(m) 1. | GMO Trust Amended and Restated Distribution and Service Plan (Class M), dated as of November 15, 2001, as amended and restated as of June 30, 2013, on behalf of GMO Emerging Countries Fund; 34 |
2. | Amended and Restated Administration Agreement, dated as of June 30, 2013, on behalf of GMO Emerging Countries Fund; 34 |
3. | Form of Service Agreement (Service Agreement), dated October 1, 2001, between American Express Financial Advisors Inc. and the Trust, on behalf of certain Funds listed on Schedule A thereto, as Schedule A may be amended from time to time; 4 |
(i) | Second Amendment to Service Agreement, dated September 9, 2005, between American Express Financial Advisors Inc. and the Trust, on behalf of certain Funds listed on Schedule A thereto; 12 and |
(ii) | Assignment Agreement, effective as of April 2, 2007, between Wachovia Bank, Ameriprise Financial Services, Inc. (f/k/a American Express Financial Advisors Inc.) and the Trust, on behalf of certain Funds listed on Schedule A thereto. 14 |
4. | Form of Services Agreement, dated as of March 2002, between Fidelity Brokerage Services LLC and National Financial Services LLC, and the Trust, on behalf of certain Funds listed on Exhibit B thereto; 5 |
5. | Funds Trading Agreement (Funds Trading Agreement), dated July 1, 2001, between Fidelity Investments Institutional Operations Company, Inc. (FIIOC), IBT, GMO, and the Trust, on behalf of certain Funds listed on Exhibit A thereto; 12 |
(i) | Second Amendment to Funds Trading Agreement, dated as of April 1, 2003, between FIIOC, IBT, GMO and the Trust, on behalf of certain Funds listed on Exhibit A thereto; 12 |
(ii) | Third Amendment to Funds Trading Agreement, dated as of November 28, 2003, between FIIOC, IBT, GMO and the Trust, on behalf of certain Funds listed on Exhibit A thereto; 12 |
10
(iii) | Fourth Amendment to Funds Trading Agreement, dated as of April 1, 2004, between FIIOC, IBT, GMO and the Trust, on behalf of certain Funds listed on Exhibit A thereto; 12 |
(iv) | Fifth Amendment to Funds Trading Agreement, dated as of February 1, 2005, between FIIOC, IBT, GMO and the Trust, on behalf of certain Funds listed on Exhibit A thereto; 12 |
(v) | Sixth Amendment to Funds Trading Agreement, dated as of July 2005, between FIIOC, IBT, GMO and the Trust, on behalf of certain Funds listed on Exhibit A thereto; 12 and |
(vi) | Seventh Amendment to Funds Trading Agreement, dated as of September, 2005, between FIIOC, IBT, GMO and the Trust, on behalf of certain Funds listed on Exhibit A thereto. 12 |
6. | Form of Funds Trading Agreement (BBH Funds Trading Agreement), dated July 1, 2001, between FIIOC, IBT, BBH, GMO and the Trust on behalf of certain Funds listed on Exhibit A thereto; 5 |
(i) | Form of First Amendment to the BBH Funds Trading Agreement, dated January 1, 2002, between FIIOC, IBT, BBH, GMO, and the Trust, on behalf of certain Funds listed on Exhibit A thereto; 5 and |
(ii) | Second Amendment to the BBH Funds Trading Agreement, dated July 1, 2002, between FIIOC, IBT, BBH, GMO, and the Trust, on behalf of certain Funds listed on Exhibit A thereto. 12 |
7. | Form of Shareholder Services Agreement (Shareholder Services Agreement), dated as of October 31, 2001, between Citistreet LLC (Citistreet) and the Trust, on behalf of certain Funds listed on Attachment A thereto; 6 and |
(i) | First Amendment to Shareholder Services Agreement, dated as of May 6, 2002, between Citistreet and the Trust, on behalf of certain Funds listed on Attachment A thereto; 12 |
(ii) | Second Amendment to Shareholder Services Agreement, dated as of October 15, 2002, between Citistreet and the Trust, on behalf of certain Funds listed on Attachment A thereto; 12 |
(iii) | Third Amendment to Shareholder Services Agreement, dated as of April 30, 2003, between Citistreet and the Trust, on behalf of certain Funds listed on Attachment A thereto; 12 |
(iv) | Fourth Amendment to Shareholder Services Agreement, dated as of July 1, 2005, between Citistreet and the Trust, on behalf of certain Funds listed on Attachment A thereto; 12 and |
(v) | Fifth Amendment to Shareholder Services Agreement, dated as of September 1, 2005, between Citistreet and the Trust, on behalf of certain Funds listed on Attachment A thereto. 12 |
8. | Operating Agreement (Operating Agreement), dated as of April 19, 2000, between Charles Schwab & Co., Inc. (Schwab) and the Trust, on behalf of certain Funds listed on Schedule I thereto. 21 |
(i) | First Amendment to Operating Agreement, dated as of March 10, 2010, between Schwab and the Trust, on behalf of certain Funds listed on Schedule I thereto. 21 |
11
(n) | Plan pursuant to Rule 18f-3 under the Investment Company Act of 1940, effective June 1, 1996, as amended and restated June 20, 2014. 40 |
(o) | Reserved. |
(p) 1. | GMO Code of Ethics, dated November 1, 2013, adopted by GMO, GMO Australasia LLC, GMO Australia Ltd., GMO Netherlands, a branch office of GMO U.K. Ltd., GMO Singapore PTE Ltd., GMO Switzerland GMBH, GMO U.K. Ltd., GMO Renewable Resources LLC, GMO Renewable Resources (in New Zealand), and GMO Renewable Resources Uruguay, SRL; 35 |
2. | GMO Trust Code of Ethics, dated September 5, 2008, adopted by the Trust; 16 and |
3. | Code of Ethics for the Independent Trustees of GMO Trust, dated as of June 1, 1996, as revised March 24, 2011, adopted by the Board of Trustees of the Trust. 23 |
1. | Previously filed with the SEC as part of Post-Effective Amendment No. 27 to the Registration Statement under the Securities Act of 1933 (the 1933 Act) and Amendment No. 28 to the Registration Statement under the Investment Company Act of 1940 Act (the 1940 Act) on March 13, 1996, and hereby incorporated by reference. |
2. | Previously filed with the SEC as part of Post-Effective Amendment No. 29 to the Registration Statement under the 1933 Act and Amendment No. 30 to the Registration Statement under the 1940 Act on June 28, 1996, and hereby incorporated by reference. |
3. | Previously filed with the SEC as part of Amendment No. 63 to the Registration Statement under the 1940 Act on July 3, 2000, and hereby incorporated by reference. |
4. | Previously filed with the SEC as part of Post-Effective Amendment No. 63 to the Registration Statement under the 1933 Act and Amendment No. 76 to the Registration Statement under the 1940 Act on March 1, 2002, and hereby incorporated by reference. |
5. | Previously filed with the SEC as part of Post-Effective Amendment No. 64 to the Registration Statement under the 1933 Act and Amendment No. 77 to the Registration Statement under the 1940 Act on May 1, 2002, and hereby incorporated by reference. |
6. | Previously filed with the SEC as part of Post-Effective Amendment No. 71 to the Registration Statement under the 1933 Act and Amendment No. 89 to the Registration Statement under the 1940 Act on June 30, 2003, and hereby incorporated by reference. |
7. | Previously filed with the SEC as part of Post-Effective Amendment No. 72 to the Registration Statement under the 1933 Act and Amendment No. 90 to the Registration Statement under the 1940 Act on October 31, 2003, and hereby incorporated by reference. |
8. | Previously filed with the SEC as part of Amendment No. 126 to the Registration Statement under the 1940 Act on November 18, 2004, and hereby incorporated by reference. |
9. | Previously filed with the SEC as part of Post-Effective Amendment No. 105 to the Registration Statement under the 1933 Act and Amendment No. 131 to the Registration Statement under the 1940 Act on March 15, 2005, and hereby incorporated by reference. |
10. | Previously filed with the SEC as part of Post-Effective Amendment No. 114 to the Registration Statement under the 1933 Act and Amendment No. 142 to the Registration Statement under the 1940 Act on August 17, 2005, and hereby incorporated by reference. |
11. | Previously filed with the SEC as part of Post-Effective Amendment No. 123 to the Registration Statement under the 1933 Act and Amendment No. 151 to the Registration Statement under the 1940 Act on May 17, 2006, and hereby incorporated by reference. |
12. | Previously filed with the SEC as part of Amendment No. 154 to the Registration Statement under the 1940 Act on June 28, 2006, and hereby incorporated by reference. |
13. | Previously filed with the SEC as part of Post-Effective Amendment No. 127 to the Registration Statement under the 1933 Act and Amendment No. 156 to the Registration Statement under the 1940 Act on May 1, 2007, and hereby incorporated by reference. |
12
14. | Previously filed with the SEC as part of Post-Effective Amendment No. 128 to the Registration Statement under the 1933 Act and Amendment No. 158 to the Registration Statement under the 1940 Act on June 29, 2007, and hereby incorporated by reference. |
15. | Previously filed with the SEC as part of Amendment No. 161 to the Registration Statement under the 1940 Act on June 27, 2008, and hereby incorporated by reference. |
16. | Previously filed with the SEC as part of Amendment No. 164 to the Registration Statement under the 1940 Act on December 24, 2008, and hereby incorporated by reference. |
17. | Previously filed with the SEC as part of Post-Effective Amendment No. 133 to the Registration Statement under the 1933 Act and Amendment No. 167 to the Registration Statement under the 1940 Act on March 13, 2009, and hereby incorporated by reference. |
18. | Previously filed with the SEC as part of Post-Effective Amendment No. 137 to the Registration Statement under the 1933 Act and Amendment No. 172 to the Registration Statement under the 1940 Act on July 17, 2009, and hereby incorporated by reference. |
19. | Previously filed with the SEC as part of Post-Effective Amendment No. 139 to the Registration Statement under the 1933 Act and Amendment No. 174 to the Registration Statement under the 1940 Act on October 30, 2009, and hereby incorporated by reference. |
20. | Previously filed with the SEC as part of Amendment No. 175 to the Registration Statement under the 1940 Act on December 3, 2009, and hereby incorporated by reference. |
21. | Previously filed with the SEC as part of Amendment No. 178 to the Registration Statement under the 1940 Act on June 25, 2010, and hereby incorporated by reference. |
22. | Previously filed with the SEC as part of Post-Effective Amendment No. 143 to the Registration Statement under the 1933 Act and Amendment No. 180 to the Registration Statement under the 1940 Act on August 2, 2010, and hereby incorporated by reference. |
23. | Previously filed with the SEC as part of Post-Effective Amendment No. 144 to the Registration Statement under the 1933 Act and Amendment No. 181 to the Registration Statement under the 1940 Act on April 15, 2011, and hereby incorporated by reference. |
24. | Previously filed with the SEC as part of Amendment No. 183 to the Registration Statement under the 1940 Act on May 20, 2011, and hereby incorporated by reference. |
25. | Previously filed with the SEC as part of Amendment No. 184 to the Registration Statement under the 1940 Act on June 27, 2011, and hereby incorporated by reference. |
26. | Previously filed with the SEC as part of Post-Effective Amendment No. 149 to the Registration Statement under the 1933 Act and Amendment No. 188 to the Registration Statement under the 1940 Act on September 13, 2011, and hereby incorporated by reference. |
27. | Previously filed with the SEC as part of Post-Effective Amendment No. 153 to the Registration Statement under the 1933 Act and Amendment No. 192 to the Registration Statement under the 1940 Act on December 6, 2011, and hereby incorporated by reference. |
28. | Previously filed with the SEC as part of Amendment No. 193 to the Registration Statement under the 1940 Act on December 8, 2011, and hereby incorporated by reference. |
29. | Previously filed with the SEC as part of Amendment No. 156 to the Registration Statement under the 1933 Act and Amendment No. 196 to the Registration Statement under the 1940 Act on December 29, 2011, and hereby incorporated by reference. |
30. | Previously filed with the SEC as part of Amendment No. 200 to the Registration Statement under the 1940 Act on March 27, 2012, and hereby incorporated by reference. |
31. | Previously filed with the SEC as part of Amendment No. 202 to the Registration Statement under the 1940 Act on June 27, 2012, and hereby incorporated by reference. |
32. | Previously filed with the SEC as part of Post-Effective Amendment No. 162 to the Registration Statement under the 1933 Act and Amendment No. 204 to the Registration Statement under the 1940 Act on July 12, 2012, and hereby incorporated by reference. |
33. | Previously filed with the SEC as part of Post-Effective Amendment No. 164 to the Registration Statement under the 1933 Act and Amendment No. 206 to the Registration Statement under the 1940 Act on September 25, 2012, and hereby incorporated by reference. |
34. | Previously filed with the SEC as part of Amendment No. 209 to the Registration Statement under the 1940 Act on June 26, 2013, and hereby incorporated by reference. |
35. | Previously filed with the SEC as part of Post-Effective Amendment No. 169 to the Registration Statement under the 1933 Act and Amendment No. 212 to the Registration Statement under the 1940 Act on December 11, 2013, and hereby incorporated by reference. |
36. | Previously filed with the SEC as part of Post-Effective Amendment No. 170 to the Registration Statement under the 1933 Act and Amendment No. 213 to the Registration Statement under the 1940 Act on February 7, 2014, and hereby incorporated by reference. |
37. | Previously filed with the SEC as part of Post-Effective Amendment No. 172 to the Registration Statement under the 1933 Act and Amendment No. 215 to the Registration Statement under the 1940 Act on April 30, 2014, and hereby incorporated by reference. |
13
38. | Previously filed with the SEC as part of Amendment No. 217 to the Registration Statement under the 1940 Act on June 25, 2014, and hereby incorporated by reference. |
39. | Previously filed with the SEC as part of Post-Effective Amendment No. 176 to the Registration Statement under the 1933 Act and Amendment No. 220 to the Registration Statement under the 1940 Act on July 18, 2014, and hereby incorporated by reference. |
40. | Previously filed with the SEC as part of Post-Effective Amendment No. 179 to the Registration Statement under the 1933 Act and Amendment No. 223 to the Registration Statement under the 1940 Act on September 15, 2014, and hereby incorporated by reference. |
41. | Previously filed with the SEC as part of Amendment No. 225 to the Registration Statement under the 1940 Act on April 13, 2015, and hereby incorporated by reference. |
42. | Previously filed with the SEC as part of Post-Effective Amendment No. 181 to the Registration Statement under the 1933 Act and Amendment No. 226 to the Registration Statement under the 1940 Act on April 16, 2015, and hereby incorporated by reference. |
Item 29. | Persons Controlled by or Under Common Control with a Fund |
Controlling Fund |
Person Controlled |
Nature of Control |
||
GMO Systematic Global Macro Opportunity Fund | GMO Alternative Asset SPC Ltd. (a) (b) | 100% Ownership (c) | ||
GMO Special Opportunities Fund | GMO Special Opportunities SPC Ltd. (a) (b) | 100% Ownership (c) | ||
GMO Implementation Fund | GMO Implementation SPC Ltd. (a) (b) | 100% Ownership (d) | ||
GMO GAAR Implementation Fund | GMO GAAR Implementation SPC Ltd. (a) (b) | 100% Ownership (e) |
(a) | Included (or, in the case of each of GMO Implementation SPC Ltd. and GMO GAAR Implementation SPC Ltd., will be included, when available) in the controlling Funds consolidated financial statements. |
(b) | Organized under the laws of Bermuda. |
(c) | As of the most recent fiscal year ended February 28, 2015. |
(d) | As of March 2, 2015. |
(e) | As of April 13, 2015. |
Item 30. | Indemnification |
Please refer to Article 4 (Indemnification) of the By-laws.
In addition, the Trust will maintain a trustees and officers liability insurance policy under which the Trust and its trustees and officers will be named insureds. The Trust also has entered into agreements with each of its trustees pursuant to which each of the Funds has agreed to indemnify each Trustee to the maximum extent permitted by applicable law against any liability and expense incurred by the Trustee by reason of the Trustee being or having been a Trustee.
Insofar as indemnification for liability arising under the Securities Act of 1933 (the Securities Act) may be permitted to trustees, officers and controlling persons of the Registrant pursuant to the Trusts By-laws, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission (SEC) such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a
14
trustee, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such trustee, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
Item 31. | Business and Other Connections of Investment Adviser |
A description of the business of Grantham, Mayo, Van Otterloo & Co. LLC, the investment adviser of the Funds of the Registrant (the Investment Adviser), is set forth under the captions Management of the Trust in the Prospectus and Investment Advisory and Other Services in the Statement of Additional Information, all forming part of this Registration Statement.
Except as set forth below, the directors, officers, and members of the Investment Adviser, have been engaged during the past two fiscal years in no business, profession, vocation or employment of a substantial nature other than as directors, officers, or members of the Investment Adviser or certain of its affiliates. Certain directors, officers, and members of the Investment Adviser serve as officers or trustees of the Registrant as set forth under the caption Management of the Trust in the Registrants Statement of Additional Information, forming part of this Registration Statement, and/or as officers and/or directors of certain private investment companies managed by the Investment Adviser or certain of its affiliates. The address of the Investment Adviser and the Registrant is 40 Rowes Wharf, Boston, Massachusetts 02110.
Name |
Position with Investment Adviser |
Other Connections |
||
Stephen P. Casper | Member of the Board of Directors | Lead Independent Director, MarketAxess, 299 Park Avenue, 10 th Floor, New York, NY 10171; Investment Committee Member, Brooklyn Museum, 200 Eastern Parkway, Brooklyn, NY 11238 | ||
Arjun Divecha | Member, Chairman of the Board of Directors, and Investment Director | Board Member, Divecha Centre for Climate Change, Indian Institute of Science, Bengaluru, India; Director, Frog Hollow Fresh LLC, P.O. Box 872, Brentwood, CA 94513 |
15
Name |
Position with Investment Adviser |
Other Connections |
||
Myra Drucker | Member of the Board of Directors | Chair of the Board, TrustedPeer Inc., 800 Noe Street, San Francisco, CA 94114; Board Member, Financial Accounting Foundation, 401 Merritt 7 #2, Norwalk, CT 06851; Investment Committee Advisor, The Boeing Company, 100 North Riverside Plaza, Chicago, IL 60606; Investment Committee Member, The Kresge Foundation, 3215 West Big Beaver Road, Troy, MI 48084; Investment Committee Chair, The Nathan Cummings Foundation, 475 Tenth Avenue, 14 th Floor, New York, NY 10018 | ||
R. Jeremy Grantham | Founding Member, Member of the Board of Directors, and Chief Investment Strategist | Board Member, RARE Conservation, 1310 North Courthouse Road, Suite 110, Arlington, VA 22201; Board Member, Divecha Centre for Climate Change, Indian Institute of Science, Bengaluru, India; CFA Institute Investors Working Group (IWG) Member, 560 Ray C. Hunt Drive, Charlottesville, VA 22903; Board Member, Imperial College of London Grantham Institute for Climate Change, London SW7 2AZ; Board Member, London School of Economics Grantham Institute for Climate Change, Houghton Street, London, WC2A 2AE; Board Member, The Nature Conservancy, 4245 North Fairfax Drive, Suite 100, Arlington, VA 22203; Trustee, The Grantham Foundation for the Protection of the Environment, 40 Rowes Wharf, Boston, MA 02110; Trustee, The Jeremy and Hannelore Grantham Environmental Trust, 40 Rowes Wharf, Boston, MA 02110 |
16
Name |
Position with Investment Adviser |
Other Connections |
||
Margaret McGetrick | Member of the Board of Directors | Investment Committee Member, Partners Healthcare, Prudential Center, 800 Boylston Street, 11 th Floor, Boston, MA, 02199; Finance and Investment Committee Member, Our Sisters School, 145 Brownell Avenue, New Bedford, MA 02740 | ||
John Rosenblum | Member and Vice Chairman of the Board of Directors | Vice Chair of the Board, Maine Media Workshops, 70 Camden Street, Rockport, ME 04856; Board Member, Maine Chapter, The Nature Conservancy, 14 Maine Street, Brunswick, ME 04011 | ||
Eyk Van Otterloo | Founding Member | Board Member, Chemonics International, 1133 20th Street, NW, Suite 600, Washington, D.C. 20036; Board Member, CliniLabs, 423 W. 55th Street, 4th Floor, New York, NY 10019 |
Item 32. | Principal Underwriters |
Item 32(a). | Funds Distributor, LLC (FD) acts as principal underwriter for the following investment companies registered under the Investment Company Act of 1940, as amended: |
GMO Series Trust |
GMO Trust |
Mirae Asset Discovery Funds |
17
Item 32(b). | FD is registered with the SEC as a broker-dealer and is a member of the Financial Industry Regulatory Authority. FDs principal business address is Three Canal Plaza, Suite 100, Portland, Maine 04101. |
Information about the Manager and Officers of FD is as follows:
Manager or Officer |
Positions and Offices with FD |
|
Mark A. Fairbanks | President | |
Richard J. Berthy | Vice President, Treasurer, and Manager | |
Jennifer E. Hoopes | Secretary | |
Nanette K. Chern | Vice President and Chief Compliance Officer | |
Lisa S. Clifford | Vice President and Managing Director of Compliance | |
Paula R. Watson | Assistant Secretary |
The above FD manager and officers do not have positions or offices with the Trust.
Item 32(c). | Distribution and Service (12b-1) Fee Payments by certain Funds of the Trust with respect to the last fiscal year (a) : |
GMO Fund Name |
Class M
(b)
Distribution and
Service (12b-1) Fees March 1, 2014 through May 2, 2014 (c) |
|||
GMO Emerging Countries Fund |
$ | 7,102.37 |
(a) | FD was entitled to receive any distribution and service (12b-1) fees paid by the Class M Shares for services rendered and expenses borne by FD which had been primarily intended to result in the sale of Class M shares and/or the provision of certain other services incidental thereto. During the last fiscal year, FD did not retain any of the distribution and service (12b-1) fees paid by the Class M Shares of the Funds and directed that the Funds remit the distribution and service (12b-1) fees directly to certain third party intermediaries who rendered services to the Funds. |
(b) | Other classes of the GMO Funds do not pay distribution (12b-1) fees or any other type of commission or compensation to FD. |
(c) | Class M liquidated on May 2, 2014. |
Item 33. | Location of Accounts and Records |
The accounts, books, and other documents required to be maintained by Section 31(a) and the rules thereunder will be maintained at the offices of the Registrant, 40 Rowes Wharf, Boston, MA 02110; the Registrants investment adviser, Grantham, Mayo, Van Otterloo & Co. LLC, 40 Rowes Wharf, Boston, MA 02110; the Registrants distributor, Funds Distributor, LLC, 3 Canal Plaza, Suite 100, Portland, Maine 04101; the Registrants custodian for certain of the Funds, Brown Brothers Harriman & Co., 50 Post Office Square, Boston, MA 02110; and the Registrants custodian for certain of the Funds and transfer agent, State Street Bank and Trust Company, One Lincoln Street, Boston, MA 02111.
18
Item 34. | Management Services |
Not applicable.
Item 35. | Undertakings |
None.
19
Notice
A copy of the Declaration of Trust, together with all amendments thereto, is on file with the Secretary of the Commonwealth of Massachusetts and notice is hereby given that this instrument is executed on behalf of the Trust by an officer of the Trust as an officer and not individually and that the obligations of this instrument are not binding upon any of the Trustees or officers of the Trust or shareholders of any series of the Trust individually but are binding only upon the assets and property of the Trust or the respective series.
20
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940 (the 1940 Act), as amended, the Registrant, GMO Trust, has duly caused this Amendment No. 228 under the 1940 Act to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boston and The Commonwealth of Massachusetts, on the 26th day of June, 2015.
GMO Trust | ||
By: |
/s/ Sheppard N. Burnett |
|
Sheppard N. Burnett | ||
Title: Chief Executive Officer; Principal Executive Officer |
GMO TRUST JUNE 2015 ANNUAL UPDATE POS AMI FILING
21
EXHIBIT INDEX
GMO TRUST
Exhibit Ref. |
Title of Exhibit |
|
(h)(1)(xiii) | FATCA Support Services Amendment to the Transfer Agency and Service Agreement, dated May 22, 2015, among the Trust, GMO and State Street Bank (as successor by merger to IBT). | |
(h)(2) | Form of Notification of Undertaking to Reimburse Selected Fund Expenses and Waive Selected Fees by GMO to the Trust, dated as of June 30, 2015. | |
(h)(3)(i) | Form of Notification of Undertaking to Reduce Supplemental Support Fees by GMO to the Trust, dated as of June 30, 2015. | |
(j) | Consent of Independent Registered Public Accounting Firm. |
22
Exhibit (h)(1)(xiii)
FATCA SUPPORT SERVICES AMENDMENT
FATCA Support Services Amendment (the Amendment) dated as of May 22, 2015 and effective as of June 1, 2014 to the Transfer Agency and Service Agreement dated as of August 1, 1991, as amended (the Agreement) by and among State Street Bank and Trust Company (as successor by merger to Investors Bank & Trust Co.), a trust company organized under the laws of The Commonwealth of Massachusetts, with its principal place of business at One Lincoln Street, Boston, Massachusetts 02111 (the Bank, or as referred to in this Amendment, the FATCA Services Provider), GMO Trust (GMO Trust), on behalf of certain of its series of the Trust as set forth on Appendix A hereto, separately and not jointly (collectively, the Funds, and each a Fund) and Grantham, Mayo, Van Otterloo & Co. LLC (GMO) (together with the FATCA Services Provider, GMO Trust and the Funds, the Parties, and each a Party).
The Parties hereto agree as follows:
1. | Duties of the FATCA Services Provider. |
From and after the date of this Agreement, the FATCA Services Provider hereby agrees to provide to each Fund in connection with such Funds efforts to comply with Sections 1471 to 1474 of the Internal Revenue Code of 1986, as amended (the Code), the regulations promulgated thereunder and applicable intergovernmental agreements entered into in connection with the implementation of such Sections of the Code (FATCA) the services (the FATCA Services) as set forth in the Services Exhibit attached hereto and as may be supplemented or modified by the Parties from time to time in writing, which upon execution and delivery shall form a part of this Amendment (the Services Exhibit), in connection with such Funds actual, or anticipated, FATCA obligations. The FATCA Services Provider shall be responsible to obtain legal or tax advice, if needed, in order to ensure its compliance with FATCA.
2. | Duties of the Funds. |
Except to the extent otherwise maintained by the FATCA Services Provider for each Fund, such Fund shall be responsible for accurately and timely supplying the FATCA Services Provider with any information reasonably requested by the FATCA Services Provider, that is not already in the possession of the FATCA Services Provider in order for the FATCA Services Provider to provide the FATCA Services set forth in the Services Exhibit. Examples of information may include but is not limited to the following:
(i) | Information related to the investors of the Fund (Investors), maintained by the Fund or any agent of the Fund, such as Fund application, contact and mailing information, including telephone numbers, (it being understood the foregoing shall be used solely for the FATCA service and shall not be used to contact any Investor directly), wire instructions details, information on the place of birth of the Investors who are individuals, information on power of attorney or signature authority granted by the Investors to other persons, formation documents for Investors that are not individuals (partnership agreements, articles of incorporation, etc.), investor account information maintained by third party transfer agents and relevant information collected by the Fund or any agent of the Fund in connection with the Funds anti-money laundering (AML) and know-your-client (KYC) process; and |
(ii) | Tax information completed by the Investors such as W-8s, W-9s and by the Fund, a W-9, including the Funds global intermediary identification number, as applicable, when issued. |
Information Classification: Limited Access
3. | With respect to each Fund, GMO Trust, on behalf of each Fund agrees to the following: |
(a) The Fund shall promptly review all data generated by the FATCA Services Provider in connection with its provision of the FATCA Services for accuracy and completeness and shall approve such data prior to the data being reported to the Internal Revenue Service (the IRS) or a local taxing authority, as appropriate. Each Fund acknowledges that the provision of the FATCA Services by the FATCA Services Provider requires the use of material assumptions, processes, methods and procedures, including decision trees. Any such material assumptions, processes, methods and procedures, including decision trees, shall be agreed in advance by the relevant Fund and the FATCA Services Provider (such procedures, collectively, the FATCA Procedures).
(b) The Fund shall be responsible for complying with FATCA and the data privacy laws and laws associated to any non-US FATCA obligations the Funds have.
(c) The Fund further acknowledges that the FATCA Services Provider does not provide legal or tax advice or guidance and the FATCA Services do not constitute such advice, and the Fund agrees that it is solely responsible to obtain legal or tax advice, if needed, in order to ensure its compliance with FATCA.
(d) The Fund hereby authorizes, approves and directs the FATCA Services Provider to access and use, in connection with the provision of the FATCA Services, any investor information that the FATCA Services Provider may have in its possession in connection with any administrative services that the FATCA Services Provider may provide to the Fund under the Agreement. The Fund further authorizes, approves and directs the FATCA Services Provider to access and use the foregoing investor information and any other information obtained or maintained by the FATCA Services Provider under this Amendment for the purposes of the FATCA Services Provider providing FATCA services to other funds or investment pools advised or managed by the Investment Manager or its affiliates. The Fund represents and warrants that it has full power and authority to provide the foregoing authorizations and that it has obtained any necessary consent or authorization from investors for the FATCA Services Provider to access and use investor information as contemplated by this Section 3(d).
(e) Each Fund acknowledges and agrees that if it is domiciled in a jurisdiction that limits the use of investor data (absent investor consent) and/or mandates notification to investors about changes in the use of their data or to a local data protection regulator, it will have the sole responsibility to obtain any such required consent or make such required notification prior to the commencement of the FATCA Services. Where investor information provided by the Fund or the Funds investors includes information about an identifiable individual, whether such individual is a natural person or otherwise (Personal Information), the Fund represents and warrants that it has obtained all consents and approvals, as required by all applicable laws, regulations, by-laws and ordinances that regulate the collection, processing, use or disclosure of Personal Information, necessary to disclose such Personal Information to the FATCA Services Provider, and as required for the FATCA Services Provider to use and disclose such Personal Information in connection with the performance of the FATCA Services. The Fund acknowledges that, subject to the restrictions contained in Section 4 below, the FATCA Services Provider may use and disclose Personal Information outside of the jurisdiction in which it was initially collected by the Fund, including the United States and that such Personal Information may be accessed by national security authorities, law enforcement and courts.
4. Data Privacy . The FATCA Services Provider shall process Personal Information received or accessed by it under this Amendment only for the purposes of providing the FATCA Services or in connection with the provision of transfer agency or tax related services, if applicable, for the relevant Fund under the Agreement. The FATCA Services Provider has implemented and maintains appropriate safeguards to prevent any access, use or
Information Classification: Limited Access
disclosure of Personal Information other than as permitted under the Agreement and the Amendment, which shall include, but not be limited to, reasonable administrative, physical and technical safeguards appropriate to (a) maintain and protect the confidentiality, security, integrity and availability of Personal Information; (b) protect against anticipated threats or hazards to the security or integrity of the Personal Information; and (c) protect against unauthorized access to or use of the Funds Personal Information that could result in material harm to the Funds or Investors.
The FATCA Services Provider may transfer the Personal Information outside of the European Economic Area (EEA) to a recipient who (i) is in a country which provides an adequate level of protection for Personal Information, (ii) is US Safe Harbor-certified, (iii) is under an agreement which covers the European Union requirements for the transfer of Personal Information to data processors outside of the EEA) or the United States, as applicable, or to the IRS, or local taxing authority (as appropriate), consistent with a Funds reporting obligations under FATCA.
5. | Liability . |
The FATCA Services Provider shall at all times exercise reasonable care and diligence and act in good faith in the performance of its duties hereunder; provided , however , that the FATCA Services Provider shall assume no responsibility and shall be without liability for any loss, liability, claim or expense suffered or incurred by a Fund unless caused solely by the FATCA Services Providers own fraud, bad faith, negligence, reckless disregard of its duties hereunder, or willful misconduct or that of its agents or employees. The FATCA Services Provider shall be responsible for the performance of only such FATCA Services as are set forth in the Services Exhibit attached hereto (which may be amended from time to time), and shall have no responsibility for the actions or activities of any other party, including other service providers to a Fund or the Investment Manager.
6. | Indemnification . |
GMO shall indemnify, hold harmless and defend the FATCA Services Provider from and against any loss, liability, claim or expense (including reasonable attorneys fees and disbursements) suffered or incurred by the FATCA Services Provider in connection with the performance of its duties hereunder, including, without limitation, any liability or expense suffered or incurred as a result of the acts or omissions of the relevant Fund or any third party whose data or services the FATCA Services Provider must rely upon in performing its duties hereunder; provided , however , that such indemnity shall not apply to any liability or expense resulting directly from the fraud, bad faith, negligence, reckless disregard for its duties hereunder, or willful misconduct of the FATCA Services Provider under this Agreement. In addition, the FATCA Services Provider shall be kept indemnified by and be without liability to a Fund for any action taken or omitted by it in reliance upon such Funds representation and warranty set forth in Section 3(e) above, including without limitation, any liability or costs in connection with claims or complaints for failure to comply with any applicable law that regulates the collection, processing, use or disclosure of Personal Information.
Notwithstanding anything herein to the contrary, in the event that the FATCA Services Provider is entitled to indemnification from GMO pursuant to the terms hereof and the Services Provider is not promptly or fully indemnified, GMO Trust agrees that GMO Trust shall indemnify the Services Provider in accordance with the provisions hereof; and all references to GMO in this Section 6 shall be deemed to refer to GMO Trust.
Information Classification: Limited Access
To the extent any provision in this Section 6 conflicts with similar provisions in the Agreement, the provisions set forth herein shall control and be applied to determine the indemnification obligation of GMO in connection with any loss, liability, claim or expense (including reasonable attorneys fees and disbursements) suffered or incurred by the FATCA Services Provider in connection with the performance of its duties under this Amendment. The indemnification obligations of this Section 6 shall survive termination of this Amendment or the Agreement.
7. | Confidentiality . |
Section 15.04 (Confidentiality) in the Agreement shall be deleted in its entirety and be replaced by the following:
The parties hereto agree that each shall treat confidentially the terms and conditions of this Agreement and all information provided by each party to the other party regarding its business and operations. All confidential information provided by a party hereto shall be used by any other party hereto solely for the purpose of rendering services pursuant to this Agreement and, except as may be required in carrying out this Agreement, shall not be disclosed to any third party without the prior consent of the party providing the information. The foregoing shall not be applicable to any information that is publicly available when provided or thereafter becomes publicly available, other than through a breach of this Agreement, or that is independently derived by any party hereto without the use of any information provided by the other party hereto in connection with this Agreement, or that is required to be disclosed by any court of competent jurisdiction or any relevant governmental or regulatory body, or otherwise by applicable law or regulation, provided that in the event that the Funds confidential information is being compelled, to the extent legally permissible, the Bank shall provide the Fund advanced notice thereof and an opportunity to contest such information disclosure with the relevant court or authority.
8. | Governing Law . |
This Amendment shall be governed by and construed in accordance with the laws of The Commonwealth of Massachusetts (excluding the law thereof which requires the application of or reference to the law of any other jurisdiction).
9. | One Agreement . |
Except as amended herein, no other terms or provisions of the Agreement are amended or modified by this Amendment. Upon the execution of this Amendment, this amendment and the Agreement shall form one agreement.
Notice
A copy of the Declaration of Trust, together with all amendments thereto, is on file with the Secretary of the Commonwealth of Massachusetts and notice is hereby given that this instrument is executed on behalf of the Trust by an officer of the Trust as an officer and not individually and that the obligations of this instrument are not binding upon any of the Trustees or officers of the Trust or shareholders of any series of the Trust individually but are binding only upon the assets and property of the Trust or the respective series.
Information Classification: Limited Access
IN WITNESS WHEREOF, this Amendment has been executed for and on behalf of the undersigned as of the day and year first written above.
STATE STREET BANK AND TRUST COMPANY
By: |
/s/ Gunjan Kedia |
|
Name: Gunjan Kedia | ||
Title: Executive Vice President | ||
GMO TRUST | ||
By: |
/s/ Megan Bunting |
|
Name: Megan Bunting | ||
Title: Vice President and Assistant Clerk | ||
GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC | ||
By: |
/s/ J.B. Kittredge |
Name: J.B. Kittredge | ||
Title: General Counsel |
Reviewed by: | /s/ Megan Bunting |
This Agreement is executed on behalf of Grantham, Mayo, Van Otterloo & Co. LLC (GMO) by a duly authorized officer or other agent solely in his or her capacity as an authorized signatory, pursuant to delegated authority from GMO, and not individually. The obligations of or arising out of this Agreement are not binding upon any officer or other agent, partner, member or director of GMO individually, but are binding upon GMO and its assets. GMOs certificate of organization is on file with the Secretary of The Commonwealth of Massachusetts.
Information Classification: Limited Access
APPENDIX A
List of Funds
GMO Alpha Only Fund |
GMO Asset Allocation Bond Fund |
GMO Benchmark-Free Fund |
GMO Benchmark-Free Allocation Fund |
GMO Benchmark-Free Bond Fund |
GMO Core Plus Bond Fund |
GMO Currency Hedged International Bond Fund |
GMO Debt Opportunities Fund |
GMO Developed World Stock Fund |
GMO Emerging Countries Fund |
GMO Emerging Country Debt Fund |
GMO Emerging Domestic Opportunities Fund |
GMO Emerging Markets Fund |
GMO Foreign Fund |
GMO Foreign Small Companies Fund |
GMO GAAR Implementation Fund |
GMO Global Asset Allocation Fund |
GMO Global Bond Fund |
GMO Global Developed Equity Allocation Fund |
GMO Global Equity Allocation Fund |
GMO Global Focused Equity Fund |
GMO Implementation Fund |
GMO International Bond Fund |
GMO International Developed Equity Allocation Fund |
GMO International Equity Allocation Fund |
GMO International Equity Fund |
GMO International Large/Mid Cap Equity Fund |
GMO International Small Companies Fund |
GMO Quality Fund |
GMO Resources Fund |
GMO Risk Premium Fund |
GMO Special Opportunities Fund |
GMO Strategic Opportunities Allocation Fund |
GMO Systematic Global Macro Opportunity Fund |
GMO Taiwan Fund |
GMO Tax-Managed International Equities Fund |
GMO U.S. Equity Allocation Fund |
GMO U.S. Treasury Fund |
GMO World Overlay Opportunity Fund |
Information Classification: Limited Access
SERVICES EXHIBIT
1.) | FATCA Support Services Reserved |
2.) | FATCA Support Services Annual Foreign Financial Institution (FFI) Documentation Assistance |
| The FATCA Services Provider will gather and maintain investor information and documentation in its possession as of July 1, 2014 (or such other applicable FATCA effective date as announced in any future government guidance) and, subject to the agreement of the FATCA Services Provider, information provided to the FATCA Services Provider by the Fund or its agents on or after the aforementioned date in this paragraph in accordance with the FATCA Procedures. |
| The FATCA Services Provider will prompt an authorized person (of each Fund), to review and approve the status of information maintained by the FATCA Services Provider. |
| Each year the FATCA Services Provider, at a time agreed upon with an authorized person of the Fund, will provide the following standardized reports to the Fund, and such additional reports at the FATCA Services Providers discretion: |
- | Certified Global Intermediary Identification Numbers (GIINs) for each Fund, as applicable. |
- | A summary report listing all new Investors. |
- | A summary report of all Investors with a Change in Circumstance or a Reason to Know (as defined in the FATCA Procedures) during the year. |
3.) | FATCA Support Services Collection & Ongoing Monitoring of Client GIINs |
| In respect of participating FFIs and registered deemed compliant FFIs, the FATCA Services Provider will collect Investor GIINs based upon information and documentation in its possession as of July 1, 2014 and, subject to the agreement of the FATCA Services Provider, information provided to the FATCA Services Provider by each Fund or its agents and/or data confirmed by the FATCA Services Provider to the IRS website on or after the aforementioned date in this paragraph in accordance with the FATCA Procedures. |
| Each year, the FATCA Services Provider will provide a summary report of the GIINs for the above described entities for validation and sign-off by an authorized person of each Fund and such additional reports at the FATCA Services Providers discretion and/or upon the reasonable request of the relevant Fund: |
- | Report of valid GIINs |
- | Report of any Change in Circumstance (as defined in the FATCA Procedures) |
4.) | FATCA Support Services E-Documentation |
| As soon as reasonably practicable after the release of the final FATCA IRS Form W-8 series, the FATCA Services Provider will make available an Internet based tool (the E-documentation system) for each Fund and its Investors to prepare, review, digitally sign and electronically submit Forms W-8 and W-9 (specific types of Form W-8 supported are identified below). |
Information Classification: Limited Access
| Each Fund will be granted access to the E-documentation system by the FATCA Services Provider, and each Funds Investors will be granted access to the E-documentation system at the direction of the Fund. |
For any hard copy Form W-8 or W-9 provided to the FATCA Services Provider by the Funds and/or their investors, the FATCA Services Provider will review such forms in accordance with the FATCA Procedures for completeness.
U.S. tax forms supported by the E-documentation system include:
W-8BEN
W-8BEN-E
W-8ECI
W-8EXP
W-8IMY
W-9
Note: Non-U.S. tax forms/certifications shall be supported, as they become available. The FATCA Services Provider will request additional information from the Fund, if the submission is not considered complete.
| The E-documentation system will provide each Fund and its Investors with the ability to print and/or download copies of the above U.S. tax forms. |
| Each Fund will have access to an administration module within the E-documentation system that will permit them to review the status of Investor documentation. |
5.) | FATCA Support Services Pre-existing Account Review & Classification |
| The FATCA Services Provider will conduct a search of the transfer agency platform utilized by the FATCA Services Provider in connection with transfer agency and/or related administration services separately provided to each Fund (the Initial Platform Search) for documentation and information in its possession that is reasonably available as of June 30, 2014 for Investors in the Funds and review (the Initial Review) such documentation and information, and, subject to the agreement of the FATCA Services Provider, supplemental documentation and information provided to the FATCA Services Provider by each Fund or its agents on or before the aforementioned date in this paragraph, in each case, in accordance with the FATCA Procedures. |
| Based upon the Initial Platform Search and Initial Review, the FATCA Services Provider will provide a standardized summary of the results of the Initial Platform Search and the Initial Review to the Funds, at a time agreed upon with the Funds (the Response Date) where the Investors in each Fund will be classified as follows: |
a. Specified US Persons
b. US Persons (not ascertained as Specified US Persons)
c. Non-reportable US Persons
d. Non-US Individuals (without US indicia)
e. Non-US Individuals (with US indicia)
f. Non-US Entities
Note: The FATCA Services Provider and the Funds may agree to alter the above groupings, to the extent that more refined Investor classifications are appropriate, based on published U.S. and/or non-U.S. guidance.
Information Classification: Limited Access
6.) | FATCA Support Services Classification of New Investors |
| For Investors that subscribe on or after July 1, 2014, the FATCA Services Provider will check (the Initial New Investor Check) the completeness of documentation and information received upon receipt of an account opening request / Fund application (the Account Opening Profile) from each Fund or an Investor in each Fund and, subject to the agreement of the FATCA Services Provider, supplemental documentation and information provided to the FATCA Services Provider by each Fund and/or its agents, all in accordance with predefined criteria contained in the applicable FATCA Procedures. The Initial New Investor Check will occur as soon as reasonably practicable, following the FATCA Services Providers receipt of such Investors tax and account information/documentation. |
| Based upon the Initial New Investor Check, the FATCA Services Provider will record within the transfer agency platform utilized by the FATCA Services Provider in connection with transfer agency related services separately provided to the Funds (the Platform) the FATCA classification results from the Initial New Investor Check of the Investors. |
| Following the Initial New Investor Check, if requested additional documentation or information is received from each Fund or Investors within agreed timelines, the FATCA Services Provider will check (the Additional New Investor Check) the completeness of that documentation or information in accordance with the agreed FATCA Procedures and based upon its results from the Additional New Investor Check, the FATCA Services Provider will update accordingly Investor records within the Platform and record the Investor FATCA classification. |
| Based upon the Initial New Investor Check and any Additional New Investor Check, the FATCA Services Provider will provide to each Fund, a standardized summary of such FATCA classification. The standardized summary will be delivered as soon as reasonably practicable at a time agreed upon with the Funds. |
7.) | FATCA Support Services Maintenance and Ongoing Monitoring of Existing Accounts |
| Commencing on July 1, 2014, the FATCA Services Provider will update Investor records maintained by the FATCA Services Provider in its transfer agency platform (the Platform) to record Investor FATCA classification information derived from the pre-existing account review procedures described above. |
| The FATCA Services Provider will provide ongoing maintenance of the Platform by updating Investor records in accordance with any Change in Circumstance (as described in the FATCA Procedures) resulting in a modification of an existing FATCA classification of an Investor. |
| The FATCA Services Provider will check additional or changed documentation and information provided by each Fund and/or each Investor for completeness (the Initial Ongoing Account Maintenance) on a periodic basis in accordance with predefined criteria contained in the applicable FATCA Procedures. |
| Following the Initial Ongoing Account Maintenance, if requested additional or missing documentation and information is received from the Funds or Investors within agreed timelines, the FATCA Services Provider will check (the Additional Ongoing Account Maintenance) the completeness of documentation and information received in accordance with the agreed FATCA Procedures and will update Investor records within the Platform and record the Investor FATCA classification as having been updated. |
Information Classification: Limited Access
| Based upon the Initial Ongoing Account Maintenance and any Additional Ongoing Account Maintenance, the FATCA Services Provider will provide the Funds with, at a time agreed upon with the Funds, a standardized summary of the results of the ongoing account monitoring. |
8.) | FATCA Support Services Remediation |
| Commencing on July 1, 2014 (or such other applicable FATCA effective date as announced in any future government guidance), for Investors in each Fund identified by the FATCA Services Provider to require additional or updated documentation and information in order to complete the Investor FATCA classification, the FATCA Services Provider will either: (a) at the direction of a Fund, contact Investors of such Fund for additional or updated documentation and information (the Remediation) in accordance with the FATCA Procedures or (b) communicate all additional Investor documentation requirements to the relevant Fund using an agreed-upon matrix (in such case, the Fund will coordinate with Investors to procure the necessary information). |
| As part of the Remediation, the FATCA Services Provider will track any follow up request made of an Investor and/or relevant Fund, as agreed upon with the relevant Fund. |
| Upon receipt of documentation and information pursuant to the Remediation within the agreed timelines and after completion of the completeness checks of that documentation and information, the FATCA Services Provider will update Investor records within the transfer agency platform utilized by the FATCA Services Provider in connection with transfer agency related services separately provided to each Fund and record the final Investor FATCA classification. |
9.) | FATCA Support Services Reserved |
10.) | FATCA Support Services Management Reporting |
| Commencing on or about July 1, 2014 (or such other applicable FATCA effective date as announced in any future government guidance), the FATCA Services Provider will compile reports based upon the information derived from the contracted services performed by the FATCA Services Provider and stored in its transfer agency platform utilized by the FATCA Services Provider in connection with transfer agency related services separately provided to the Funds (the Management Reporting). |
| The FATCA Services Provider will provide each Fund, at a time agreed upon with the relevant Fund, with a selection of the above FATCA standardized reports as described in the FATCA Procedures. The criteria for each report will be determined based on the reporting requirements of the relevant Fund, the IRS and/or non-U.S. tax authorities reporting requirements. |
| The FATCA Services Provider represents that the following items shall be furnished and/or represented on an annual basis and upon reasonable request: |
| the FATCA Service Provider has promptly identified recalcitrant Investors. |
| all requirements for additional and/or updated Fund and Investor tax documentation has been timely made to the relevant Fund. |
Information Classification: Limited Access
| the criteria pertaining to the due diligence for the identification and documentation of account holders any Investors pursuant to the FATCA Procedures. |
| Provide support/reports that are reasonably requested by the relevant Fund, the IRS, the Funds audit firm and/or other applicable non-U.S. tax or regulatory bodies. |
| The Funds and the FATCA Services Provider may, from time to time, agree upon additional customized reports. |
11.) | FATCA Support Services Annual Reporting |
| For each Fund the FATCA Services Provider will compile FATCA reports and any additional reporting required in the Funds domicile in connection with the FATCA-like intergovernmental agreements signed in 2013 between the United Kingdom and its Crown Dependencies and Overseas Territories and applicable guidance (UK CDOT), in each case as is required by the IRS or other tax authorities (the Annual Reporting) based upon the information derived from the contracted services performed by the FATCA Services Provider and stored in its transfer agency platform. |
| The FATCA Services Provider will provide the Fund, or on the Funds behalf will provide to affected Investors in the Fund (subject to the Funds approval), information related to the investor specific reporting to be provided by the Fund to relevant tax authorities as part of the Annual Reporting. |
| The FATCA Services Provider will provide the Fund with the Annual Reporting at a time or times and in a format as described in the agreed FATCA Procedures. |
| The FATCA Services Provider will prepare Form 1042s and/or any other applicable FATCA-related tax forms, as agreed to between the Funds and the FATCA Services Provider from time to time. |
Information Classification: Limited Access
Exhibit (h)(2)
GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC
Form of Notification of Undertaking to Reimburse
Selected Fund Expenses and Waive Selected Fees
NOTIFICATION made as of June 30, 2015 by GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC, a Massachusetts limited liability company (the Advisor), to GMO TRUST, a Massachusetts business trust (the Trust).
WHEREAS, the Advisor has historically paid for some of the operating expenses of the series of the Trust (the Funds); and
WHEREAS, the Advisor has historically waived some or all of the management and shareholder service fees charged by Funds that invest in other Funds in order to prevent the double payment of such fees; and
WHEREAS, the Advisor wishes to simplify those expense reimbursement undertakings and combine them into one document.
NOW, THEREFORE, the Advisor hereby notifies the Trust that, provided that the fee rates set forth in (i) the Management Contracts between each Fund and the Advisor and (ii) the Amended and Restated Servicing and Supplemental Support Agreement between the Trust and the Advisor remain unchanged, the Advisor shall, as set forth below, pay a portion of the expenses of the Funds through June 30, 2016 (and any subsequent periods as may be designated by the Advisor by notice to the Trust).
Operating Expense Reimbursement
For all Funds listed on Exhibit A
The Advisor will reimburse each Fund listed on Exhibit A for its Specified Operating Expenses (as defined below).
For GMO Benchmark-Free Bond Fund, GMO Emerging Countries Fund, GMO Global Bond Fund, GMO Resources Fund and GMO Special Opportunities Fund
The Advisor will reimburse each Fund for the portion of its Specified Operating Expenses (as defined below) that exceed the percentage of the Funds average daily net assets (the Operating Expense Limitation) set forth in the table below.
Fund |
Operating
Expense Limitation |
|
GMO Benchmark-Free Bond Fund | 0.05% | |
GMO Emerging Countries Fund | 0.35% | |
GMO Global Bond Fund | 0.06% | |
GMO Resources Fund | 0.10% | |
GMO Special Opportunities Fund | 0.10% |
Specified Operating Expenses
As used in this Notification, subject to the exceptions noted below, Specified Operating Expenses means: audit expenses, fund accounting expenses, pricing service expenses, expenses of non-investment related tax services, transfer agency expenses, expenses of non-investment related legal services provided to the Funds by or at the direction of the Advisor, federal securities law filing expenses, printing expenses, state and federal registration fees and custody expenses. In the case of GMO Emerging Markets Fund, Specified Operating Expenses does not include custody expenses; in the case of GMO Emerging Domestic Opportunities Fund, Specified Operating Expenses only includes custody expenses to the extent that they exceed 0.10% of the Funds average daily net assets; and in the case of GMO GAAR Implementation Fund, Specific Operating Expenses only includes custody expenses to the extent that they are non-emerging market custody expenses.
Management Fee Waiver
For each Fund (other than GMO Benchmark-Free Allocation Fund 1 ) that pays the Advisor a management fee, the Advisor will waive or reduce the Funds management fee, but not below zero, to the extent necessary to offset the management fees paid to the Manager that are directly or indirectly borne by the Fund as a result of the Funds direct or indirect investments in other GMO Funds.
Shareholder Service Fee Waiver
For each Fund (other than GMO Benchmark-Free Allocation Fund 2 ) that charges a shareholder service fee, the Advisor will waive or reduce the shareholder service fee charged to holders of each class of shares of the Fund, but not below zero, to the extent necessary to offset the shareholder service fees directly or indirectly borne by the class of shares of the Fund as a result of the Funds direct or indirect investments in other GMO Funds.
1 | GMO Benchmark-Free Allocation Funds management contract contains a contractual management fee reduction. |
2 | The Trusts Amended and Restated Servicing and Supplemental Support Agreement contains a contractual shareholder service fee reduction for GMO Benchmark-Free Allocation Fund. |
-2-
In addition, the Advisor will waive the shareholder service fees charged to holders of each class of shares of GMO Emerging Markets Fund listed below, but not below zero, to the extent necessary to prevent the shareholder service fees borne by each class from exceeding the specified percentage of the classs average daily net assets (the Shareholder Service Fee Expense Limitation) set forth below.
Class |
Shareholder
Service Fee Expense Limitation |
|
II |
0.20% | |
III |
0.15% | |
IV |
0.10% | |
V |
0.05% | |
VI |
0.02% |
Miscellaneous
In providing this Notification, the Advisor understands and acknowledges that the Trust intends to rely on this Notification, including in connection with the preparation and printing of the Trusts prospectuses and its daily calculation of each Funds or classs net asset value.
Please be advised that all previous notifications by the Advisor with respect to fee waivers and/or expense limitations regarding any of the Funds shall hereafter be null and void and of no further force and effect.
IN WITNESS WHEREOF, the Advisor has executed this Notification on the day and year first above written.
GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC | ||
By: |
|
|
Name: J.B. Kittredge | ||
Title: General Counsel |
-3-
Exhibit A |
U.S. Equity Allocation Fund |
Quality Fund |
Systematic Global Macro Opportunity Fund |
International Large/Mid Cap Equity Fund |
International Equity Fund |
Foreign Fund |
Foreign Small Companies Fund |
International Small Companies Fund |
Emerging Markets Fund |
Tax-Managed International Equities Fund |
Developed World Stock Fund |
Core Plus Bond Fund |
International Bond Fund |
Currency Hedged International Bond Fund |
Alpha Only Fund |
U.S. Treasury Fund |
Asset Allocation Bond Fund |
Benchmark-Free Allocation Fund |
International Equity Allocation Fund |
Global Asset Allocation Fund |
Global Equity Allocation Fund |
Debt Opportunities Fund |
World Opportunity Overlay Fund |
Strategic Opportunities Allocation Fund |
Global Developed Equity Allocation Fund |
International Developed Equity Allocation Fund |
High Quality Short-Duration Bond Fund |
-4-
Exhibit A |
Emerging Domestic Opportunities Fund |
Benchmark-Free Fund |
Global Focused Equity Fund |
Implementation Fund |
Risk Premium Fund |
GAAR Implementation Fund |
-5-
Exhibit (h)(3)(i)
GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC
Form of Notification of Undertaking to Reduce
Supplemental Support Fees
NOTIFICATION made as of June 30, 2015, by GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC, a Massachusetts limited liability company (the Advisor), to GMO TRUST, a Massachusetts business trust (the Trust).
WHEREAS, the Advisor has historically paid for some of the operating expenses of the series of the Trust (the Funds); and
WHEREAS, the Advisor has undertaken in the Amended and Restated Servicing and Supplemental Support Agreement between the Trust and the Advisor (the Servicing and Supplemental Support Agreement) to reduce or waive the Class MF Supplemental Support Fees charged to GMO Benchmark-Free Allocation Fund (BFAF) by an amount equal to any Service Fees indirectly borne by Class MF Shares and paid to GMO as a result of BFAFs investment in other GMO funds (the Existing Waiver).
WHEREAS, the Advisor wishes to further reduce the Class MF Supplemental Support Fees charged to BFAF.
NOW, THEREFORE, the Advisor hereby notifies the Trust that, provided that the fee rates set forth in (i) the Management Contracts between each Fund and the Advisor and (ii) the Servicing and Supplemental Support Agreement remain unchanged, the Advisor shall, as set forth below, reduce the Supplemental Support Fees charged to Class MF shares of BFAF through June 30, 2016 (and any subsequent periods as may be designated by the Advisor by notice to the Trust).
Supplemental Support Fee Reduction
The Advisor will reduce the Supplemental Support Fees charged to Class MF Shares of BFAF to the Reduced Supplemental Support Fee Rate (calculated as described below), provided that the effective Reduced Supplemental Support Fee Rate charged at any time will not be reduced to less than 0.06% (as a percentage of Class MFs average daily net assets).
The effective Reduced Supplemental Support Fee to be charged in any month (starting on the first business day of that month) shall be calculated based on Class MF net assets as of the last business day of the preceding month based on the following schedule:
Class MF Net Assets as of each Month-End |
Reduced Supplemental
Support Fee Rate |
|
On the first $6 billion | 0.10% | |
On the next $2 billion | 0.05% | |
On the next $2 billion | 0.03% | |
Thereafter | 0.01% |
For sake of clarity, the Reduced Supplemental Support Fee Rates and the 0.06% minimum effective Reduced Supplemental Support Fee described above shall be calculated before giving effect to any reduction or waiver mandated by the Existing Waiver, and any applicable Existing Waiver shall serve to further reduce the Supplemental Support Fees paid to GMO.
Miscellaneous
In providing this Notification, the Advisor understands and acknowledges that the Trust intends to rely on this Notification, including in connection with the preparation and printing of the Trusts prospectuses, preparation of financial statements, and its daily calculation of BFAFs Class MF net asset value.
IN WITNESS WHEREOF, the Advisor has executed this Notification on the day and year first above written.
GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC
By: |
|
|
Name: J.B. Kittredge | ||
Title: General Counsel | ||
Reviewed by: |
Exhibit (j)
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form N-1A of our reports dated April 24, 2015, relating to the financial statements and financial highlights of GMO World Opportunity Overlay Fund and GMO Systematic Global Macro Opportunity Fund, which appear in the February 28, 2015 Annual Reports to Shareholders and which are also incorporated by reference into the Registration Statement. We also consent to the references to us under the headings Financial Highlights, Financial Statements, Investment Advisory and Other ServicesIndependent Registered Public Accounting Firm and Disclosure of Portfolio HoldingsOngoing Arrangements to Make Portfolio Holdings Available in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
June 25, 2015
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the references to us in this Registration Statement on Form N-1A of GMO GAAR Implementation Fund and GMO High Quality Short-Duration Bond Fund, under the headings Investment Advisory and Other ServicesIndependent Registered Public Accounting Firm and Disclosure of Portfolio HoldingsOngoing Arrangements to Make Portfolio Holdings Available in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
June 25, 2015